<SEC-DOCUMENT>0001193125-21-117232.txt : 20210415
<SEC-HEADER>0001193125-21-117232.hdr.sgml : 20210415
<ACCEPTANCE-DATETIME>20210415090555
ACCESSION NUMBER:		0001193125-21-117232
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		24
CONFORMED PERIOD OF REPORT:	20210526
FILED AS OF DATE:		20210415
DATE AS OF CHANGE:		20210415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		21827454

	BUSINESS ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d63026ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #3f3f3f">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>UNITED STATES
</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f;width:27%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT
 COLOR="#3f3f3f"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Securities Exchange Act of 1934
(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;) </B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f;width:27%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#3f3f3f">&#9746;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#3f3f3f">&#9744;</FONT> </FONT></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Check the appropriate box: </FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Preliminary Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9746;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Definitive Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Definitive Additional Materials</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT></FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g87b92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>EXELIXIS, INC. </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>(Exact name of registrant as specified in its charter) </B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>(Name of Person(s) Filing Proxy Statement, if other than
the Registrant) </B></FONT></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Payment of Filing Fee (Check the appropriate box): </FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9746;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT COLOR="#3f3f3f">No fee required.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT COLOR="#3f3f3f">Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(1)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Title of each class of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(2)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Aggregate number of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(3)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
<FONT STYLE="white-space:nowrap">0-11</FONT> (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Proposed maximum aggregate value of transaction:</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(5)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Total fee paid:</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT COLOR="#3f3f3f">Fee paid previously with preliminary materials.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"><FONT STYLE="font-family:Times New Roman; " COLOR="#3f3f3f">&#9744;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT COLOR="#3f3f3f">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(1)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Amount Previously Paid:</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(2)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Form, Schedule or Registration Statement No.:</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(3)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Filing Party:</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt" COLOR="#3f3f3f">(4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Date Filed:</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #3f3f3f; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #3f3f3f">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #3f3f3f">&nbsp;</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g63026g87b92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">DEAR FELLOW STOCKHOLDERS, </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">While we could never have envisioned the magnitude and impact of the COVID-19 pandemic, Exelixis responded well to the challenges presented and
never lost focus of its critical mission to help cancer patients recover stronger and live longer. We, and the rest of the Board, are incredibly proud of the entire Exelixis team&#146;s ability throughout 2020 to advance the company&#146;s business,
while always putting the highest priority on protecting one another&#146;s health and safety and ensuring an uninterrupted supply of Exelixis medicines for the patients that depend upon them. Exelixis&#146; actions reflect its core values to <I>Be
Exceptional, Excel for Patients </I>and<I> Exceed Together.</I> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The success and growth Exelixis achieved in 2020 would be noteworthy
in any year, but is even more striking in the context of the pandemic. In particular, we: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Achieved positive top-line results from two pivotal clinical trials, including data that supported
U.S. Food and Drug Administration and European Commission approvals of our franchise molecule CABOMETYX<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (cabozantinib) in combination with
OPDIVO<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (nivolumab) as a first-line treatment for patients with advanced renal cell carcinoma in early 2021; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Advanced enrollment in multiple potentially label-enabling trials and initiated three new pivotal
studies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Presented seven data sets from clinical trials evaluating CABOMETYX<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> in a variety of settings and tumor types; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Progressed our product pipeline by expanding the ongoing phase 1b trial of XL092, in-licensing and
readying XL102 and XB002 for clinical development, and advancing our internal programs; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:9pt"><FONT COLOR="#3f3f3f">Expanded our workforce by 25% with the skill and experience required to support our future growth
plans, and laid the groundwork necessary to scale sustainably and efficiently, including through the continued expansion of our Alameda headquarters. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our achievements during the year were supported by a strong foundation of sound governance practices, including the continued evolution of our
governance profile to reflect the scale and opportunity of our business. Launched shortly before the onset of the pandemic, the newly established Risk Committee of the Board served as an additional avenue through which management was able to
communicate to the Board on the impact of and responses to the COVID-19 pandemic. In addition, the existing Research &amp; Development and Compensation Committees provided important oversight and support for the drug discovery and development
activities integral to our progress, and also worked with management to support the company&#146;s efforts to recruit, retain, and cultivate the unified workforce that accomplished so much during the year. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Critical to our success in 2020 was the dedication of our employees and our collective ability to maintain the Exelixis culture of resilience,
despite a primarily remote work environment. As a socially responsible company conscious of the expanding racial injustice movement, it was also critical for us to focus on our human capital management strategy and equity, diversity and inclusion
initiatives. While there is always work to do, we are proud of our progress and are committed to fostering a culture where every employee feels a sense of belonging to the Exelixis team and our mission. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Exelixis&#146; accomplishments last year not only create the potential for additional eligible cancer patient communities to benefit from
CABOMETYX and the investigational products in our growing pipeline, but we believe they also position us very well to deliver long-term revenue and earnings growth and continue to create value for our stockholders. We remain committed to delivering
results for all of our stakeholders, and we thank you for your continued support. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We hope you will join us for the Exelixis 2021
Annual Meeting of Stockholders, which will be held in a virtual format on May&nbsp;26, 2021, beginning at 9:00 a.m. Pacific Time. Due to the ongoing public health impact of the COVID-19 pandemic and to support the health and well-being of our
stockholders and employees, we determined it would be appropriate to maintain the virtual format we used for last year&#146;s meeting. You will be able to view the meeting, submit questions and vote online
at&nbsp;<I>www.virtualshareholdermeeting.com/EXEL2021</I>. The following notice of our Annual Meeting contains details of the business to be conducted at the Annual Meeting, as well as information regarding how and when to vote. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Very truly yours, </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g63026g77n77.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;


<IMG SRC="g63026g74j57.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos, PhD</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Chair of the Board</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Charles Cohen, PhD</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Chair of the Compensation Committee</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Calibri"></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g63026g87b92.jpg" ALT="LOGO">
</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1851 Harbor Bay Parkway </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Alameda, CA 94502 </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri"><FONT
 COLOR="#6d6d6d">N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri"><FONT COLOR="#6d6d6d"><SMALL>OF</SMALL>
S<SMALL>TOCKHOLDERS</SMALL> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02">T<SMALL>O</SMALL> B<SMALL>E</SMALL> H<SMALL>ELD</SMALL> <SMALL>ON</SMALL> M<SMALL>AY</SMALL>&nbsp;26,
2021 </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To the Stockholders of Exelixis, Inc.: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>NOTICE IS HEREBY GIVEN</B> that the 2021 Annual Meeting of Stockholders (Annual Meeting) of Exelixis, Inc., a Delaware corporation (Exelixis),
will be held on Wednesday, May&nbsp;26, 2021, at 9:00 a.m., Pacific Time. The Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the virtual Annual Meeting, view
our list of stockholders as of the record date, submit your questions and vote your shares online during the meeting by visiting <I>www.virtualshareholdermeeting.com/EXEL2021</I> and using your <FONT STYLE="white-space:nowrap">16-digit</FONT>
control number to enter the Annual Meeting. In addition, you may submit your questions and vote your shares online in advance of the Annual Meeting by visiting <I>www.proxyvote.com</I> and using your <FONT STYLE="white-space:nowrap">16-digit</FONT>
control number. The Annual Meeting will be held for the following purposes: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To elect the eleven nominees for director named in the Proxy Statement accompanying this Notice of
Annual Meeting to hold office until the next annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her death, resignation or removal. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To ratify the selection by the Audit Committee of the Board of Directors of Ernst&nbsp;&amp; Young
LLP as Exelixis&#146; independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To approve, on an advisory basis, the compensation of Exelixis&#146; named executive officers, as
disclosed in the Proxy Statement accompanying this Notice of Annual Meeting. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#fc7841">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To conduct any other business properly brought before the meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">These items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">You will only be able to attend the virtual Annual Meeting by using your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided
on your Notice of Internet Availability of Proxy Materials (Notice of Availability), your proxy card<B> </B>or your voting instruction form in order to gain access to the virtual Annual Meeting. Therefore, it is important to retain your Notice of
Internet Availability of Proxy Materials or a copy of your proxy card or voting instruction form to enable you to gain access to the virtual Annual Meeting. If you are a beneficial owner of shares held in &#147;street name&#148; who did not receive
a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or on your Notice of Availabilty or voting instruction form, and you wish to attend the Annual Meeting, please follow the specific instructions from your broker, bank or
other stockholder of record, including any requirement to obtan a valid legal proxy. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are mailing to most of our stockholders a
Notice of Availability instead of a paper copy of our Proxy Statement and our Annual Report for the fiscal year ended January&nbsp;1, 2021 (Annual Report). The Notice of Availability contains instructions on how to access those documents over the
Internet. The Notice of Availability also contains instructions on how to request a paper copy of our proxy materials, including this Proxy Statement, our Annual Report and a form of proxy card or voting instruction form. All stockholders who do not
receive a Notice of Availability will receive a paper copy of the proxy materials by mail. We believe that this process will allow us to provide our stockholders with the information they need in a more timely manner, while reducing the
environmental impact and lowering the costs of printing and distributing our proxy materials. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The record date for the Annual Meeting
is March&nbsp;29, 2021. Only stockholders of record at the close of business on that date may vote at the meeting or any postponement or adjournment thereof. </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #fc4c02; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.56em; margin-right:0.56em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Important
notice regarding the availability of proxy materials for the 2021 Annual Meeting of Stockholders to be held on May&nbsp;26, 2021, at 9:00 a.m., Pacific Time, via live webcast at </B><B><I>www.virtualshareholdermeeting.com/EXEL2021</I></B><B>. You
will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Internet Availability of Proxy Materials, your proxy card or your voting instruction form in order to gain access to the virtual Annual
Meeting.</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.56em; margin-right:0.56em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>The
Proxy Statement and Annual Report to stockholders are available at </B><B><I>www.exel-annualstockholdermeeting.com</I></B><B>.</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.56em; margin-right:0.56em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>The Board of Directors recommends that you vote &#147;FOR&#148; Proposal Nos. <FONT
STYLE="white-space:nowrap">1-3</FONT> identified above.</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">By Order of the Board of Directors </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g63026g99m98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">JEFFREY J. HESSEKIEL </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Executive Vice President and General Counsel </FONT></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Alameda, California </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">April&nbsp;15, 2021 </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>YOUR VOTE IS IMPORTANT </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">WHETHER OR NOT YOU PLAN TO ATTEND THE VIRTUAL ANNUAL MEETING, TO ENSURE THAT YOU ARE REPRESENTED AT THE MEETING AND TO ENSURE THAT A QUORUM IS
PRESENT, WE URGE YOU TO VOTE YOUR PROXY ONLINE, BY TELEPHONE OR BY RETURNING A PROXY CARD BY MAIL AS INSTRUCTED IN THE PROXY MATERIALS. EVEN IF YOU HAVE VOTED BY PROXY, YOU MAY STILL VOTE IF YOU ATTEND THE VIRTUAL ANNUAL MEETING. PLEASE NOTE,
HOWEVER, THAT IF YOU HOLD YOUR SHARES THROUGH A BROKER, BANK OR OTHER NOMINEE, THEN THAT ENTITY IS THE STOCKHOLDER OF RECORD, AND YOU WILL NEED TO FOLLOW THE INSTRUCTIONS ON THE VOTING INSTRUCTION FORM THEY SEND TO YOU, AND THEY WILL VOTE YOUR
SHARES AS YOU DIRECT. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1851 Harbor Bay Parkway </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Alameda, CA 94502 </FONT></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:22pt; font-family:Calibri"><FONT
 COLOR="#6d6d6d">P<SMALL>ROXY</SMALL> S<SMALL>TATEMENT</SMALL> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:21pt; font-family:Calibri"><FONT COLOR="#fc4c02">F<SMALL>OR</SMALL> <SMALL>THE</SMALL> 2021 A<SMALL>NNUAL</SMALL>
M<SMALL>EETING</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDERS</SMALL> </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02">May&nbsp;26, 2021 </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Proposals to be voted on at the 2021 Annual Meeting of Stockholders </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-TOP:1px solid #fc4c02" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:1px solid #fc4c02" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">1.</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To elect the eleven nominees for director named in the Proxy Statement accompanying this Notice of Annual Meeting to hold office
until the next annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her death, resignation or removal.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To ratify the selection by the Audit Committee of the Board of Directors of Ernst&nbsp;&amp; Young LLP as Exelixis&#146; independent registered public
accounting firm for the fiscal year ending December&nbsp;31, 2021.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">3.</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To approve, on an advisory basis, the compensation of Exelixis&#146; named executive officers, as disclosed in the Proxy Statement
accompanying this Notice of Annual Meeting.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc7841">4.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">To conduct any other business properly brought before the meeting.</FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Table of Contents </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc"></A>TABLE OF CONTENTS </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_1">Questions and Answers about these Proxy Materials and Voting</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>1</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_2">Proposal 1: Election of Directors</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>8</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_3">Corporate Governance</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_4">Board Committees and Meetings</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_5">Annual Meeting; Attendance</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_6">Compensation of Directors</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>27</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_7">Director Compensation Table</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_8">Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>31</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_9">Report of the Audit Committee</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>33</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_10">Proposal 3: Advisory Vote on the Compensation of the Named Executive Officers</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>34</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_11">Required Vote and Board of Directors
Recommendation</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_12">Security Ownership of Certain Beneficial Owners and Management</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>35</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_13">Information about our Executive Officers</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>38</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_14">Compensation of Executive Officers</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>40</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_15">Compensation Discussion and Analysis</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_16">Executive Summary</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_17">Objectives of the Compensation Program</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_18">How We Determine Executive Compensation</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_19">Compensation Elements</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_20">Compensation Mix</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_21">2020 Compensation Decisions</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_22">Other Compensation Information</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_23">Compensation Policies and Practices as They Relate to Risk Management
</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_24">Summary of Compensation</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_25">Grants of Plan-Based Awards</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_26">Compensation Arrangements</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_27">Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End</FONT></A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_28">Option Exercises and Stock Vested</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">74</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_29">Potential Payments Upon Termination or Change in
Control</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A HREF="#toc63026_30">CEO Pay Ratio</A></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_31">Compensation Committee Report</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_32">Compensation Committee Interlocks and Insider Participation</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_33">Delinquent Section&nbsp;16(a) Reports</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_34">Certain Relationships and Related Party Transactions</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_35">Householding of Proxy Materials</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>81</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_36">Annual Report of Form <FONT STYLE="white-space:nowrap">10-K</FONT></A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>81</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B><A HREF="#toc63026_37">Other Matters</A></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>81</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">i</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_1"></A><A NAME="toc63026_1"></A><A NAME="tx63026_a10"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING
</FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why am I receiving these materials? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have made these materials available to you on the Internet or, upon your request, have delivered printed versions of these materials to you by
mail because the Board of Directors (the Board), of Exelixis, Inc. (sometimes referred to as &#147;we,&#148; &#147;us,&#148; the &#147;company&#148; or &#147;Exelixis&#148;) is soliciting your proxy to vote at the 2021 Annual Meeting of Stockholders
(Annual Meeting), including at any adjournments or postponements of the meeting. The virtual Annual Meeting will be held on Wednesday, May&nbsp;26, 2021, at 9:00 a.m., Pacific Time, via live webcast at
<I>www.virtualshareholdermeeting.com/EXEL2021</I>. We invite you to attend the virtual Annual Meeting to vote on the proposals described in this Proxy Statement, and you will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number
provided on your Notice of Internet Availability of Proxy Materials (described below), your proxy card or your voting instruction form in order to gain access to the virtual Annual Meeting. Therefore, it is important to retain your Notice of
Internet Availability of Proxy Materials or a copy of your proxy card or voting instruction form to enable you to gain access to the virtual Annual Meeting. However, you do not need to attend the virtual Annual Meeting to vote your shares. Instead,
you may simply complete, sign and return a proxy card, or follow the instructions below to vote your shares over the telephone or on the Internet. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">We intend to send or make available these materials to stockholders on April&nbsp;15, 2021. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why is the Annual
Meeting being held as a virtual Annual Meeting? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Due to concerns regarding the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic and to assist in protecting the health and well-being of our stockholders and employees, the Annual Meeting will be held virtually via live webcast on the Internet. After utilizing a virtual format for our 2020 Annual Meeting of
Stockholders, we have designed a similar virtual format for the Annual Meeting to ensure that our stockholders who attend virtually will be afforded the same rights and opportunities to participate as they would at an
<FONT STYLE="white-space:nowrap">in-person</FONT> meeting. Accordingly, as stockholders from any location at the world and at no cost, you will be able to listen, submit your questions and vote your shares online at
<I>www.virtualshareholdermeeting.com/EXEL2021</I> by using your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Internet Availability of Proxy Materials, your proxy card or your voting instruction form that
accompanied your proxy materials. In addition, you may submit your questions and vote your shares online in advance of the meeting by visiting <I>www.proxyvote.com</I> and using your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The live webcast will begin promptly at 9:00 a.m., Pacific Time. We encourage you to access the meeting prior to the start time, as
you should allow ample time for the <FONT STYLE="white-space:nowrap">check-in</FONT> procedures. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What is included in these proxy
materials? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">These proxy materials include: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The Notice of Annual Meeting; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The Proxy Statement for the Annual Meeting; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
January&nbsp;1, 2021, as submitted to the Securities and Exchange Commission (SEC) on February&nbsp;10, 2021 (Annual Report). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">If you requested printed versions by mail, these proxy materials also include the proxy card or voting instruction form for the virtual Annual Meeting. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Why did I receive a notice in the mail regarding Internet availability of proxy materials instead of a full set of printed proxy materials?
</B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Pursuant to rules adopted by the SEC, we have elected to use the Internet as the primary means of furnishing proxy materials to
our stockholders this year. This method allows us to deliver the proxy materials to you more quickly, lowers our costs significantly and helps to conserve natural resources. Accordingly, we are sending a Notice of Internet Availability of Proxy
Materials (Notice of Availability) to our stockholders who have not asked us to provide proxy materials in printed form. All stockholders receiving a Notice of Availability can request a printed set of proxy materials. Moreover, all stockholders can
access the proxy materials at <I>www.exel-annualstockholdermeeting.com</I>, irrespective of whether they receive a Notice of Availability or a printed copy of the proxy materials. Instructions on how to access the proxy materials on the Internet or
how to request a printed copy may be found in the Notice of Availability and in this Proxy Statement. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">1</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In addition, a
stockholder may ask to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. We encourage stockholders to take advantage of the option to receive proxy materials electronically by email to help reduce the
environmental impact of our annual meeting and to reduce costs associated with the physical printing and mailing of materials. If you choose to receive future proxy materials by email, you will receive an email message next year with instructions
containing a link to those materials and a link to the proxy voting website. Your election to receive proxy materials by email will remain in effect until you terminate it. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How can I access the list of stockholders of record? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The list of stockholders of record entitled to vote at the virtual Annual Meeting will be available for 10 days prior to the Annual Meeting for
any purpose germane to the Annual Meeting, between the hours of 9:00 a.m. and 5:00 p.m., Pacific Time, at our principal executive offices located at 1851 Harbor Bay Parkway, Alameda, California 94502 by contacting our Corporate Secretary. Due to the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, registered stockholders must make an appointment and must comply with our <FONT STYLE="white-space:nowrap">COVID-19</FONT> protocols. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The list of stockholders of record will also be available at and through the conclusion of the Annual Meeting via the virtual meeting website at
<I>www.virtualshareholdermeeting.com/EXEL2021</I>. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Who may vote at the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Only stockholders of record at the close of business on March&nbsp;29, 2021 (the Record Date) will be entitled to vote at the virtual Annual
Meeting. On the Record Date, there were 313,097,850 shares of common stock outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder of Record:
Shares Registered in Your Name </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If on March&nbsp;29, 2021, your shares were registered directly in your name with our transfer agent,
Computershare Trust Company, N.A., then you are a stockholder of record. As a stockholder of record, you may vote at the virtual Annual Meeting or vote by proxy. Whether or not you plan to attend the virtual Annual Meeting, we urge you to vote by
proxy over the telephone or on the Internet as instructed below, or complete and mail the proxy card if you received printed materials. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#fc4c02">Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Stockholder of Record (<I>i.e.</I>, &#147;Street Name&#148;) </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">If on March&nbsp;29, 2021, your shares were held in an account at a brokerage firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in &#147;street name,&#148; and these proxy materials
are being forwarded to you by that organization. The organization holding your shares is considered to be the stockholder of record for purposes of voting at the virtual Annual Meeting. As a beneficial owner, you have the right to direct your
broker, bank or other stockholder of record regarding how to vote the shares in your account, and we invite you to attend the virtual Annual Meeting. Many stockholders of record will provide you with a
<FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or in your Notice of Availability or voting instruction form in order to attend and vote your shares at the virtual Annual Meeting. If you did not receive a <FONT
STYLE="white-space:nowrap">16-digit</FONT> control number via email or on your Notice of Availabilty or voting instruction form, you will be provided with other instructions from your broker, bank or other stockholder of record that must be
followed, including any requirement to obtan a valid legal proxy, in order for your broker, bank or other stockholder of record to vote your shares per your instructions or to attend and vote your shares at the Annual Meeting. Many brokers, banks or
other stockholders of record allow a stockholder to obtain a valid legal proxy either online or by mail, and we recommend that you contact your broker, bank or other stockholder of record to do so. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What am I voting on? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">There are three matters scheduled for a vote at the virtual Annual Meeting. They are as follows: </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Election of the eleven nominees for director named herein to hold office until the next annual
meeting of stockholders and until his or her successor is duly elected and qualified or until his or her death, resignation or removal; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Ratification of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm
for the fiscal year ending December&nbsp;31, 2021; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Advisory approval of the compensation of our named executive officers, as disclosed in this Proxy
Statement. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">2</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How do I vote? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Whether or not you plan to attend the virtual Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend
the virtual Annual Meeting and vote even if you have already voted by proxy. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder of Record: Shares Registered in Your Name
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a stockholder of record, you have four ways to vote. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g63026g59s99.jpg" ALT="LOGO">
<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>At&nbsp;Virtual&nbsp;Meeting</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">To vote at the virtual Annual Meeting, follow the instructions at<I> www.virtualshareholdermeeting.com/EXEL2021</I>. You will need your
<FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Availability, your proxy card or your voting instruction form in order to gain access to the virtual Annual Meeting.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-bottom:0pt; margin-top:0pt" ALIGN="center">


<IMG SRC="g63026g01w73.jpg" ALT="LOGO">
</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Via&nbsp;Internet</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To vote on the Internet, go to <I>www.proxyvote.com</I> and follow the instructions provided in the Notice of Availability. You
will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your Notice of Availability, your proxy card or your voting instruction form in order to vote your shares in advance of the meeting. Your vote must be
received by 11:59 p.m., Eastern Time, on May&nbsp;25, 2021, to be counted.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g63026g28x28.jpg" ALT="LOGO">
<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>By&nbsp;Telephone</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">To vote by telephone, follow the instructions and call the number provided in the proxy materials to transmit your voting instructions. Your vote must be received by
11:59 p.m. Eastern Time, on May&nbsp;25, 2021, to be counted.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g63026g90v60.jpg" ALT="LOGO">
<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>By Mail</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">To vote by mail, follow the instructions provided in the proxy materials, request a paper copy of the proxy materials and then complete, sign and date the proxy card
enclosed with the paper copy of the proxy materials and return it promptly in the envelope that will be provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841">Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Stockholder of Record </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a beneficial owner of shares registered in the name of your broker, bank, or other stockholder of record, you should have received the
Notice of Availability containing voting instructions from that organization rather than from us. You must follow these instructions for your bank, broker or other stockholder of record to vote your shares per your instructions. Alternatively, many
brokers and banks provide the means to grant proxies or otherwise instruct them to vote your shares by telephone and via the Internet, including by providing you with a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or on
your Notice of Availability or your voting instruction form. If your shares are held in an account with a broker, bank or other stockholder of record providing such a service, you may instruct them to vote your shares by telephone (by calling the
number provided in the proxy materials) or over the Internet as instructed by your broker, bank or other stockholder of record. If you did not receive a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number via email or on your Notice of
Availability or voting instruction form, and you wish to vote prior to or at the virtual Annual Meeting, you must follow the instructions from your broker, bank or other stockholder of record, including any requirement to obtain a valid legal
proxy.. Many brokers, banks and other stockholders of record allow a beneficial owner to obtain a valid legal proxy either online or by mail, and we recommend that you contact your broker, bank or other stockholder of record to do so. </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #fc4c02; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>We provide Internet proxy voting
to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage
charges from Internet access providers and telephone companies.</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How many votes do I have? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">On each matter to be voted upon, you have one vote for each share of common stock you own as of the Record Date, March&nbsp;29, 2021. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How are proxies voted? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All shares represented by valid proxies received prior to the taking of the vote at the Annual Meeting will be voted and, where a stockholder
specifies by means of a proxy a choice with respect to any matter to be acted upon, the shares will be voted in accordance with the stockholder&#146;s instructions. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">3</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>If I am a
stockholder of record, what happens if I return a proxy card but do not make specific choices? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a stockholder of record
and you return a signed and dated proxy card without marking any voting selections, your shares will be voted on the proposals as follows: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;For&#148; the election of Drs. Cohen, Freire, Garber, Marchesi, Morrissey, Papadopoulos,
Poste and Willsey, Messrs. Feldbaum and Wyszomierski and Ms.&nbsp;Smith, as described in Proposal 1; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;For&#148; the ratification of our selection of Ernst&nbsp;&amp; Young LLP as our
independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2021, as described in Proposal 2; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;For&#148; the advisory approval of the compensation of our named executive officers, as
described in Proposal 3. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If any other matter is properly presented at the Annual Meeting, your proxyholder (one of
the individuals named on your proxy card), if permitted, will vote your shares using his best judgment. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a1"></A>If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting
instructions, what happens? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a beneficial owner of shares registered in the name of your broker, bank or other
stockholder of record and you do not provide the broker, bank or other stockholder of record holding your shares with voting instructions, your broker, bank or other stockholder of record will determine if it has the discretionary authority to vote
on the particular matter. If you are a beneficial owner whose shares are held of record by a broker and you do not provide voting instructions, your shares will not be voted on any proposal on which the broker does not have discretionary authority
to vote. This is called a &#147;broker <FONT STYLE="white-space:nowrap">non-vote.&#148;</FONT> In these cases, the broker can register your shares as being present at the Annual Meeting for purposes of determining the presence of a quorum, but will
not be able to vote on those matters for which specific authorization is required under the rules of the New York Stock Exchange. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If
you are a beneficial owner whose shares are held of record by a broker, your broker has discretionary voting authority under the rules of the New York Stock Exchange to vote your shares on Proposal No.&nbsp;2 (the ratification of the appointment of
Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2021), even if your broker does not receive voting instructions from you. However, your broker does not have discretionary
authority to vote on Proposal No.&nbsp;1 or Proposal No.&nbsp;3 without voting instructions from you, in which case a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will occur, and your shares will not be voted on Proposal No.&nbsp;1 or
Proposal No.&nbsp;3. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Who is paying for this proxy solicitation? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are soliciting proxies and will bear the entire cost of soliciting proxies, including the preparation, printing and mailing of the Notice of
Availability, the Notice of Annual Meeting, the Proxy Statement, the proxy card and any additional information furnished to stockholders. We have engaged Morrow&nbsp;Sodali LLC, located at 470 West Ave, Stamford, Connecticut&nbsp;06902, to assist in
the solicitation of proxies from shareholders for a fee of $13,000 plus reimbursement of customary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses. Copies of solicitation materials will be
furnished to banks, brokerage houses, fiduciaries and custodians holding in their names shares of our common stock beneficially owned by others to forward to such beneficial owners. We may reimburse persons representing beneficial owners of our
common stock for their costs of forwarding solicitation materials to such beneficial owners. Original solicitation of proxies by mail may be supplemented by telephone, telegram or personal solicitation by our directors, officers or other regular
employees. No additional compensation will be paid to directors, officers or other regular employees for such services. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What does
it mean if I receive more than one Notice of Availability or proxy card? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you receive more than one Notice of Availability or
proxy card, your shares are registered in more than one name or are registered in different accounts. Please follow the instructions on each Notice of Availability or proxy card to ensure that all of your shares are voted. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">4</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Can I change my vote after submitting my proxy? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. You may revoke your proxy in the following ways:
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841">Stockholder of Record: Shares Registered in Your Name </FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Your proxy may be revoked by filing with the Secretary of Exelixis at our principal executive
office, Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502, either (1)&nbsp;a written notice of revocation or (2)&nbsp;a duly executed proxy card bearing a later date. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Your proxy may also be revoked by granting a subsequent proxy by telephone or on the Internet
(your latest telephone or Internet proxy is the one that is counted). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Your proxy may also be revoked by attending the virtual Annual Meeting and voting online via the
live webcast. Attendance at the Annual Meeting will not, by itself, revoke your proxy. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841">Beneficial Owner: Shares
Registered in the Name of Broker, Bank or Other Stockholder of Record </FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">If your shares are held by your broker or bank as nominee or agent, you should follow the
instructions provided by your broker or bank to revoke any prior voting instructions, which may include attending the virtual Annual Meeting and voting online via the live webcast. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What is the quorum requirement for the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A majority of the outstanding shares entitled to vote at the virtual Annual Meeting must be present or represented by proxy at the Annual Meeting
to hold a valid meeting. This is called a &#147;quorum.&#148; As this is a virtual Annual Meeting, holders of record attending via the live webcast will be deemed to be present at the virtual Annual Meeting. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a stockholder of record, your shares will be counted towards the quorum only if you vote at the virtual Annual Meeting or have
properly voted by proxy on the Internet, by telephone or by submitting a proxy card by mail. You may vote &#147;For,&#148; &#147;Against&#148; or &#147;Abstain&#148; with respect to Proposal Nos. 1, 2 and 3. Abstentions will be counted towards the
number of shares considered to be present at the meeting for purposes of determining whether a quorum is present. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you are a
beneficial owner holding your shares in &#147;street name&#148; then only the broker, bank or other stockholder of record can vote your shares unless you obtain a valid legal proxy from the broker, bank or other stockholder of record, or are
otherwise provided with a separate means to vote your shares (such as a <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided via email or on your Notice of Availability or voting instruction form). See &#147;<A HREF="#tx63026_a1">If
 I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens?</A>&#148; above. Shares represented by &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;</FONT> will be
counted in determining whether there is a quorum present. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Votes will be counted by the inspector of election appointed for the Annual
Meeting. If there is no quorum, either the chairperson of the Annual Meeting or the holders of a majority of shares present or represented by proxy at the Annual Meeting may adjourn the Annual Meeting to another date. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How many votes are needed to approve each proposal, how are votes counted, and how are abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> treated? </B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><B><I>Proposal <FONT STYLE="white-space:nowrap">1-Election</FONT> of Directors:</I></B> Directors
in an uncontested election, such as this one, are elected by a majority of the votes cast. Accordingly, each of the eleven nominees must receive &#147;For&#148; votes from the holders of a majority of the votes cast with respect to such director
(i.e., the number of shares voted &#147;For&#148; a director must exceed the number of shares voted &#147;Against&#148; that director). Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are not counted for purposes of electing
directors and will have no effect on the results of this vote. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><B><I>Proposal <FONT STYLE="white-space:nowrap">2-Ratification</FONT> of
Ernst</I></B><B><I></I></B><B><I>&nbsp;&amp; Young LLP: </I></B>The affirmative vote of a majority of shares present or represented by proxy at the Annual Meeting and entitled to vote on the proposal is required to ratify the selection of
Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2021. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as votes
against the proposal. Broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> if any, will have no effect and will not be counted towards the vote total. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><B><I>Proposal <FONT STYLE="white-space:nowrap">3-Advisory</FONT> Vote on Executive
Compensation:</I></B> The affirmative vote of a majority of shares present or by represented proxy at the Annual Meeting and entitled to vote on the proposal is required to approve the <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory
vote on executive compensation. Abstentions will be counted toward the tabulation of votes </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">5</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">cast on the proposal and will have the same effect as votes against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect and will not be counted towards the
vote total. Since the vote is advisory, it is not binding on the Board or on us. Nevertheless, the views expressed by our stockholders, whether through this vote or otherwise, are very important to the Board and the management team and, accordingly,
the Compensation Committee and Board intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements. Your vote will serve as an additional tool to guide the Compensation Committee and
Board as they continue to improve the alignment of our executive compensation programs with business objectives and performance and with the interests of our stockholders. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Do I have dissenters&#146; rights? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">No. We are organized as a corporation under Delaware law. Under the Delaware General Corporation Law, our stockholders are not entitled to dissenters&#146; rights with respect to any of the proposals set forth in this Proxy
Statement and we will not independently provide the stockholders with any such rights. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How can I find out the results of the
voting at the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We expect to announce preliminary voting results at the Annual Meeting. In addition, final voting
results will be published in a current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form <FONT
STYLE="white-space:nowrap">8-K</FONT> within four business days after the Annual Meeting, we intend to file a <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> to publish preliminary results and, within four business days after the final results
are known to us, file an additional Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish the final results. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Will other
matters be voted on at the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are not aware of any matters to be presented at the Annual Meeting other than those
described in this Proxy Statement. If any other matters not described in the Proxy Statement are properly presented at the meeting, proxies will be voted in accordance with the best judgment of the proxyholders. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What proxy materials are available on the Internet? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This Proxy Statement and our Annual Report are available at <I>www.exel-annualstockholdermeeting.com</I>. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>What is the deadline for submitting stockholder proposals for the 2022 Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To be considered for inclusion in the 2022 proxy materials, your proposal must be submitted in writing by December&nbsp;[16], 2021, to
Exelixis&#146; Secretary at Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502, and you must comply with all applicable requirements of Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> promulgated under the Securities Exchange Act
of 1934, as amended (Exchange Act). However, if our 2022 Annual Meeting of Stockholders is held before April&nbsp;26, 2022, or after June&nbsp;25, 2022, then the deadline will be a reasonable time prior to the time that we make our proxy materials
available to our stockholders, either online or in printed form. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If you wish to submit a proposal or nominate a director at the 2022
Annual Meeting of Stockholders, but you are not requesting that your proposal or nomination be included in next year&#146;s proxy materials, you must submit your proposal in writing, in the manner set forth in our Bylaws, to Exelixis&#146; Secretary
at Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502, to be received no earlier than the close of business on February&nbsp;25, 2022, and no later than the close of business on March&nbsp;27, 2022. However, if our 2022 Annual
Meeting of Stockholders is held before April&nbsp;26, 2022, or after June&nbsp;25, 2022, then you must notify Exelixis&#146; Secretary, in writing, not earlier than the close of business on the 90th day prior to the date of the 2022 Annual Meeting
of Stockholders and not later than the close of business on the later of (i)&nbsp;the 60th day prior to the date of the 2022 Annual Meeting of Stockholders or (ii)&nbsp;if we publicly announce the date of the 2022 Annual Meeting of Stockholders
fewer than 70 days prior to the date of the 2022 Annual Meeting of Stockholders, the 10th day following the day that we first make such public announcement of the date of the 2022 Annual Meeting of Stockholders. We also advise you to review our
Bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations. The chairperson of the 2022 Annual Meeting of Stockholders may determine, if the facts warrant, that a matter has not been properly
brought before the meeting and, therefore, may not be considered at the meeting. In addition, unless prohibited by Rule <FONT STYLE="white-space:nowrap">14a-4(c)</FONT> promulgated under the Exchange Act, our management will have discretionary
authority to vote all shares for which it has proxies for any such stockholder proposal or director nomination, including in opposition to such stockholder proposal or director nomination. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">6</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proxy Statement&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Questions and Answers about these Proxy Materials and Voting </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>How may I obtain a printed copy of the Proxy Materials? </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Instructions on how to obtain a printed copy of the proxy materials are set forth in the Notice of Availability. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc7841"><B>Forward-Looking Statements </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">This Proxy Statement contains forward-looking statements, including, without limitation, statements related to: Exelixis&#146; expectations that its employees and partners will commit to the highest standards of ethical behavior and
maintain values and principles that reflect both global awareness and sustainability; Exelixis&#146; dedication of financial resources to offer patients high-quality cancer treatments and commitment to providing patients with access to Exelixis
medicines; Exelixis&#146; strategies for quality monitoring and compliance in developing its products; Exelixis&#146; potential to attain future environmental stability; Exelixis&#146; ongoing efforts towards the achievement of key priorities and
anticipated milestones for 2021 and beyond; Exelixis&#146; expectation that the combination of CABOMETYX and OPDIVO will be a key driver of revenue growth; Exelixis&#146; plans to file with the FDA for accelerated approval of the combination of
cabozantinib and atezolizumab in an mCRPC indication, if warranted by the data; the potential for Exelixis to add clinical-stage assets to its product pipeline; the anticipated organizational growth of Exelixis; Exelixis&#146; strategic planning for
potential future commercial indications for cabozantinib, the further development of XL092 and other potential business development assets; and other statements that are not historical fact.&nbsp;Any statements that refer to expectations,
projections or other characterizations of future events or circumstances are forward-looking statements and are based upon Exelixis&#146; current plans, assumptions, beliefs, expectations, estimates and projections. Forward-looking statements
involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of these risks and uncertainties, which include, without limitation: the continuing
<FONT STYLE="white-space:nowrap">COVID-19</FONT> global pandemic and its impact on Exelixis&#146; clinical trial, drug discovery and commercial activities; the degree of market acceptance of CABOMETYX and other&nbsp;Exelixis&nbsp;products in the
indications for which they are approved and in the territories where they are approved, and Exelixis and its partners&#146; ability to obtain or maintain coverage and reimbursement for these products; the effectiveness of CABOMETYX and
other&nbsp;Exelixis&nbsp;products in comparison to competing products; the level of costs associated with Exelixis&#146; commercialization, research and development, <FONT STYLE="white-space:nowrap">in-licensing</FONT> or acquisition of product
candidates, and other activities; Exelixis&#146; ability to maintain and scale adequate sales, marketing, market access and product distribution capabilities for its products or to enter into and maintain agreements with third parties to do so; the
availability of data at the referenced times; the potential failure of cabozantinib and other&nbsp;Exelixis&nbsp;product candidates, both alone and in combination with other therapies, to demonstrate safety and/or efficacy in clinical testing;
uncertainties inherent in the drug discovery and product development process; Exelixis&#146; dependence on its relationships with its collaboration partners, including their pursuit of regulatory approvals for partnered compounds in new indications,
their adherence to their obligations under relevant collaboration agreements and the level of their investment in the resources necessary to complete clinical trials or successfully commercialize partnered compounds in the territories where they are
approved; complexities and the unpredictability of regulatory review and approval processes in the U.S. and elsewhere; Exelixis&#146; continuing compliance with applicable legal and regulatory requirements; unexpected concerns that may arise as a
result of the occurrence of adverse safety events or additional data analyses of clinical trials evaluating cabozantinib and other Exelixis products; Exelixis&#146; dependence on third-party vendors for the development, manufacture and supply of its
products and product candidates; Exelixis&#146; ability to protect its intellectual property rights; market competition, including the potential for competitors to obtain approval for generic versions of Exelixis&#146; marketed products; changes in
economic and business conditions; and other factors discussed under the caption &#147;Risk Factors&#148; in Exelixis&#146; Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> submitted to the SEC on February&nbsp;10, 2021, and in
Exelixis&#146; future filings with the SEC. All forward-looking statements in this Proxy Statement are based on information available to Exelixis as of the date of this Proxy Statement, and Exelixis undertakes no obligation to update or revise any
forward-looking statements contained herein, except as required by law. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">7</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_2"></A>P<SMALL>ROPOSAL</SMALL> 1 </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT
 COLOR="#6d6d6d">E<SMALL>LECTION</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Certificate of Incorporation and Bylaws
provide for the annual election of each director. There are currently eleven directors on the Board, and all eleven directors have been nominated and are standing for <FONT STYLE="white-space:nowrap">re-election</FONT> this year: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Director Nominees</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Age</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Position</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Director<BR>Since</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1995</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum,
Esq.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">77</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2007</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">66</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2005</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">85</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2001</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">60</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President&nbsp;and Chief&nbsp;Executive&nbsp;Officer</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2010</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">72</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Chair&nbsp;of&nbsp;the&nbsp;Board</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1994</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM,
Ph.D., FRS</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">76</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2004</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie Anne
Smith</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">59</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1997</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L.
Wyszomierski</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Independent Director</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2004</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If elected at the Annual Meeting, each of these director nominees would serve until the next annual meeting of
stockholders and until the director&#146;s successor is elected and has qualified, or, if sooner, until the director&#146;s death, resignation or removal. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">As this is an uncontested election, each director will be elected by a majority of the votes cast with respect to that director. A majority of the votes cast means that the number of shares voted &#147;for&#148; a director must
exceed the number of votes cast &#147;against&#148; that director. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the election of directors. If any nominee becomes unavailable for election as a result
of an unexpected occurrence, your shares will be voted for the election of such substitute nominee as the Board, after receiving the recommendation of the Nominating and Corporate Governance Committee of the Board, may propose. Each person nominated
for election has agreed to serve if elected, and we have no reason to believe that any nominee will be unable to serve. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Majority
Voting Standard and Resignation Policy </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Corporate Governance Guidelines require that all director nominees set forth in this Proxy
Statement have tendered an irrevocable resignation as a director conditioned upon: (i)&nbsp;such director failing to receive a majority of the votes cast at the Annual Meeting; and (ii)&nbsp;acceptance by the Board of such resignation. If a director
nominee who is serving as a director at the time of the election does not receive a majority of the votes cast at the Annual Meeting, then the Board will take the following actions: </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">The Nominating and Corporate Governance Committee will act to determine whether to recommend to the
Board that it accept the director&#146;s conditional resignation. In making their respective decisions, the Nominating and Corporate Governance Committee and the Board will evaluate the best interests of Exelixis and its stockholders and shall
consider all factors and information deemed relevant by the respective body. The director who tenders his or her conditional resignation shall not participate in the Nominating and Corporate Governance Committee&#146;s recommendation or Board action
regarding whether to accept the conditional resignation of such director. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">The Board will act on the Nominating and Corporate Governance Committee&#146;s recommendation
within ninety days following certification of the stockholder vote. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f">If the Board determines not to accept the conditional resignation of a director, the Board will
promptly disclose its decision-making process and decision to reject the conditional resignation in a Form <FONT STYLE="white-space:nowrap">8-K</FONT> furnished to the SEC. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">8</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Election of Directors </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Board Independence, Diversity and Skills </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Board regularly evaluates the skills and experiences that it believes are desirable to be represented on the Board and best align with our strategic vision and business and operations. Below are certain qualifications, skills
and experiences of our current directors that contribute the Board&#146;s effectiveness as a whole. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g30r52.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In addition, set forth below is biographical information for each nominee for election to our Board at the
Annual Meeting. Incorporated within each biography is a description of the specific qualifications, skills and experiences of each nominee that led our Board to conclude that the individual should serve as a director as of the date of this Proxy
Statement. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">9</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="tx63026_a20"></A><A NAME="tx63026_aa"></A><B>Director Nominees</B> </FONT></P>
<P STYLE="line-height:3.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Charles Cohen, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Independent Biotechnology Investor</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Former Chief Executive Officer, Perform Biologics, Inc. and On Target Therapeutics, LLC</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 1995</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 70</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Cohen should continue to serve as a director of Exelixis due to his training as a scientist, his knowledge and experience with respect to the biotechnology, pharmaceutical and healthcare industries,
his broad leadership experience resulting from service on various boards and as a chief executive officer, and his knowledge and experience with respect to finance matters.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Audit
Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Compensation Committee (chair)</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen, Ph.D., has been a director since November
1995. Dr.&nbsp;Cohen is an independent investor and from March 2015 to May 2019, he served as Chief Executive Officer and as a member of the board of directors of Perform Biologics, Inc., a privately held biotechnology
<FONT STYLE="white-space:nowrap">start-up</FONT> company. Previously, Dr.&nbsp;Cohen served as Chief Executive Officer and as a member of the board of directors of On Target Therapeutics, LLC, a privately held biotechnology <FONT
STYLE="white-space:nowrap">start-up</FONT> company, from June 2015 to June 2017. From May 2007 to December 2015, Dr.&nbsp;Cohen was a managing director of Synthesis Capital (formerly Advent Healthcare Ventures), a venture capital firm. From 2003 to
2007, Dr.&nbsp;Cohen was Vice President of Advent International, a global private equity firm. From 2000 to 2002, Dr.&nbsp;Cohen was the Chief Executive Officer of Cellzome AG, a post-genomics biotechnology company. Prior to that time,
Dr.&nbsp;Cohen <FONT STYLE="white-space:nowrap">co-founded</FONT> Creative BioMolecules, Inc., a biotechnology company, in 1982 and was one of its directors and its Chief Executive Officer from 1985 to 1995. Dr.&nbsp;Cohen served as a member of the
board of directors of the following publicly held companies: Anadys Pharmaceuticals, Inc., a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, from 2000 to 2005; and
Anesiva, Inc., a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management from 2005 to 2007. Dr.&nbsp;Cohen also served as the Chairman of the Supervisory Board of Cellzome AG,
prior to its acquisition by GlaxoSmithKline in May 2012, and as the Chief Executive Officer of several other companies. Dr.&nbsp;Cohen received his B.A. from the State University of New York at Buffalo and his Ph.D. from New York University School
of Medicine.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Carl B. Feldbaum, Esq.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President Emeritus, Biotechnology Innovation Organization</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2007</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 77</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Mr.&nbsp;Feldbaum should continue to serve as a director of Exelixis due to his training as an attorney, his knowledge and experience with respect to the biotechnology, pharmaceutical and healthcare
industries, his broad leadership experience resulting from service on various boards and as an executive officer and his knowledge and experience with policymaking, regulatory issues and other governmental matters.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Risk
Committee (chair)</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company
Boards:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum, Esq., has been a director since
February 2007. Mr.&nbsp;Feldbaum serves as a member emeritus of the board of directors of BIO Ventures for Global Health, a <FONT STYLE="white-space:nowrap">non-profit</FONT> organization, and is president emeritus of the Biotechnology Innovation
Organization (BIO), which is the world&#146;s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Mr.&nbsp;Feldbaum served as president of BIO from 1993 until his retirement in 2005. Prior to joining BIO, Mr.&nbsp;Feldbaum was chief of staff to Senator Arlen Specter of Pennsylvania. He also was president and founder of Palomar Corporation, a
national security &#147;think tank&#148; in Washington, D.C. Before founding Palomar Corporation, Mr.&nbsp;Feldbaum was Assistant to the Secretary of Energy and served as the Inspector General for defense intelligence in the U.S. Department of
Defense. Mr.&nbsp;Feldbaum served as a member of the board of directors of the following publicly held companies: Actelion, Ltd, a biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases
with significant unmet medical needs (acquired by Johnson&nbsp;&amp; Johnson in 2017), from 2005 to 2015; Trovagene, Inc., a precision medicine biotechnology company focused on the development of oncology therapeutics for improved cancer care, from
2014 to 2015; and Connetics Corporation, a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market, from 2005 until its acquisition by Stiefel Laboratories, Inc. in
2006. Mr.&nbsp;Feldbaum holds an A.B. in Biology from Princeton University and a J.D. from the University of Pennsylvania Law School.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">10</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Director Nominees </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Maria C. Freire, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President and Executive Director, Foundation for the National Institutes of Health</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2018</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 66</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Freire should continue to serve as a director of Exelixis due to her training as a scientist, her knowledge and experience with respect to medical research, the pharmaceutical industry and
government healthcare policymaking, as well as her leadership experience in the public sector.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Risk
Committee</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company
Boards:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Alexandria Real Estate Equities, serving on the Nominating&nbsp;&amp;
Corporate Governance Committee and the Science&nbsp;&amp; Technology Committee (chair)</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire, Ph.D., has been a director since April
2018. Since November 2012, Dr.&nbsp;Freire has served as President and Executive Director and as a member of the board of directors of the Foundation for the National Institutes of Health. From March 2008 to November 2012, she served as President
and as a member of the board of directors of the Albert and Mary Lasker Foundation. Prior to joining the Lasker Foundation, Dr.&nbsp;Freire served as President and Chief Executive Officer of the Global Alliance for TB Drug Development from 2001 to
2008 and Director of the Office of Technology Transfer at the National Institutes of Health from 1995 to 2001. Dr.&nbsp;Freire has served on the board of directors of Alexandria Real Estate Equities, Inc. a publicly held urban office real estate
investment trust uniquely focused on collaborative life science and technology campuses, since April 2012, and has previously served on the boards of numerous national and international organizations, including the Science Board of the U.S. Food and
Drug Administration, the World Health Organization Commission on Intellectual Property Rights, Innovation and Public Health and the United Nations Secretary General&#146;s High Level Panel on Access to Medicines. Dr.&nbsp;Freire is also a member of
the National Academy of Medicine and the Council on Foreign Relations, and she is the recipient of numerous awards, including a 2017 Gold Stevie Award for &#147;Woman of the Year,&#148; the U.S. Department of Health and Human Services
Secretary&#146;s Award for Distinguished Service, the Arthur S. Fleming Award and the Bayh-Dole Award. Dr.&nbsp;Freire holds a Ph.D. in Biophysics from the University of Virginia and a B.S. from the Universidad Peruana Cayetano Heredia in Lima,
Peru.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Alan M. Garber, M.D., Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Provost of Harvard University</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2005</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 65</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Garber should continue to serve as a director of Exelixis due to his training as a physician and economist, his knowledge and experience with respect to the life sciences, healthcare and
pharmaceutical industries, and his knowledge and experience with policymaking, regulatory issues and other governmental matters.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee (chair)</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Vertex
Pharmaceuticals Incorporated, serving on the Audit&nbsp;&amp; Finance Committee and the Scientific&nbsp;&amp; Technology Committee</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D., Ph.D., has been a director since
January 2005. He became Provost of Harvard University, Mallinckrodt Professor of Health Care Policy at Harvard Medical School, and a Professor in the Harvard Kennedy School of Government and in the Department of Economics at Harvard in September
2011. Before moving to Harvard, from 1998 until August 2011, he was the Henry J. Kaiser Jr. Professor, a Professor of Medicine, and a Professor (by courtesy) of Economics, Health Research and Policy, and of Economics in the Graduate School of
Business at Stanford University. Dr.&nbsp;Garber also served as the Director of the Center for Primary Care and Outcomes Research and the Center for Health Policy at Stanford. During his tenure at Stanford University, Dr.&nbsp;Garber also served as
a Senior Fellow at the Freeman Spogli Institute for International Studies and as a staff physician at the VA Palo Alto Health Care System. Dr.&nbsp;Garber has served as a member of the board of directors of Vertex Pharmaceuticals Incorporated, a
publicly held biotechnology company focused on developing and commercializing therapies for the treatment of cystic fibrosis, since June 2017. In addition, Dr.&nbsp;Garber is a one of several <FONT STYLE="white-space:nowrap">co-founders</FONT> and
serves as the chair of the board of directors for the Center for Advanced Biological Innovation and Manufacturing, a public benefit limited liability company in the Boston metro area created to encourage collaboration among multiple institutions,
with the ultimate aim of promoting the development and production of cell and gene therapies, biologics, immunotherapies and other emerging technologies that can benefit patients. Dr.&nbsp;Garber is a member of the National Academy of Medicine, the
American Society of Clinical Investigation, the Association of American Physicians and the American Academy of Arts and Sciences. He is a Fellow of the American College of Physicians, the Royal College of Physicians and the American Association for
the Advancement of Science. Dr.&nbsp;Garber is also a Research Associate with the National Bureau of Economic Research and served as founding Director of its Health Care Program for nineteen years. He has also served as a member of the National
Advisory Council on Aging at the National Institutes of Health, as a member of the Board of Health Advisers of the Congressional Budget Office and as Chair of the Medicare Evidence Development and Coverage Advisory Committee at the Centers for
Medicare and Medicaid Services. Dr.&nbsp;Garber previously served on the editorial board of a number of acclaimed scientific journals and has received numerous awards and honors. Dr.&nbsp;Garber holds an A.B. summa cum laude, an A.M. and a Ph.D.,
all in Economics, from Harvard University, and an M.D. with research honors from Stanford University.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">11</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Vincent T. Marchesi, M.D., Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Professor of Pathology and Cell Biology, Yale University</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="8"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2001</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 85</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Marchesi should continue to serve as a director of Exelixis due to his training as a physician and scientist and his research and experience in the fields of healthcare and life sciences, with a
particular focus on biotechnology.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee
Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Compensation Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi, M.D., Ph.D., has been a director
since May 2001. Since 1973, Dr.&nbsp;Marchesi has been a Professor of Pathology and Cell Biology at Yale University and, since 1991, the Director of the Boyer Center for Molecular Medicine at Yale University. In 1982, Dr.&nbsp;Marchesi <FONT
STYLE="white-space:nowrap">co-founded</FONT> Molecular Diagnostics, Inc., a diagnostic development company. Dr.&nbsp;Marchesi was formerly Chair of Pathology at the <FONT STYLE="white-space:nowrap">Yale-New</FONT> Haven Hospital. Dr.&nbsp;Marchesi
holds an M.D. from Yale University and a Ph.D. from Oxford University, and is a member of the National Academy of Sciences and the Institute of Medicine.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I><A NAME="tx63026_12a"></A>Michael M. Morrissey, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President and Chief Executive Officer, Exelixis, Inc.</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2010</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 60</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Morrissey should continue to serve as a director of Exelixis due to his leadership role as the President and Chief Executive Officer of Exelixis. Beyond his role as Exelixis&#146; principal
executive officer, the Board also considered Dr.&nbsp;Morrissey&#146;s extensive qualifications, including his training as a scientist, his significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical
industries, comprehensive leadership background resulting from service as an executive in the biotechnology industry, and his ability to bring historic knowledge and continuity to the Board.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D., has served as a director and
as Exelixis&#146; President and Chief Executive Officer since July 2010. Dr.&nbsp;Morrissey has held positions of increasing responsibility at Exelixis since he joined the company in February 2000, including serving as President of Research and
Development from January 2007 until July 2010. From 1991 to 2000, Dr.&nbsp;Morrissey held several positions at Berlex Biosciences, last holding the position of Vice President, Discovery Research. Earlier in his career, Dr.&nbsp;Morrissey served as a
Senior Scientist and Project Team Leader in Medicinal Chemistry at CIBA-Geigy Corporation. Since 2020, Dr.&nbsp;Morrissey has served as a member of the board of directors of XWPharma Incorporated, a privately held, clinical-stage biopharmaceutical
company dedicated to the discovery and development of therapeutics that apply novel platform chemistry to time-regulated neurobiology. He is the author of numerous scientific publications in medicinal chemistry and drug discovery and an inventor on
70 issued U.S. patents and 25&nbsp;additional published U.S. patent applications. Dr.&nbsp;Morrissey holds a B.S. (Honors) in Chemistry from the University of Wisconsin and a Ph.D. in Chemistry from Harvard&nbsp;University.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:6pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">12</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Director Nominees </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Stelios Papadopoulos, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><FONT STYLE="white-space:nowrap">Co-Founder</FONT> and Chair of the Board, Exelixis, Inc.</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 1994</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 72</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Papadopoulos should continue to serve as a director of Exelixis due to his training as a scientist, his knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical
industries, his broad leadership experience resulting from extensive service on various boards, his knowledge and experience with respect to finance matters, and his ability to bring historic knowledge and continuity to the Board.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Audit
Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Biogen
Inc. (chair), serving on the Corporate Governance Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Regulus Therapeutics, Inc. (chair), serving on the Audit Committee and the
Nominating and Governance Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Eucrates Biomedical Acquisition Corp. (chair)</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos, Ph.D., a <FONT
STYLE="white-space:nowrap">co-founder</FONT> of Exelixis, has been a director since December 1994 and the Chair of the Board since January 1998. Dr.&nbsp;Papadopoulos retired as Vice Chairman of Cowen&nbsp;&amp; Co., LLC in August 2006 after six
years as an investment banker with the firm, where he focused on the biotechnology and pharmaceutical sectors. Prior to joining Cowen&nbsp;&amp; Co., he spent 13 years as an investment banker at PaineWebber, Incorporated, where he was most recently
Chairman of PaineWebber Development Corp., a PaineWebber subsidiary focusing on biotechnology. He joined PaineWebber in April 1987 from Drexel Burnham Lambert, where he was a Vice President in the Equity Research Department covering the
biotechnology industry. Prior to Drexel, he was a biotechnology analyst at Donaldson, Lufkin&nbsp;&amp; Jenrette. Before coming to Wall&nbsp;Street in 1985, Dr.&nbsp;Papadopoulos was on the faculty of the Department of Cell Biology at New&nbsp;York
University Medical Center. Dr.&nbsp;Papadopoulos was a <FONT STYLE="white-space:nowrap">co-founder</FONT> of Anadys Pharmaceuticals, Inc., a publicly held biopharmaceutical company dedicated to improving patient care by developing novel medicines
for the treatment of hepatitis C, acquired by <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Inc. in November 2011. Dr.&nbsp;Papadopoulos served as a member of the board of directors of Anadys Pharmaceuticals from 2000 to 2011 and as its
chairman in 2011, prior to its acquisition. Dr.&nbsp;Papadopoulos has also served as a member of the board of directors of four other publicly held companies: Biogen, Inc., a biopharmaceutical company focused on the treatment of serious diseases,
since 2008 and as its chairman since 2014; Regulus Therapeutics Inc., a biopharmaceutical company focused on the development of medicines targeting microRNAs, since 2008, and as its chairman since 2013; Eucrates Biomedical Acquisition Corp., a
special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, and as its chairman, since 2020; and BG
Medicine, Inc., a diagnostics company focused on the development and commercialization of cardiovascular diagnostic tests, from 2003 until 2018. Dr.&nbsp;Papadopoulos was also <FONT STYLE="white-space:nowrap">co-founder</FONT> and member of the
board of directors of Cellzome Inc., a privately held drug discovery company acquired by GlaxoSmithKline in May 2012. In the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> sector, Dr.&nbsp;Papadopoulos
is a <FONT STYLE="white-space:nowrap">co-founder</FONT> and Chairman of Fondation Sant&eacute;, a member of the board of visitors of Duke Medicine, and a member of the Global Advisory Board of the Duke Institute for Health Innovation.
Dr.&nbsp;Papadopoulos holds an M.S. in Physics, a Ph.D. in Biophysics and an M.B.A. in Finance, all from New York University.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>George Poste, DVM, Ph.D., FRS</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Chief Scientist, Complex Adaptive Systems Initiative</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2004</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 76</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Poste should continue to serve as a director of Exelixis due to his training as a scientist, his knowledge and experience with respect to the life sciences, healthcare and pharmaceutical industries,
his broad leadership experience resulting from service on various boards, and his knowledge and experience with policymaking, regulatory issues and other governmental matters.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee (chair)</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Risk
Committee</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company
Boards:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM, Ph.D., FRS, has been a director since
August 2004. Since February 2009, Dr.&nbsp;Poste has been the Chief Scientist at Complex Adaptive Systems Initiative and Regents&#146; Professor and Del E. Webb Professor of Health Innovation at Arizona State University. From May&nbsp;2003 to
February 2009, Dr.&nbsp;Poste served as the director of the Biodesign Institute at Arizona State University. Dr.&nbsp;Poste has served as the Chief Executive Officer of Health Technology Networks, a consulting company that specializes in the
application of genomic technologies and computing in healthcare, since 2000. From 1992 to 1999, he was the Chief Science and Technology Officer and President, R&amp;D, of SmithKline Beecham Corporation, a pharmaceutical company (later merged into
GlaxoSmithKline plc). Dr.&nbsp;Poste served on the Defense Science Board of the U.S. Department of Defense from 2001 to 2010 and is a member of other organizations dedicated to advancing defenses against bioweapons and biowarfare. Dr.&nbsp;Poste has
served as a member of the board of directors of Caris Life Sciences, a privately held medical diagnostics company, since 2009. Previously, Dr.&nbsp;Poste served as a member of the board of directors of Monsanto Company, a publicly held provider of
agricultural products and solutions, from February 2003 until its acquisition by Bayer Aktiengesellschaft in June 2018, and as the <FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman of Orchid Cellmark, Inc., a publicly held DNA forensics
company, from April 2000 until its acquisition by the Laboratory Corporation of America in August&nbsp;2009. Dr.&nbsp;Poste is a Fellow of the Royal Society, the UK Academy of Medical Sciences, Hoover Institution, Stanford&nbsp;University, and
various other prestigious organizations and has been awarded honorary doctorates from several universities. Dr.&nbsp;Poste holds a DVM in veterinary medicine and a Ph.D. in Virology from the University of Bristol, England and Board Certification in
Pathology from the Royal College of Pathologists.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">13</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Julie Anne Smith</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President and Chief Executive Officer, ESCAPE Bio Inc.</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2016</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 50</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Ms.&nbsp;Smith should continue to serve as a director of Exelixis due to her knowledge and experience with respect to biotechnology, healthcare and pharmaceutical industries and her broad leadership
experience resulting from service as an executive in the pharmaceutical industry.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Audit Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Compensation Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Stoke
Therapeutics, Inc., serving on the Compensation Committee</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie Anne Smith has been a director since September
2016. Since August 2018, Ms.&nbsp;Smith has served as President and Chief Executive Officer and as a member of the board of directors of ESCAPE Bio Inc., a privately held, clinical-stage biopharmaceutical company developing novel, precisely targeted
therapeutics for genetically defined neurodegenerative diseases. From July 2017 until June 2018, Ms.&nbsp;Smith served as President and Chief Executive Officer and as a member of the board of directors of Nuredis, Inc., a privately held
biotechnology company. Prior to Nuredis, she served as President and Chief Executive Officer of Raptor Pharmaceutical Corp., a publicly held biopharmaceutical company focused on developing and commercializing transformative treatments for people
affected by rare and debilitating diseases, from January 2015 until the company&#146;s acquisition by Horizon Pharma plc in October 2016, where she also served as Executive Vice President and Chief Operating Officer from 2012 to 2014. From 2008 to
2012, Ms.&nbsp;Smith served as Chief Commercial Officer of Enobia Pharmaceuticals prior to the company&#146;s acquisition by Alexion Pharmaceuticals, Inc. Previously, Ms.&nbsp;Smith served as Vice&nbsp;President of Commercial at Jazz Pharmaceuticals
plc from 2006 to 2008, as Vice President, Global Marketing at Genzyme General from 2001 to 2005, and helped to establish the operations and business development function for the biotech <FONT STYLE="white-space:nowrap">start-up,</FONT> Novazyme
Pharmaceuticals, from 2000 to 2001. Ms.&nbsp;Smith began her industry career at Bristol-Myers Squibb Company in 1996. Ms.&nbsp;Smith has served as a member of the board of directors of Stoke Therapeutics, Inc., a publicly held biotechnology company
pioneering a new way to treat the underlying cause of genetic diseases by precisely unregulating protein expression, since June 2020. Previously, Ms.&nbsp;Smith served as a member of the board of directors of Audentes Therapeutics, Inc. a publicly
held, clinical-stage biotechnology company focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects, from December 2016 until its acquisition by
Astellas Pharma Inc. in January 2020, and as a Director on the Health and Emerging Companies Sections of the BIO board. Ms.&nbsp;Smith holds a B.S. in biological and nutritional sciences from Cornell University.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Lance Willsey, M.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Founding Partner, DCF Capital</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 1997</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 59</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Dr.&nbsp;Willsey should continue to serve as a director of Exelixis due to his skill as a physician, his knowledge and experience with respect to the life sciences and healthcare industries, and his
knowledge and experience with respect to finance matters.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Compensation Committee</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Research&nbsp;&amp; Development Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;None</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey, M.D., has been a director since April
1997. Dr.&nbsp;Willsey was a founding partner of DCF Capital, a hedge fund focused on investing in the life sciences, from July 1998 to March 2002, and currently is a consultant to institutional investors in the field of oncology. Since 2000,
Dr.&nbsp;Willsey has served on the Visiting Committee of the Department of Genitourinary Oncology at the Dana-Farber Cancer Institute at Harvard Medical School. From July 1997 to July 1998, Dr.&nbsp;Willsey served on the Staff Department of Urologic
Oncology at the Dana-Farber Cancer Institute. From July 1996 to July 1997, Dr.&nbsp;Willsey served on the Staff Department of Urology at Massachusetts General Hospital at Harvard University School of Medicine, where he was a urology resident from
July 1992 to July 1996. From 2000 to 2010, Dr.&nbsp;Willsey served a member of the board of directors of Exact Sciences Corporation, a publicly held molecular diagnostics company focused on the early detection and prevention of the deadliest forms
of cancer. Dr.&nbsp;Willsey holds a B.S. in Physiology from Michigan State University and an M.S. in Biology and an M.D., both from Wayne State University.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">14</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Director Nominees </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Jack L. Wyszomierski</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Former Executive Vice President and Chief Financial Officer,</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>VWR&nbsp;International, LLC</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="8"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Director since 2004</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Age 65</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Key Qualifications and Expertise:</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our Board concluded that Mr.&nbsp;Wyszomierski should continue to serve as a director of Exelixis due to his extensive financial reporting, accounting and finance experience, as well as his experience in the healthcare and life
sciences industries. These qualities have also formed the basis for the Board&#146;s decision to appoint Mr.&nbsp;Wyszomierski as a member and Chair of the Audit Committee.</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Committee Assignments:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Audit
Committee (chair)</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Nominating and Corporate Governance Committee</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Other Current Public Company Boards:</B></FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;XOMA
Corporation, serving on the Audit Committee, the Compensation Committee (chair) and the Nominating and Corporate Governance Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;Athersys, Inc., serving on the Audit Committee and the Nominations
Committee</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.88em; text-indent:-2.13em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8194;&#8202;SiteOne Landscape Supply, Inc., serving on the Audit Committee and the
Nominating&nbsp;&amp; Corporate Governance Committee (chair)</FONT></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L. Wyszomierski, has been a director since February
2004. From June 2004 to June 2009, Mr.&nbsp;Wyszomierski served as the Executive Vice President and Chief Financial Officer of VWR International, LLC, a supplier of laboratory supplies, equipment and supply chain solutions to the global research
laboratory industry. From 1982 to 2003, Mr.&nbsp;Wyszomierski held positions of increasing responsibility within the finance group at Schering-Plough Corporation, a health care company, culminating with his appointment as Executive Vice President
and Chief Financial Officer in 1996. Prior to joining Schering-Plough, he was responsible for capitalization planning at Joy Manufacturing Company, a producer of mining equipment, and was a management consultant at Data Resources, Inc.
Mr.&nbsp;Wyszomierski has served: as a member of the board of directors of XOMA Corporation, a publicly held biotech royalty aggregator, since August 2010; as a member of the board of directors of Athersys, Inc., a publicly held company engaged in
the discovery and development of therapeutic product candidates, since June 2010; as a member of the board of directors of Solenis LLC, a privately held manufacturer of chemical products, since August 2014; and as a member of the board of directors
of SiteOne Landscape Supply, Inc., a publicly held company that distributes landscape supply products, since April 2016. Mr.&nbsp;Wyszomierski previously served as a member of the board of directors of: Unigene Laboratories, Inc., a publicly held
biopharmaceutical company, from April 2010 to July 2013; and AssuraMed Holding, Inc., a privately held distributor of home healthcare products, from January 2011 until its acquisition by Cardinal Health Inc. in March 2013. Mr.&nbsp;Wyszomierski
holds a M.S. in Industrial Administration and a B.S. in Administration, Management Science and Economics from Carnegie Mellon University.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:6pt">
<TD VALIGN="top"><FONT COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;background-color:#e5e5e5;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; EACH NAMED NOMINEE. </B></FONT></P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">15</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_3"></A>Corporate Governance </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Please note that information found
on, or accessible through, our website is not a part of, and is not incorporated into, this Proxy Statement. </I></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Corporate
Governance Guidelines </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have adopted written Corporate Governance Guidelines, which may be viewed at <I>www.exelixis.com</I> under
the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Corporate Governance Documents.&#148; This document covers, among other topics, director independence, board composition, structure and functioning, director selection
criteria, committees of the board, board and board committee evaluations, overboarding guidelines and our majority voting policy. Our Board regularly reviews, and modifies from time to time, our Corporate Governance Guidelines, Board committee
charters and Board practices. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Corporate Code of Conduct </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have adopted a Corporate Code of Conduct, which functions as our Code of Ethics under the SEC rules and applies to all directors, officers and
employees, including the principal executive officer and principal financial/accounting officer. The Corporate Code of Conduct is posted on our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate
Governance&#151;Corporate Governance Documents.&#148; We intend to satisfy the disclosure requirement under Item&nbsp;5.05 of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> regarding an amendment to, or waiver from, a provision of this
Corporate Code of Conduct by posting such information on our website, at the address and location specified above and, to the extent required by the listing standards of the Nasdaq Stock Market, by filing a Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> with the SEC, disclosing such information. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Corporate Code of Conduct reflects our corporate
values and describes how our officers, directors, employees and contractors are expected to conduct themselves when representing Exelixis. It also underscores our commitment to strive to comply with laws that regulate our business activities as a
biotechnology company. Our employees receive regular training on our Corporate Code of Conduct, which includes consequences of taking actions that would constitute a violation of our Corporate Code of Conduct. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Included in our Corporate Code of Conduct are procedures for employees to report potential violations to our Ethics Committee, which is chaired
by our Chief Executive Officer and includes other members of our senior management team. To ensure our employees feel comfortable raising good faith questions or concerns with respect to our Corporate Code of Conduct or our other policies, these
reports can be made confidentially (or anonymously) via our Ethics Hotline, and we maintain a strict policy against any retaliation or discrimination towards an employee who makes such a report. The Board, through the Audit Committee, regularly
receives reports of disclosures made through the Ethics Hotline, as well as any concerns raised to the Ethics Committee or otherwise submitted through our internal compliance reporting system. The Audit Committee is responsible for the oversight of
such matters, or as appropriate, will assign such oversight to another committee of the Board. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Director Independence </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We have adopted standards for director independence pursuant to Nasdaq listing standards, which require that a majority of the members of a
listed company&#146;s board of directors qualify as &#147;independent,&#148; as affirmatively determined by the board of directors. An &#147;independent director&#148; means a person other than an officer or employee of Exelixis or one of our
subsidiaries, or another individual having a relationship that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Consistent with these considerations, after
review of all relevant transactions or relationships between each director, or any of his or her family members, and Exelixis, its senior management or its independent registered public accounting firm, the Board has affirmatively determined that
Drs. Cohen, Freire, Garber, Marchesi, Papadopoulos, Poste and Willsey, Messrs.&nbsp;Wyszomierski and Feldbaum and Ms.&nbsp;Smith, who are ten of the eleven members of the Board, represent a majority of the Board and are independent under applicable
SEC rules and the Nasdaq listing standards. Dr.&nbsp;Morrissey, our President and Chief Executive Officer, is not independent by virtue of his employment with Exelixis. In addition, the Board has also determined that: (i)&nbsp;all directors who
serve on the Audit, Compensation and Nominating and Corporate Governance Committees are independent under applicable Nasdaq listing standards; and (ii)&nbsp;all members of the Audit Committee meet the independence requirements under the Exchange
Act. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><B><I>Special Note Regarding Independence of Dr.&nbsp;Papadopoulos.</I></B></FONT><FONT
STYLE="font-family:Calibri" COLOR="#3f3f3f"> Dr.&nbsp;Papadopoulos is considered a <FONT STYLE="white-space:nowrap">&#147;co-founder&#148;</FONT> of Exelixis as a result of financial contributions he made during the earliest part of its history and
his role in assembling and advising the </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">16</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Corporate Governance </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">scientists who ultimately served as the company&#146;s earliest management team. However, he has never been employed by us or otherwise involved
with any daily business operations and, moreover, Exelixis&#146; management team today is composed of entirely different individuals from the company&#146;s earliest management team. Accordingly, the Board has determined that Dr.&nbsp;Papadopoulos
is independent under applicable SEC rules and the Nasdaq listing standards and is qualified to serve as our Chair and on our Audit Committee, as the Board believes that he has no interest, business or other relationship (including no family
relationships) that could, or could reasonably be perceived to, materially interfere with his ability to act in the best interests of Exelixis. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT
 COLOR="#fc4c02">Board Leadership Structure </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board does not have a formal policy on whether the role of Chair and Chief Executive
Officer should be separate or combined. Our Corporate Governance Guidelines provide that the Board will select its Chair and the Chief Executive Officer in the manner it considers to be in the best interests of our company. Currently, we have an
independent Chair of the Board separate from the Chief Executive Officer. The Board believes this bifurcated structure provides for independent oversight of management and strong Board leadership, while allowing for the effective management of
company affairs. The Board believes that if the positions of Chair and Chief Executive Officer are combined, the appointment of a lead independent director would be necessary for effective governance. Accordingly, our Corporate Governance Guidelines
provide that if the roles are combined, the independent directors of the Board must appoint a lead independent director. Our Corporate Governance Guidelines further provide that the lead independent director would: (i)&nbsp;preside at all meetings
of the Board at which the Chair is not present, including executive sessions of the independent directors; (ii)&nbsp;have the authority to call meetings of the independent directors; (iii)&nbsp;serve as the principal liaison on Board-wide issues
between the independent directors and the Chair; and (iv)&nbsp;have such other authority and duties as the Board may from time to time determine. The Board believes that this flexible approach provides it with the ability to establish a leadership
structure that, based upon its judgment, is in the best interests of our company and those of our stockholders at any given time. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Role of the Board in Risk Oversight </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Management is responsible for assessing, managing and mitigating the various risks associated with our business and operational activities, including, without limitation, strategic, operational, financial, regulatory and
cybersecurity risks that may exist from time to time. Management has implemented appropriate risk management structures, policies and procedures, and manages our risk exposure on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> basis. In accordance with our Corporate Governance Guidelines, the Board, both directly and through its committees (including the Risk Committee formed in
December 2019), oversees the proper functioning of our internal risk management processes. In their specific risk oversight roles, the Board and the Risk Committee evaluate whether management has reasonable controls in place to address material
risks currently facing our company and those we may face in the future. The Board, the Risk Committee and other committees meet at regularly scheduled and special meetings throughout the year at which management reports to the Board concerning the
results of its risk management activities, as well as external changes that may change the levels of business risk to which we are exposed. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Board delegates certain of its risk oversight responsibilities to its various committees as follows: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Audit Committee</FONT><FONT COLOR="#3f3f3f"> oversees the
management of risks relating to financial reporting or fraud, securities trading and tax matters. Our Audit Committee also reviews any proposed related party transactions to ensure we do not engage in transactions that would create a conflict of
interest or result in harm to us. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Compensation Committee</FONT><FONT COLOR="#3f3f3f"> periodically
assesses our compensation policies and practices, including structuring and reviewing our executive compensation programs, in order to determine whether any such policies or practices are reasonably likely to have a material adverse effect on us.
Our Compensation Committee also assists the Board in its oversight of our human capital management function. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Nominating and Corporate Governance Committee</FONT><FONT
 COLOR="#3f3f3f"> oversees our governance practices and the management of related risks, including director independence and Board composition and succession of both the Board and CEO, and the development and administration of our Code of Conduct.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Research&nbsp;&amp; Development Committee</FONT><FONT
 COLOR="#3f3f3f"> evaluates risks associated with the scientific discovery process, preclinical and clinical development programs, to the extent not within the purview of the Risk Committee&#146;s oversight of our compliance programs.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc7841">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Our </FONT><FONT COLOR="#fc7841">Risk Committee</FONT><FONT COLOR="#3f3f3f"> assists the Board
with oversight of our internal risk management framework, policies, guidelines and infrastructure, and, if called for, its administration of government and other investigations and
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">17</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">material litigation matters. The Risk Committee receives reports from management&#146;s Ethics Committee and also oversees management in the dispatch of its responsibility to administer our various
compliance programs, including, but not limited to, data privacy (including cybersecurity), drug safety, healthcare compliance and quality management. Finally, the Risk Committee oversees our business and operational risks that are not specifically
allocated to the Board or another committee of the Board. The Risk Committee provides periodic reports to the full Board. </FONT></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Senior management presents the full Board with frequent business updates during monthly teleconferences, at which time the Board provides management with feedback, makes recommendations and, as needed, issues directives to address
our risk exposure. </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:1px solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:12pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; padding-left:8pt; padding-right:2pt"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">BOARD OVERSIGHT OF
<FONT STYLE="white-space:nowrap">COVID-19</FONT> IMPACT AND COMPANY RESPONSES</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:1px solid #fc4c02; padding-left:8pt; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.30em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> global pandemic, management provided regular reports to
both the Risk Committee and the full Board regarding potential and actual impacts of the pandemic on our clinical trial, drug discovery and commercial activities, as well as our general business operations. Included in these reports were the various
strategies and mitigation efforts undertaken by management to maintain business continuity while protecting the health and safety of employees, contractors and patients that rely on our critical cancer medicines. Both the Risk Committee and the full
Board will continue to receive information from management relating to the effects of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the company, its operations and employees on a frequent and regular basis for the foreseeable
future.</FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Prohibitions on Derivative, Hedging, Monetization and Other Transactions </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We maintain an insider trading policy that applies to directors and employees, including our executive officers, which prohibits certain
transactions in our stock, including short sales, puts, calls or other transactions involving derivative securities, hedging or monetization transactions, purchases of Exelixis securities on margin or borrowing against an account in which Exelixis
securities are held, or, subject to the following exception, pledging Exelixis stock as collateral for a loan. There are no exceptions to these prohibitions, other than the pledging of Exelixis stock as collateral for a loan, which requires prior
approval of Exelixis&#146; Securities Compliance Committee (comprising senior members of our legal and finance teams). Before granting the exception, the Securities Compliance Committee will require such director or employee to establish his or her
financial capacity to repay the loan without resort to the pledged securities, and the pledged securities may not be sold without the advance written consent of the Securities Compliance Committee. As of the date of this Proxy Statement, no shares
of Exelixis stock are pledged by any of our directors or executive officers. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Corporate Responsibility and Sustainability </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Exelixis&#146; mission is to help cancer patients recover stronger and live longer. As we strive to extend and improve cancer patients&#146;
lives, we recognize the need also to contribute positively to society as a whole. To that end, Exelixis expects that its employees will commit to the highest standards of ethical behavior and maintain values and principles that reflect both global
awareness and sustainability. This entails integrating environmental, social and governance (ESG) considerations directly into our research and development projects, business operations and investment processes as we strive to create sustained value
for all our stakeholders by translating science into impact for patients and all those we serve. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">18</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Corporate Governance </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We seek to achieve these commitments through a number of initiatives, including those listed below: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Our Governance and Compliance </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g63026g41k86.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>At Exelixis, we recognize that good governance, corporate responsibility and accountability are critical to
our quest to treat and defeat cancer. We embed strong compliance practices and oversight into our scientific and business activities with the goal that these business activities be conducted in a legal and ethical manner and in the best interests of
all Exelixis&#146; stakeholders, in particular, the patients we serve.
</I></FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Strong internal governance structure relies upon the management-level Ethics Committee and its subcommittees, overseen by the Board-level Risk Committee </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Requirement for systematic and periodic reporting to senior management and our Board of Directors on matters relating to our Corporate Code of Conduct, including responding to and escalating key
issues and concerns as needed </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Commitment to high standards and ethics across all departments and company stakeholders, as reflected by our internal policies, including our <I>Policy for Recoupment of Variable Compensation
(Clawback Policy)</I> </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Comprehensive training programs covering various compliance matters and utilizing both live <FONT STYLE="white-space:nowrap">(in-person</FONT> or virtual) classroom sessions and interactive online
modules.<I> </I> </FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Access to Health </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g63026g48v36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>At Exelixis, we value being exceptional in what we do and how we lead, excelling for patients by going the
extra mile to care for them and exceeding together as a business and contributor to the scientific community. We dedicate substantial financial resources and work tirelessly in our efforts to offer patients high-quality, safe and effective cancer
treatments. Moreover, once our products are available, our goal is to ensure that no patient prescribed an Exelixis medicine will go without it due to lack of insurance or inability to pay. </I></FONT></P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Long history of dedicated research and development efforts, focused on creating better treatments for patients </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Thoughtful pricing decisions that account for patient access (including discounting and rebates for certain group purchases), reinvestment designed to improve our drugs and production costs
</FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Exelixis Access Services (EASE), a comprehensive resource that provides <FONT STYLE="white-space:nowrap">co-pay</FONT> assistance, allows qualifying uninsured or underinsured patients to receive
medication free of charge and connects patients with healthcare providers to assist with their treatment </FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">19</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Taking Responsibility
for Our Products </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g63026g97h93.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The well-being of patients is a top priority for us. Our Corporate Code of Conduct holds every Exelixis
employee accountable to safe and ethical standards of work and behavior, and is designed to ensure our products are developed in compliance with Good Practice quality guidelines. As a core reflection of Exelixis values, product responsibility is
monitored by teams with a direct chain of reporting to our Ethics Commmittee and overseen by our Board of Directors. This process is designed to allow us to escalate and address issues quickly and holistically. </I></FONT></P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Quality assurance program designed to ensure safe and ethical development and manufacturing practices </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Initiatives designed to provide transparency to clinical patients regarding important study considerations and pseudonymization of all patient data designed to protect sensitive personal
information </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Anticounterfeiting and serialization practices designed to safeguard product integrity in our supply chain and system to manage product recalls (should one become necessary)
</FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Environmental </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g63026g97o48.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Exelixis is committed to conducting business in a way that respects our environment and the Earth&#146;s
changing climate, and that is also consistent with serving the well-being of our patients, employees and all our stakeholders. We have already incorporated many environmentally sustainable practices into our facilities and operations, and we plan to
incorporate more of these practices as we continue to grow.
</I></FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Continued implementation of more energy-efficient systems in our headquarters and use of renewable energy sources, including for additional office space currently under construction
</FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Employee commuter programs designed to take cars off the road, as well as electric vehicle charging stations, which together reduce emission of greenhouse gases </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Waste reduction practices with an emphasis on recycling by employees and a commitment to adherence to applicable laws and regulations that govern the handling and disposal of hazardous materials
</FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Human Capital Management and
Workforce Diversity </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g63026g06f64.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Our mission to help cancer patients recover stronger and live longer depends on the talent and dedication
of our employees. We therefore invest in building their collective strength as a team by hiring the best qualified candidates available and fostering growth opportunities for individuals. At Exelixis, we
value</I><B><I></I></B><I></I><B><I>&nbsp;being exceptional</I></B><I>&nbsp;in what we do and how we lead,</I><B><I></I></B><I></I><B><I>&nbsp;excelling for patients</I></B><I>&nbsp;by going the extra mile to care for them
and</I><B><I></I></B><I></I><B><I>&nbsp;exceeding together</I></B><I>&nbsp;as a business and contributor to the scientific community.
</I></FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Program Highlights: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Integrate our strong corporate values into our new hire interview process, performance evaluations and promotion criteria </FONT></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Support of diversity in our workforce (with 48% and 46% of managerial roles held by <FONT STYLE="white-space:nowrap">non-whites</FONT> and women, respectively, as of the end of fiscal 2020) and
insistence upon anti-discrimination in hiring and promotion practices </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Comprehensive safety measures in response to <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, combined with regular inspections and training to promote general workplace safety and low
rate of accidents </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="19">&nbsp;</TD>
<TD WIDTH="22" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Competitive benefits programs to recruit and retain talented employees and a collaborative workplace culture that fosters individual development while embodying our corporate values
</FONT></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Further information about
our ESG programs and sustainability efforts is available on our website at <I>www.exelixis.com</I> under the caption &#147;Impact&#151;Environmental, Social and Governance.&#148; </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">20</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Corporate Governance </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder Communications with the Board </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Board welcomes communications from Exelixis&#146; stockholders. Stockholders may communicate with the Board by sending a written communication to &#147;Exelixis, Inc., Board of Directors c/o Corporate Secretary, 1851 Harbor Bay
Parkway, Alameda, California 94502.&#148; Stockholders may also communicate with the Board by facsimile at <FONT STYLE="white-space:nowrap">(650)&nbsp;837-7951</FONT> or by <FONT STYLE="white-space:nowrap">e-mail</FONT> at info@exelixis.com, with
each of the foregoing sent with &#147;Attn: Board of Directors&#148; in the &#147;Subject&#148; line. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each communication must set
forth the name and address of the stockholder as it appears in the Exelixis&#146; records (and, if the stock is held by a nominee, the name and address of the beneficial owner of the stock). After confirming the stock ownership of the author of the
communication, the Corporate Secretary will review and evaluate the communication, and shall have the authority to and will screen out communications from stockholders that are not directly related to the duties and responsibilities of the Board.
The Corporate Secretary may also disregard duplicative communications. If deemed directly related to the duties and responsibilities of the Board, the Corporate Secretary will forward the communication, depending on the subject matter, to the Chair
of the Nominating and Corporate Governance Committee, the Chair of the Audit Committee, the Chair of the Board, the independent directors, or the full Board, as deemed appropriate. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Stockholder Outreach </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We
maintain a robust program for stockholder outreach to elicit a better understanding of the concerns and perspectives of our stockholder base, and we have implemented the feedback received from our stockholders into our executive compensation
program, governance practices and other areas of our business. For additional details about our stockholder outreach efforts during fiscal 2020, please see &#147;<A HREF="#tx63026_a2">Compensation Discussion and Analysis&#151;How We Determine Executive
 Compensation&#151;Stockholder Outreach</A>.&#148; </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="tx63026_a35"></A>Stock Ownership Guidelines for <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We maintain Stock Ownership Guidelines for our directors and Named Executive
Officers (as defined below) to further align their financial interests with those of our stockholders, as well as to promote sound corporate governance. For our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, we amended our Stock
Ownership Guidelines in February 2021 to provide an ownership target of the value equivalent to 5 times the annual cash Board retainer, an increase from the prior target of the lesser of the value equivalent to 3 times the annual cash Board retainer
or 3,000 shares. All <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are expected to achieve their stock ownership targets within five years of becoming subject to these guidelines. The policy includes procedures for granting
exemptions in the case of severe financial hardship. Ownership targets for our Named Executive Officers (including those serving on our Board) are described below under<I></I><I>&nbsp;
&#147;</I><A HREF="#tx63026_a3">Compensation Discussion and Analysis&#151;Other Compensation Information&#151;Stock Ownership Guidelines</A>.&#148; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">In determining ownership levels for each <FONT STYLE="white-space:nowrap">non-employee</FONT> director under our Stock Ownership Guidelines, credit is provided for&nbsp;shares held outright (including shares owned through trusts,
the Amended and Restated Exelixis, Inc. 401(k) Plan (401(k)&nbsp;Plan), or by a spouse), as well as 50% of the number of vested, but unexercised, stock options. No credit is provided for RSUs (as defined below) until they vest. The values for all
shares determined to be held by our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and Named Executive Officers are based on the <FONT STYLE="white-space:nowrap">200-day</FONT> average stock price as of the measurement date. As of
February&nbsp;5, 2021, all of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors had met the required ownership targets. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><A NAME="toc63026_4"></A>Board Committees and Meetings </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board held seven meetings during 2020, and all of our directors attended at least 75% of the total meetings of the Board and of the
committees on which they served. The independent directors met four times in regularly scheduled executive sessions. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2020, the
Board had five standing committees: the Audit Committee; the Compensation Committee; the Nominating and Corporate Governance Committee; the Research&nbsp;&amp; Development Committee; and the Risk Committee. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">21</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Committee membership in
2020 was as follows: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">


<TR STYLE="visibility:hidden; line-height:0pt; color:white">

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD nowrap STYLE="font-size:8pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Board Member</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f"><B>Audit<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Compensation</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Committee</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f"><B>Nominating<BR>and&nbsp;Corporate<BR>Governance<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Research &amp;</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Development<BR>Committee</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f"><B>Risk<BR>Committee</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum,
Esq.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM,
Ph.D., FRS</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George A. Scangos,
Ph.D.&#094;</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A.
Smith</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L.
Wyszomierski</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Chair*</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#3f3f3f">Member</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #f2f2f2" BGCOLOR="#e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Number of Meetings Held
in Fiscal 2020</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>4</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>11</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>3</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>4</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-LEFT:1px solid #f2f2f2; BORDER-BOTTOM:1px solid #999999">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #999999" BGCOLOR="#e5e5e5"><FONT COLOR="#fc4c02"><B>2</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Designated by the Board as an &#147;audit committee financial expert.&#148;
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#094;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Scangos did not stand for <FONT STYLE="white-space:nowrap">re-election</FONT> at the 2020
Annual Meeting of Stockholders and resigned from the Board effective as of May&nbsp;20, 2020. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Audit Committee
</FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Audit Committee
assists the Board in overseeing our financial reporting process and ensuring the integrity of our financial statements. The Audit Committee is composed entirely of independent directors and performs several functions, including: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating the performance, qualifications, compensation and
continued engagement of the independent registered public accounting firm, as well as resolving any disagreements between the independent registered public accounting firm and management</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing our tax strategy, the status of any material tax
audits and proceedings and any other material tax matters</FONT></P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#ffffff">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#ffffff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing, providing oversight of, and approving related person
transactions</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the financial statements for inclusion in our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and preparing the Audit Committee&#146;s report for inclusion in our Proxy Statement or Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Establishing procedures to receive and address complaints
regarding accounting, internal accounting controls or auditing matters</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the results of the annual audit and the results of our
quarterly financial statement reviews with management and the independent registered public accounting firm</FONT></P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#ffffff">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#ffffff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing our management of risks relating to financial
reporting or fraud, securities trading and tax matters</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Serving as the Qualified Legal Compliance Committee within the
meaning of Rule 205.2(k) of Title 17, Chapter II of the Code of Federal Regulations</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Maintaining compliance with SEC and Nasdaq rules applicable to
audit committees</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing and approving our decisions to enter into certain
swaps and other derivatives transactions, as well as our overall hedging strategy</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board has determined that each member of the Audit Committee is an &#147;audit committee financial
expert&#148; as defined in applicable SEC rules. Although Mr.&nbsp;Wyszomierski, the Chair of our Audit Committee, also serves as a director and a member of the audit committee for three other publicly traded companies, he attended all Exelixis
Board and Audit Committee meetings during 2020 and makes himself generally available to assit or advise Exelixis management. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">22</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Board Committees and Meetings </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Audit Committee&#146;s report is set forth in &#147;<A HREF="#tx63026_a5">Report of the Audit Committee</A>&#148; below. The Audit
Committee has a written charter, which is available on our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Committee Composition and Charters.&#148; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Compensation Committee </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee assists the Board in overseeing our compensation policies, plans and programs. The Compensation Committee is composed
entirely of independent directors and performs several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing and determining the compensation to be paid to
executive officers</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing our Compensation Discussion and Analysis and preparing
the Compensation Committee&#146;s report for inclusion in our Proxy Statement</FONT></P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#ffffff">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#ffffff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Addressing any conflict of interest with any compensation
adviser engaged by management or the Compensation Committee</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Establishing general policies relating to compensation and
benefits of employees, including executive officers</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating director compensation and recommending any changes to
the Board for approval</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Administering the issuance of equity awards under our stock
plans</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Assisting the Board in its oversight of our policies and
strategies relating to our human capital management function, including reruiting, retention, career development and progression, <FONT STYLE="white-space:nowrap">non-CEO</FONT> management succession, diversity and employment
practices</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Assessing compensation policies and practices in order to
determine whether they are reasonably likely to have a material adverse effect on us.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee&#146;s report is set forth in &#147;<A HREF="#tx63026_a6">Compensation Committee Report
</A>&#148; below. Information on the Compensation Committee&#146;s processes and procedures for consideration of executive compensation are addressed in &#147;<A HREF="#tx63026_a7">Compensation Discussion and Analysis</A>&#148; below. For
information regarding our processes and procedures for the consideration and determination of director compensation, please see &#147;<A HREF="#tx63026_a8">Compensation of Directors</A>&#148; below. The Compensation Committee has a written charter,
which is available on our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Committee Composition and Charters.&#148; In accordance with its charter, the Compensation Committee also
may delegate any of its authority or responsibility to the Chair of the Compensation Committee or to a subcommittee composed of one or more members of the Compensation Committee and/or other members of the Board and/or officers of Exelixis.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><I>Compensation Consultants. </I></FONT><FONT STYLE="font-family:Calibri" COLOR="#3f3f3f">The
Compensation Committee retained Radford, a compensation consulting firm serving technology and life sciences companies, as its external compensation consultant to assist the Compensation Committee in its duties related to executive and <FONT
STYLE="white-space:nowrap">non-employee</FONT> director compensation during 2020. In this capacity, Radford reported directly to the Compensation Committee or through its Chair. In addition, at the direction of the Compensation Committee, management
retained Radford, principally to provide benchmark and industry compensation data for executive and broad-based compensation analyses. In consideration for compensation related services provided during 2020 we paid Radford an aggregate of $219,737.
Radford also provided our management with access to the Radford Global Life Sciences Survey, Radford Global Technology Survey, Radford Global Sales Survey, Radford U.S. Benefits Survey and similar materials, for which we paid Radford an aggregate of
$28,857 in 2020. Radford is an Aon Hewitt company and an affiliate of Aon Risk Services which provided insurance brokerage services to us during 2020 at a total cost of $205,000. See &#147;<A HREF="#tx63026_a9">Compensation Discussion and
Analysis</A>&#148; for more information regarding the Compensation Committee&#146;s engagement of Radford. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">23</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Nominating and
Corporate Governance Committee </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Nominating and Corporate Governance Committee oversees all aspects of our corporate governance functions on behalf of the Board. The Nominating and Corporate Governance Committee is composed entirely of independent directors and
performs several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing our governance practices, including reviewing and
recommending to the Board for approval any changes to our corporate governance framework</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Ensuring effective communication between the Board, its
committees and management, as well developing and administering policies and procedures for stockholders&#146; communications to the Board</FONT></P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#ffffff">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#ffffff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Conducting periodic assessments of the performance of the Board
and its committees and compliance with SEC and Nasdaq requirements for independence and expertise</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Facilitating our CEO Succession Plan in the event our Chief
Executive Officer is no longer able to serve in that position</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Identifying, reviewing and evaluating candidates to serve as
directors and recommending qualified candidates to the Board</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Developing a set of Corporate Governance Guidelines, as well as
administering our Corporate Code of Conduct</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In addition, as part of its oversight of our governance practices, the Nominating and Corporate Governance
Committee oversees management in its preparation of public disclosures pertaining to our ESG programs and sustainability efforts. The Nominating and Corporate Governance Committee has a written charter, which is available on our website at
<I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Corporate Governance&#151;Committee Composition and Charters.&#148; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
STYLE="font-family:Calibri" COLOR="#fc7841"><I>Director Qualifications; Diversity.</I></FONT><FONT STYLE="font-family:Calibri" COLOR="#3f3f3f"> The Nominating and Corporate Governance Committee does not have a fixed set of minimum qualifications for
candidates for membership on the Board. Instead, in considering candidates for directorship, the Nominating and Corporate Governance Committee will generally consider all relevant factors, including the candidate&#146;s applicable expertise and
demonstrated excellence in his or her field, the usefulness of such expertise to us, the availability of the candidate to devote sufficient time and attention to the affairs of Exelixis, the existence of any relationship that would interfere with
the exercise of the candidate&#146;s independent judgment, and the candidate&#146;s demonstrated character and judgment. In addition, the Board believes that its members should reflect a diversity of viewpoints, background, experience and other
characteristics such as gender and race. Accordingly, when evaluating candidates for nomination as new directors, the Nominating and Corporate Governance Committee considers (and will ask any search firm that it engages to provide) candidates who
would contribute to Board diversity, including women and individuals from historically underrepresented communities who meet the relevant business and search criteria. Both the Nominating and Corporate Governance Committee and full Board evaluate
the effectiveness of this diversity policy as part of their periodic performance assessments. In the director candidate review process, the Nominating and Corporate Governance Committee evaluates prospective candidates for directorship in the
context of the existing membership of the Board (including the qualities and skills of the existing directors), our operating requirements and the long-term interests of our stockholders. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Nominating and Corporate Governance Committee regularly evaluates the needs of the Board with respect to skills and experiences that may be
filled by a new director candidate. In addition, the Nominating and Corporate Governance Committee is authorized to access external resources as it deems necessary or appropriate to fulfill its defined responsibilities, including engagement of
executive search firms to help identify director candidates. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><I>Director Nominations. </I></FONT><FONT
STYLE="font-family:Calibri" COLOR="#3f3f3f">The Nominating and Corporate Governance Committee considers and assesses all candidates recommended by our directors, officers and stockholders. Evaluations of candidates generally involve a review of
background materials, internal discussions and interviews with selected candidates as appropriate. If, after its review, the Nominating and Corporate Governance Committee supports a candidate, it would recommend the candidate for consideration by
the full Board. The Nominating and Corporate Governance Committee considers stockholder recommendations for directors using the same criteria as potential nominees recommended by the members of the Nominating and Corporate Governance Committee or
others. The Nominating and Corporate Governance Committee has not received any recommended nominations from any stockholder holding 5% or more of our common stock in connection with the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">24</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 1&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Board Committees and Meetings </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stockholders who wish to recommend individuals for consideration by the
Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by delivering a written recommendation to the Nominating and Corporate Governance Committee within the timeframe specified in our Bylaws that is
applicable to matters to be brought before an annual meeting of stockholders as set forth under &#147;<A HREF="#tx63026_a10">Questions and Answers About These Proxy Materials and Voting</A>&#148; above. Such communications should be sent to the
following address: Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502, Attn: Nominating and Corporate Governance Committee of the Board. Submissions must include (a)&nbsp;the name, age, business address and residence address of such
person, (b)&nbsp;the principal occupation or employment of such person, (c)&nbsp;the class and number of shares of the corporation which are beneficially owned by such person, (d)&nbsp;a description of all arrangements or understandings between the
stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder, (e)&nbsp;a statement whether such person, if elected, intends to comply with our
Corporate Governance Guidelines, including with respect to matters relating to the election of directors, and (f)&nbsp;any other information relating to such person that is required to be disclosed in solicitations of proxies for election of
directors, or is otherwise required, in each case pursuant to Regulation&nbsp;14A under the 1934 Act (including without limitation such person&#146;s written consent to being named in the proxy statement, if any, as a nominee and to serving as a
director if elected). </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#fc7841"><I>Performance Assessments.</I></FONT><FONT
STYLE="font-family:Calibri" COLOR="#3f3f3f"> The Nominating and Corporate Governance Committee performs periodic assessments of the performance of the Board and its committees. As part of this process, each director, under the direction of the
Nominating and Corporate Governance Committee, completes an annual assessment questionnaire for the full Board and each committee on which such director serves to evaluate, anonymously, the overall performance of the Board and its committees and
identify areas for improvement. The factors considered in the annual assessment questionnaires include, but are not limited to: the appropriateness of the size of the Board; whether the directors possess the skills and expertise appropriate for the
company; the effectiveness of the Board&#146;s selection criteria for new director candidates (including with respect to the Board&#146;s diversity policy); the overall effectiveness of and efficient use of time at Board and committee meetings; and
the process for management to report important information to committees or the full Board, as appropriate. The annual assessment questionnaires also provide each director with an opportunity to provide open-ended responses with respect to ways to
improve Board and/or committee performance. In addition, as part of the performance assessment process during certain years, each director will interview with an independent legal counsel to the Board to discuss his or her perspectives about the
Board&#146;s performance, as well as corporate governance goals and potential risks facing the company, and summaries of these interviews are then reported to the Board. The Nominating and Corporate Governance Committee and the full Board also seek
input from management and external advisors as part of the performance assessment process. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Research&nbsp;&amp; Development Committee
</FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Research&nbsp;&amp;
Development Committee assists the Board in overseeing various scientific matters related to our drug discovery and preclinical and clinical development programs. The Research&nbsp;&amp; Development Committee is composed entirely of independent
directors and performs several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing our clinical development program and internal drug
discovery activities</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating and discussing trends in the oncology treatment
landscape and potential effects on our pipeline strategy and other business needs</FONT></P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#ffffff">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#ffffff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the progress of preclinical assets that we have <FONT
STYLE="white-space:nowrap">in-licensed</FONT> or acquired and evaluating potential future business development opportunities</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Advising the Board on other matters of scientific importance as
the Board, in consultation with management, may designate from time to time</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">25</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Risk Committee
</FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #3f3f3f">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Risk Committee of the
Board assists the Board in overseeing management&#146;s responsibility to assess, manage and mitigate risks associated with our business and operational activities. The Risk Committee is composed entirely of independent directors and performs
several functions, including: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing our overall risk management framework and
infrastructure designed to identify, assess, manage and mitigate our material risks</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing management&#146;s administration of our various
compliance programs, including, but not limited to, those relating to data privacy (including cybersecurity), drug safety, healthcare compliance and quality management</FONT></P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#ffffff">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#ffffff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Reviewing the policies, guidelines and practices aimed at the
management of business and operational risks</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing management&#146;s administration of government and
other investigations and material litigation matters</FONT></P></TD></TR>
<TR BGCOLOR="#ffffff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Overseeing management&#146;s identification, assessment and
management of our business and operational risks not specifically allocated to the Board or another committee of the Board, and obtaining periodic reports from our Ethics Committee</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.10em; text-indent:-1.70em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#149;&#8195;&#8202;Evaluating and discussing trends in the relevant areas of risk
management and advising the Board on best practices with respect to risk management strategy and implementation</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_5"></A>Annual Meeting; Attendance </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board does not have a formal
policy with respect to the attendance of its members at Annual Meetings of Stockholders. Drs. Papadopoulos, Cohen and&nbsp;Morrissey were in attendance at the 2020 Annual Meeting of Stockholders. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">26</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Directors </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_6"></A><A NAME="tx63026_a8"></A>COMPENSATION OF
DIRECTORS </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Overview of Director Compensation </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The compensation program for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors is intended to be competitive and fair so that we
can attract optimal talent to our Board and recognize the time and effort required of a director given the size and complexity of our operations. In accordance with its charter, our Compensation Committee is responsible for recommending to the Board
for approval the annual compensation for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and acts on behalf of the Board in discharging the Board&#146;s responsibilities with respect to overseeing our compensation policies for <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. To assist with the Compensation Committee&#146;s and the Board&#146;s review, the Compensation Committee&#146;s external compensation consultant prepares a comprehensive annual assessment of
our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program. The assessment includes benchmarking director compensation against the same 2020 peer group used for executive compensation purposes, an update in recent trends
in director compensation and a review of related corporate governance best practices. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Cash Compensation Arrangements
</B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each <FONT STYLE="white-space:nowrap">non-employee</FONT> director receives an annual cash retainer for his or her service on the
Board, as well as an additional annual cash retainer if he or she serves as the Chair of the Board, on a committee or as the chair of a committee. In addition, our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors receive meeting fees
for attendance at each Board meeting or at each of their respective committee meetings in excess of the <FONT STYLE="white-space:nowrap">pre-determined</FONT> number of meetings for the fiscal year, which is included in the full description of the
2020 cash compensation arrangements for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in the table below. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The
table below provides information regarding the cash compensation arrangements for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for 2020. Dr.&nbsp;Morrissey receives no compensation in his capacity as a member of the Board.
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:41pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:41pt"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Service</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Fee Type</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>Cash&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>Compensation&nbsp;($)&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Board</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">31,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(2)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,500&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Audit Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">12,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">13,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(3)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Compensation Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(3)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Nominating&nbsp;&amp; Corporate Governance Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Research&nbsp;&amp; Development Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Risk Committee</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Additional&nbsp;Chair&nbsp;Retainer&nbsp;Fee</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Meeting Fee (1)(4)</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting for which minutes are generated count toward the meeting threshold to determine when
Meeting Fees are to be paid. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting Fee paid for all meetings in excess of eight meetings. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting Fee paid for all meetings in excess of seven meetings. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Meeting Fee paid for all meetings in excess of four meetings. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All cash compensation is paid to each director in arrears on a quarterly basis for services performed during the prior fiscal quarter.
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">27</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a11"></A><A NAME="tx63026_a12"></A>Equity Compensation Arrangements </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are also eligible to receive equity as part of their Board service, including
an initial award upon joining the Board and an annual award on the day following each annual meeting of stockholders. Grants to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are made under our 2017 Equity Incentive Plan (2017
Plan), pursuant to the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Equity Compensation Policy, as amended (Directors&#146; Policy), as adopted by the Board.&nbsp;To address changes in the trading price of our common stock, we
utilize a value-based approach for determining the number of shares subject to <FONT STYLE="white-space:nowrap">non-employee</FONT> director equity awards. Under the terms of the Directors&#146; Policy, the aggregate value of each <FONT
STYLE="white-space:nowrap">one-time</FONT> initial award is $680,000, and the aggregate value of each annual award is $400,000. The value of each initial award and annual award is then divided approximately evenly between a nonstatutory stock option
and a restricted stock unit (RSU) award. However, effective as of February 2020, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director may instead elect to receive the full value of his or her annual award in the form of either RSUs or
nonstatutory stock options. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under the Directors&#146; Policy, the total number of options and RSUs granted as part of each initial
award and annual award is determined using a formula based upon the Black-Scholes Merton option pricing model and the average of the daily closing sale prices of our common stock for the trading days during the
<FONT STYLE="white-space:nowrap">30-day</FONT> calendar period ending on (and including) the last calendar day immediately prior to the relevant grant date. The value of each award, as determined in accordance with the Directors&#146; Policy, may be
greater or lesser than the grant date fair value computed for financial reporting purposes and reflected in the &#147;<A HREF="#tx63026_29a">Director Compensation Table</A>&#148; below. This is a result of the different calculation employed to
determine the grant date fair value, which uses a formula based upon the Black-Scholes Merton option pricing model and the closing sale price of our common stock on the grant date. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Options granted under the 2017 Plan in accordance with the Directors&#146; Policy are not incentive stock options under the Internal Revenue Code
of 1986, as amended (the Code). The exercise price of each initial and annual stock option granted under the 2017 Plan is equal to 100% of the fair market value of a share of common stock on the grant date. Under the terms of the Directors&#146;
Policy, the <FONT STYLE="white-space:nowrap">one-time</FONT> initial options are immediately exercisable, but shares issued upon early exercise are subject to a repurchase right and will vest at the rate of 25% of the underlying shares on the first
anniversary of the grant date and monthly thereafter over the next three years. The annual options are immediately exercisable, but shares issued upon early exercise are subject to a repurchase right and will vest at the rate of 100% of the
underlying shares on the first anniversary of the grant date. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As long as the <FONT STYLE="white-space:nowrap">non-employee</FONT>
director continues to serve with us or with an affiliate of ours, the options continue to vest and be exercisable during their terms, and shares issued upon early exercise continue to vest. When the option holder&#146;s service terminates, we have
the right to repurchase any unvested shares acquired upon exercise of the option at the original exercise price without interest. The post-termination exercise period for the vested portion of options granted to our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors is generally set to terminate the earlier of three years after a <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s service terminates or the remainder of the term of
the option, as described in the form of option agreement for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors under the 2017 Plan (not to exceed seven years from the date of grant). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The initial RSU awards vest at the rate of 25% of the underlying shares on each of the first four anniversaries of the grant date, and the annual
RSU awards vest at the rate of 100% of the underlying shares on the first anniversary of the grant date, in each case so long as the <FONT STYLE="white-space:nowrap">non-employee</FONT> director continues to serve with us or with an affiliate of
ours. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In the event of a change in control, 100% of the <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s
outstanding and unvested equity awards will immediately vest, and any applicable repurchase rights we may have will terminate. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Reimbursement of Expenses </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The members of the Board are eligible for reimbursement of certain expenses incurred in connection with their attendance at Board meetings and their service on the Board in accordance with our policy. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Meaningful Limits on Director Compensation </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The aggregate value of all compensation granted or paid to any individual solely for service as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director may not exceed (a) $750,000 in total value with respect to any calendar
year after a <FONT STYLE="white-space:nowrap">non-employee</FONT> director is first appointed or elected to the Board or (b) $1,500,000 in total value with respect to the calendar year during which a
<FONT STYLE="white-space:nowrap">non-employee</FONT> director is first appointed or elected to the Board, in each case calculating the value of any stock awards based on the grant date fair value of such awards for financial reporting purposes.
These limits on <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation were approved by our stockholders and are included in our 2017 Plan. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">28</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation of Directors </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_7"></A><A NAME="tx63026_29a"></A>Director Compensation
Table </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following
table shows compensation information for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for the fiscal year ended January&nbsp;1, 2021. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Director Compensation for Fiscal 2020 </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fees&nbsp;Earned&nbsp;or<BR>Paid&nbsp;in&nbsp;
Cash<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock&nbsp;Awards<BR>($)(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option&nbsp;Awards<BR>($)(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">91,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">358,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">449,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum,
Esq.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">358,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">428,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">190,263</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">180,149</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">435,412</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">358,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">428,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">69,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">190,263</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">180,149</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">439,412</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">98,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">382,546</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">480,546</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM,
Ph.D., FRS</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">382,546</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">452,546</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George A. Scangos,
Ph.D.(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A.
Smith</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">76,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">382,546</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">458,546</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">68,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">358,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">426,410</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L.
Wyszomierski</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">190,263</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">180,149</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">450,412</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">On May&nbsp;21, 2020, each of Drs. Freire, Marchesi, Papadopoulos and Poste, Ms.&nbsp;Smith and
Mr.&nbsp;Wyszomierski were granted an RSU award pursuant to the Directors&#146; Policy. Each of Drs. Papadopoulos and Poste, and Ms.&nbsp;Smith elected to receive 100% of their annual award in the form of RSU awards. RSU awards granted to Drs.
Freire and Marchesi and Mr.&nbsp;Wyszomierski accounted for approximately 50% of the total value of their annual award. Amounts shown in this column reflect the grant date fair value of the RSU award as computed in accordance with Financial
Accounting Standards Board (FASB), Accounting Standards Codification Topic 718 (ASC 718). See &#147;<A HREF="#tx63026_a11">Equity Compensation Arrangements</A>&#148; above for a description of the RSU awards made to
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors on May&nbsp;21, 2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Only one RSU award was granted to each of Drs. Freire, Marchesi, Papadopoulos and Poste,
Ms.&nbsp;Smith and Mr.&nbsp;Wyszomierski during fiscal 2020 and, accordingly, the grant date fair value of that RSU award is reflected in the table. The aggregate number of shares subject to all RSUs held by each of these <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors as of January&nbsp;1, 2021, is as follows: Dr.&nbsp;Freire&#151;14,788 Dr.&nbsp;Marchesi&#151;7,728; Dr.&nbsp;Papadopoulos&#151;15,538; Dr.&nbsp;Poste&#151;15,538; Ms.&nbsp;Smith&#151;15,538
and Mr.&nbsp;Wyszomierski&#151;7,728. None of the other <FONT STYLE="white-space:nowrap">non-employee</FONT> directors received any RSU awards during fiscal 2020, and none of the other <FONT STYLE="white-space:nowrap">non-employee</FONT> directors
held any outstanding RSU or other stock awards as of January&nbsp;1, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">On May&nbsp;21, 2020, seven of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors
were granted an option to purchase our common stock pursuant to the Directors&#146; Policy. Each of Drs. Cohen, Garber and Willsey, and Mr.&nbsp;Feldbaum elected to receive 100% of their annual award in the form of options to purchase our common
stock, while each of Drs. Freire and Marchesi, and Mr.&nbsp;Wyszomierski elected to receive approximately 50% of their annual award in the form of options to purchase our common stock and approximately 50% of their annual award in the form of an RSU
award. Amounts shown in this column reflect the aggregate grant date fair value for the option awards granted in fiscal 2020 as computed in accordance with FASB ASC 718. The assumptions used to calculate the value of option awards are set forth in
Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended January&nbsp;1, 2021, submitted to the SEC on February&nbsp;
10, 2021. See &#147;<A HREF="#tx63026_a12">Equity Compensation Arrangements</A>&#148; above for a description of the option grants made to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors on May&nbsp;21, 2020. There can be no assurance
that the options will ever be exercised (in which case no value will actually be realized by the director) or that the value on exercise of stock options will be equal to the grant date fair value shown in this column. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Only one stock option award was granted to each of Drs. Cohen, Freire , Garber, Marchesi and
Willsey and Messrs.&nbsp;Feldbaum and Wyszomierski during fiscal 2020 and, accordingly, the grant date fair value of that stock option is reflected in the table. The aggregate number of shares subject to all stock options held by each of our current
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors as of January&nbsp;1, 2021, is as follows: Dr.&nbsp;Cohen&#151;248,049; Mr.&nbsp;Feldbaum&#151;228,049;
Dr.&nbsp;Freire&#151;</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">29</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">80,204; Dr.&nbsp;Garber&#151;248,049; Dr.&nbsp;Marchesi&#151;103,650; Dr.&nbsp;Papadopoulos&#151;168,194; Dr.&nbsp;Poste&#151;128,194; Ms.&nbsp;Smith&#151;139,919; Dr.&nbsp;Willsey&#151;248,049;
and Mr.&nbsp;Wyszomierski&#151;183,650. </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Scangos did not stand for <FONT STYLE="white-space:nowrap">re-election</FONT> at the
2020 Annual Meeting of Stockholders and resigned from the Board effective as of May&nbsp;20, 2020. As of January&nbsp;1, 2021, Dr.&nbsp;Scangos did not hold any options to purchase shares of our common stock or any outstanding RSU awards. The
compensation paid to Dr.&nbsp;Scangos in 2020 reflects the portions of his annual cash retainers for his service as a director and as a member of the Research&nbsp;&amp; Development Committee and Risk Committee earned during the first two quarters
of fiscal 2020. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">30</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Proposal 2&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Ratification of Selection of Independent Registered Public Accounting Firm </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_7"></A><A NAME="toc63026_8"></A>P<SMALL>ROPOSAL</SMALL>
2 </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#6d6d6d">R<SMALL>ATIFICATION</SMALL> <SMALL>OF</SMALL> S<SMALL>ELECTION</SMALL> <SMALL>OF</SMALL> I<SMALL>NDEPENDENT</SMALL>
R<SMALL>EGISTERED</SMALL> P<SMALL>UBLIC</SMALL> A<SMALL>CCOUNTING</SMALL> F<SMALL>IRM</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Audit Committee of the Board has
selected Ernst&nbsp;&amp; Young LLP as Exelixis&#146; independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2021. The Board, on behalf of the Audit Committee, has further directed that management submit the
selection of the independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. Ernst&nbsp;&amp; Young LLP has audited our financial statements for each of the twenty fiscal years in the period ended
January&nbsp;1, 2021. Representatives of Ernst&nbsp;&amp; Young LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of Ernst&nbsp;&amp; Young
LLP as Exelixis&#146; independent registered public accounting firm. However, the Board is submitting the selection of Ernst&nbsp;&amp; Young LLP to the stockholders for ratification as a matter of good corporate governance. If the stockholders fail
to ratify the selection, the Audit Committee of the Board will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment of a different independent
registered public accounting firm at any time during the year if they determine that such a change would be in the best interests of Exelixis and its stockholders. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The affirmative vote of the holders of a majority of the shares present or represented by proxy at the Annual Meeting and entitled to vote on
this proposal is required to ratify the selection of Ernst&nbsp;&amp; Young LLP. Abstentions will be counted toward the tabulation of votes cast on this proposal and will have the same effect as votes against this proposal. Broker <FONT
STYLE="white-space:nowrap">non-votes,</FONT> if any, will have no effect. </FONT></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;background-color:#e5e5e5;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; PROPOSAL 2. </B></FONT></P></div>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02">Principal Accountant Fees and Services </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The aggregate fees billed by Ernst&nbsp;&amp; Young LLP for the last two fiscal years for the services described below are as follows: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fiscal Year Ended</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:1pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">January&nbsp;1,<BR>2021</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">January&nbsp;3,<BR>2020</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Audit fees (1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,076,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,004,195</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Audit-related fees (2)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">66,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Tax fees:</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">477,736</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">515,748</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax compliance fees (3)</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>132,200</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>226,600</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other tax fees (4)</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>345,536</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>289,148</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All other fees (5)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">6,010</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,255</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>&nbsp;&nbsp;&nbsp;&nbsp;Total
Fees</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>$</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>2,639,746</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>$</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>2,594,198</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B></B>&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Audit fees&#148; consist of fees billed for professional services rendered for the audit of
our consolidated financial statements and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by Ernst&nbsp;&amp; Young LLP in connection with statutory and regulatory filings
and other engagements such as consents and review of documents filed with the SEC. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Audit-related fees&#148; consist of fees billed for assurance and related services that are
reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported under &#147;Audit fees.&#148; During fiscal 2020 and 2019 these services included consultations relating to various
transactions. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Tax compliance fees&#148; consist of fees for tax compliance and tax preparation.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Other tax fees&#148; consist of fees for tax advice and tax planning.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;All other fees&#148; consist of fees for products and services other than the services
described above. During fiscal 2020 and 2019, these fees related to an <FONT STYLE="white-space:nowrap">on-line</FONT> subscription to an Ernst&nbsp;&amp; Young LLP database. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">31</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All fees described
above were <FONT STYLE="white-space:nowrap">pre-approved</FONT> by the Audit Committee. The Audit Committee has determined that the rendering of the services other than audit services by Ernst&nbsp;&amp; Young LLP is compatible with maintaining the
independence of the independent registered public accounting firm. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> of
Services </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2020 and 2019, the Audit Committee of the Board <FONT STYLE="white-space:nowrap">pre-approved</FONT> the audit
and <FONT STYLE="white-space:nowrap">non-audit</FONT> services to be performed by Exelixis&#146; independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP. <FONT STYLE="white-space:nowrap">Non-audit</FONT> services are defined as
services other than those provided in connection with an audit or a review of our financial statements. The Audit Committee <FONT STYLE="white-space:nowrap">pre-approves</FONT> all audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services
rendered by Ernst&nbsp;&amp; Young LLP. The Audit Committee generally <FONT STYLE="white-space:nowrap">pre-approves</FONT> specified services in the defined categories of audit services, audit-related services, tax services and all other services up
to specified amounts. <FONT STYLE="white-space:nowrap">Pre-approval</FONT> may also be given as part of the Audit Committee&#146;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual
explicit <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis before the independent auditor is engaged to provide each service. The Audit Committee or its Chair, whom the Audit Committee has designated
as a <FONT STYLE="white-space:nowrap">one-person</FONT> subcommittee with <FONT STYLE="white-space:nowrap">pre-approval</FONT> authority, <FONT STYLE="white-space:nowrap">pre-approved</FONT> all audit fees, audit-related fees, tax fees and other
fees in 2020 and 2019. Any <FONT STYLE="white-space:nowrap">pre-approvals</FONT> by the subcommittee must be and were presented to the Audit Committee at its next scheduled meeting. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">32</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Report of the Audit Committee </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_9"></A><A NAME="tx63026_a5"></A>R<SMALL>EPORT</SMALL>
<SMALL>OF</SMALL> <SMALL>THE</SMALL> A<SMALL>UDIT</SMALL> C<SMALL>OMMITTEE</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The material in this report is not
&#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the Securities and Exchange Commission and is not deemed to be incorporated by reference in any filing of Exelixis under the Securities Act of 1933, as amended, or the Securities
Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In connection with the audited consolidated financial statements for the fiscal year ended January&nbsp;1, 2021, of Exelixis, Inc.
(&#147;Exelixis&#148;), the Audit Committee of the Board of Directors of Exelixis has: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(1) reviewed and discussed the
audited financial statements for the fiscal year ended January&nbsp;1, 2021, with management of Exelixis; </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(2)
discussed with Ernst&nbsp;&amp; Young LLP, Exelixis&#146; independent registered public accounting firm (&#147;Ernst&nbsp;&amp; Young&#148;), the matters required to be discussed by the applicable requirements of the Public Company Accounting
Oversight Board (&#147;PCAOB&#148;) and the SEC; and </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(3)&nbsp;received the written disclosures and the letter from
Ernst&nbsp;&amp; Young required by the applicable requirements of the PCAOB regarding Ernst&nbsp;&amp; Young&#146;s communications with the Audit Committee concerning independence, and has discussed with Ernst&nbsp;&amp; Young that accounting
firm&#146;s independence. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Based on the foregoing, the Audit Committee has recommended to the Board of Directors that the audited
financial statements be included in Exelixis&#146; Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended January&nbsp;1, 2021. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Audit Committee: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Jack L.
Wyszomierski, Chair </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Charles Cohen </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Stelios Papadopoulos </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Julie A. Smith </I></FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">33</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_10"></A>P<SMALL>ROPOSAL</SMALL> 3 </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#6d6d6d">A<SMALL>DVISORY</SMALL> V<SMALL>OTE</SMALL> O<SMALL>N</SMALL> T<SMALL>HE</SMALL> C<SMALL>OMPENSATION</SMALL> O<SMALL>F</SMALL> T<SMALL>HE</SMALL>
N<SMALL>AMED</SMALL> E<SMALL>XECUTIVE</SMALL> O<SMALL>FFICERS</SMALL> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our stockholders are entitled to vote to approve, on an
advisory basis, the compensation, as disclosed in this Proxy Statement, of our Chief Executive Officer, Chief Financial Officer and the other executive officers appearing in the table entitled &#147;<A HREF="#tx63026_a15">Summary Compensation
Table</A>&#148; later in this Proxy Statement (collectively, the Named Executive Officers). This vote is not intended to address any specific item of compensation, but rather the overall compensation of our Named Executive Officers and the
philosophy, policies and practices described in this Proxy Statement. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board encourages our stockholders to review the
compensation tables and read the disclosures set forth in the &#147;<A HREF="#tx63026_40a">Compensation Discussion and Analysis</A>&#148; section of this Proxy Statement that describe our executive compensation program and the compensation of our
Named Executive Officers for fiscal 2020. For the reasons described in this Proxy Statement, the Board believes that our executive compensation program strongly aligns with the interests of our stockholders, effectively ties executive compensation
with our performance and results in the attraction and retention of highly talented executives. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Accordingly, the Board recommends
that our stockholders vote FOR the following resolution: </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; margin-right:8%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#147;<B>RESOLVED,</B> that the
compensation paid to the Named Executive Officers, as disclosed pursuant to Item&nbsp;402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.&#148; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_11"></A>Required Vote and Board of Directors Recommendation </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Advisory approval of Proposal 3
requires the affirmative vote of a majority of the shares present or represented by proxy at the Annual Meeting and entitled to vote on this proposal. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the
same effect as votes against this proposal. Broker non-votes, if any, will have no effect. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our stockholders have expressed a
preference, and our Board has determined, to hold an advisory vote on executive compensation annually. We are presenting this Proposal 3 as required by Section&nbsp;14A of the Exchange Act. Our Board believes that approval of Proposal 3 is in our
best interests and the best interests of our stockholders for the reasons stated above. Because the vote is advisory, it is not binding on the Board or on us. Nevertheless, the views expressed by our stockholders, whether through this vote or
otherwise, are very important to the Board and the management team and, accordingly, the Compensation Committee and Board intend to consider the results of this vote in making determinations in the future regarding executive compensation
arrangements. Your vote will serve as an additional tool to guide the Compensation Committee and Board as they continue to improve the alignment of our executive compensation programs with business objectives and performance and with the interests
of our stockholders. Unless our Board changes the frequency of future advisory votes on executive compensation, the next advisory vote on executive compensation will be held at the 2022 Annual Meeting of Stockholders. </FONT></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;background-color:#e5e5e5;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:12pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#fc4c02"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; PROPOSAL 3. </B></FONT></P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">34</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Security Ownership of Certain Beneficial Owners and Management </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_12"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table sets forth certain information regarding the ownership of our common stock as of
February&nbsp;28, 2021, (except as noted) by: (i)&nbsp;each director and nominee for director; (ii)&nbsp;each of the executive officers named in the <A HREF="#tx63026_a16">Summary Compensation Table</A>; (iii)&nbsp;all current executive officers and
directors of Exelixis as a group; and (iv)&nbsp;all those known by us to be beneficial owners of more than five percent of our common stock. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Beneficially&nbsp;Owned&nbsp;(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;Name of Beneficial
Owner</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;of<BR>Common&nbsp;Stock</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Percentage<BR>of&nbsp;Total</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Officers and
Directors</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D. (2)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,206,563</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.
(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,389,159</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner
(4)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">778,861</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D. (5)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">722,307</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley
(6)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">491,517</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen, Ph.D.
(7)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">389,424</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Carl B. Feldbaum, Esq.
(8)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">216,570</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Maria C. Freire, Ph.D.
(9)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">109,048</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alan M. Garber, M.D.,
Ph.D. (10)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">260,767</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent T. Marchesi,
M.D., Ph.D. (11)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">162,037</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Stelios Papadopoulos,
Ph.D. (12)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,341,553</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">George Poste, DVM, Ph.D.,
FRS (13)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">270,648</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A. Smith
(14)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">140,682</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Lance Willsey, M.D.
(15)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">632,464</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jack L. Wyszomierski
(16)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">373,731</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">*</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All current directors,
executive officers as a group (16 persons) (17)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,480,854</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3.3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>5%
Stockholders</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">BlackRock, Inc.
(18)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">55 East 52nd Street</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">New York, New York 10055</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">31,387,574</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10.0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Vanguard Group
(19)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">100 Vanguard Blvd.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Malvern, Pennsylvania 19355</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">28,470,067</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9.1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Renaissance Technologies
LLC (20)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">800 Third Avenue</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">New York, New York 10022</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21,682,651</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">6.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">T. Rowe Price
Associates, Inc. (21)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">100 E. Pratt Street</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Baltimore, Maryland 21202</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">17,588,494</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5.6</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Less than one percent. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">This table is based upon information supplied by executive officers and directors and upon
information gathered by us about principal stockholders known to us. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, we believe that each of the stockholders named in this table has
sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 312,817,909 shares outstanding on February&nbsp;28, 2021, adjusted as required by rules promulgated by the SEC. The
percentage of beneficial ownership as to any person as of a particular date is calculated by dividing the number of </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">35</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">shares beneficially owned by such person, which includes the number of shares as to which such person has the right to acquire voting or investment power within 60 days of February&nbsp;28, 2021,
by the sum of the number of shares outstanding as of such date plus the number of shares as to which such person has the right to acquire voting or investment power within 60 days of February&nbsp;28, 2021. Consequently, the denominator for
calculating beneficial ownership percentages may be different for each beneficial owner. </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 1,059,683 shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the
Morrissey Family Living Trust dated July&nbsp;21, 1994, as amended. Also includes 1,129,152 shares Dr.&nbsp;Morrissey has the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2021. Also includes 17,728 shares held
by Dr.&nbsp;Morrissey under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 1,004,765 shares Dr.&nbsp;Schwab has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2021. Also includes 14,880 shares held by Dr.&nbsp;Schwab under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 627,890 shares Mr.&nbsp;Senner has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2021. Also includes 2,723 shares held by Mr.&nbsp;Senner under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 268,515 shares Mr.&nbsp;Hessekiel has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2021. Also includes 999 shares held by Mr.&nbsp;Hessekiel under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 23,539 shares held by Mr.&nbsp;Haley&#146;s spouse. Also includes 382,663 shares
Mr.&nbsp;Haley has the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2021. Also includes 10,648 shares held by Mr.&nbsp;Haley under our 401(k) Plan, determined based upon information provided in plan
statements. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 208,049 shares Dr.&nbsp;Cohen has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2021, 30,750 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 208,049 shares Mr.&nbsp;Feldbaum has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2021, 30,750 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 3,530 shares issuable pursuant to RSUs that will vest within 60 days of
February&nbsp;28, 2021 and 80,204 shares Dr.&nbsp;Freire has the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2021, 22,516 of which would be subject to repurchase by us, if so exercised.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 248,049 shares Dr.&nbsp;Garber has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2021, 30,750 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 103,650 shares Dr.&nbsp;Marchesi has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2021, 15,456 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 168,194 shares Dr.&nbsp;Papadopoulos has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 88,194 shares Dr.&nbsp;Poste has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 139,919 shares Ms.&nbsp;Smith has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 208,049 shares Dr.&nbsp;Willsey has the right to acquire pursuant to options exercisable
within 60 days of February&nbsp;28, 2021, 30,750 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Includes 183,650 shares Mr.&nbsp;Wyszomierski has the right to acquire pursuant to options
exercisable within 60 days of February&nbsp;28, 2021, 15,456 of which would be subject to repurchase by us, if so exercised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Total number of shares includes 4,560,196 shares of common stock held by our current directors
and executive officers as of February&nbsp;28, 2021, and entities affiliated with such directors and executive officers. Also includes 3,530 shares issuable pursuant to RSUs that will vest within 60 days of February&nbsp;28, 2021. Also includes
5,853,045 shares our directors and executive officers have the right to acquire pursuant to options exercisable within 60 days of February&nbsp;28, 2021, 176,428 of which would be subject to repurchase by us, if so exercised. Also includes 64,083
shares held by our current directors and executive officers under our 401(k) Plan, determined based upon information provided in plan statements. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">36</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Security Ownership of Certain Beneficial Owners and Management </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(18)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">BlackRock, Inc. reported that it has sole voting power over 30,304,654 of such shares and sole
dispositive power over all of the shares. Blackrock, Inc. also reported that Blackrock Fund Advisors beneficially owns 5% or more of our outstanding common stock. The information is based solely on a Schedule 13G/A, filed with the SEC on
January&nbsp;27, 2021, which provides information only as of December&nbsp;31, 2020, and, consequently, the beneficial ownership of BlackRock may have changed between December&nbsp;31, 2020 and February&nbsp;28, 2021. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(19)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The Vanguard Group reported that it has shared voting power over 217,705 of such shares, sole
dispositive power over 28,003,214 of such shares and shared dispositive power over 466,853 of such shares. The information is based solely on a Schedule 13G/A, filed with the SEC on February&nbsp;10, 2021, which provides information only as of
December&nbsp;31, 2020, and, consequently, the beneficial ownership of Vanguard may have changed between December&nbsp;31, 2020 and February&nbsp;28, 2021. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(20)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These shares are beneficially owned by Renaissance Technologies LLC (RTC), and Renaissance
Technologies Holdings Corporation (RTHC), the majority owner of RTC. RTC reported that it and RTHC each have sole voting power over 21,520,637 of such shares and sole dispositive power over all of the shares. The information is based solely on a
Schedule 13G/A filed with the SEC on February&nbsp;11, 2021, which provides information only as of December&nbsp;31, 2020, and, consequently, the beneficial ownership of RTC and RTHC may have changed between December&nbsp;31, 2020 and
February&nbsp;28, 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(21)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">T. Rowe Price Associates, Inc. reported that it has sole voting power over 3,195,069 of such
shares and sole dispositive power over all of the shares. The information is based solely on a Schedule 13G filed with the SEC on February&nbsp;16, 2021, which provides information only as of December&nbsp;31, 2020, and, consequently, the beneficial
ownership of T. Rowe Price Associates may have changed between December&nbsp;31, 2020 and February&nbsp;28, 2021. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">37</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_13"></A>INFORMATION ABOUT OUR EXECUTIVE OFFICERS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following chart sets forth certain information regarding our executive officers as of March&nbsp;29, 2021: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="70%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Age</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Position</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.&nbsp;(1)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">60</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President and Chief Executive Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">64</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President, Product Development and Medical Affairs and Chief Medical Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">53</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">45</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Commercial</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">52</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President and General Counsel</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">60</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Scientific Strategy and Chief Scientific Officer</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Please see &#147;<A HREF="#tx63026_12a">Director Nominees</A>&#148; in this Proxy Statement for
Dr.&nbsp;Morrissey&#146;s biography. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Gisela M. Schwab, M.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>President, Product Development and Medical Affairs and Chief Medical Officer</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D., has served as President, Product
Development and Medical Affairs and Chief Medical Officer since February 2016. Previously she served as Executive Vice President and Chief Medical Officer from January&nbsp;2008 to February 2016 and as Senior Vice President and Chief Medical Officer
from September 2006 to January 2008. From 2002 to 2006, she held the position of Senior Vice President and Chief Medical Officer at Abgenix, Inc., a human antibody-based drug development company. She also served as Vice President, Clinical
Development, at Abgenix from 1999 to 2001. Prior to working at Abgenix, from 1992 to 1999, she held positions of increasing responsibility at Amgen Inc., most recently as Director of Clinical Research and Hematology/Oncology Therapeutic Area Team
Leader. She has served as a member of the board of directors of Cellerant Therapeutics, Inc., a privately held biopharmaceutical company, since June 2012, and as a member of the board of directors of Genocea Biosciences, Inc., a publicly held
biopharmaceutical company, since February 2020. Previously, Dr.&nbsp;Schwab served as a member of the board of directors of Topotarget A/S, a publicly held biopharmaceutical company, from August 2011 through July 2014, and as a member of the board
of directors of Nordic Nanovector A.S., a Norwegian biotechnology company, from March 2015 through June 2020. She received her Doctor of Medicine degree from the University of Heidelberg, trained at the University of Erlangen-Nuremberg and the
National Cancer Institute and is board certified in internal medicine and hematology and oncology.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Christopher J. Senner</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President and Chief Financial Officer</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner, has served as Executive Vice
President and Chief Financial Officer (and in such capacity, as our principal financial officer and principal accounting officer, as defined under applicable securities laws) since July 2015. Prior to joining Exelixis, Mr.&nbsp;Senner served as Vice
President, Corporate Finance for Gilead Sciences, Inc., a biopharmaceutical company, from March 2010 to July 2015, where he was accountable for controllership, tax, treasury and corporate and operational financial planning. Mr.&nbsp;Senner
previously spent eighteen years at Wyeth, a pharmaceutical company acquired by Pfizer Inc. in 2009, in a variety of financial roles with increasing responsibility, most notably as Chief Financial Officer of Wyeth&#146;s U.S. pharmaceuticals business
and the BioPharma Business Unit. Since 2019, Mr.&nbsp;Senner has served as a member of the board of directors of Cortexyme, Inc., a publicly held clinical-stage biopharmaceutical company. Mr.&nbsp;Senner holds a B.S. in Finance from Bentley
College.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Patrick J. Haley</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President, Commercial</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley, has served as the company&#146;s
Executive Vice President, Commercial since February 2020 and has held positions of progressive commercial leadership since September 2010, serving as Senior Vice President, Commercial from December 2016 to February 2020, Vice President, Commercial
from November 2014 to November 2016, Executive Director, Sales&nbsp;&amp; Marketing from September 2013 to October 2014, Senior Director, Marketing from March 2012 to August 2013, and as Director, Marketing from September 2010 to February 2012.
Prior to joining Exelixis, from 2007 to 2010, he held positions of increasing responsibility at Genentech, Inc., on the Avastin marketing team, most recently Group Product Manager. Between 2003 and 2007, Mr.&nbsp;Haley served in various sales and
marketing roles at Amgen, Inc. He served as an analyst at PWC Securities, Lehman Brothers and Accenture from 1998 to 2001. Mr.&nbsp;Haley holds a Masters of Business Administration from University of Michigan, Ross School of Business, and a Bachelor
of Arts in Art History and Medieval and Renaissance Studies from Duke University.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">38</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Information About Our Executive Officers </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Jeffrey J. Hessekiel, J.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President and General Counsel</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:Calibri; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D., has served as Executive Vice
President and General Counsel since February 2014 and as Secretary from October 2014 to September 2017. From 2012 to 2014, he held the position of Senior Counsel at Arnold&nbsp;&amp; Porter Kaye Scholer LLP, where he advised emerging growth and
public companies, primarily in the life sciences sector, on complex legal issues connected with strategic transactions, healthcare compliance programs and investigations, and regulatory matters. Prior to working with Arnold&nbsp;&amp; Porter, from
2002 to 2012, he held positions of increasing responsibility at Gilead Sciences, Inc., most recently as Chief Compliance&nbsp;&amp; Quality Officer where he was responsible for the creation and management of Gilead&#146;s Corporate
Compliance&nbsp;&amp; Quality department. From 1998 to 2002, Mr.&nbsp;Hessekiel held the position of Associate, working on both litigation and corporate matters for Wilson Sonsini Goodrich and Rosati PC. Mr.&nbsp;Hessekiel also worked as an
Associate focusing on litigation matters for Heller Ehrman LLP from 1996 to 1998. Prior to joining Heller Ehrman LLP, Mr.&nbsp;Hessekiel also worked for several international <FONT STYLE="white-space:nowrap">non-governmental</FONT> organizations.
Mr.&nbsp;Hessekiel received his J.D. from The George Washington University Law School and is admitted to practice in California. Mr.&nbsp;Hessekiel received a B.A. in Political Science from Duke University.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.22em; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><I>Peter Lamb, Ph.D.</I></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Executive Vice President, Scientific Strategy and Chief Scientific Officer</B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:4pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #999999"><FONT STYLE="font-family:Calibri; font-size:4pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Peter Lamb, Ph.D., has served as Executive Vice
President, Scientific Strategy and Chief Scientific Officer since February 2016. Previously, he served as Executive Vice President, Discovery Research and Chief Scientific Officer from September 2009 to February 2016, as Senior Vice President,
Discovery Research and Chief Scientific Officer from January 2007 until September 2009, as Vice President, Discovery Pharmacology from December&nbsp;2003 until January 2007 and as Senior Director, Molecular Pharmacology and Structural Biology from
October 2000 until December 2003. Prior to joining Exelixis, from June 1992 until September 2000, Dr.&nbsp;Lamb held positions of increasing responsibility at Ligand Pharmaceuticals, a pharmaceutical company, most recently serving as Director of
Transcription Research. Dr.&nbsp;Lamb has held post-doctoral research fellowships at the Carnegie Institution, Department of Embryology, with Dr.&nbsp;S.L. McKnight and the University of Oxford with Dr.&nbsp;N.J. Proudfoot, working in the field of
gene regulation. He has authored numerous articles in the fields of gene expression, signal transduction and oncology, and is an author on multiple issued and pending U.S. patents. He has a Ph.D. in Molecular Biology from the ICRF/University of
London and a B.A. in Biochemistry from the University of Cambridge.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">39</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_14"></A>COMPENSATION OF EXECUTIVE OFFICERS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_15"></A><A NAME="tx63026_a7"></A><A NAME="tx63026_a9"></A><A NAME="tx63026_40a"></A>Compensation Discussion and Analysis
</FONT></P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This Compensation
Discussion and Analysis (CD&amp;A) explains the strategy, design, and decision-making related to our compensation programs and practices for our principal executive officer, our principal financial officer and our three other most highly compensated
executive officers, who we refer to collectively as our Named Executive Officers. This CD&amp;A is intended to provide perspective on the information contained in the tables that follow this discussion. For fiscal 2020, our Named Executive Officers
were: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Named Executive Officers</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02"><B>Title</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President and Chief Executive Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">President, Product Development and Medical Affairs and Chief Medical Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President and General Counsel</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J.
Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Executive Vice President, Commercial</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">While the principal purpose of this CD&amp;A is to discuss the compensation of our Named Executive Officers,
many of the programs discussed apply to other members of senior management who, together with the Named Executive Officers, are collectively referred to as our executive officers. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_16"></A>Executive Summary </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Our Business </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are an oncology-focused biotechnology company that strives to accelerate the discovery,
development and commercialization of new medicines for difficult-to-treat cancers. Since we were founded in 1994, four products resulting from our discovery efforts&nbsp;have progressed through clinical development, received regulatory approval and
established a commercial presence in various geographies around the world. Two are derived from cabozantinib, our flagship molecule, an inhibitor of multiple tyrosine kinases including MET, AXL, VEGF receptors and RET. Our cabozantinib products are:
CABOMETYX<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (cabozantinib) tablets, approved for advanced renal cell carcinoma (RCC), both alone and in combination with Bristol-Myers Squibb Company&#146;s OPDIVO<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (nivolumab), and previously treated hepatocellular carcinoma (HCC); and COMETRIQ<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (cabozantinib) capsules, approved for progressive,
metastatic medullary thyroid cancer. For these types of cancer, cabozantinib has become or is becoming a standard of care. The two other products resulting from our discovery efforts are:
COTELLIC<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (cobimetinib), an inhibitor of MEK approved as part of a combination regimen to treat specific forms of advanced melanoma and marketed under a collaboration with Genentech, Inc. (a
member of the Roche Group) (Genentech); and MINNEBRO<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in
Japan and licensed to Daiichi Sankyo Company, Limited. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Our COVID-19 Response </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In January 2020, prior to the onset of the COVID-19 pandemic, we outlined a series of strategic priorities and anticipated milestones for the
year, including generating&nbsp;top-line&nbsp;data from important clinical trials, completing enrollment of ongoing studies, initiating new pivotal trials and progressing our&nbsp;mid- and early-stage&nbsp;product pipeline. As the COVID-19 pandemic
crisis quickly developed in the early part of the year and imposed challenges on our business, we remained determined to make 2020 a period of focused execution and achievement for Exelixis. We rapidly devised and implemented COVID-19 response plans
across all facets of the organization in order to mitigate the impact of the pandemic on our business, our employees and the patients who rely on our medicines. We called on our team&#146;s collective resilience, focus and commitment to making every
day count, as we continued in our efforts on behalf of cancer patients. </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><I>Workplace Safety.</I> We were able to mitigate the risk of transmission of the virus by
reducing the number of employees working on-site at our Alameda headquarters, while simultaneously implementing enhanced safety and social distancing protocols and an on-site testing program. Despite displacement of most of our staff to their home
offices, we maintained efficiencies in our workstreams and organizational cohesion by expanding the use of technology systems, increasing the frequency and clarity of communications from executive management, and finding ways to improve coordination
across business units. In the context of these adjustments, we were also able to expand our workforce by 25% from 617 to 773 employees. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">40</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><I>Clinical Trials.</I> We convened a COVID-19 task force to meet daily and evaluate means to
moderate the impact of the pandemic on site activation, patient screening and enrollment, as well as help prevent material delays to our clinical trials through an ongoing assessment of the pandemic&#146;s impact. Wherever possible, we took
proactive steps in compliance with guidance issued by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and other regulatory agencies to support the safety of our patients and their access to treatment, as well as to
maintain the high quality of our clinical trials. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><I>Commercial Activities.</I> We maintained engagement with healthcare professionals and our
ability to educate and respond to questions about our products by transitioning our sales force from in-person promotional activities to primarily telephonic and virtual interactions. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><I>Supply Chain.</I> Notwithstanding global supply chain risks posed by the COVID-19 pandemic, we
took advantage of our longstanding practice of maintaining substantial inventories of drug substance and drug product and were able to safeguard the timely production and delivery of our products by working closely with third-party contract
manufacturers, distributors and suppliers, as well as collaboration partners. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f"><I>Pipeline Expansion.</I> We mitigated the impact of periods when the COVID-19 pandemic forced
lab closures by making efficient use of available third-party laboratory resources for early-stage drug discovery work, and once we were able to partially reopen our labs, we prioritized critical late-stage drug discovery activities.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2020 Financial Performance Highlights<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Despite the challenges posed by the COVID-19 pandemic, we delivered strong financial results in fiscal 2020, increasing total revenues by 2%
year-over-year and ending fiscal 2020 with a healthy cash and investments balance of over $1.5&nbsp;billion. Other key financial highlights from fiscal 2020 include: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Cabozantinib franchise net product revenues of $741.6&nbsp;million; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Total revenues of $987.5&nbsp;million, reflecting both strong product demand and significant
financial contributions generated from our collaborations; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Total operating expenses of $877.5&nbsp;million, up 47% from the prior fiscal year, underscoring
our commitment to investing in our product pipeline, while exercising disciplined expense management; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A fourth full year of operating profit, resulting in diluted earnings per share of $0.35.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts included in 2020 Financial Performance Highlights are calculated in accordance with U.S.
Generally Accepted Accounting Principles. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">41</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2020 Corporate
Performance Highlights </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g55e90.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g85y76.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We were able to continue to drive growth during fiscal 2020 in spite of the COVID-19 pandemic. We executed
commercially by devising new strategies to maintain engagement with prescribers despite restricted in-person access; we succeeded in the clinic by adjusting the operation of our clinical trials in compliance with established protocols, always
placing the highest priority on patient safety; and we created opportunity with drug discovery by advancing our research where it could be done safely and by supplementing it with research collaborations and in-licensing arrangements. Key highlights
of our corporate performance include: </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Navigation of Regulatory Pathways Toward Approval of CABOMETYX as Part of a
Combination Regimen to Treat Patients with Advanced RCC </B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Following acceptance of our supplemental New Drug Application (sNDA) in August 2020, on
January&nbsp;22, 2021, the FDA approved CABOMETYX in combination with OPDIVO as a first-line treatment for patients with advanced RCC, the most common form of kidney cancer. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">FDA approval was based on the results from Checkmate -9ER, a phase 3 pivotal trial evaluating the
combination regimen compared with sunitinib in previously untreated advanced or metastatic RCC, which read out positively in April 2020. The compelling results from CheckMate -9ER, which revealed that the combination of CABOMETYX and OPDIVO
significantly improved progression-free survival, overall survival, objective response rate and quality of life compared to sunitinib, are expected to be a key driver of revenue growth in 2021 and beyond. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To make the combination regimen available to eligible RCC patients outside of the U.S, we worked
closely with our collaboration partners Ipsen Pharma SAS (Ipsen) and Takeda Pharmaceutical Company Limited (Takeda) on their respective regulatory strategies. In October 2020, Takeda submitted a supplemental application to the Japanese Ministry of
Labour, Health and Welfare (MHLW) to manufacture and market the combination of CABOMETYX and OPDIVO as a treatment for patients with advanced RCC, and in March 2021, Ipsen received regulatory approval from the European Commission for the combination
of CABOMETYX and OPDIVO as a first-line treatment for advanced RCC. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Successful
Commercialization of CABOMETYX in Approved RCC and HCC Indications </B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In the U.S., we continued to promote CABOMETYX within its labeled RCC and HCC indications and
educate physicians on the product&#146;s unique clinical profile. These efforts helped drive continued strong product demand in 2020 despite increased competition from therapies that combine an immune checkpoint inhibitor (ICI) with another targeted
agent to treat cancer. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In markets outside of the U.S., we worked closely with our partners Ipsen and Takeda in support
of their respective regulatory strategies and commercialization efforts for CABOMETYX. As a result of additional approvals in territories outside of the U.S., CABOMETYX continued to grow both in sales revenues and the number of RCC and HCC patients
benefiting from its clinical effect in 2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In the Japanese market, our partner Takeda achieved two important regulatory milestones,
including approval from the Japanese MHLW to manufacture and market CABOMETYX as a treatment for patients with curatively unresectable or metastatic RCC in March 2020 and for patients with unresectable HCC that progressed after cancer chemotherapy
in November 2020. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">42</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Achievement of Positive Results from Potential
Label-Enabling Clinical Trials and Further Evaluation of Cabozantinib in Multiple Phase 3 Pivotal Trials </B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In December 2020, we announced positive top-line results from COSMIC-311, our pivotal phase 3
trial evaluating cabozantinib versus placebo in patients with radioactive iodine-refractory differentiated thyroid cancer (DTC). The trial met its co-primary endpoint of demonstrating significant improvement in progression-free survival with a
hazard ratio of 0.22, providing evidence of cabozantinib&#146;s efficacy as a monotherapy in this patient population, and shortly after year-end, the FDA granted Breakthrough Therapy Designation to cabozantinib as a potential treatment for this
indication. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To expand late-stage development of cabozantinib in combination with other therapies, we
completed enrollment for COSMIC-312, a phase 3 pivotal trial evaluating cabozantinib in combination with atezolizumab, an anti-PD-L1 ICI developed by F. Hoffmann-La Roche Ltd. (Roche), versus sorafenib in previously untreated advanced HCC in August
2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To reinforce our efforts in RCC, we substantially advanced the enrollment of COSMIC-313, a phase
3 pivotal trial evaluating the triplet combination of cabozantinib, nivolumab and ipilimumab versus the combination of nivolumab and ipilimumab in patients with previously untreated advanced intermediate- or poor-risk RCC.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Encouraging results from an interim analysis of the metastatic castration-resistant prostate
cancer (mCRPC) cohort of COSMIC-021,&nbsp;our phase 1b trial evaluating the combination of cabozantinib and atezolizumab in patients with locally advanced or metastatic solid tumors, were presented at the American Society of Clinical Oncology&#146;s
Genitourinary Cancer Symposium in February 2020. Based on regulatory feedback, we intend to file with the FDA for accelerated approval in an mCRPC indication in 2021, if such a strategy continues to be warranted by the emerging clinical data.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Also based on the encouraging clinical activity observed in COSMIC-021, in June and July 2020 we
initiated three phase 3 pivotal trials in collaboration with&nbsp;Roche, CONTACT-01, CONTACT-02 and CONTACT-03, evaluating the combination of cabozantinib with atezolizumab in patients with metastatic non-small cell lung cancer (NSCLC), mCRPC and
advanced RCC, respectively. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Expansion of Product Pipeline Beyond the Cabozantinib Franchise
</B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">We made substantial progress on our evaluation of XL092, a next-generation oral tyrosine kinase
inhibitor, including generating data that supports the expansion of XL092&#146;s clinical development and enrolling the first patient in the combination arm of the phase 1 trial evaluating the safety, tolerability, pharmacokinetics and preliminary
anti-tumor activity of XL092, both alone and in combination with atezolizumab in patients with advanced solid tumors. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In December 2020, the FDA accepted our investigational new drug (IND) application for XL102, a
potent, selective and orally bioavailable covalent inhibitor of cyclin-dependent kinase 7, and shortly after year-end, we initiated a phase 1 trial designed to evaluate XL102&#146;s safety, tolerability, pharmacokinetics and preliminary anti-tumor
activity, both as a single agent and in combination with other anti-cancer therapies in patients with locally-advanced or metastatic solid tumors. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In December 2020, we exercised our exclusive option for XB002, the lead oncology antibody-drug
conjugates (ADC) program under our research collaboration with Iconic Therapeutics, Inc. and subsequently filed an IND with the FDA in March 2021. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In an effort to expand our pipeline to encompass a variety of promising therapeutic modalities,
in September 2020 we entered into two collaboration and license agreements with NBE-Therapeutics AG (NBE) and entities affiliated with Catalent, Inc. (together, Catalent), each focused on the development of ADCs that have the potential to become
anti-cancer therapies. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In July 2020, we achieved a significant milestone under our collaboration agreement with
Genentech, when the FDA approved COTELLIC<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (cobimetinib) in combination with TECENTRIQ<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (atezolizumab) and ZELBORAF<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>(vemurafenib) for the treatment of patients with previously untreated BRAF V600 mutation positive advanced melanoma. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">43</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2020 Executive
Compensation Program Highlights </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The unprecedented nature of 2020 for Exelixis, as well as for all of our stakeholders, required
an equally unprecedented response from our management team and the entire Exelixis organization. From the onset of the COVID-19 pandemic, we moved decisively to protect our patients, our employees, and our business, and to ensure a reliable supply
of our critical cancer medicines for the patients who depend upon them. Despite the challenges of this unforeseeable global public health crisis, we were nevertheless able to achieve mission-critical research, development, commercial and operational
objectives established by the Compensation Committee prior to the onset of the pandemic. We were also able to create value for our stockholders by driving the expansion and depth of our commercial and investigational product offerings, growing our
revenues and improving our future business prospects through important partnerships with emerging biotech companies. The Compensation Committee believes that the 2020 compensation of all our employees, including our Named Executive Officers, is
appropriate not only due to the achievement of critical milestones under exceedingly difficult conditions, but also to continue to encourage their extraordinary efforts towards the achievement of our key priorities and anticipated milestones in 2021
and beyond. In consideration of the company&#146;s performance as summarized above, the Board and Compensation Committee took the following key actions with respect to 2020 compensation for our employees, including our Named Executive Officers:
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Key Compensation
Actions</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Description</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Approved Salary
Increases for Named Executive Officers</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In February 2020, the Compensation
Committee increased base salaries for all but one of our Named Executive Officers by between 4.0% and 5.0% over salaries for 2019. Mr. Haley received a base salary increase of 10.2% in connection with his promotion to the level of Executive Vice
President in February 2020.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maintained a 100%
Performance-Based Long-Term Incentive Program (LTIP)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In September 2020, as part of our
long-term incentive program, the Compensation Committee granted 100% performance-based RSU awards (PSUs). A 100% PSU approach strongly aligns our Named Executive Officers&#146; compensation with the interests of our stockholders because the PSUs
only vest upon the achievement of clinical and regulatory milestones critical to our future long-term growth.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Did Not Adjust
Performance Targets for LTIP or Annual Cash Bonus Plan</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Notwithstanding the challenges imposed by
the COVID-19 pandemic on our business, the Compensation Committee did not adjust the performance targets for either our LTIP or our Annual Cash Bonus Plan. Rather, the Compensation Committee believed that the established programs were appropriate
and that the performance targets remained critical business objectives for the company.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Approved Annual
Cash Bonuses That Are Aligned With Strong Company Performance</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In February 2021, the Compensation
Committee approved the payment of cash bonuses in amounts between 114% and 144% of each Named Executive Officer&#146;s 2020 target cash bonus amounts. These decisions reflected the Compensation Committee&#146;s assessment of our strong corporate
performance, including the overall achievement of our pre-determined 2020 corporate goals, and the individual contribution of each Named Executive Officer toward achievement of our corporate goals. In its decision-making, the Compensation Committee
considered the unforeseen burden of the COVID-19 pandemic on our operations and the extraordinary response taken by our Named Executive Officers to mitigate its impact on the various facets of our organization, while simultaneously achieving
critical business milestones under exceptionally challenging conditions. The Compensation Committee believed it was important to recognize this extraordinary effort to secure the retention of our Named Executive Officers, whose leadership is
critical to our ability to maintain business continuity during these challenging times and to achieve our future objectives. Accordingly, the Compensation Committee decided to exercise discretion afforded to it under the Annual Cash Bonus Plan to
increase the corporate performance factor from 108% to 120%. Understanding that our 2020 achievements would not have been possible without the support of our entire organization, the Compensation Committee also approved a bonus pool for employees
who did not participate in the Annual Cash Bonus Plan in an amount equal to 120% of the aggregate target cash bonus amounts for all such employees.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">44</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Compensation Practices and Governance Highlights </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="64%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Pay for
Performance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We link the compensation of our Named Executive Officers to our corporate performance.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Stockholder
Alignment</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We use long-term equity incentives to align the interests of our Named Executive Officers with those of our stockholders.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Alignment of
Compensation Metrics and Corporate Strategy</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Compensation Committee establishes long-term incentive compensation programs based on metrics that are aligned with our corporate strategy and designed to build value for our
stockholders.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Compensation
Governance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Compensation Committee is made up entirely of independent directors and engages an independent compensation consultant to advise on executive compensation matters.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Stockholder
Feedback</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We value the feedback of our stockholders and solicit it on a regular basis, including through an annual stockholder vote to approve our say-on-pay proposal.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Recoupment (or
Clawback) Policy</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We maintain a Clawback Policy that permits the company to recoup variable compensation from senior level employees, including our Named Executive Officers, in the event of misconduct that
causes material harm to the company.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Annual Cash Bonus
Amounts Subject to Payment Maximums</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Annual Cash Bonus Plan sets a cap of 200% on the payouts of target bonus payments for individual and/or corporate performance.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Equity Plan
Features</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Applies a maximum 7-year term for stock options.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Prohibits repricing of underwater stock options without prior stockholder approval.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;The 2017 Plan also includes minimum vesting requirements of no less than one year for all types of awards, subject to limited exceptions.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Stock Ownership
Guidelines</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We apply stock ownership guidelines to directors and executive officers to further align their interests with those of our stockholders.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Change in Control
Provisions</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Does not include excessive change in control or severance payments.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Provides &#147;double-trigger&#148; change in control benefits.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Does not include tax gross-ups on severance or change in control benefits.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Perquisites,
Retirement and Pension Benefits</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Named Executive Officers do not receive excessive perquisites or post-termination retirement or pension benefits that are not available to all employees generally.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Prohibition on
Hedging and Margin Loans</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We prohibit hedging and purchases on margin by executive officers and directors.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Meaningful Limits on
Pledging</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;We limit pledging of our common stock by executive officers and directors to circumstances where the individual can clearly demonstrate the financial capacity to repay the loan without
resorting to the pledged securities. No executive officers or directors pledged our common stock during 2020.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#6d6d6d"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#6d6d6d"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Compensation Risk
Assessment</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.80em; text-indent:-1.80em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8195;&#8202;Our Compensation Committee conducts an annual risk assessment of our compensation policies and practices to ensure that our programs are not reasonably likely to have a material adverse
effect on us.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_17"></A>Objectives of the Compensation Program </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The primary goals of our executive compensation program are to: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Provide market-competitive compensation that attracts, retains and motivates our executive
officers to achieve our short- and long-term business objectives; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">45</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Align our executive officers&#146; compensation with the interests of our stockholders; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Reward our executive officers for success in achieving our corporate goals.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The success of any biotechnology company depends in large part upon the quality of its work force. Therefore, we
believe it is critical to our business that we retain our core team of highly qualified employees, including our Named Executive Officers. As a testament to the high demand for their services in the marketplace, large pharmaceutical and
biotechnology companies and strong local competitors have pursued our executives and other highly skilled employees. In light of this competitive pressure, each year we design our executive compensation program to help attract, motivate and retain
highly qualified individuals with relevant experience in the biotechnology industry to manage the varied aspects of our growing business operations. We believe the twelve-year average tenure of our executive officers and the strength of our
corporate and financial performance are evidence of what we believe to be the effectiveness of our compensation program with respect to retention and building value for our stockholders. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_18"></A>How We Determine Executive Compensation </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Role of the Compensation Committee, Compensation Consultants and Executive Officers in Compensation Decisions </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Role of the Compensation Committee </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Compensation Committee is responsible for evaluating and approving the compensation packages offered to our Named Executive Officers. When appropriate, the Compensation Committee will solicit the input of, or present its
recommendations on compensation matters for consideration and approval to, the full Board. The Compensation Committee acts on behalf of the Board in discharging the Board&#146;s responsibilities with respect to overseeing our compensation policies,
plans and programs, and establishing and reviewing general policies relating to compensation and benefits of our employees. The Compensation Committee also administers our equity and other incentive plans. The Compensation Committee does not
delegate any of its functions to others in determining executive compensation. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Role of Compensation Consultants </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under its charter, the Compensation Committee has the authority to obtain the advice and assistance from external advisors to assist it in the
performance of its duties. In accordance with this authority, the Compensation Committee engages external advisors to advise on executive officer compensation, including base salaries, bonus targets and equity compensation, as well as director
compensation. These advisors also prepare industry compensation data, assist with the development of our peer group, and advise the Compensation Committee on best industry practices and relevant changes to regulations that may impact the
Compensation Committee&#146;s decision-making process with regard to executive officer and director compensation determinations. For 2020 compensation matters, the Compensation Committee retained the consulting firm Radford, to advise and assist
with the following: </FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Development of a peer group to be used in the evaluation of 2020 executive and director
compensation determinations. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Documentary support, including peer group and industry data with respect to base salaries, target
annual cash bonuses and equity compensation. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A market analysis of executive officer compensation compared to our peer group, which market
analysis was reviewed with the Compensation Committee and used to guide 2020 base salary and bonus target decisions for our Named Executive Officers. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A market analysis of long-term incentive compensation of our executive officers compared to our
peer group, which market analysis was reviewed with the Compensation Committee and used to guide 2020 long-term equity compensation determinations. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee assessed the independence of Radford pursuant to SEC rules and concluded that the work performed by Radford for the
Compensation Committee did not raise any conflicts of interest. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Role of Executive Officers </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Dr.&nbsp;Morrissey, our President and Chief Executive Officer, also participates in the Compensation Committee&#146;s deliberations with respect
to Named Executive Officer compensation other than his own; he is not present during deliberations and voting concerning his compensation. Each year, Dr.&nbsp;Morrissey and other senior management develop annual corporate goals and performance
targets for long-term incentive awards for the company, which are reviewed and, subject to their input, approved by the Compensation Committee. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">46</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis, Inc. </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Compensation Committee Process </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In setting the level of salary, annual cash bonus and long-term incentive compensation for our Named Executive Officers, the Compensation
Committee typically considers various factors, including: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the performance of the company during the prior year; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the contribution of each Named Executive Officer toward achievement of our corporate goals;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the criticality of each Named Executive Officer&#146;s skill set and relative expected future
contributions to our business; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the growing complexity of our business and expanding workforce resulting in increased workloads
and responsibilities of our Named Executive Officers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the appropriate mix of compensation for each Named Executive Officer;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the historical salary, cash bonus and percentage of vested versus unvested equity awards held by
each Named Executive Officer; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">market data, which include competitive information relating to compensation levels for comparable
positions in the biotechnology and life sciences sector and for our specific peer group. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee
balances each of these factors, as applicable in any given year, against our cash resources and the critical need to prioritize clinical development and pipeline expansion investments over other expenditures, as well as our aggregate equity burn
rate. For 2020, due to the risk of the COVID-19 pandemic to our business and the extraordinary response of our Named Executive Officers to mitigate that risk, the Compensation Committee considered the importance of recognizing this effort to secure
the retention of our Named Executive Officers, whose leadership is critical to our ability to maintain business continuity during these challenging times and achieve our future business objectives. Using this process, our Compensation Committee
strives to ensure that our executive compensation program as a whole is competitive. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a2"></A>Stockholder
Outreach </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">An integral part of the review process for our executive compensation program are our stockholder outreach initiatives,
pursuant to which we elicit and obtain a better understanding of the concerns and perspectives of our stockholders. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:2.5pt">
<TD VALIGN="top"> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Range of Governance and Business Topics Discussed
with Stockholders During 2020</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #fc4c02; font-size:2.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;COVID-19 Response</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Human Capital Managment</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Equity, Diversity and Inclusion</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;ESG Disclosures</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Executive Compensation</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:3pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f"> &nbsp;&nbsp;&nbsp;&nbsp;Board Independence, Composition, Tenure and Refreshment</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #b2b2b2; font-size:3pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Each year, during the period following the filing of our Proxy Statement with the SEC and the date of our annual
meeting, we engage with our stockholders to seek support for our annual meeting proposals and request feedback regarding governance matters. This outreach effort also provides us with the opportunity to gather our stockholders&#146; opinions
concerning the executive compensation measures that are in the best interest of our stockholders and to reaffirm our commitment to align pay and performance. Participants at these meetings typically include members of the management team and the
Chair of our Compensation Committee, depending on availability. Stockholder feedback is then reported to the appropriate committee and/or the entire Board for consideration. During the Fall each year, we again reach out to stockholders to solicit
additional feedback on matters critical to our stockholders&#146; evaluation of our governance profile. Participants in the Fall 2020 stockholder outreach program included members of the management team, as well as the Chair of our Board and/or the
Compensation Committee. These conversations provided us with the opportunity to discuss the extraordinary efforts taken by management to mitigate the impact of the COVID-19 pandemic on our business, as well as our equity, diversity and inclusion
initiatives. It also yielded constructive feedback with respect to stockholder views on ESG disclosures, executive compensation programs and board independence, tenure and refreshment, all of which was summarized and reported to the Board for
consideration in its ongoing evaluation of our governance profile. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">47</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We intend to continue
to engage with our stockholders throughout the year, and we invite you to reach out with any comments or questions at any time. Please see our website at <I>www.exelixis.com</I> under the caption &#147;Investors&nbsp;&amp; Media&#151;Contact
IR&#148; for the appropriate contact information. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Stockholder Advisory Vote on Executive Compensation </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We provide our stockholders the opportunity to cast an annual advisory vote on our executive compensation program, and the Compensation Committee
takes the results of this vote into account when determining compensation of the company&#146;s Named Executive Officers. At our annual meeting of stockholders held in May 2020, approximately 97% of the votes present and entitled to vote voted in
favor of the say-on-pay proposal. Our Compensation Committee considered these votes to be an endorsement of the Compensation Committee&#146;s policies and practices. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Competitive Assessment </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A key objective of our executive compensation program is to ensure that the overall compensation packages we offer our executive officers remain
competitive with the packages offered by companies with which we compete for executive talent. The Compensation Committee consults with its independent compensation consultant, to develop a peer group of companies to serve as the basis for comparing
our executive compensation program to the market. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Peer Group Development Process and How We Used the Data </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee reviews and makes adjustments to the composition of the peer group on an annual basis, or more often as deemed
necessary, to account for changes in both our business and the businesses of the companies in the peer group. The Compensation Committee does not have a specific target compensation level for the Named Executive Officers. Instead, we review data
concerning practices at our peer group companies and within the general biotechnology market as a reference point to assist in developing programs that will attract and retain exceptional talent and drive company performance. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In developing the 2020 peer group, the Compensation Committee considered the continued evolution of our business and meaningful developments in
comparison to the 2019 peer group companies. It also considered what other companies might make suitable additions to the 2020 list. The key qualitative and quantitative considerations that influenced the development of the 2020 peer group were:
</FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">industry&#151;including, biotechnology and pharmaceutical companies;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">therapeutic area, including companies with an oncology product focus, while avoiding the
inclusion of companies marketing solely orphan and rare disease drugs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">stage of business, as reflected by the existence of at least one marketed product;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the size of the organization to reflect organizational complexity; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">whether the company is traded on a major U.S. exchange; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">market capitalization between 0.3x&#151;3.0x of our then-current market capitalization
(approximately $1.5 billion&#151;approximately $15.0 billion); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">revenues between 0.5x&#151;2.5x of our then revenues (approximately $500
million&#151;approximately $2.5 billion). </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">48</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Following this analysis, the Compensation Committee, in consultation with
management and Radford, identified the following 20 publicly-traded, U.S&#151;based biotechnology/pharmaceutical companies as our peer group to be used in reviewing compensation for 2020: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="31%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fiscal 2020 Peer Group</FONT></B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">ACADIA Pharmaceuticals
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Blueprint Medicines Corporation</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Nektar Therapeutics</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Agios Pharmaceuticals,
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Corcept Therapeutics Incorporated</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Neurocrine Biosciences, Inc.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alkermes Public Limited
Company</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Horizon Therapeutics Public Limited Company</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Novocure Ltd.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alnylam Pharmaceuticals,
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Incyte Corporation</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Sarepta Therapeutics, Inc.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">BeiGene,
Ltd.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Ionis Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Seagen, Inc.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">BioMarin Pharmaceutical
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Ironwood Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">United Therapeutics Corporation</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">bluebird bio,
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Jazz Pharmaceuticals Public Limited Company</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Positioning Relative to 2020 Peers </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>(as of November 2019) </B></FONT></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g08x65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">Percentile Rank </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Of these 20 companies, 14 companies (Agios Pharmaceuticals, Inc. Alkermes Public Limited Company, Alnylam Pharmaceuticals, Inc. BioMarin
Pharmaceutical Inc., Blueprint Medicines Corporation, Corcept Therapeutics Incorporated, Incyte Corporation, Ionis Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., Jazz Pharmaceuticals Public Limited Company, Nektar Therapeutics, Neurocrine
Biosciences, Inc., Sarepta Therapeutics, Inc., Seagen, Inc., and United Therapeutics Corporation) were in our 2019 peer group. The Compensation Committee did not include in our 2020 peer group six companies (Array BioPharma Inc., Halozyme
Therapeutics, Inc., Ligand Pharmaceuticals Incorporated, Loxo Oncology, Inc., OPKO Health, Inc. and Supernus Pharmaceuticals, Inc.) that were in our 2019 peer group, because they were either acquired or had a market capitalization or revenues that
fell below the selection criteria. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">49</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_19"></A>Compensation Elements </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Our executive compensation program generally consists of three principal components: base salary; annual cash bonus; and long-term incentive compensation. A description and objective(s) for each element of compensation, which may
vary from year to year, is set forth below: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Element</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Description</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Objective(s)</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Annual Base
Salary</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Fixed cash compensation to recognize each Named Executive Officer&#146;s role and responsibilities.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Provide an appropriate and competitive base level of current cash income for Named Executive Officers.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Annual Cash
Bonus</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Variable cash compensation based on corporate performance, including achievement against pre-determined corporate goals
and the individual contributions of each Named Executive Officer toward the achievement of such corporate goals.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Align our Named Executive Officers&#146; compensation with our
annual corporate goals.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Rewards Named Executive Officers for
overall corporate performance and their individual contributions toward achievement of our critical business objectives.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #b2b2b2" BGCOLOR="#f2f2f2">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Long-Term Incentive Compensation</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#f2f2f2" STYLE=" BORDER-LEFT:1px solid #b2b2b2; BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#f2f2f2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>RSUs (or PSUs, if
performance-</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>based)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Variable share-based compensation, subject to either performance-based vesting or time-based vesting based on the
achievement of key corporate goals.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Align the interests of our Named Executive Officers with those of
our stockholders.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Motivate our Named Executive Officers to
achieve long-term corporate performance objectives.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Promote
retention, including during periods of stock price volatility common to biotechnology companies.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" BGCOLOR="#f2f2f2" STYLE=" BORDER-LEFT:1px solid #b2b2b2; BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#f2f2f2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Stock Options</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Variable share-based compensation whereby value is derived from appreciation in stock price.</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Align the interests of our Named Executive Officers with those of our
stockholders.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Motivate our Named Executive Officers to pursue
our critical business objectives, because stock options only have value if the value of our company as reflected by our stock price increases over time.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As explained under &#147;<I><A HREF="#tx63026_a30">&#151;2020 Compensation Decisions&#151;2020 Long-Term Incentive Awards
</A> </I>&#147; in more detail below, for 2020, the Compensation Committee determined that an entirely performance-based equity program consisting solely of PSUs would be the most appropriate incentive structure for our Named Executive Officers in
2020 to reward performance over time and achieve our retention objective; accordingly, no stock options or time-based RSUs were granted to our Named Executive Officers under our long-term incentive compensation program for 2020. As explained under
&#147;<I><A HREF="#tx63026_a30">&#151;2020 Compensation Decisions&#151;2020 Long-Term Incentive Awards</A> </I>&#147; in more detail below, in February 2020, Mr.&nbsp;Haley received a time-based RSU award in connection with his promotion to
Executive Vice President, Commercial. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">50</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a39"></A>Other Compensation and Benefits
</B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In addition to the primary elements of compensation described above, all of our employees, including our Named Executive Officers
are also eligible to participate, on the same basis as other employees, in our 401(k) Plan, our employee stock purchase plan (ESPP) and other benefit programs generally available to all employees. These programs are intended to provide
tax-beneficial ways to save toward retirement, promote health and wellness and encourage stock ownership. Our Named Executive Officers are also eligible to participate in our Change in Control and Severance Benefit Plan, a compensation program that
incentivizes our Named Executive Officers to remain with our company, and objectively evaluate and facilitate an acquisition of our company should consideration of such a transaction be determined appropriate by the Board and in the best interests
of our stockholders. The Compensation Committee believes that considered together, these benefits are critical for retaining and motivating these leaders and are consistent with compensation arrangements provided in the competitive market for
executive talent. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.40em; font-size:10pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Element</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Description</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>401(k)
Plan</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Named Executive Officers contribute their own funds, as salary deductions, on a pre-tax or after-tax basis, subject to
plan and government limits. For 2020, we matched pre-tax and Roth 401(k) contributions dollar-for-dollar up to $10,000. As of January 2021, we increased the annual match to $11,000 per calendar year.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Employee Stock Purchase
Plan</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Our ESPP allows for Named Executive Officers to purchase shares of our common stock at a price equal to the lower of 85%
of the closing price on the first day of the six-month offering period or 85% of the closing price on the final day of such offering period, subject to specified limits.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Health Care, Dental and
Vision Benefits</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Subject to applicable laws, these health and welfare benefits are available to all eligible employees, including our
Named Executive Officers.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="middle" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Change in Control
and Severance Benefit Plan (1)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A double-trigger plan, in which each participant receives plan
benefits only if the participant is terminated without cause or is constructively terminated in connection with a change in control. We adopted a double-trigger plan because it protects the participants from post-change in control events that are
not related to the participants&#146; performance, encourages them to stay throughout a transition period in the event of a change in control, and does not provide for benefits for a participant who remains with the surviving company in a comparable
position.</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To ensure our best interests, the plan requires a
release of claims against us as a condition to receiving any severance benefits.</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A description of the Change in Control and Severance Benefit Plan is set forth below under the
heading &#147;<A HREF="#tx63026_a33">Potential Payments Upon Termination or Change in Control.</A>&#148; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">51</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_20"></A>Compensation Mix </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The Compensation Committee has not established formal policies or guidelines for allocating compensation between annual and long-term incentive compensation, or between cash and non-cash compensation. Instead, through our
compensation program, the Compensation Committee seeks to align pay and performance. To that end, a significant portion of our Named Executive Officers&#146; compensation is &#147;at risk&#148; because it is variable, performance-based and in large
part dependent on the success of our company. At-risk compensation for 2020 included PSUs, RSUs and annual incentive cash bonuses, which annual incentive cash bonuses relate to the Compensation Committee&#146;s assessment of our overall corporate
performance, including achievement against our pre-determined 2020 corporate goals under difficult conditions, and, other than for Dr.&nbsp;Morrissey, the Compensation Committee&#146;s consideration of the individual contributions of each Named
Executive Officer toward the achievement of our corporate goals. The following charts highlight the 2020 pay mix for our Chief Executive Officer and all of our other Named Executive Officers as a group. </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>Chief Executive Officer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>Pay Mix</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><B>90% of CEO 2020 Compensation is
Considered Variable and At-Risk</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>All Other Named Executive Officers</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><B>Pay Mix</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><B>84% of All Other Named Executive
Officers (as a group) 2020<BR>Compensation is Considered Variable and At-Risk</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center">


<IMG SRC="g63026g93t37.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g63026g22a35.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_21"></A>2020 Compensation Decisions </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a21"></A>2020 Base Salaries </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In considering the appropriate level of base salaries for our Named Executive Officers for 2020, the Compensation Committee did not apply a
formula, but rather employed a holistic analysis of multiple relevant factors using its professional judgment and experience, emphasizing the following: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the individual contribution of the Named Executive Officer to our exceptional 2019 research,
development, regulatory, pipeline expansion and financial achievements, as explained in more detail below; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the criticality of each Named Executive Officer&#146;s skill set and relative expected future
contributions to our business; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the growing complexity of our business resulting in increased workloads and responsibilities of
each of our Named Executive Officers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the competitive position of each Named Executive Officer&#146;s base salary relative to similarly
situated executives at our 2020 peer group companies; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the fiercely competitive hiring market for life sciences companies in the San Francisco Bay Area.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">52</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Following such analysis, in February 2020, the Compensation Committee
determined that each Named Executive Officer should receive an increase in his or her base salary for 2020 as follows: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2019 Base<BR>Salary</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020 Base<BR>Salary</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Percentage<BR>Increase</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D. (1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,017,140</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,067,997</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5.0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.
(2)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">717,949</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">750,257</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.5</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner
(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">628,067</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">653,189</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D. (4)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">558,061</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">580,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4.0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley
(5)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">462,956</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">510,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10.2</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Morrissey&#146;s base salary increase reflects the strength of our overall corporate
performance during 2019, including the progress of our discovery programs, our clinical and regulatory achievements and the commercial success of CABOMETYX. Dr.&nbsp;Morrissey&#146;s leadership was also viewed as critical to achieving our key
priorities for 2020, including maximizing clinical development opportunities for CABOMETYX and advancing a pipeline of potential new medicines. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Schwab&#146;s base salary increase reflects her strong leadership of our product
development and medical affairs organizations and her performance with respect to the achievement of our product development goals in 2019, particularly with respect to the FDA&#146;s approval of CABOMETYX for HCC, the initiation and management of
multiple potentially label-enabling clinical trials of cabozantinib and support of cabozantinib worldwide regulatory filings by collaboration partners. Dr.&nbsp;Schwab&#146;s leadership was also viewed as critical to our ability to execute on our
2020 product development goals, including with respect to regulatory filings, late-stage clinical trial initiation, the continued evaluation of cabozantinib and XL092 and anticipated organizational growth. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Senner&#146;s base salary increase reflects his leadership of our finance organization
and his performance with respect to the achievement of our financial goals in 2019, particularly with respect to the management of operating expenses and positioning the business to support future growth. Mr.&nbsp;Senner&#146;s leadership was also
viewed as critical to our ability to execute on our 2020 business development, technology infrastructure and fiscal management objectives. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Hessekiel&#146;s base salary increase reflects his leadership of our legal, compliance
and government affairs organizations and his performance with respect to the achievement of our business and legal goals in 2019, particularly with respect to his appropriate management of business risks and the establishment of Exelixis&#146; brand
recognition within the U.S. government to support our business and the interests of patients. Mr.&nbsp;Hessekiel&#146;s leadership was also viewed as critical to the management of our Abbreviated New Drug Application (ANDA) litigation against MSN
Pharmaceuticals, Inc. (MSN) and our ability to ensure the continued strength of our compliance program during a period of rapid growth. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Haley&#146;s base salary increase is primarily related to his promotion to Executive
Vice President, Commercial and reflects his leadership of our commercial organization, including his performance with respect to the generation of record cabozantinib net product revenues in 2019 and the successful commercial launch of CABOMETYX for
HCC . Mr.&nbsp;Haley&#146;s leadership was also viewed as critical to our efforts to commercially execute on any future potential indications for cabozantinib, if approved by the FDA. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a22"></A><A NAME="tx63026_a31"></A>2020 Annual Cash
Bonuses </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Rigorous Process for Determining Annual Cash Bonus </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Our Annual Cash Bonus Plan is an annual incentive program designed to provide our senior management team, including our Named Executive Officers,
with incentives and rewards for working to achieve the strongest possible corporate performance, while also enhancing our ability to attract and retain highly talented individuals. Under our Annual Cash Bonus Plan, Named Executive Officers are
eligible to receive an annual performance-based cash bonus award, the amount of which is based on a pre-set target percentage of the Named Executive Officer&#146;s annual base salary earned during the year. The Compensation Committee is responsible
for establishing the bonus target percentages, as well as the relative percentage contributions of corporate performance and individual performance. For each Named Executive Officer, the amount of the cash bonus award for each fiscal year depends
upon our overall corporate performance, including the achievement of applicable corporate goals established by the Compensation Committee for that year, and, as applicable, the Compensation Committee&#146;s consideration of the individual
contributions of each Named Executive Officer toward the achievement of our corporate goals. Under appropriate circumstances, the Compensation Committee may use discretion to acknowledge progress toward
</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">53</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">achievement of a goal
when factors outside of our control rendered a performance target impossible or impractical to achieve. The corporate goals under the Annual Cash Bonus Plan may be based on criteria such as the following: sales or commercial goals; research,
development and clinical activities; financial metrics; hiring, retention and other operational goals; commercial, clinical and strategic collaborations and alliance management; acquisitions and licensing or partnering transactions; manufacturing
and supply goals; quality goals; regulatory goals; compliance and government affairs and public policy goals. Individual performance may be assessed by the Compensation Committee based on the Named Executive Officer&#146;s contributions toward the
achievement of our corporate goals, recommended by the Chief Executive Officer and approved by the Compensation Committee, for the Named Executive Officer&#146;s area of responsibility. Taking these factors into account, the Compensation Committee
assigns an individual performance percentage for each Named Executive Officer, other than Dr.&nbsp;Morrissey. For any year, the achieved corporate performance percentage and/or individual performance percentage may exceed 100%, provided that neither
percentage may exceed 200%. </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2020 Bonus Targets </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Bonus targets (expressed as a percentage of base salary) are based on the seniority of the applicable position. They are reviewed annually by the
Compensation Committee, taking into consideration competitive market data and the criticality of the role for the organization, and adjusted if deemed appropriate by the Compensation Committee. Following such review, in February 2020, the
Compensation Committee determined bonus targets for each Named Executive Officer for 2020 as follows: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Named Executive Officer</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020&nbsp;Bonus<BR>Target</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D. (1)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.
(2)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">60</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner
(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D. (3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley
(3)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In February 2020, following a review of a market analysis prepared by Radford, the Compensation
Committee determined that Dr.&nbsp;Morrissey&#146;s 2020 bonus target should remain at the same level as 2019. The Compensation Committee&#146;s decision regarding Dr.&nbsp;Morrissey&#146;s 2020 bonus target was based on its assessment that the
previously established target was both appropriate and reflective of the critical importance of his leadership toward driving the company&#146;s achievement of its 2020 business and financial objectives, and also continued to align competitively
with our 2020 peer group. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A review of the market analysis for Dr.&nbsp;Schwab indicated that her existing bonus target was
aligned at the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of market peers. However, in addition to reviewing market data, the Compensation Committee also considered (i)&nbsp;the ambitious goals for both the cabozantinib
clinical development program and the advancement of our early-stage product pipeline during 2020 and (ii)&nbsp;the criticality of Dr.&nbsp;Schwab&#146;s ability to influence our achievement of those objectives while serving in her leadership role as
President of the Product Development and Medical Affairs organization. With such consideration, the Compensation Committee approved an increase to Dr.&nbsp;Schwab&#146;s 2020 bonus target to 60% from 50% in 2019. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">A review of the market analysis for Messrs. Senner, Hessekiel and Haley indicated that each of
their existing bonus targets were aligned at or below the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of market peers. In order to better align their bonus targets with those of peer executives at the companies in our 2020
peer group and in recognition of their ability to influence future company performance and achievement of our 2020 business and financial objectives, the Compensation Committee approved an increase to each of Messrs. Senner, Hessekiel and
Haley&#146;s 2020 bonus target to 50% from 45% in 2019. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2020 Corporate Goal Development and Weighting
</I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In connection with establishing the bonus program for 2020, the Compensation Committee reviewed management&#146;s proposed
discovery, business development, product development, commercial, and finance, legal and business operations goals and recommended them to the Board for approval. In February 2020, prior to the onset of the COVID-19 pandemic, the Board then reviewed
and approved the proposed corporate goals for 2020, as identified in the table below. In selecting these goals, the Compensation Committee and the Board believed they were appropriate drivers for our business, as they provided a balance between the
efforts necessary to continue the successful commercialization of CABOMETYX in its approved RCC and HCC </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">54</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">indications, further our cabozantinib development program and advance our
early-stage product pipeline, all while maintaining a strong financial position, which together would enhance stockholder value. At the time the 2020 corporate goals were set, the Compensation Committee and management believed that such goals were
challenging and achieving them would require not only continued strong commercial performance, research and product development success, and prudent fiscal and legal management, but also a high level of effort and execution on the part of our Named
Executive Officers. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee also applied a performance weighting to each goal relative to the overall performance
of the company to reflect the prioritization of key business objectives. Target and maximum achievement levels were defined for certain goals and, depending on the level of achievement, Named Executive Officers were eligible to receive a payout
ranging from 0% to 150% for such goal. Additionally, a weighting between corporate performance and individual performance was also applied for each Named Executive Officer to reflect the level of impact such individual would be able to make on the
overall corporate performance. The relative weighting for each corporate goal and corporate versus individual performance is as follows: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP BGCOLOR="#fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Corporate Goals</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" BGCOLOR="#fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Weighting</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>(%)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#FFFFFF"><B>Named Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" BGCOLOR="#fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Weighting&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Corporate</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
 COLOR="#FFFFFF"><B>Goals</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" BGCOLOR="#fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Weighting&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Individual</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
 COLOR="#FFFFFF"><B>Performance</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#FFFFFF"><B>Assessment</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#fc4c02">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Discovery</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">20</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Business/Corporate
Development</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Product Development</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">40</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Commercial</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">20</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Finance, Legal and Business
Operations</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f"><B>Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>100</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I><A NAME="tx63026_a221"></A>2020 Performance Evaluation </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2020, management reported regularly to the Compensation Committee and the Board on the status of the company&#146;s performance against
our 2020 goals, including in formal meetings in February, May, September and December. Included in these reports were details regarding the impact of the COVID-19 pandemic on our progress toward achievement of the 2020 goals and the focus of our
Named Executive Officers to mitigate the pandemic&#146;s impacts. Notwithstanding the extent of these challenges and disruptions, the Compensation Committee did not adjust the performance targets because, regardless of the pandemic, these targets
remained critical business objectives for the company. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">55</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In February 2021, the
Compensation Committee evaluated the company&#146;s performance in relation to the 2020 goals, as well as the individual contributions of each Named Executive Officer (other than Dr.&nbsp;Morrissey) toward the achievement of those goals. In
conducting its evaluation, the Compensation Committee prioritized its ongoing commitment to maintain a pay program that both motivates and retains our high-quality management team and pays for performance that generates long-term stockholder value.
To these ends, the Compensation Committee took into consideration the unprecedented nature of the COVID-19 pandemic, and despite its heavy operational burden on our business, our ability to make progress toward and achieve critical business
objectives that will drive the growth of our commercial business and the expansion and depth of our product offerings. Examples of operational burdens imposed by the COVID-19 pandemic and the extraordinary efforts taken by our organization, led by
our Named Executive Officers, to mitigate the impact on our business include: </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g54b79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee particularly focused on the following progress made toward the execution of our
2020 corporate goals: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Discovery</I>: Entering 2020, our Discovery team was highly focused on expanding our product
pipeline beyond cabozantinib by moving product candidates through lead optimization to development candidate status and ultimately to IND filing. However, when Alameda County&#146;s COVID-19 shelter-in-place orders restricted access to the new
state-of-the art laboratory facilities, our Discovery team was forced to overhaul its plans. The team focused its efforts on a limited number of product candidates that it believed offered the greatest potential for success in the clinic. By
combining this prioritization strategy with efficient oversight of global third-party contractors conducting preclinical development work and close coordination with research collaboration partners to maximize productivity under the circumstances,
our Discovery team was still able to achieve or make substantial progress toward each of its 2020 business objectives. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Business Development</I>: Our Business Development team did not waver from its focus on the
identification and execution of transactions that facilitate the expansion of our product pipeline despite unique market conditions created in part by the COVID-19 pandemic. As the pandemic progressed, the market dynamics enabled biotechnology
companies in possession of early-stage clinical assets to gain unprecedented access to the capital markets, leading to tremendous inflation in the values of clinical-stage companies and in-licensing targets previously identified by our Business
Development team. In response, the team shifted its focus to early-stage pre-clinical assets and coordinated with our Discovery and Finance teams to complete multiple in-licensing transactions to access critical ADC technology platforms from NBE and
Catalent in 2020, and related technologies from Adagene, Inc. (Adagene) and WuXi Biologic (WuXi) in early 2021, enabling us to build capacity and depth in this critical area of drug discovery more rapidly than
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">56</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD VALIGN="top"><FONT COLOR="#3f3f3f">previously anticipated. Notwithstanding this shift, our Business Development team continued to pursue clinical-stage assets for our product pipeline and progressed numerous clinical-stage business development
opportunities to term sheet status, thereby maximizing the potential for execution on this business objective in 2021. </FONT></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Commercial</I>: With healthcare professionals acutely focused on modifying their medical
practices to adjust for the COVID-19 pandemic, our Commercial team proved itself highly capable of adapting to changing market conditions in order to remain engaged with healthcare professionals and continue to promote CABOMETYX in its approved RCC
and HCC indications. The sales force transitioned from in-person to primarily telephonic and virtual interactions and remained productive throughout the course of the year, ultimately delivering revenues within the range of financial guidance we
provided in early January 2020 before disruptions due to the pandemic began and building CABOMETYX into the market leading second-line agent for RCC. Beyond sales and marketing activities, our Commercial team&#146;s research analytics and market
evaluation activities also contributed significantly to our corporate development and planning activities, and the strategic direction of our XL092 development plan. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Product Development</I>: Our 2020 product development goals were already bold and substantial
before the COVID-19 pandemic; however, when the pandemic hit, it markedly increased the challenges faced by our Product Development team. Our clinical trials are conducted across the globe, and in virtually every region, our Product Development team
experienced and largely overcame challenges to patient screening and enrollment activity, delays in new treatment site activations, and heavy restrictions on the access to treatment sites required by study protocols to monitor clinical trial
progress and administration. Despite these disruptions to the core development activities that drive future regulatory and commercial success, and the effort required to mitigate their impact on the business, our Product Development team
substantially progressed our broad cabozantinib development program through the achievement and presentation of clinical trial results from multiple clinical trials evaluating cabozantinib, both alone and in combination with ICIs. Included among
those trials were positive top-line results from two label-enabling studies, CheckMate -9ER and COSMIC-311, which helped position us to execute on our long-term cabozantinib franchise net product revenue goals. In addition to the achievement and
management of clinical trial results, our Product Development team successfully navigated the challenges of the COVID-19 pandemic to progress or complete enrollment for multiple other potentially label-enabling studies, including COSMIC-021,
COSMIC-312 and COSMIC-313, and initiated three new phase 3 pivotal trials in collaboration with Genentech. On the regulatory front, the achievements continued with the filing of our sNDA for CABOMETYX in combination with OPDIVO as a first-line
treatment for patients with advanced RCC, which was reviewed under the FDA&#146;s Real-Time Oncology Review pilot program and received Fast Track designation. In addition, in order to contribute to speedy and ultimately successful regulatory filings
outside of the U.S., our Product Development team also extensively supported our partners Ipsen and Takeda as they navigated regulatory approval pathways for CABOMETYX in their respective territories. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Calibri; font-size:10pt"><FONT COLOR="#3f3f3f"><I>Business Operations</I>: Our successful business execution in 2020 would not have been possible
without the talent and hard work of the employees that were sourced and integrated by a Human Resources team focused on our critical mission to expand the organization with talented new employees. While relying on an entirely remote interview and
integration process, in just one year we grew our employee base by 25% and maintained a turnover rate that was consistently below average for the U.S. life sciences industry generally, as well as for life sciences companies located in Northern
California, despite the fierce competition for biotechnology employees and many people choosing to move out of the San Francisco Bay Area following the onset of the COVID-19 pandemic. Throughout the year, our Business Operations team remained highly
focused on plans to safely return our growing employee population to the office following the ongoing pandemic. While the state and county mandated shelter-in-place order in the first quarter of 2020 resulted in the delay of construction activity
for all of our buildings, the delays proved to be inconsequential for the business due to our remote work policy implemented in March 2020 to protect the health and safety of our employees. Nonetheless, our Business Operations team continued to work
closely with our landlords and contractors throughout the year and by year-end achieved all construction related objectives included in our 2020 corporate goals. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Following its evaluation, the Compensation Committee concluded that 2020 was a year of meaningful accomplishments. In appropriate circumstances,
the Compensation Committee exercised its discretion to acknowledge progress made toward achievement of certain performance targets that, due to the COVID-19 pandemic and related market conditions, were rendered impossible or impractical to fully
achieve during 2020. As a reflection of these considerations, the Compensation Committee set the bonus payout for the corporate performance metric at 120% of the target incentive amount, which exceeded the achievement reflected in the table below by
12%.</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">57</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="11%"></TD></TR>



<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PERFORMANCE OBJECTIVES</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENTS</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">TARGET&nbsp;%</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENT&nbsp;%</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Discovery</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Submit IND applications to FDA for two of three lead product
candidates</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Submit and receive
notification of acceptance of IND for three lead product candidates</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;&#8194;&#8201;&#8202;Submitted IND for XL102.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Submitted IND for XB002 (March 2021).</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7.5%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Advance one internally developed and one partnered program to
Development Candidate status (DC)</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Advance
two internally developed and two partnered programs to DC status</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Declared XL265, XL114 and one additional internal compound DCs.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Advance four early stage partnered programs with Aurigene to lead
optimization decision</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Advance one
additional partnered program to DC status</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Advanced three programs into lead optimization decision and progressed one additional program toward lead
optimization decision.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2%</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Business/Corporate Development</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Acquire or in-license one clinical -stage asset</B></FONT></P>
<P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Acquire or in-license two clinical -stage assets or one
clinical -stage asset with near-term market entry and a target threshold for peak sales</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Executed a collaboration and license agreement with NBE and Catalent to discover and develop ADCs.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Executed transactions with Adagene and WuXi (January and March 2021, respectively).</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Progressed numerous clinical-stage business development projects to term sheet status.</FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">0%</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Calibri; font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Product Development and Medical Affairs</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Achieve and manage disclosure of results for five key clinical trials
evaluating cabozantinib</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Achieve and
manage disclosure of results for three additional key clinical trials evaluating cabozantinib where results are event-based</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Top-line results from CheckMate -9ER and COSMIC-311.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Presented data from COSMIC-021 cohorts (CRPC, Bladder, NSCLC, clear cell RCC and non-clear cell RCC) and CheckMate
040 at various medical conferences.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Top-line results from CANTATA.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Top-line results from EXAMINER (February 2021).</FONT></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">16%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">23.5%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Complete trial enrollment of COSMIC-312 and currently existing cohorts
of COSMIC-021</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Complete trial enrollment
of COSMIC-311 by year end and COSMIC-312 by the second quarter of 2020</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed enrollment of COSMIC-312 based on original protocol in June 2020.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Near complete enrollment of COSMIC-021.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Stopped enrollment of COSMIC-311 (due to positive efficacy).</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">6%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8.5%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Initiate three CONTACT pivotal trials</B></FONT></P>
<P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Initiate three CONTACT pivotal trials during the first
half of 2020</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Initiated CONTACT-01 and CONTACT-02 in June 2020.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Initiated CONTACT-03 (July 2020).</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Advance enrollment of COSMIC-313 by initiating 95% of planned
countries and sites and initiate combination cohorts of phase 1 XL092 clinical trial</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Enroll 629 patients in COSMIC-313</B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Enrolled 745 patients in COSMIC-313, following activation of 100% of planned countries and 97% of sites.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Initiated XL092 combination cohorts with atezolizumab.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">6%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">9%</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">58</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="11%"></TD></TR>



<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">PERFORMANCE OBJECTIVES</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENTS</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">TARGET&nbsp;%</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENT&nbsp;%</FONT></B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): File sNDA for CABOMETYX as a first-line treatment for patients with
advanced RCC by the end of the third quarter of 2020</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): File sNDA for CABOMETYX as a first-line treatment for patients with advanced RCC by August 2020</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Filed sNDA
for CABOMETYX for first-line advanced RCC in August 2020.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">5%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">7.5%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target (100%): Support cabozantinib worldwide regulatory filings by collaboration partners</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Supported
Ipsen&#146;s worldwide CABOMETYX regulatory approvals, including its application to the EMA for the combination of CABOMETYX and OPDIVO in RCC.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Assisted
Takeda with its applications to the Japanese MHLW for approvals of CABOMETYX in HCC and RCC (in combination with OPDIVO).</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target (100%): Ensure continuous process improvements to enable expeditious and compliant trial execution</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed
extensive process and technology improvements and upgrades for key clinical trial systems.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Grew and
restructured the Product Development organization commensurate with the expanding number and scope of development programs.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Identified and
integrated key informatic/analytics leader into the Product Development organization.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f">1%</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Commercial</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="middle" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Meet cabozantinib franchise net product revenue target established by
the Board</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Exceed 105% of cabozantinib franchise net product revenue target established by the
Board</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Generated&nbsp;cabozantinib
 franchise net product revenues of $741.6&nbsp;million.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">15%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">15%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Achieve launch readiness by October 2020 for CABOMETYX in first-line
RCC</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Execute organizational planning and launch readiness for all potential future indications in 2021 and
beyond</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Commercial
organization achieved launch readiness in August 2020.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed
broad commercial reorganization to facilitate potential launches in RCC, HCC, mCRPC and DTC.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">4%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">6%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target (100%): Provide commercial evaluation and assessment of new assets from strategic and busines development activity and for cabozantinib lifecycle
management</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Conducted
strategic evaluations of potential assets identified for acquisition or in-licensing.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Supported
XL092 strategic planning to enable a robust and broad development plan.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="2" COLSPAN="5"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt" COLOR="#fc4c02"><B>&nbsp;&nbsp;&nbsp;&nbsp;Finance, Legal and Business Operations</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Successfully manage the initial stage of the ANDA litigation against
MSN</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Early settlement of ANDA litigation
against MSN</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Vigorously
prosecuted our ANDA infringement litigation against MSN.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">2%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">2%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target (100%): Manage cash balance and operating expenses within budget established by the Board</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Managed
operating expenses to $877.5&nbsp;million and ended fiscal 2020 with a cash and investments balance of $1.54&nbsp;billion.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">2%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">2%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD ROWSPAN="2" VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target (100%): Complete upgrade of SAP to S/4 HANA platform</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed
upgrade of SAP to S/4 HANA platform.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f"><B>Target (100%): Complete build-out of Building 1601 by the first quarter of 2020; substantially advance build-out of Building 1701 and initiate construction on Building
1951</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed
build-out of Building 1601 (June 2020).</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Substantially progressed construction of Building 1701.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT><FONT COLOR="#3f3f3f">&#8194;&#8201;&#8202;Initiated
construction on Building 1951.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">1%</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">59</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="11%"></TD></TR>

<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PERFORMANCE OBJECTIVES</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENTS</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">TARGET&nbsp;%</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">ACHIEVEMENT&nbsp;%</FONT></B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Target (100%): Achieve year-end headcount of 769 full-time employees
(FTEs)</B></FONT></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Maximum (150%): Achieve an overall turnover rate
of less than 10%</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Achieved headcount of 773 FTEs.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Achieved annual overall turnover rate of 10.6%.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Target (100%): Integrate and implement compliance into all aspects of organizational activities</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Completed all planned monitoring activities, as adjusted for COVID-19 restrictions.</FONT></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Compliance programs operated effectively across the enterprise, with appropriate monitoring and
oversight.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Target (100%): Build Exelixis brand recognition within U.S. Government to support our business and the interests of
patients</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Conducted bi-partisan engagement with Congress, resulting in positive associations with the Exelixis
brand.</FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT
STYLE="font-family:Calibri; " COLOR="#fc4c02">&#155;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#8194;&#8201;&#8202;Participated in development of academic white paper focused on the disparate impact of the 340B drug discount program
on small to mid-size innovative drug companies.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1%</FONT></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">100%</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">108%</FONT></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Individual Performance Assessments of our Named Executive Officers other than the CEO </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee also recognized the individual contributions of each Named Executive Officer, other than Dr.&nbsp;Morrissey, toward
achievement of the 2020 corporate goals. In evaluating the individual contributions of each Named </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Executive Officer, the Compensation
Committee determined that all Named Executive Officers performed above expectations and considered the following contributions from each in such determination: </FONT></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Dr.&nbsp;Schwab&#146;s overall leadership of our product development and medical affairs
organizations and her performance with respect to the achievement of our product development goals in 2020, particularly regarding: the filing of the sNDA for CABOMETYX in combination with OPDIVO as a treatment for patients with advanced RCC under
the FDA&#146;s Real-Time Oncology Review pilot program; achievement of positive top-line results for COSMIC-311; the initiation of CONTACT-01, CONTACT-02 and CONTACT-03 and management of other potentially label-enabling clinical trials, including
COSMIC-312, COSMIC-313 and COSMIC-021; support of cabozantinib worldwide regulatory filings by collaboration partners; and the oversight of a rapidly growing Product Development organization. The Compensation Committee gave specific weight to the
criticality of Dr.&nbsp;Schwab&#146;s performance with respect to the management of our clinical trial programs during the COVID-19 pandemic and their strategic importance to the continued success of the Exelixis business.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Senner&#146;s overall leadership of our finance organization and his performance with
respect to the achievement of our financial goals in 2020, particularly regarding: our disciplined expense management; his role in positioning the company to be able to execute on future strategic initiatives; and the successful upgrade of our SAP
system to the S/4 HANA platform. The Compensation Committee also considered the expansion of Mr.&nbsp;Senner&#146;s responsibilities to lead the Information Technology organization and implement initiatives to further enhance our technology
infrastructure. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Hessekiel&#146;s overall leadership of our legal and compliance organizations and his
performance with respect to the achievement of our business and legal goals in 2020, particularly regarding: the growth in the volume and complexity of our business agreements and arrangements; the rapid adjustments made to our compliance program in
order to maintain an effective oversight function following the evaluation of new methods of interactions with healthcare professionals due to the COVID-19 pandemic; and our level of organizational preparedness for potential shifts in healthcare
regulations applicable to our business. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Mr.&nbsp;Haley&#146;s overall leadership of our Commercial organization and his performance with
respect to the achievement of our commercial goals in 2020, particularly regarding: the continued strong CABOMETYX demand in 2020 and building the brand into the leading second line agent in RCC despite increased competition in the indications for
which CABOMETYX is approved; early achievement of launch readiness for CABOMETYX in combination with OPDIVO as a treatment for first-line advanced RCC; and the reorganization of the Commercial team to achieve scalability for future potential
launches in RCC, HCC, mCRPC and DTC. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">60</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In consideration of the foregoing, in February 2021, the Compensation
Committee approved annual cash bonus payments for each Named Executive Officer as reflected in the table below. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Base</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Salary</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Award</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Corporate</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Weighting</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Approved</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Corporate</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Individual</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Weighting</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Individual</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Annual&nbsp;Cash</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Bonus&nbsp;Payout</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(%&nbsp;of&nbsp;Target</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Award)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Annual</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cash&nbsp;Bonus</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Payout</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Michael M. Morrissey,
Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,067,997</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,281,596</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Gisela M. Schwab,
M.D.</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">750,257</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">60</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">200</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">144</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">648,222</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Christopher J.
Senner</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">653,189</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">135</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">125</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">406,610</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Jeffrey J. Hessekiel,
J.D.</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">580,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">114</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">330,819</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:Calibri"><FONT COLOR="#fc4c02"><B>Patrick J. Haley</B></FONT></P></TD>

<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">510,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">70</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">120</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">114</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">$</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">290,700</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a30"></A>2020 Long-Term Incentive Awards </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Consistent with our goal to align executive compensation with performance that advances our critical business objectives, a significant portion of the Named Executive
Officers&#146; total compensation typically has consisted of, and is expected to continue to consist of, equity-based awards. In evaluating the mix of equity awards for 2020, the Compensation Committee considered market trends, as well as feedback
from stockholders and proxy advisory firms, and determined that an entirely performance-based program consisting solely of PSUs would be the most appropriate incentive structure for our Named Executive Officers to reward performance over time and
achieve our retention objectives.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g63026g03l09.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Determination of September 2020 Performance Target for Long-Term Incentive Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee seeks to develop long-term incentive compensation programs based on metrics that are aligned with our corporate
strategy and designed to build value for our stockholders. Accordingly, the PSUs granted to Named Executive Officers in 2020 vest upon or following achievement of the following performance targets: </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2020 PSU Grant #1 </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">positive top-line results of one or more clinical trials evaluating a product for which we own, or have licensed to a
collaboration partner, development or commercialization rights, that provides data that can reasonably support regulatory evaluation of safety and efficacy to determine the risk/benefit profile of the product </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>2020 PSU Grant #2 </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">the approval by the FDA for the commercial sale and marketing of one or more products for which we own, or have licensed to a
collaboration partner, development or commercialization rights, in one or more new indications or an indication for which the product has previously received FDA approval, if such product is intended to treat a new, additional or expanded set of
patients or is part of a combination therapy </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee selected these performance targets because they represent
the most critical business objectives for which the Named Executive Officers are responsible, thereby linking executive compensation with our <FONT STYLE="white-space:nowrap">long-term</FONT> growth strategy. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For each 2020 PSU award, the Named Executive Officers are eligible to vest up to a maximum of 200% of the target number of shares of Exelixis
common stock subject to the PSU award. Failure to achieve a performance target by December&nbsp;31, 2024 will result in forfeiture of 100% of the applicable 2020 PSU award. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">61</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Vesting Percentage of Performance </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2" COLSPAN="3"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">0%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">50%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">100%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:20pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#fc4c02">150%</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">200%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" COLSPAN="3" STYLE="BORDER-LEFT:1.00pt solid #fc4c02; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1.00pt solid #fc4c02; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">Failure to Achieve: </FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achievement on or after January&nbsp;1, 2025</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">Threshold Achievement:
</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achievement with respect to one performance</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">target on&nbsp;or before
December&nbsp;31,&nbsp;2024</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">Target Achievement: </FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achievement with respect to two performance targets on or before December&nbsp;31,
2024</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">Partial Over Achievement: </FONT><FONT
STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achievement with respect to three</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">performance targets on&nbsp;or before
December&nbsp;31,&nbsp;2024</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">Early Achievement:
</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achievement with respect to at least two performance targets&nbsp;on&nbsp;or&nbsp;before December&nbsp;31, 2022</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">Over Achievement:
</FONT><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Achievement with respect to more than three performance targets on&nbsp;or before December&nbsp;31,&nbsp;2024</FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Upon achievement of a performance target, the Compensation Committee will certify the applicable level of
achievement and determine the number of shares that are entitled to vest based on such achievement, which will be equal to the target number of shares subject to the applicable 2020 PSU award multiplied by the applicable vesting percentage
(&#147;2020 PSU Certified Shares&#148;). Each 2020 PSU award will vest as to 50% of the 2020 PSU Certified Shares upon the Compensation Committee&#146;s certification that we have achieved the performance goal and 50% of the 2020 PSU Certified
Shares on the first quarterly vesting date (i.e. February&nbsp;15th,&nbsp;May&nbsp;15th,&nbsp;August&nbsp;15th and November&nbsp;15th) following the one-year anniversary of the Compensation Committee&#146;s certification. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Potential PSU Payouts </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>(% of Target) </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g14u56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vesting of these PSUs will cease upon termination of service as an employee for any reason. Pursuant to the
terms of the award agreements, following certain change in control events wherein the PSU awards are assumed by the surviving entity, the PSU awards will convert to time-based vesting, as though the target number of shares subject to each PSU award
had been subject to a vesting schedule pursuant to which the shares would have vested annually over a four-year period following the grant date (with any portion that would have vested on or prior to the change in control event under such vesting
schedule becoming vested on the date of the change in control event and any portion that is unvested following the date of the change in control event vesting in accordance with such vesting schedule). The purpose of this conversion feature is to
account for the fact that the goal may not be achievable in the context of the newly formed organization. In addition, the Named Executive Officers are party to our Change in Control and Severance Benefit Plan, which provides for acceleration of
vesting of the award in the event of certain specified change in control events involving us, as further described under the caption &#147;<A HREF="#tx63026_a33">Potential Payments Upon Termination or Change in Control</A>&#148; below. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>Determination of Long-Term Incentive Awards </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">When determining the appropriate value of equity incentive awards, the Compensation Committee asked Radford to provide guidance with respect to
implementing a program that would incentivize our Named Executive Officers to achieve key company priorities and increase stockholder value over the long-term, while maintaining competitive market practices and being mindful of the company&#146;s
equity burn rate. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">62</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">As part of the decision-making process, the Compensation Committee
considered the challenges of managing a rapidly expanding organization, as well as our need to retain a cohesive management team to facilitate the achievement of product development and pipeline expansion objectives, while supporting the continued
commercial success of CABOMETYX, that would position the company for future success. The Compensation Committee also believed it was important that the value of the equity awards continue to reflect the individual performance of each Named Executive
Officer during the fiscal year to </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">date and the criticality of each Named Executive Officer&#146;s skill set and expected future
contributions to our business. Taking these factors into consideration and applying Radford&#146;s market analysis of long-term incentive compensation of our Named Executive Officers compared to our 2020 peer group, the Compensation Committee
determined that the aggregate value of the equity awards granted to each of our Named Executive Officers should be between the 50th and 75th percentile of market peers and approved the aggregate grant amounts to the Named Executive Officers
summarized in the table below. The actual number of PSUs granted to each executive officer was determined by dividing the value the Compensation Committee intended to deliver by the 30-day&nbsp;average trailing stock price (as of July&nbsp;31,
2020), and this number of PSUs was then allocated equally between Performance Target #1 (Positive Top-Line Results) and Performance Target #2 (Regulatory Approvals). A&nbsp;30-day&nbsp;average share price was used, rather than a single day share
price, in order to provide a more stabilized share value less susceptible to possible swings in the market. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to 2020<BR>PSUs &#150; Threshold<BR>Achievement</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to&nbsp;2020<BR>PSUs &#150; Target<BR>Achievement</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to 2020<BR>PSUs &#150; Partial<BR>Over<BR>Achievement</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to&nbsp;2020<BR>PSUs &#150; Early/<BR>Over<BR>Achievement</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum<BR>Number&nbsp;of&nbsp;Shares<BR>Subject&nbsp;to&nbsp;2020&nbsp;PSUs</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">188,005</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">376,010</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">564,015</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">752,020</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">752,020</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65,135</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">130,270</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">195,405</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">260,540</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">260,540</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">65,135</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">130,270</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">195,405</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">260,540</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">260,540</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">57,900</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115,800</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">173,700</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">231,600</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">231,600</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">57,900</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">115,800</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">173,700</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">231,600</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">231,600</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Promotion Grant to Mr.&nbsp;Haley </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In February 2020, Mr.&nbsp;Haley was promoted to Executive Vice President, Commercial. In connection with Mr.&nbsp;Haley&#146;s promotion, the
Compensation Committee granted him a time-based RSU award for 35,000 shares having a target award value of $650,300. Mr.&nbsp;Haley&#146;s RSUs will vest as to 25% of the original number of shares subject to his RSU award on each May&nbsp;15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> with a final vesting date of May&nbsp;15, 2024. Vesting of these RSUs will cease upon Mr.&nbsp;Haley&#146;s termination of service for any reason. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2018 Long-Term Incentive Awards Achievements </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2018, the Compensation Committee granted PSUs to Named Executive Officers allocated among five separate awards that only vest upon the
achievement of certain commercial, clinical development and pipeline expansion performance targets. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">On September&nbsp;2, 2020, the
Compensation Committee certified the achievement of 2018 PSU Grant #3, which was one of the two clinical development performance goals established for the 2018 PSU awards. Upon such certification, the PSUs vested as to 50% of the original number of
shares subject to the award. The remaining 50% of the original number of shares subject to the award will vest on November&nbsp;15, 2021. The following chart reflects the pre-established clinical development performance target and the actual results
achieved. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="39%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;2018&nbsp;PSU<BR>&nbsp;&nbsp;Grant #</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Business Focus</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Pre-Established Performance Target</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Achievement</FONT></B></FONT>
</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>Clinical Development</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Initiation of 4 label-enabling clinical trials evaluating cabozantinib alone or in combination with another therapy, in
each case sponsored by Exelixis or one or more collaborators</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">COSMIC-313 Initiated May 2019</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">PDIGREE initiated June 2019</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">CONTACT-01 initiated June 2020</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">CONTACT-02 initiated June 2020</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">63</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>2019 Long-Term
Incentive Awards Achievements </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2019, the Compensation Committee granted PSUs to the Named Executive Officers that only vest
upon the achievement of regulatory approval of a product in the U.S. On October&nbsp;22, 2020, following the FDA&#146;s approval of cobimetinib in combination with atezolizumab and vemurafenib as a treatment for patients with BRAF V600 melanoma, the
Compensation Committee certified the early achievement of the 2019 PSU award, representing 150% of the target amount of shares subject to the award. Cobimetinib, which our collaboration partner Genentech commercializes as COTELLIC and which we
co-promote in the U.S., is one of the four products discovered previously in Exelixis laboratories, that has progressed through clinical development and received regulatory approval. Upon certification of such early achievement by the Compensation
Committee, the 2019 PSU award vested as to 75% of the target number of shares subject to the award. An additional 75% of the target number of shares subject to the award will vest on November&nbsp;15th, 2021 based on such early achievement.
</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_22"></A>Other Compensation Information </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Timing of Equity Awards </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Annual grants of equity awards to our executive officers, including our Named Executive Officers, are generally determined and approved at
pre-scheduled Compensation Committee meetings, with such meeting date typically serving as the grant date. However, the Compensation Committee may sometimes approve the grant of equity awards to executive officers and other employees in advance of
its next scheduled meeting, either at a special meeting or by unanimous written consent, in connection with certain new hires, promotions and other circumstances where the Compensation Committee deems it appropriate to make such grants. The grant
dates for these equity awards are typically the same date that a newly hired officer begins employment or the effective date of an officer&#146;s promotion, as applicable. Grants made to new hires below the level of Vice President, are approved on a
monthly basis by our Equity Award Committee, comprised solely of Dr.&nbsp;Morrissey, acting in his capacity as a director pursuant to authority delegated to him by the Compensation Committee. All stock options are granted with an exercise price that
is not less than the closing price of our common stock on The Nasdaq Global Select Market on the grant date. We have no plan or practice to&nbsp;time&nbsp;option grants in coordination with the release of non-public information,&nbsp;and we do not
time&nbsp;the release of non-public information&nbsp;to affect the value of executive compensation. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a3"></A>Stock Ownership Guidelines for Named Executive Officers </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board maintains Stock Ownership Guidelines for our Named Executive Officers in order to further align their financial interests with those of
our stockholders, as well as to promote sound corporate governance. For our Names Executive Officers, we amended our Stock Ownership Guidelines in February 2021 to establish the following ownership targets: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="69%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Ownership Level</FONT></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Chief Executive
Officer</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Value equivalent to 5 times annual base salary</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Other Named Executive
Officers</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Value equivalent to 3 times annual base salary</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">These new ownership targets represent increases from the prior targets of, for the Chief Executive Officer, the
lesser of the value equivalent to 5 times the annual base salary or 160,000 shares, and for other Named Executive Officers, the lesser of the value equivalent to 1.5 times annual base salary or 25,000 shares. All Named Executive Officers are
expected to achieve their stock ownership targets within five years of becoming subject to these guidelines. The policy includes procedures for granting exemptions in the case of severe financial hardship. In determining ownership levels for each
Named Executive Officer under our Stock Ownership Guidelines, credit is provided for shares held outright (including shares owned through trusts, our 401(k) Plan, or by a spouse), as well as 50% of the number of vested, but unexercised, stock
options. No credit is provided for RSUs or PSUs until they vest. The values for all shares determined to be held by Named Executive Officers are based on the 200-day average stock price as of the measurement date. As of February&nbsp;5, 2021, all of
our Named Executive Officers had met the required ownership targets. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">64</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Compensation&nbsp;Discussion&nbsp;and&nbsp;Analysis </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Clawback Policy </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We are dedicated to maintaining a culture of high integrity and accountability, and to discourage conduct harmful to our business and the
interests of our various stakeholders. In response to this dedication, we adopted a Clawback Policy that applies to all forms of compensation, except base salary, granted after the adoption of the Clawback Policy. A triggering event under the
Clawback Policy shall occur when a covered employee (which includes all Named Executive Officers): </FONT></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63026g31z78.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For clarity, &#147;material harm&#148; includes, but is not limited to, the requirement to prepare an
accounting restatement for any fiscal quarter or year commencing after adoption of the Clawback Policy due to our material noncompliance with any financial reporting requirement. If triggered, then to the fullest extent permitted by law, we may
recoup all variable compensation granted or paid to the covered employee during each fiscal year in which the covered employee&#146;s &#147;misconduct&#148; occurred. </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Accounting and Tax Considerations </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Under FASB ASC 718, we are required to estimate and record an expense for each award of equity compensation (including stock options, RSUs and PSUs) over the vesting period of the award. As long as stock options, RSUs and PSUs
remain the sole components of our long-term compensation program, we expect to record stock-based compensation expense on an ongoing basis according to ASC 718. Compensation expense relating to awards subject to performance conditions is recognized
if it is probable that the performance goals will be achieved. The probability of achievement of such goals is assessed on a quarterly basis. The Compensation Committee has considered, and may in the future consider, the grant of restricted stock to
our executive officers in lieu of stock option grants, RSU and/or PSU awards. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under Section&nbsp;162(m) of the Internal Revenue Code
(&#147;Section 162(m)&#148;), compensation paid to each of the Company&#146;s &#147;covered employees&#148; that exceeds $1 million per taxable year is generally non-deductible unless the compensation qualifies for certain grandfathered exceptions
(including the &#147;performance-based compensation&#148; exception) for certain compensation paid pursuant to a written binding contract in effect on November&nbsp;2, 2017 and not materially modified on or after such date. Although the Compensation
Committee will continue to consider tax implications as one factor in determining executive compensation, the Compensation Committee also looks at other factors in making its decisions and retains the flexibility to provide compensation for the
Named Executive Officers in a manner consistent with the goals of the company&#146;s executive compensation program and the best interests of the company and its stockholders, which may include providing for compensation that is not deductible by
the company due to the deduction limit under Section&nbsp;162(m). The Compensation Committee also retains the flexibility to modify compensation that was initially intended to be exempt from the deduction limit under Section&nbsp;162(m) if it
determines that such modifications are consistent with the company&#146;s business needs. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_23"></A>Compensation
Policies and Practices as They Relate to Risk Management </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In 2020, the Compensation Committee reviewed our compensation policies and
practices and concluded that the mix and design of these policies and practices are not reasonably likely to encourage our employees to take excessive risks.&nbsp;In connection with its evaluation, the Compensation Committee considered, among other
things, the structure, philosophy and design characteristics of our primary incentive compensation plans and programs in light of our risk management and governance procedures, as well as other factors that may calibrate or balance potential
risk-taking incentives.&nbsp;Based on this assessment, the Compensation Committee concluded that risks arising from our compensation policies and practices for all employees, including executive officers, are not reasonably likely to have a material
adverse effect on us. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">65</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_24"></A><A NAME="tx63026_a40"></A>Summary of Compensation </FONT></P>
<P STYLE="line-height:3.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table shows for the
fiscal years ended January&nbsp;1, 2021, January&nbsp;3, 2020 and December&nbsp;28, 2018 (referred to as fiscal 2020, fiscal 2019 and fiscal 2018, respectively), compensation awarded to, paid to or earned by our Chief Executive Officer, our Chief
Financial Officer, and our other three most highly compensated executive officers in 2020, which we refer to as our &#147;Named Executive Officers.&#148; </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B><A NAME="tx63026_a15"></A><A NAME="tx63026_a16"></A><A NAME="tx63026_66a"></A>Summary Compensation Table </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name&nbsp;and&nbsp;Principal&nbsp;Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Year<BR>(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Salary<BR>($)(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Bonus<BR>($)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock<BR>Awards<BR>($)(4)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Awards<BR>($)(5)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff"><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive&nbsp;
Plan<BR>Compensation<BR>($)(6)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">All Other<BR>Compensation<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,058,216</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">128,159</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,153,437</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,349,812</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;President and Chief</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,005,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,118,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,132,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">945,080</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,111,403</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,064,983</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">744,044</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">37,813</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">610,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,402,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;President, Product Development</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">710,751</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">409,231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,128,482</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;and Medical Affairs and Chief</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">672,301</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,227,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">466,156</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,374,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Medical Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">648,358</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">27,434</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">379,176</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,064,968</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President and</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">622,866</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">310,893</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">942,259</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">594,740</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,227,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">338,074</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,168,814</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">576,091</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">24,376</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">306,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">916,910</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President and</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">553,934</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">276,240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">838,674</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;General Counsel</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2018</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">531,880</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,227,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">301,836</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,069,716</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">500,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21,420</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">763,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">269,280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,564,653</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President,</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>&nbsp;&nbsp;&nbsp;&nbsp;Commercial</I></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The compensation reflected in the Summary Compensation Table reflects a <FONT
STYLE="white-space:nowrap">52-week</FONT> period for fiscal 2020, a <FONT STYLE="white-space:nowrap">53-week</FONT> period for fiscal 2019 and a <FONT STYLE="white-space:nowrap">52-week</FONT> period for fiscal 2018. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The amount in this column represents the amount actually earned by each Named Executive Officer
for the indicated fiscal year. For information regarding 2020 base salaries, please see &#147;<A HREF="#tx63026_a21">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020 Base Salaries</A>.&#148;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The amounts in this column represents the discretionary portion of the cash bonuses awarded under
our Annual Cash Bonus Plan for fiscal 2020. For a description of the company&#146;s Annual Cash Bonus Plan for fiscal 2020 and the discretion applied, see &#147;<A HREF="#tx63026_a221">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020
 Annual Cash Bonuses&#151;2020 Performance Evaluation</A>&#148; above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column reflect the aggregate grant date fair value in the indicated fiscal
year for the RSU and PSU awards as computed in accordance with FASB ASC 718. Other than as reflected in footnote 7 to the Summary Compensation Table, there were no time-based RSUs granted to the Named Executive Officers in fiscal 2020, fiscal 2019
or fiscal 2018. With respect to PSU awards granted to the Named Executive Officers during fiscal 2020, the grant date fair values, as computed in accordance with FASB ASC 718, excluding the estimate of estimated forfeitures, and presented in the
table above, are based upon the then-probable outcome of the performance conditions, which was $0 for each Named Executive Officer. Assuming &#147;Threshold Achievement&#148; (i.e. &#147;Threshold Payout&#148;), &#147;Target Achievement&#148; (i.e.
&#147;Target Payout&#148;) and &#147;Over Achievement&#148; or &#147;Early Achievement&#148; (i.e. &#148;Maximum Payout&#148;) of the performance conditions for the PSU awards granted to each Named Executive Officer during fiscal 2020, and in each
case other than Dr.&nbsp;Morrissey, assuming a closing stock price of $21.73 per share of our common stock on the September&nbsp;11, 2020 grant date (and for Dr.&nbsp;Morrissey, assuming a closing stock price of $21.83 per share of our common stock
on the October&nbsp;22, </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">66</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Summary of Compensation </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">2020 grant date) and excluding estimates of forfeiture, the values of the PSU awards granted to each Named Executive Officer during fiscal 2020 at the grant date were as follows:
</FONT></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name and Principal
Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Threshold&nbsp;Payout&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target&nbsp;Payout&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum&nbsp;Payout</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">of&nbsp;PSUs&nbsp;Granted</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2020</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,104,149</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,208,298</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">16,416,597</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,415,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,830,767</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,661,534</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,415,384</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,830,767</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,661,534</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,258,167</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,516,334</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,032,668</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J.
Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,258,167</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,516,334</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,032,668</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">For a description of the PSU awards granted during fiscal 2020, see &#147;<A HREF="#tx63026_a30">Compensation
 Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020 Long-Term Incentive Awards</A>&#148; above. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">With
respect to PSU awards granted to the Named Executive Officers during fiscal 2019, the grant date fair values, as computed in accordance with FASB ASC 718, excluding the estimate of estimated forfeitures, and presented in the table above, are based
upon the then-probable outcome of the performance conditions, which was $0 for each Named Executive Officer. Assuming &#147;Target Achievement&#148; (i.e. &#147;Target Payout&#148;) and &#147;Over Achievement&#148; (i.e. &#147;Maximum Payout&#148;)
of the performance conditions for the PSU awards granted to each Named Executive Officer during fiscal 2019, and in each case assuming a closing stock price of $19.56 per share of our common stock on the September&nbsp;20, 2019 grant date and
excluding estimates of forfeiture, the values of the PSU awards granted to each Named Executive Officer other than Mr.&nbsp;Haley during fiscal 2019 at the grant date were as follows: </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Name and Principal Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target&nbsp;Payout&nbsp;of</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2019</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum&nbsp;Payout</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">of&nbsp;PSUs&nbsp;Granted</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;2019</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,774,107</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">17,548,215</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,788,982</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">5,577,964</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,324,139</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,648,278</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,324,139</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">4,648,278</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">With respect to PSU awards granted during fiscal 2018, the grant date fair values, as computed in
accordance with FASB ASC 718, excluding the estimate of estimated forfeitures, and presented in the table above, are based upon the then-probable outcome of the performance conditions, which was $0 for each Named Executive Officer. Assuming
achievement of the target level of the performance conditions for the PSU awards granted to each Named Executive Officer during fiscal 2018 (which was also the maximum level of performance), and assuming a closing stock price of $18.80 per share of
our common stock on the September&nbsp;10, 2018 grant date and excluding estimates of forfeiture, the values of the PSU awards granted to each Named Executive Officer other than Mr.&nbsp;Haley during fiscal 2018 at the grant date were as follows:
</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="5" STYLE="BORDER-TOP:2.00pt solid #fc4c02">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-RIGHT:1px solid #fc4c02">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Name and Principal Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:2.00pt solid #fc4c02"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target/Maximum&nbsp;Payout&nbsp;of</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted&nbsp;in&nbsp;2018</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey,
Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,912,552</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,221,398</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J.
Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,221,398</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel,
J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">657,680</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f"><A NAME="tx63026_a32"></A>(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column do not reflect compensation actually received or amounts that may be
realized in the future by the Named Executive Officers. The amounts shown reflect the aggregate grant date fair value in the indicated fiscal years for option awards as computed in accordance with FASB ASC 718. The assumptions used to calculate the
value of option awards are set forth in Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended January&nbsp;1, 2021, submitted to the SEC
on February&nbsp;10, 2021. With respect </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">67</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">to the performance-based option award granted to Dr.&nbsp;Morrissey during fiscal 2018, the grant date fair value, as computed in accordance with FASB ASC 718 and presented in the table above, is
based upon the then-probable outcome of achieving the market performance condition and excluding estimates of forfeiture. There can be no assurance that the stock option awards will ever be exercised (in which case no value will actually be realized
by the executive) or that the value on exercise will be equal to the FASB ASC 718 value shown in this column. </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The amounts in this column represent the portion of the cash bonuses awarded under our Annual
Cash Bonus Plan that was based on the Compensation Committee&#146;s assessment of the achievement of <FONT STYLE="white-space:nowrap">pre-determined</FONT> corporate goals. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown reflect the grant date fair value of the time-based RSU award granted to
Mr.&nbsp;Haley in connection with his promotion to Executive Vice President, Commercial as computed in accordance with FASB ASC 718. The grant date fair value of the RSU award was measured based on the closing price of $21.80 per share of our common
stock on the February&nbsp;19, 2020 grant date. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">68</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Grants of Plan-Based Awards </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_25"></A>Grants of Plan-Based Awards </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table shows for the
fiscal year ended January&nbsp;1, 2021, certain information regarding grants of plan-based awards to the Named Executive Officers: </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT
 COLOR="#3f3f3f"><B>Grants of Plan-Based Awards in Fiscal&nbsp;2020 </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD COLSPAN="2" ROWSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Estimated&nbsp;Future<BR>Payouts&nbsp;
Under<BR><FONT STYLE="white-space:nowrap">Non-Equity&nbsp;Incentive</FONT><BR>Plan&nbsp;Awards&nbsp;(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Estimated&nbsp;Future<BR>Payouts&nbsp;Under<BR>Equity&nbsp;Incentive<BR>Plan&nbsp;
Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="right" STYLE="BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">All Other<BR>Stock&nbsp;Awards:<BR>Number of<BR>Shares of<BR>Stock or
Units<BR>($)(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="3" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="right" STYLE="BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant&nbsp;Date<BR>Fair&nbsp;Value&nbsp;
of<BR>Stock<BR>Awards<BR>($)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="3" STYLE=" BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:1pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="10" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="10" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant Date</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Approval<BR>Date</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Threshold<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Threshold<BR>(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target<BR>(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Maximum<BR>(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #fc4c02; BORDER-BOTTOM:2.00pt solid #fc4c02">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael&nbsp;M.&nbsp;Morrissey,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">94,002</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">188,005</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">376,010</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">94,002</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">188,005</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">376,010</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,067,997</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,553,936</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">65,135</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">130,270</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">65,135</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">130,270</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">450,154</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">728,575</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">65,135</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">130,270</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">65,135</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">130,270</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">326,595</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">528,593</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">57,900</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">115,800</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">57,900</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">115,800</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">290,192</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">469,676</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-1.00em; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">02/19/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">02/19/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">35,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">763,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">57,900</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">115,800</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">09/02/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">57,900</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">115,800</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">N/A</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">255,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">412,718</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:13pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The dollar amount represents the target and maximum amounts of each Named Executive Officer&#146;s
potential annual cash bonus award pursuant to our Annual Cash Bonus Plan for the fiscal year ended January&nbsp;1, 2021. The amounts shown under &#147;Target&#148; reflects the applicable target payment under the Annual Cash Bonus Plan if
(i)&nbsp;we achieved 100% of the <FONT STYLE="white-space:nowrap">pre-determined</FONT> 2020 corporate goals established by the Compensation, and (ii)&nbsp;as applicable, each Named Executive Officer&#146;s individual performance percentage was
assessed at 100% by the Compensation Committee with respect to his or her contributions toward the achievement of our corporate goals. The amounts shown under &#147;Maximum&#148; reflects the applicable maximum payment under the Annual Cash Bonus
Plan if (i)&nbsp;we achieved 145.5% of the <FONT STYLE="white-space:nowrap">pre-determined</FONT> 2020 corporate goals established by the Compensation Committee, and (ii)&nbsp;as applicable, each Named Executive Officer&#146;s individual performance
percentage was assessed at 200% by the Compensation Committee with respect to his or her contributions toward the achievement of our corporate goals and the departmental achievements in each Named Executive Officer&#146;s area of responsibility that
drove the achievement of such corporate goals; provided, however, that neither the corporate performance percentage nor the individual performance percentage may exceed 200% in any given year. There is no threshold or minimum possible payment under
the Annual Cash Bonus Plan. For more information regarding our Annual Cash Bonus Plan, please see &#147;<A HREF="#tx63026_a31">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020 Annual Cash Bonuses</A>&#148; above.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The RSU award was granted pursuant to our 2017 Plan. The RSU award will vest as to 1/4th of the
shares subject to the RSU award on May&nbsp;15, 2021 and thereafter as to 1/4th of the number of shares subject to the RSU award on each May 15th until fully vested. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Amounts shown in this column do not reflect compensation actually received or amounts that may be
realized in the future by the Named Executive Officers. The amounts shown in this column reflect the aggregate grant date fair value in fiscal year 2020 for the RSU and PSU awards as computed in accordance with FASB ASC 718. The assumptions used to
calculate the grant date fair value of the PSU awards are set forth in Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
January&nbsp;1, 2021, submitted to the SEC on February&nbsp;10, 2021. The grant date fair values of the PSU awards, as computed in accordance with FASB ASC 718, granted to each Named Executive Officer presented in the table above are based upon the
then-probable outcome of the performance conditions, which was $0 for each Named </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">69</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">Executive Officer. For additional information regarding the values of the PSU awards granted to each Named Executive Officer during fiscal 2020, see Footnote 5 to the <A HREF="#tx63026_66a">Summary Compensation
Table</A> above. The grant date fair value of the RSU award was measured based on the closing price of our common stock on the date of grant. </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The PSU award was granted pursuant to our 2017 Plan. The PSU award will vest as to (i) 50% of the
2020 PSU Certified Shares upon the Compensation Committee&#146;s certification that the company has achieved positive <FONT STYLE="white-space:nowrap">top-line</FONT> results of one or more clinical trials evaluating a product for which we own, or
have licensed to a partner, development or commercialization rights, that provides data that can reasonably support regulatory evaluation of safety and efficacy to determine the risk/benefit profile of the product, and (ii) 50% of the 2020 PSU
Certified Shares on the first quarterly vesting date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August
15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s
certification. Depending on the level of achievement of such performance target, Named Executive Officers are eligible to vest up to a maximum of 200% of the target number of shares of Exelixis common stock subject to the PSU award. For more
information regarding the PSUs granted in 2020, please see &#147;<A HREF="#tx63026_a30">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020 Long-Term Incentive Awards</A>&#148; above. Failure to achieve the aforementioned
performance target by December&nbsp;
31, 2024 will result in forfeiture of 100% of the PSU award, and vesting is subject to acceleration as described under the caption &#147;<A HREF="#tx63026_a33">&#151;Potential Payments Upon Termination or Change in Control</A>&#148; below.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">The PSU award was granted pursuant to our 2017 Plan. The PSU award will vest as to (i) 50% of the
2020 PSU Certified Shares upon the Compensation Committee&#146;s certification that the company has obtained approval by the FDA for the commercial sale and marketing of one or more products for which we own, or have licensed to a partner,
development or commercialization rights, in one or more new indications or an indication for which the product has previously received FDA approval, if such product is intended to treat a new, additional or expanded set of patients or is part of a
combination therapy, and (ii) 50% of the 2020 PSU Certified Shares on the first quarterly vesting date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification.
Depending on the level of achievement of such performance target, Named Executive Officers are eligible to vest up to a maximum of 200% of the target number of shares of Exelixis common stock subject to the PSU award. For more information regarding
the PSUs granted in 2020, please see &#147;<A HREF="#tx63026_a30">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020 Long-Term Incentive Awards</A>&#148; above. Failure to achieve the aforementioned performance target by
December 31, 2024 will result in forfeiture of 100% of the PSU award, and vesting is subject to acceleration as described under the caption &#147;<A HREF="#tx63026_a33">&#151;Potential Payments Upon Termination or Change in Control</A>&#148; below.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_26"></A>Compensation Arrangements </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Base Salaries.</I></B> For a
description of actions taken by the Compensation Committee with respect to base salaries for our Named Executive Officers for fiscal 2020, please see &#147;<A HREF="#tx63026_a21">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020
 Base Salaries</A> &#148; above. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Annual Cash Bonuses.</I></B> In 2018, we adopted our Annual Cash Bonus Plan that provides for
annual bonus awards based on our corporate performance, including achievement against <FONT STYLE="white-space:nowrap">pre-determined</FONT> corporate goals and the individual contributions of each Named Executive Officer toward the achievement of
such corporate goals. For more information regarding our Annual Cash Bonus Plan, please see &#147;<A HREF="#tx63026_a22">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020 Annual Cash Bonuses</A>&#148; above. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Stock Awards and Option Awards.</I></B> Our 2017 Plan provides for the grant of RSUs, PSUs and time-based and performance-based stock
options to our Named Executive Officers and other employees. In September 2020, we granted PSU awards, which will only vest following our achievement of a certain performance target in line with our longer-term business strategy, to all of our Named
Executive Officers. In addition, in February 2020, we granted a time-based RSU award to Mr.&nbsp;Haley. For information regarding PSU and RSU awards granted to the Named Executive Officers in fiscal 2020, including the number of underlying shares
and vesting conditions related thereto, please see &#147;<A HREF="#tx63026_a30">Compensation Discussion and Analysis&#151;2020 Compensation Decisions&#151;2020 Long-Term Incentive Awards</A>&#148; above. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Employment Agreements. </I></B>We have no employment agreements with our Named Executive Officers. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Change in Control and Severance Benefit Plan.</I></B> Each of our Named Executive Officers participates in our Change in Control and
Severance Benefit Plan, a description of which is included below under the heading &#147;<A HREF="#tx63026_a33">Potential Payments Upon Termination or Change in Control.</A>&#148; </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B><I>Other Compensatory Arrangements.</I></B> Please see &#147;<A HREF="#tx63026_a39">Compensation Discussion and Analysis&#151;Compensation Elements&#151;Other
 Compensation</A>&#148; above for a description of other executive compensatory arrangements, including our 401(k) Plan and other benefits. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">70</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Outstanding Equity Awards at Fiscal Year&#150;End </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_27"></A>Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End</FONT> </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">The following table shows certain information regarding outstanding equity awards at January&nbsp;1, 2021, for the Named Executive Officers. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Outstanding Equity Awards at January&nbsp;1, 2021 </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt"> &nbsp;&nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option Awards(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock Awards(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.57em; font-size:7pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Exercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Unexercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Exercise<BR>Price</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Expiration</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;or<BR>Units
of<BR>Stock&nbsp;That<BR>Have&nbsp;Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Market<BR>Value&nbsp;of<BR>Shares<BR>or&nbsp;Units<BR>of&nbsp;Stock<BR>That<BR>Have&nbsp;
Not<BR>Vested<BR>($)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Plan
Awards:<BR>Number&nbsp;of<BR>Unearned&nbsp;Shares,<BR>Units&nbsp;or<BR>Other&nbsp;Rights That<BR>Have Not<BR>Vested</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive<BR>Plan
Awards:<BR>Market&nbsp;or<BR>Payout&nbsp;Value&nbsp;of<BR>Unearned<BR>Shares,&nbsp;Units or<BR>Other Rights<BR>That Have&nbsp;Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/11/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">150,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4.20</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/10/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/26/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">360,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">15.31</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/25/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">380,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">100,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">20,000(5)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">401,400</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">173,455</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">134,910</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(6)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18,591(7)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">373,121</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">11,619(8)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">233,193</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">23,238</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">466,387</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">46,478</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">932,813</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">336,431</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">6,752,170</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">224,287</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,501,440</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">94,002</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,886,620</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/22/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">94,002</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(14)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,886,620</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12.0pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/19/2014</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">200,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1.70</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/18/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/5/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">250,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1.90</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/4/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/16/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">245,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">6.21</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/15/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/11/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">75,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4.20</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/10/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/22/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">120,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14.74</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/21/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">118,750</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">31,250</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18,750</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">376,313</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">72,738</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">56,576</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">7,796</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(7)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">156,466</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,873</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(8)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">97,801</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9,745</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">195,582</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">19,491</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">391,184</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">106,940</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2,146,286</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">71,293</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,430,851</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">653,620</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(14)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">653,620</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">71</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>

<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt"> &nbsp;&nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:2pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option Awards(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="padding-bottom:2pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock Awards(2)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#fc4c02">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.57em; font-size:7pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Exercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Unexercisable</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Exercise<BR>Price</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Expiration</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;or<BR>Units
of<BR>Stock&nbsp;That<BR>Have&nbsp;Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Market<BR>Value&nbsp;of<BR>Shares<BR>or&nbsp;Units<BR>of&nbsp;Stock<BR>That<BR>Have&nbsp;
Not<BR>Vested<BR>($)(3)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Plan
Awards:<BR>Number&nbsp;of<BR>Unearned&nbsp;Shares,<BR>Units&nbsp;or<BR>Other&nbsp;Rights That<BR>Have Not<BR>Vested</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Incentive<BR>Plan
Awards:<BR>Market&nbsp;or<BR>Payout&nbsp;Value&nbsp;of<BR>Unearned<BR>Shares,&nbsp;Units or<BR>Other Rights<BR>That Have&nbsp;Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">7/15/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">120,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">3.66</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">7/14/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/16/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">225,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">6.21</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/15/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/22/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">120,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14.74</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/21/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">98,958</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">26,042</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">15,625</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">313,594</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">72,738</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">56,576</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">7,796</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(7)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">156,466</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,873</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(8)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">97,801</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9,745</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">195,582</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">19,491</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">391,184</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">89,116</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,788,558</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">59,411</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,192,379</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">653,620</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">32,567</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(14)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">653,620</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/10/2014</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">30,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">7.27</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/9/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/5/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">20,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1.90</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/4/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/22/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">97,500</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">14.74</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/21/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">79,166</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">20,834</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">12,500</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">250,875</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">72,738</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">56,576</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,498</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(7)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">90,275</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2,499</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(8)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">50,155</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,998</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">100,310</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9,994</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">200,580</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">89,116</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,788,558</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">59,411</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,192,379</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">581,027</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(14)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">581,027</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/19/2014</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">25,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1.70</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/18/2021</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/5/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">60,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1.90</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/4/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/16/2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">60,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">6.21</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/15/2022</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/11/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">25,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4.20</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/10/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">12/19/2016</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">50,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">16.29</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">12/18/2023</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">79,166</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">20,834</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">24.41</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/2/2024</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">10/3/2017</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">12,500</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">250,875</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">65,465</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">50,918</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(11)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">18.80</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/9/2025</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,048</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(7)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">81,243</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2,249</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(8)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">45,137</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">4,498</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(9)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">90,275</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/10/2018</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">8,995</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(10)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">180,530</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/20/2019</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">89,116</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,788,558</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">59,411</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(12)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">1,192,379</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">2/19/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">35,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(15)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">702,450</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(13)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">581,027</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">9/11/2020</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">28,950</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">(14)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">581,027</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Option awards granted on or after May&nbsp;18, 2011, and prior to May&nbsp;28, 2014, were issued
under our 2011 Equity Incentive Plan (2011 Plan) and were either subject to time-based vesting or were subject to performance-based vesting and expire seven years from the date of grant or earlier upon
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">72</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Outstanding Equity Awards at Fiscal Year&#150;End </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">termination of continuous service. Option awards granted on or after May&nbsp;28, 2014, and prior to May&nbsp;24, 2017, were issued under our 2014 Equity Incentive Plan (2014 Plan) and are either
subject to time-based vesting or were subject to performance-based vesting and expire seven years from the date of grant or earlier upon termination of continuous service. Vesting of option awards granted under the 2014 Plan is set forth in the
applicable footnote accompanying the entry. Option awards granted pursuant to our 2014 Plan subject to time-based vesting vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on
the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the vesting commencement date and thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on each monthly
anniversary of the vesting commencement date. Option awards granted pursuant to our 2014 Plan subject to performance-based vesting are vested in full. Option awards granted on or after May&nbsp;24, 2017 were issued under our 2017 Plan and are
subject to time-based vesting and expire seven years from the date of grant or earlier upon termination of continuous service. Vesting of option awards granted under the 2017 Plan is set forth in the applicable footnote accompanying the entry.
Option awards granted pursuant to our 2017 Plan subject to time-based vesting vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on the
<FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the vesting commencement date and thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the option on each monthly
anniversary of the vesting commencement date. Vesting of all options issued to our Named Executive Officers are subject to acceleration as described under the caption &#147;<A HREF="#tx63026_a33">Potential Payments Upon Termination or Change in Control
</A>&#148; below. </FONT></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">RSU awards granted on or after May&nbsp;28, 2014 and prior to May&nbsp;24, 2017 were issued under
our 2014 Plan, and RSU awards granted on or after May&nbsp;24, 2017 were issued under our 2017 Plan. RSU awards generally vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the RSU award
on the first established RSU vesting date following the one year anniversary of the grant date and thereafter as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to the RSU award on each
anniversary of the first established RSU vesting date following the one year anniversary of the grant date, until fully vested. We have established February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>, August&nbsp;15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November&nbsp;15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> as quarterly vesting dates. Vested shares will be
delivered to the Named Executive Officer on the applicable quarterly vesting date, provided that delivery may be delayed pursuant to the terms of the award agreement. In addition, PSU awards granted pursuant to our 2017 Plan vest based on the
achievement of certain performance targets set by the Compensation Committee as described below in Footnotes 7, 8, 9, 10, 12, 13 and 14. Vesting of all RSU awards and PSU awards issued to our Named Executive Officers is subject to acceleration as
described under the caption &#147;<A HREF="#tx63026_a33">Potential Payments Upon Termination or Change in Control</A>&#148; below. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">For purposes of determining market value, we assumed a stock price of $20.07, the closing sale
price per share of our common stock on December&nbsp;31, 2020, the last business day of our last fiscal year. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Option vests as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original
number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date and thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to
the option on each monthly anniversary of the grant date with a final vesting date of October&nbsp;3, 2021 (assuming that such options are not accelerated). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">RSUs vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number
of shares subject to the RSU award on each November 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> with a final vesting date of November&nbsp;15, 2021 (assuming that such RSUs are not accelerated). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Option vests as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original
number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date and thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to
the option on each monthly anniversary of the grant date with a final vesting date of September&nbsp;10, 2022 (assuming that such options are not accelerated). The option became exercisable upon the achievement of the performance condition that
required the closing market price of our common stock to be equal to or greater than 125% of the exercise price of the option over a period of at least 30 consecutive calendar days. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the original number of shares subject to the award upon the
Compensation Committee&#146;s certification that Exelixis has achieved a net product revenue target over four consecutive fiscal quarters, and (ii) 50% of the original number of shares subject to the award on the first quarterly vesting date (i.e.
February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). On December&nbsp;4,
2019, the Compensation Committee convened to determine that the net product revenue target over four consecutive fiscal quarters had been achieved during the three months ended September&nbsp;27, 2019, resulting in the immediate vesting of 50% of
the PSU award, and the remaining 50% vested on February&nbsp;15, 2021 (reported in the table as unvested, since such PSUs were still unvested as of January&nbsp;1, 2021). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the original number of shares subject to the award upon the
Compensation Committee&#146;s certification that Exelixis has initiated a target number of potentially label-enabling clinical trials for cabozantinib (both alone or in combination with another therapy), and (ii) 50% of the original number of shares
subject to the award on the first quarterly vesting date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August
15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s
certification (assuming that such PSUs are not accelerated). On September&nbsp;2, 2020, the Compensation Committee convened to determine that the target number of potentially label-enabling clinical trials had been achieved, resulting in the
immediate vesting of 50% of the PSU award, and the remaining 50% (reported in the table) will vest on November&nbsp;15, 2021 (assuming such PSUs are not accelerated). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the original number of shares subject to the award upon the
Compensation Committee&#146;s certification that Exelixis has achieved either (x)&nbsp;full target enrollment, as specified in the applicable clinical trial protocol, or (y)&nbsp;positive <FONT STYLE="white-space:nowrap">top-line</FONT> results, in
each case with respect to a target number of potentially label-enabling clinical trials for cabozantinib (both alone or in combination with another therapy), and (ii) 50% of the original number of shares subject to the award on the first quarterly
vesting date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). On February&nbsp;3,
2021, the Compensation Committee convened to determine that full target enrollment and/or positive <FONT STYLE="white-space:nowrap">top-line</FONT> results from the target number of potentially label-enabling clinical trials had been achieved,
resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% (reported in the table) will vest on February&nbsp;15, 2022 (assuming such PSUs are not accelerated); however, because the Compensation Committee had not yet certified
the achievement of the performance criteria as of January&nbsp;1, 2021, this PSU award is reported as &#147;unearned&#148; in the table above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the original number of shares subject to the award upon the
Compensation Committee&#146;s certification that a target number of IND applications have become effective with respect to product candidates that have either (x)&nbsp;been discovered by Exelixis or
<FONT STYLE="white-space:nowrap">(y)&nbsp;in-licensed</FONT> or acquired by Exelixis, and (ii) 50% of the original number of shares subject to the award on the first quarterly vesting date (i.e. February 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November
15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). Failure to
achieve the aforementioned performance target by December&nbsp;31, 2021 will result in forfeiture of 100% of the PSU award. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family:Calibri; " COLOR="#fc4c02">73</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Option vests as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original
number of shares subject to the option on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date and thereafter as to 1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number of shares subject to
the option on each monthly anniversary of the grant date with a final vesting date of September&nbsp;10, 2022 (assuming that such options are not accelerated). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the number of shares subject to the award that are entitled to vest
based upon the Compensation Committee&#146;s certification that the company has obtained approval by the FDA for the commercial sale and marketing of one or more products for which we hold, or have licensed to a partner, development and
commercialization rights in the U.S. in one or more new indications, on the date of such certification, and (ii) 50% of the number of shares subject to the award that are entitled to vest based on such certification on the first quarterly vesting
date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). On October&nbsp;22,
2020, the Compensation Committee convened to determine that certain performance criteria had been achieved early, resulting in the immediate vesting of 75% of the target number of shares subject to the PSU award, and an additional 75% of the target
number of shares subject to the PSU award (reported in the table) will vest on November&nbsp;15, 2021 (assuming such PSUs are not accelerated). On February&nbsp;3, 2021, the Compensation Committee convened to determine that the maximum performance
criteria had been achieved, resulting in the immediate vesting of an additional 25% of the target number of shares subject to the PSU award, and an additional 25% of the target number of shares subject to the PSU award will vest on February&nbsp;15,
2022 (assuming such PSUs are not accelerated); however, because the Compensation Committee had not yet certified the maximum achievement of the performance criteria as of January&nbsp;1, 2021, this portion of the PSU award (representing 50% of the
target number of shares of Exelixis common stock) is reported as &#147;unearned&#148; in the table above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the 2020 PSU Certified Shares upon the Compensation Committee&#146;s
certification that the company has achieved positive <FONT STYLE="white-space:nowrap">top-line</FONT> results of one or more clinical trials evaluating a product for which we own, or have licensed to a partner, development or commercialization
rights, that provides data that can reasonably support regulatory evaluation of safety and efficacy to determine the risk/benefit profile of the product, and (ii) 50% of the 2020 PSU Certified Shares on the first quarterly vesting date (i.e.
February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). The number of shares
reported in the table above represents threshold achievement, or 50% of the target number of shares of Exelixis common stock subject to the PSU award. Depending on the level of achievement of such performance target, Named Executive Officers are
eligible to vest up to a maximum of 200% of the target number of shares of Exelixis common stock subject to the PSU award. Failure to achieve the aforementioned performance target by December&nbsp;31, 2024 will result in forfeiture of 100% of the
PSU award. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">PSUs vest as to (i) 50% of the 2020 PSU Certified Shares upon the Compensation Committee&#146;s
certification that the company has obtained approval by the FDA for the commercial sale and marketing of one or more products for which we own, or have licensed to a partner, development or commercialization rights, in one or more new indications or
an indication for which the product has previously received FDA approval, if such product is intended to treat a new, additional or expanded set of patients or is part of a combination therapy, and (ii) 50% of the 2020 PSU Certified Shares on the
first quarterly vesting date (i.e. February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and November 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) following the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Compensation Committee&#146;s certification (assuming that such PSUs are not accelerated). The number of shares
reported in the table above represents threshold achievement, or 50% of the target number of shares of Exelixis common stock subject to the PSU award. Depending on the level of achievement of such performance target, Named Executive Officers are
eligible to vest up to a maximum of 200% of the target number of shares of Exelixis common stock subject to the PSU award. Failure to achieve the aforementioned performance target by December&nbsp;31, 2024 will result in forfeiture of 100% of the
PSU award. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">RSUs vest as to 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the original number
of shares subject to the RSU award on each May 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> with a final vesting date of May&nbsp;15, 2024 (assuming that such RSUs are not accelerated). </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_28"></A>Option Exercises and Stock Vested </FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table includes certain
information with respect to stock options exercised and stock awards that vested during the fiscal year ended January&nbsp;1, 2021. </FONT></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT
 COLOR="#3f3f3f"><B>Options Exercised and Stock Vested in Fiscal 2020 </B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9.5pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #fc4c02; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise(#)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Realized&nbsp;on<BR>Exercise($)(1)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Shares</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Acquired&nbsp;on</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Vesting(#)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Realized&nbsp;on</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Vesting($)(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>

<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,005,284</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">40,643,720</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">395,443</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,537,011</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">440,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,230,955</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">140,759</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">3,018,930</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">130,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,855,222</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">119,810</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,567,545</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">467,698</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">8,283,166</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">111,175</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,390,094</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.47em; text-indent:-1.00em; font-size:9.5pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">41,055</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">944,743</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">112,430</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,415,040</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Value Realized on Exercise&#148; reflects the closing market price of our common stock on
the applicable exercise date, net of the applicable exercise price, multiplied by the number of shares acquired upon exercise of stock options. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">&#147;Value Realized on Vesting&#148; reflects the closing market price of our common stock on
the applicable vesting date, multiplied by the number of units vested. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">74</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Potential Payments Upon Termination or Change in Control </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_29"></A><A NAME="tx63026_a33"></A>Potential Payments
Upon Termination or Change in Control </FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Change in Control and Severance Benefit Plan </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board, upon recommendation of the Compensation Committee,
has adopted a Change in Control and Severance Benefit Plan that provides for certain severance benefits to our officers in connection with specified termination events. Eligible plan participants may include any employee having a rank of vice
president or above, which includes the Named Executive Officers. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">If a Named Executive Officer&#146;s employment terminates due to an
involuntary termination without cause or a constructive termination (Covered Termination) during a period starting one month prior to and ending 13 months following a change in control (Change in Control Termination), then the Named Executive
Officer would be entitled to the following benefits under the plan: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">a cash payment paid in installments pursuant to our regularly scheduled payroll periods equal to
the sum of the Named Executive Officer&#146;s base salary and target bonus for (i) 18 months for Named Executive Officers (other than the Chief Executive Officer) and (ii) 24 months for the Chief Executive Officer; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">the vesting of up to all of the Named Executive Officer&#146;s options, RSUs and PSUs will
accelerate in full, and the exercise period of such options will be extended to the later of: (i) 12 months after the later of (x)&nbsp;the participant&#146;s termination date, or (y)&nbsp;the change in control; and (ii)&nbsp;the post-termination
exercise period provided for in the applicable option agreement; the plan also provides that any reacquisition or repurchase rights held by us in respect of common stock issued or issuable pursuant to any stock awards granted under any of our equity
incentive plans shall lapse; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">payment of COBRA premiums, or the cash equivalent thereof, for any health, dental or vision plan
sponsored by Exelixis for a period of up to (i) 18 months for Named Executive Officers (other than the Chief Executive Officer) and (ii) 24 months for the Chief Executive Officer; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">payment of outplacement services for (i) 18 months for Named Executive Officers (other than the
Chief Executive Officer), subject to a $30,000 limit and (ii) 24 months for the Chief Executive Officer, subject to a $50,000 limit. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">In the event of a Covered Termination of a Named Executive Officer that is not also a Change in Control Termination, such Named Executive Officer would be entitled to receive a cash severance benefit under the plan equal to 12
months of base salary paid in installments pursuant to our regularly scheduled payroll periods. In such circumstances, we would also pay for a period of up to 12 months of such Named Executive Officer&#146;s COBRA premiums, or the cash equivalent
thereof, for any health, dental or vision plan that we sponsored and that the Named Executive Officer is enrolled in. However, such Named Executive Officer would not be entitled to any vesting acceleration benefits by virtue of such termination.
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The payments and benefits described above are subject to certain reductions and offsets if, for example, the Named Executive Officer
received other severance benefits from us pursuant to a written employment agreement. In addition, if any of the severance benefits payable under the plan would constitute a &#147;parachute payment&#148; subject to the excise tax imposed by
Section&nbsp;4999 of the Code, a Named Executive Officer may receive a reduced amount of the affected severance benefits. The plan does not provide for the gross up of any excise taxes imposed by Section&nbsp;4999 of the Code. No Named Executive
Officer would receive benefits under the plan if (i)&nbsp;the Named Executive Officer has entered into an individually negotiated employment agreement that provides for severance or change in control benefits, (ii)&nbsp;the Named Executive Officer
voluntarily terminates employment with us to accept employment with another entity that is controlled by us or is otherwise affiliated with us or (iii)&nbsp;the Named Executive Officer does not confirm in writing that he or she is subject to
agreements with us relating to proprietary and confidential information. In addition, as a general matter, to be eligible to receive benefits under the plan and if requested by Exelixis, a Named Executive Officer must execute a general waiver and
release of claims, and such release must become effective in accordance with its terms. A Named Executive Officer&#146;s right to receive payment of benefits under the plan will immediately terminate if, at any time prior to or during the period the
Named Executive Officer is receiving such benefits, the Named Executive Officer, without the prior written approval of Exelixis, (i)&nbsp;willfully breaches a material provision of a proprietary and confidential information agreement with Exelixis
or (ii)&nbsp;willfully encourages or solicits any of Exelixis&#146; then current employees to leave Exelixis&#146; employ. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>Treatment of Equity Awards </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Pursuant to our 2011 Plan, 2014 Plan and 2017 Plan, in the event of an asset sale, merger or consolidation in which we are not the surviving corporation, or a reverse merger in which we are the surviving corporation but our common
stock is </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">75</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">converted by virtue of
the merger into other property, then any surviving or acquiring corporation may assume outstanding stock awards or substitute similar stock awards for those under the plan. If any surviving or acquiring corporation refuses to assume such outstanding
stock awards or substitute similar stock awards, stock awards held by participants whose service has not terminated will be accelerated in full. In addition, if any person, entity or group acquires beneficial ownership of more than 50% of our
combined voting power, then stock awards held by participants whose service has not terminated will be accelerated in full. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The
following table sets forth the potential severance payments and benefits under our Change in Control and Severance Benefit Plan to which a Named Executive Officer would be entitled in connection with specified termination events, as if such Named
Executive Officers&#146; employment terminated as of January&nbsp;1, 2021, the last day of our last fiscal year. In addition, the table sets forth the amounts to which such Named Executive Officers would be entitled under our equity plans either
(i)&nbsp;in connection with a change in control transaction in which the successor corporation did not assume or substitute outstanding stock awards (and with respect to PSU awards granted to each Named Executive Officer, a change in control
transaction in which a successor corporation does assume outstanding stock awards), or (ii)&nbsp;an entity or group acquired more than 50% of our combined voting power, in each case, as of January&nbsp;1, 2021. There are no other agreements,
arrangements or plans that entitle any of the above-mentioned Named Executive Officers to severance, perquisites or other enhanced benefits upon termination of employment, other than certain extensions of the termination date to avoid violation of
registration requirements under the Securities Act of 1933, as amended, or for such Named Executive Officer&#146;s death or disability. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f"><B>Potential Payments Table </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The following table shows the potential payments upon termination of employment or a
change in control for the Named Executive Officers. The table assumes that the triggering event took place on January&nbsp;1, 2021, the last day of our 2020 fiscal year. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><FONT COLOR="#3f3f3f"><B>Potential Payments Upon Termination or Change in Control Table </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Benefit</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change&nbsp;in&nbsp;Control&nbsp;and&nbsp;Severance<BR>Benefit
Plan</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity Plans</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cause&nbsp;or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;in</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">with&nbsp;a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">of&nbsp;Control&nbsp;($)(1)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cause or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;Not</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">with a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">in Control ($)(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Certain</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Control</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Transactions</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael&nbsp;M.&nbsp;Morrissey,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Base&nbsp;Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,135,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,067,997</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">2,135,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21,420,249</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">21,420,249</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">71,067</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">35,533</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>25,813,304</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>1,103,530</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>21,420,249</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">1,125,386</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">750,257</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">675,231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,740,818</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,740,818</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">34,482</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">22,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>9,605,917</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>773,245</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>7,740,818</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">979,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">653,189</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">489,892</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,215,847</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">7,215,847</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">53,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">35,533</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">Outplacement&nbsp;Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>8,768,823</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>688,722</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>7,215,847</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">76</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;Potential Payments Upon Termination or Change in Control </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>

<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Benefit</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change&nbsp;in&nbsp;Control&nbsp;and&nbsp;Severance<BR>Benefit Plan</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;border-bottom:1.00px solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity Plans</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cause&nbsp;or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;in</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">with&nbsp;a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">of&nbsp;Control&nbsp;($)(1)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Involuntary</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cause or</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Constructive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination&nbsp;Not</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">in&nbsp;Connection</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">with a Change</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">in Control ($)(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Certain</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Change of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Control</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Transactions</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">without</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Termination</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">870,576</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">580,384</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">435,288</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,358,477</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,358,477</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">53,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">35,533</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;<B>Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>7,747,641</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>615,917</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>6,358,477</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Base Salary</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">765,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">510,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Bonus</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">382,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">Vesting&nbsp;Acceleration (4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,903,237</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">6,903,237</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">COBRA Payments</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">93,068</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">62,045</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">Outplacement Services</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT COLOR="#3f3f3f">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><B>&nbsp;&nbsp;&nbsp;&nbsp;Benefit
Total</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>8,173,805</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>572,045</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #3f3f3f">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f" ALIGN="right"><FONT COLOR="#3f3f3f"><B>6,903,237</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #3f3f3f"><FONT COLOR="#3f3f3f"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These benefits would be payable under the Change in Control and Severance Benefit Plan if the
involuntary termination without cause or constructive termination occurred during a period starting one month prior to and ending 13 months following the change in control. The amounts shown in this column do not include any value associated with
the extension, if any, of the post-termination exercise period provided for in the Change in Control and Severance Benefit Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These benefits would be payable under the Change in Control and Severance Benefit Plan if the
involuntary termination without cause occurred more than one month before the change in control or if the involuntary termination without cause or a constructive termination occurred more than 13 months following the change in control.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">These benefits would be payable under the 2014 Plan and/or the 2017 Plan if either (i)&nbsp;a
successor corporation does not assume outstanding stock awards in a change in control transaction or (ii)&nbsp;a person, entity or group acquires beneficial ownership of more than 50% of our combined voting power, and, in each case, the Named
Executive Officers do not terminate employment in connection with such a transaction or event. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">77</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In addition, if a successor corporation does assume outstanding stock awards in a change in
control transaction and the Named Executive Officers do not terminate employment in connection with such a transaction, then each Named Executive Officer&#146;s then outstanding PSUs will be revised in a manner as though target number of shares
subject to such PSUs had been subject solely to a time-based vesting schedule pursuant to which one third of the target number of shares subject to such PSUs (and for the PSUs granted during fiscal 2020, one fourth) would have vested on each of the
first three anniversaries (and for the PSUs granted during fiscal 2020, each of the first four anniversaries) of the date the PSUs were granted, subject to the Named Executive Officer&#146;s continuous service through the applicable vesting date
(with any portion that would have vested on or prior to the change in control transaction under such vesting schedule becoming vested on the date of the change in control transaction and any portion that is unvested following the date of the change
in control transaction vesting in accordance with such vesting schedule). With respect to PSU awards granted during fiscal 2020, the vesting acceleration benefit for each Named Executive Officer would be $0 because the first anniversary of the grant
date will not yet have occurred as of January&nbsp;1, 2021. With respect to PSU awards granted during fiscal 2019, the vesting acceleration benefit for each Named Executive Officer would be $0, because the performance criteria for the target number
of such PSUs had already been achieved as of January&nbsp;1, 2021. With respect to PSU awards granted during fiscal 2018, the vesting acceleration benefit for each Named Executive Officer would be as follows: </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="98%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#fc4c02" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:Calibri"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name and Principal
Position</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Vesting&nbsp;Acceleration&nbsp;Benefit&nbsp;for&nbsp;
Outstanding</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">PSUs&nbsp;Granted&nbsp;in&nbsp;2018</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Calibri" ALIGN="right"><FONT STYLE="font-family:Calibri" COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Michael M. Morrissey, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">932,793</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Gisela M. Schwab, M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">391,164</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Christopher J. Senner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">391,164</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Jeffrey J. Hessekiel, J.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #b2b2b2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">200,580</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #b2b2b2"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Patrick J. Haley</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #fc4c02">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02" ALIGN="right"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">180,510</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #fc4c02"><FONT STYLE="font-family:Calibri; " COLOR="#3f3f3f">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">Assumes that the triggering event occurred on December&nbsp;31, 2020, the last business day of
our last fiscal year, when the closing sale price per share of our common stock was $20.07. The amount of the vesting acceleration is determined by: (i)&nbsp;aggregating for all accelerated options, the amount equal to (A)&nbsp;the excess, if any,
of $20.07 over the relevant exercise price of the option, multiplied by (B)&nbsp;the number of shares underlying unvested options at such exercise price as of December&nbsp;31, 2020; and (ii)&nbsp;aggregating for all accelerated RSUs and PSUs, the
amount equal to (X) $20.07 multiplied by (Y)&nbsp;the number of shares underlying the unvested RSUs and PSUs. There can be no assurance that a similar triggering event would produce the same or similar results as those estimated if such event occurs
on any other date or at a time when our closing sale price is different. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><A NAME="toc63026_30"></A>CEO Pay Ratio
</FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #fc4c02">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">We believe that we
provide fair and equitable compensation to our employees through a combination of competitive base pay, incentives, retirement plans and other benefits. In accordance with Item 402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT>
promulgated by the Dodd Frank Act, we determined the ratio of: (a)&nbsp;the annual total compensation of our Chief Executive Officer; to (b)&nbsp;the median of the annual total compensation of all of our employees, except for our Chief Executive
Officer, both calculated in accordance with the requirements of Item 402(c)(2)(x) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> (CEO Pay Ratio). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">In order to determine the median of the annual total compensation of all of our employees, we were required to identify the &#147;median
employee&#148; of our workforce, without regard to his or her location or employment status (full-time or part-time). The applicable SEC rules require us to identify a median employee only once every three years, as long as there have been no
material changes in our employee population or employee compensation arrangements that we believe would significantly impact the calculation of our CEO Pay Ratio. However, because there was a significant increase in our employee population between
October 2019, when we identified our median employee to calculate our CEO Pay Ratio for fiscal 2019, and October 2020, we decided to identify a new median employee for purposes of calculating our CEO Pay Ratio for fiscal 2020. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Consistent with the process we adopted for prior fiscal years, to determine the median of the annual total compensation of all of our employees,
except for our Chief Executive Officer, we used the following methodology: </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To identify our employee population, we used tax and payroll records to determine all full-time
and part-time employees, excluding our Chief Executive Officer, who were employed as of October&nbsp;31, 2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">To identify the median employee with respect to annual total compensation of all of our
employees, we calculated each employee&#146;s &#147;target total direct compensation,&#148; which consists of: (i)&nbsp;fiscal 2020 base salary (using a reasonable </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">78</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Compensation&nbsp;of&nbsp;Executive&nbsp;Officers&nbsp;</FONT><FONT
STYLE="font-family:Calibri; font-size:10pt" COLOR="#fc4c02">|</FONT><FONT STYLE="font-family:Calibri; font-size:10pt" COLOR="#3f3f3f">&nbsp;CEO Pay Ratio </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#3f3f3f">estimate of the hours worked and overtime actually paid during fiscal 2020 for hourly employees); (ii) target cash bonus; and (iii)&nbsp;the grant date fair value of any equity awards granted
during fiscal 2020 (using the same methodology that we use for estimating the value of the equity awards granted to our Named Executive Officers and reported in our <A HREF="#tx63026_a40">Summary Compensation Table</A>). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#3f3f3f">&#155;</FONT><FONT COLOR="#fc4c02">&#155;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Calibri; " ALIGN="left"><FONT COLOR="#3f3f3f">In making this determination, we annualized the base salary and target cash bonus for all
full-time and part-time employees who were employed by us for less than the entirety of fiscal 2020. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Once our
representative median employee was identified in the manner described above, we calculated the annual total compensation of the representative median employee using the same methodology that we used to determine the annual total compensation of our
Chief Executive Officer, as reported in the <A HREF="#tx63026_a40">Summary Compensation Table</A> included in this Proxy Statement. For fiscal 2020, the median of the annual total compensation of our employees (other than our Chief Executive
Officer) was $297,489 and the annual total compensation of our Chief Executive Officer, as reported in the <A HREF="#tx63026_a40">Summary Compensation Table</A> included in this Proxy Statement, was $2,349,812. Based on this information, our CEO Pay
Ratio for fiscal 2020 was 8 to 1. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This CEO Pay Ratio represents our reasonable estimate calculated in a manner consistent with Item
402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> and applicable guidance, which provide significant flexibility in how companies identify the median employee. Each company may use a different methodology and make different
assumptions particular to that company. As a result, and as explained by the SEC when it adopted these rules, in considering this CEO Pay Ratio disclosure, stockholders should keep in mind that the rule was not designed to facilitate comparisons of
CEO Pay Ratios among different companies, even companies within the same industry, but rather to allow stockholders to better understand and assess each particular company&#146;s compensation practices and CEO Pay Ratio disclosures. Neither the
Compensation Committee nor our management used our fiscal CEO Pay Ratio for fiscal 2020 in making compensation decisions. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">79</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_31"></A><A NAME="tx63026_a6"></A>COMPENSATION COMMITTEE REPORT </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the Securities and Exchange
Commission and is not deemed to be incorporated by reference in any filing of Exelixis under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of
any general incorporation language in any such filing. </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Compensation Committee of the Board of Directors of Exelixis, Inc.,
consisting solely of independent directors, has reviewed and discussed with management the Compensation Discussion and Analysis contained in this Proxy Statement and, based on this review and discussion, the Compensation Committee recommended to the
Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated into our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended January&nbsp;1, 2021. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Compensation Committee: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Charles Cohen, Chair </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Vincent
T. Marchesi </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Julie A. Smith </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT
 COLOR="#3f3f3f">Lance Willsey </FONT></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_32"></A>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2020, the Compensation Committee comprised Drs. Cohen, Marchesi and Willsey and Ms.&nbsp;Smith. None of the members of the Compensation
Committee during 2020 has at any time been an officer or employee of Exelixis, except that Dr.&nbsp;Cohen served as our acting Chief Scientific Officer from December 1995 to April 1997, and was named an officer of one of our former subsidiaries from
2001 through March 2005, for which he did not receive any compensation. No interlocking relationship exists between the Board or Compensation Committee and the board of directors or compensation committee of any other company, nor has any
interlocking relationship existed in the past. </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_33"></A>DELINQUENT SECTION 16(a) REPORTS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and executive officers and persons who own more
than ten percent of a registered class of our equity securities to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities of Exelixis. Officers, directors and greater than
ten percent stockholders are required by SEC regulation to furnish us with copies of all Section&nbsp;16(a) forms they&nbsp;file. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">To
our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the fiscal year ended January&nbsp;3, 2021, all Section&nbsp;16(a) filing requirements
applicable to our officers, directors and greater than ten percent beneficial owners were complied with, except as follows: a Form 4 relating to a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan transaction by George A. Scangos,
then a director, in which fifty thousand (50,000) shares of our common stock were sold on February&nbsp;18, 2020 was not timely filed. A Form 4 reporting the transaction was subsequently filed on February&nbsp;21, 2020. </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_34"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board recognizes that related party transactions can present a heightened risk of potential or actual conflicts of interests. The Board
adopted a written Statement of Policy with respect to Related Person Transactions entered into with related parties. Under this policy, the Audit Committee has been tasked with responsibility to review and approve related party transactions. The
policy provides that management shall present related party transactions to the Audit Committee for approval. The policy does not prevent management from entering into any related party transaction without prior approval of the Audit Committee, so
long as such related party transaction is thereafter presented to the Audit Committee for ratification. If ratification is not forthcoming, then management shall make all reasonable efforts to cancel or annul such transaction. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#fc4c02">80</FONT><FONT COLOR="#3f3f3f">&nbsp;&nbsp;&nbsp;&nbsp;Exelixis,&nbsp;Inc.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><FONT COLOR="#3f3f3f">Certain Relationships and Related Party Transactions </FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Under the policy, a &#147;related party&#148; includes: any senior officer
(including each executive officer or officer subject to Section&nbsp;16 of the Exchange Act) or director of Exelixis; a person who is an immediate family member of a senior officer, director or director nominee; a security holder who is known to own
of record or beneficially more than 5% percent of any class of our securities; a person who is an immediate family member of such security holder; or an entity which is owned or controlled by one of the aforementioned persons, or an entity in which
one of the aforementioned persons has a substantial ownership interest in or control over such entity. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">All related party transactions
shall be disclosed in our applicable filings with the SEC as required under SEC rules. There were no related party transactions reportable under the SEC rules during fiscal 2019, other than as follows: </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">During 2020, BlackRock, Inc. (BlackRock), a global provider of investment, advisory and risk management solutions and a greater than 5% holder of
our common stock, managed a portion of our cash and investments portfolio. As of January&nbsp;1, 2021 and January&nbsp;3, 2020, respectively, the fair value of cash and investments managed by BlackRock was $574.6&nbsp;million and
$515.1&nbsp;million, which included $10.3 and $1.4&nbsp;million invested in the BlackRock Liquidity Money Market Fund. We incurred $0.3&nbsp;million in fees for BlackRock advisory services performed during the year ended January&nbsp;1, 2021.
</FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT COLOR="#fc4c02"><A NAME="toc63026_35"></A>HOUSEHOLDING OF PROXY MATERIALS </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers, banks and other fiduciaries) to satisfy the delivery
requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice or other Annual Meeting materials addressed to
those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">This year, a number of brokers with account holders who are our stockholders will be householding proxy materials. A single Notice will be
delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be householding communications to your address,
householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate Notice, please notify your broker or direct your
written request to Investor Relations, Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502 or contact Exelixis, Inc., Investor Relations at <FONT STYLE="white-space:nowrap">(650)&nbsp;837-7000.</FONT> Stockholders who currently
receive multiple copies of the Notice at their address and would like to request householding of their communications should contact their broker. </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT
 COLOR="#fc4c02"><A NAME="toc63026_36"></A>ANNUAL REPORT ON FORM <FONT STYLE="white-space:nowrap">10-K</FONT> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">A copy of our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended January&nbsp;1, 2021, including the consolidated financial statements, schedules and list of exhibits, and any particular exhibit specifically requested, is
available without charge upon written request to: Investor Relations, Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, California 94502. </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:Calibri"><FONT
 COLOR="#fc4c02"><A NAME="toc63026_37"></A>OTHER MATTERS </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">The Board knows of no other matters that will be presented for
consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:68%; text-indent:-2%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">By Order of the Board of Directors </FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:68%; text-indent:-2%">


<IMG SRC="g63026g99m98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:68%; text-indent:-2%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">JEFFREY J. HESSEKIEL </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:68%; text-indent:-2%; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Executive Vice President and General Counsel </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">Alameda, California </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri"><FONT COLOR="#3f3f3f">April&nbsp;15, 2021 </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Calibri; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Calibri; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT COLOR="#3f3f3f">2021 Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT COLOR="#fc4c02">81</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:24pt; margin-bottom:0pt; margin-left:30pt; font-size:6pt; font-family:Times New Roman"><I>EXELIXIS, INC. </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30pt; font-size:6pt; font-family:Times New Roman"><I>1851 HARBOR BAY PARKWAY </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30pt; font-size:6pt; font-family:Times New Roman"><I>ALAMEDA, CA 94502
</I></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>VOTE BY INTERNET </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B></B><I>Before The Meeting </I><B></B>- Go to <B><U>www.proxyvote.com</U> </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on May 25, 2021. Have your
proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B></B><I>During The Meeting</I><B></B> - Go to <B><U>www.virtualshareholdermeeting.com/EXEL2021</U> </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and
follow the instructions. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>VOTE BY PHONE - 1-800-690-6903 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time on May 25, 2021. Have your proxy card in hand when you call
and then follow the instructions. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>VOTE BY MAIL </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Mark,
sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" COLSPAN="7"><FONT STYLE="font-family:Times New Roman; ">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="5" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD COLSPAN="7" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">D49740-P53795</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="right">KEEP THIS PORTION FOR YOUR RECORDS</TD></TR>
</TABLE> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt dashed #000000">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="21" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:7pt; font-family:Times New Roman" ALIGN="right">DETACH AND RETURN THIS PORTION ONLY</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.</B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="border-radius:4pt; BORDER-LEFT: 1px solid #000000 ; BORDER-Top: 1px solid #000000 ; BORDER-RIGHT: 1px solid #000000 ; BORDER-BOTTOM: 1px solid #000000 ; ; font-family:Times New Roman; font-size:7pt" ALIGN="center">



<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle" COLSPAN="13"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman"><B>&nbsp;&nbsp;&nbsp;&nbsp;EXELIXIS, INC.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="5"><B>The Board of Directors recommend a vote <U>FOR</U> all the nominees listed in Proposal 1 and <U>FOR</U> Proposals 2 and 3.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="3">To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Nominees:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1a.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Charles Cohen, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">1b.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Carl B. Feldbaum, Esq.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as Exelixis&#146; independent registered public accounting firm for the fiscal year ending December 31, 2021.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1c.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Maria C. Freire, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1d.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Alan M. Garber, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">To approve, on an advisory basis, the compensation of Exelixis&#146; named executive officers, as disclosed in the accompanying Proxy Statement.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1e.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Vincent T. Marchesi, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD ROWSPAN="2" VALIGN="middle"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1f.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Michael M. Morrissey, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.50em; text-indent:-3.50em; font-size:7pt; font-family:Times New Roman"><B>NOTE:</B> Such other
business as may properly come before the meeting or any adjournment thereof.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1g.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Stelios Papadopoulos, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1h.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">George Poste, DVM, Ph.D., FRS</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1i.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Julie Anne Smith</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1j.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Lance Willsey, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">1k.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">Jack L. Wyszomierski</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="20"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="19"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary,
please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="middle" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Signature [PLEASE SIGN WITHIN BOX]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Signature (Joint Owners)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Notice and Proxy Statement and Annual Report are available at
www.proxyvote.com. </P> <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px dashed #000000">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="right">D49741-P53795
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="border-radius:8pt; BORDER-LEFT: 1.50pt solid #000000 ; BORDER-Top: 1.50pt solid #000000 ; BORDER-RIGHT: 1.50pt solid #000000 ; BORDER-BOTTOM: 1.50pt solid #000000 ; ; font-family:Times New Roman; font-size:10pt" ALIGN="center">



<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="21"></TD>
<TD HEIGHT="21" COLSPAN="2"></TD>
<TD HEIGHT="21" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EXELIXIS, INC.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annual Meeting of Stockholders</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>May&nbsp;26, 2021 9:00 AM</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is solicited by the Board of Directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; margin-right:2.00em; font-size:10pt; font-family:Times New Roman">The undersigned hereby appoints Michael M. Morrissey, Christopher J. Senner and
Jeffrey J. Hessekiel, and each of them, as attorneys and proxies of the undersigned, with full power of substitution, to vote all of the shares of stock of Exelixis, Inc. that the undersigned may be entitled to vote at the Annual Meeting of
Stockholders of Exelixis, Inc. to be held at www.virtualshareholdermeeting.com/EXEL2021 on Wednesday, May 26, 2021, at 9:00 a.m. Pacific Time, and at any and all postponements, continuations and adjournments thereof, with all powers that the
undersigned would possess if personally present, upon and in respect of the following matters and in accordance with the following instructions, with discretionary authority as to any and all other matters that may properly come before the
meeting.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; margin-right:2.00em; font-size:10pt; font-family:Times New Roman"><B>UNLESS A CONTRARY DIRECTION IS INDICATED, THIS PROXY WILL BE VOTED &#147;FOR&#148;
ALL NOMINEES LISTED IN PROPOSAL 1 AND &#147;FOR&#148; PROPOSALS 2 AND 3, AS MORE SPECIFICALLY DESCRIBED IN THE PROXY STATEMENT. IF SPECIFIC INSTRUCTIONS ARE INDICATED, THIS PROXY WILL BE VOTED IN ACCORDANCE THEREWITH.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Continued and to be signed on reverse side.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g63026g01w73.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g01w73.jpg
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M"  )&EB7$A,4&);2UPIWMM81%18A(B,R-SA4F/_$ !<! 0$! 0
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; _+^@.$R3PA=U_&GAXL9RE@/R_J*$R3PA__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g63026g03l09.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g03l09.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ A@"& P$1  (1 0,1 ?_$ )D  0 " @,! 0$
M       &!P4( @,$"0$* 0$  04  P               0(%!@<( P0)$
M!@$$ 0(% @,'!0     ! @,$!08' !$2""$3%#%!(A4)42-A)!=Q@9$R0C,6
ML6*"DC01  $#! (! @4$ P$        ! @,1! 4&$@<A,1-!42(5"#(C%!9A
M<8&1_]H # ,!  (1 Q$ /P#^_C0#0#0#0#0&%D[%"0_B0D6Z!]P#T0,*SCSR
MV$6Z!5%BE$2B'(2@7?YZ K][E=F0=H^*<. !3B)W:Z;4!2+Q^LA$BNA$3CR
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M04.DH0=A#<IR"4Q1V'XAH"T(+)KQN*:$VE[QN1-7DZ0*4KT3 !11+PW305V
M!*._$P[@(F\#R NAF]:2#<CIDN1P@H!1 Y!'<!,4IP*H0P =)0"G 1*8 ,&_
MD T!ZM - - - - 0VW6YO6V_HH^DXF'"0G:MC[F2;I&$Q"OGP$,0X-@.0P)I
M@8JC@Y1*42E*JJD!KY*2[^8<"X?.55S>> '-N5,HF$VQ"!L0@;F'P4  /@
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MVQHY(%3DKOJ55/J@.VX[;[;CMO\ ';Y;_P =M=E+2OCT/G E:>?4_-02- -
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E#\"[  %JDX<2^GQX;!PX;<>.WCCMXVV^&V@.6@&@&@&@&@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g63026g06f64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g06f64.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!% P$1  (1 0,1 ?_$ *H   (" P #
M      <)  @%!@H! P0! 0 " P$! 0$            '" 4&"00# @H0   '
M 0 ! P," @8+      $" P0%!@<($@ 1$Q05"2(7(18Q020UMG@R0K0F=H8W
MMQ@X&1$  @(! P,"! (&!P<%     0(#! 4 $082$P<A,4%1% AA(G$R0E(5
M"6)R(S.S-+2!H5-S='5V);46-C?_V@ , P$  A$#$0 _ .XC7^F>=N?C1">Y
M;ED^1+S_ +C!M-$OU8J+V83(J""KF-8S<DS=O6;=4?%59,ADD1_TS%]--";K
M;K.GX7QOK73=)NV:6!.(RZT6+))=Y;H5U2KU< A'ZE,C8:5920-;4$K,I)@F
MT8+F7? 4R21BF-Y%::6KROT9M\1TQQ?37G=]3[>K77^8:7<M7I\94,ZB5L*>
MU3.5+_"W6J+YS'MY. J$E:_*K#'V'X% 7$ (0S@BB;5II^?IIJ>FFE";*ST?
MJ_OB\<GR/2.P\V9+C'/V>ZQ'UOG^Y&R_5]NL.BV6S1#ZU'T-O'.YQOG^;#6T
MF#ABP,D5>1?$%90Y?)(K30?YR_(<MSW/='<[]$RG2/2$#SMN,SG=+ZHI^#W+
M4XR8JP5&#M84G6;;EE=D(HVK9P[DU(V46%NBL[ 45E4D_90_IIK?LAO'</Y"
MX6U]#89U/#<B\Z.;M>JCSU 1?/M-U2Z:=7:!:92FO-)U=QK'@ZK"4W98!ZFC
M!QB$>[;-R>*RY52>:K36#)W_ -2*8(YS0E!S@>[F?9K'@)S)><V&(IWR2IDA
MI3+?_H!2">/15LOBG$G]K*8717J?L9,$#%1%IK[N!\TQ?9]M[_O>]U"GZ1U7
M#=::AG5J8:9!1MGF*'AD NT:87!4B'L[)<8K-)NC&3<MGS5ND274,<5CJBD0
M"--!#C/D;CFU_D@[L)4:)4-#RGG67Q!]DE3D'ZUARO$MHO\ "6F9VICF- 7=
M/*4V<C.P$<X7<E:^4)(IBU:?$"8E2::8W?)_@7\=A9V^MLWQ[&[E?T%EG$7D
MF:5&$TK04$5TE%&J32N1T4Z6AROT 4$[Q=M%$=B8YE"K*")M)YIY#XKP*H+/
M(; 29P3'"@ZYI-OW$W'IOZ=;E4!]"P.I=\3^#?)'FG)M0X-1,M6)@)[4I[52
MOOZCNS$'=MO411+),1^98R 2%6Z?^<?3)!ZY;X[CU,K,4!U$F\EH+Z8MLRX1
M_4";O[? O:K&Q;DP" _$95^F00$/,X#ZJUG?NHSDTK)QO&UH*^Y :PSRN1\^
MF-HE4_AO(!\SKHUPW^6_P^K727GV?R%R[L"T=%(JT2GXKUS)9DD7W'4%@8^_
M2N@A&_F>[#8O%G+EKD4PBJL"I(Z2I,HDS;D RH_3(GB+5%2!D1!0 ]U%SJ>Q
M"_J]_(3:M#]S/DB*0NZXZ12=^EH' 'OZ#HE1MOTL3Z#U]]Y&M_R^? EFNL,+
MYZO(%V+QVXR['T_,1+6D3?T)_*@7U/Y?;8EO^Z.*^S9>F-.]>:_M-@J?U36K
M[%FENO\ "R-?;RJ:R,HP7E<^G*AJ</5W::Q_F9-Y*8;KG/Y';^X>7J5N)_=%
MB;LJU>84FID^G?A)EB!^;1D=Q%']$RG\!JM?DS^75R;$UI,EXMRR955!/T=M
M5KV"![".P&^GE<_*1:RC]XGTTVU]L7'7 _*U+>XK!0*^<3CM*O8)E6*^-IM>
MWZ+8ES$C:O2DDW4E,7*YV"4_O"0>K+KH>*BSY8/C-ZM#C\C0RU*/(XR:.Q0E
M7=)(V#(P_ C<>_H?B""#ZC7.S.8+-<9RT^"Y#5L4LS6?IEAF1HY$;WV9& (W
M!!!]F4A@2"#JH/-',WY4L#HMH+G5]Y!K$-M-QT'85L&T^NZC96O+-IT^U2=G
M>4K/;U3;#\5_B8TLG\[Y%VBV8A,"M]&84#'6<^W6)T< _&>J7G$],+N-B#JA
M7H5+LY3I\(*/!13J]!JLQ0M!Z "GV8^8HP#A2 )6A/\ 3E@E#)@;Y3"H+35B
M-[_'QR%TO=6^E:WD2,AHJ,4$"O?:?<]"RRX2\#X(HC!V.Q9;;*;*6>*^C0*W
M(C(J.BHH?H2^/V#V::6_W9S3S'PKG67[GRS]3R?O.>OHRDYE^TC=%2/URMC+
M$F[11]IK4TX<--'K!H\[APO+2AG$FU=J(&!=4PI(FCCRCY!J>.N,OE7"R924
MF.M$?9Y2-]VV(/;C'YG((W]%!#,#J>OMU\'Y/SMY BXW$SP<=K*)[]A=MXJX
M;;IC)!7OS-_9Q @@?FD*LD;#2!=.T2_ZS<Y?2-+FY2QVJWKJ2CJ8DP,4'2(+
MK-$DHQ("IM6L/'G;&;-T&Y2MVQ$?B(4H$\0YJ9W,Y?D.3DS6<EDFR%DEB[?$
M;D */8(NQ554!5 Z0!MMKO\ \.XIQ?@_'X.)<0K0U,)041K%'^R=@Q,AW+-*
MX82.\A,DA?K8DMN;8\A<NQ.M5[0=7NS&2L=;HD+<E*9ET$Z?QU@VF\TVGJ72
M5J;*7C63]W#P\%#K,UI%5$GU:QI!JW;""JWFG(7CG@=?D-.YR#*(\U*I%-V:
ML999+L\,/>>)756*)&A0R$#K/<C1/S-N(/\ ._F>]P;*8OA''9(:F7R=BJ+>
M1F5)(,33MVA4CLO%(Z+++-*)5@5CVE$$TLVZ1]+8&M:UA6HSB.?:IA.59!5;
M I]GA].RQ&^15GRZ37)]+$6";2GKK9&5[K3-T"82[=\@9X=J*RS=9-P4H&\=
M'D/%,]:&'S^)Q^-H3'H2U5$Z2U6/HDCB2>19X@=N\KKUE.ID97 WR>7X-Y*X
M9C6Y3PKDN;SV:JCNRX[(FE)7R,8/5+!"8:E=Z=AUZOI9(7$0D$<<L;Q$D5SU
M/++=CUM6IUR2B1?_ &^.FXN3K\[$V>N6.N3;<KV!LU<L$&[>QLK!SD><J[=4
MAP,)#>QRD.!B%TO/X#(\;R)QN2$?=Z%=6CD26.2-QU1RQR(65TD79E(.^Q]0
M#N!+/"^:X+GV#7/\?:?Z;NR0R1SPRUYX)X6Z)J\\$RI)%-"X*2*1MN-U9E(8
MG+B;H:!YKZ*H&IW&J1EQ@8)O/5DZTFR^YS-!A[N:,0LUISTRPJ%A;&*$8B5R
M9 @*/V +-!,4%O,DB>)?*F1\=YA8IV>7B]AP+$/J>G?T[T0_9D3W('I(HZ6]
M>AD@K[FOMPP/G3BLEBG'%7\B4HF-*UL%,FWK]+8;]N"0^BLWK!(>XAZ3+')V
MN0LS%6.'B;#!2#66@YV,83,-*L5BN&,G%2C5)]'2#-<@B1=J]:+D43.'\#$,
M A_3ZZ2U;->[6CN5'62K*BNCJ=U9& 96!^(8$$'X@ZX%Y#'W<3?GQ63B>#)5
MIGBEC<%7CDC8I(CJ?4,C JP/J""-9/U]]>/4]--<D'Y==E>Z7UG-4Q)PH:MX
MS#1M+BFWN'P&FI!HUL-KDBD\0.5PJ_?I,CB(B!B1R8A[?U\[_N*Y++G/(4N,
M4GZ+&1+"@^'6P$DK?I+,$/X1C7='[$_']?B'@VOR!T R_(+$EN1OB(49H*T>
M_L5"(TP^1G8'1?SVSK6K'^!H-EFD+HC:UV0<@L-1L^!Y_I-5:U>)TJR-+Q,1
M>H.HP^B4BVOXR;9/5F#<Y$$$E#OTW"!@,"NQX>\U_CG$:D5&*ZEB?Z.2&6A7
MLQ")+,@G=;17ZB"5E=',:D*H)F5T._5H?*L-'A>>^3\E9S%C$S4:?\4@M5\U
M>H66LRX^NU.*3'+(*-RLDD,T*S."[LJU7BD!'1\&,)+-:37:_E4TO!R+:Z]X
M8A17K&<&.49ZO<Z7G]BQXK>S*/FZC*2NL=4OMT6X^4"F?,"^RGDHH)/EQE6C
MQ<-/C\IBF6UGJ,#*_3M;F@KR4]I>H=+3K#VXFW]9(QL=R2/5Y!>.;D5O*<VK
MK9J/CN&9>XCP]P-C:EN[!E2U<(P>.I)9[]A.DD0S'==E4,/\4U'J>;O5AE=O
MA85&B9;7;?/:O<=3YWR(TE%N82MRIZ_#S=VM.;)VEY<;!;?HF3!J9\I).W2P
M>)%"@IZP_&,]SZUEIK'*8HAB:$,TEN:UCJG4A2-^VCSRUNZ9I)NA(U[AD=V]
M 0&UM'D/AGA7&\:JTO'-BPW)<U;JPXVKC<[E.W(LUB/ORPU*U\UDJP5>]+-(
M(5KQ1H=V0E-6_I#Y@G8=0U&]Q%KM>_Q'+6.5%9[37[2K:+6+,]YSN&J7-S3)
M1M!2XPNG&BXB-9I+(1RHQZ!'27B*?FF,CXN6);E_/9:.Q8Y?'@*<):%A%9BE
M;'36IC"PC?HM=*1H"L9[:B1=NG<&!N1UK+XK"\+XU/2I>+Y^:96T$M(UFA8K
MIGJN-J+;C::+O8_N2V)65YU[[F!^H/TL*8]UP];E\<P+1%&=_/I;U@P3M]CU
M"2@)309R+N<,YLL!&W%]"4^FJR3ZMDBU#LG;Y!=^JPDB%475230\(R\KUJ-G
MC6(S++<.<9%[TEIHWL.DR&2-9F2&$LT?02CNK2&.0 NRA-K!_;5?R]#G_*.*
M))BQQ".5S5@QT<\=&&2I*M>>2JDUJV(TG,BB:.%TA6:NQ2)':7J;E^'#9G^C
M<Q/J#-.SNY7%[6O6F"BJ@JK#39YN$]6R+*'_ %^S)ZI(LT2_Q*FU:I$*/L %
M+8G[:^339K@KXBTQ:QC+!B7<[GLR#N1[_P!5NX@'P5% ]MA17[_/'U7B7F./
MD^.0)2Y#2%AP!L/JH6[-@@#T_.@@E<^[22.Q]3N6V>K#ZHQJ>FFN([IR#?VK
MN+<:S(N19.+%TO>8!-X**2HM6$MHS^-BG/P(F2(L"$8NB<"B8IS@'ZA\A$?7
M+GG567(>4\K1F;I>;.3Q@[ [*]EE0[#;?92#\S\?77]%WAS)5L)]N/&\Q43N
M15.'TYBNY'4\5!))%W.Y&\BL-]B!\!L -7FK&K8WCE)[8I5&Q>TLX/')"#JK
M+PZ+WVO?N4[<:(KFDK.:=#T>_56M.59!N5-<$8QFQ*F@!VAC*IJ"H65:'(.-
M<:Q?*,7BL986KC72)?\ U&_']238-9WM)!8BB)8;-TQ(FR[QDL&W%;<SPCG_
M #_D7COD7).0TI,EGXIK+[X+"S_P]5HC(10X^6Y2LV%"-U(7L2S%G*SJJ,G2
M916O$E.A8*KZ#(6JHUGJ^C9[J<=E4V>2DL\R.Z4R;ML36INRZJTE4[JE5[=(
M-Y%H0&S-609PT@<[IT7W25(Q,?B[&UHJ&8>Q7H\@JU[2U'ZFKU)H7F2)Y;8<
M3B*9A(@Z4,B0R$R2#\K!R6?[BL_D+.9XM%2OYCA&2O8V3)0B..]DZEN&M+8A
MKXUHS4-FJC02GN2K!+;@58(6V=&M[M.B<FIU69L6Q;?8MKI>NVEIMCBCRND7
M>=BZU^WEDOM02JG+<0G28J L4&^T].4C7(R3J+9JP:#9RH42%*\)(W)\SX]&
M/EN<DRLV4QF1L"Z8'LSR+%]/+/"(L6G82.1&M=V)NXT2&!4=AL!(('\>\4\X
MMFZ^*X#QRIQWD."I-B%N1T*<,ECZZO2M&SR.4W))X)DQQK6(^Q'8E6X\T*'J
M)@:M$!K>;TF_9A<:NZTS5$>\=@D[!<).9O=^Q-[1(1W?1H!ZU'5_*+LU1=VJ
M =34HF234D7#,S($"-T$RG-XZ/4Y%A,7EZ&2H->OKRW)-),SSV*30(;'T_:6
M.I. 98R\H$ID9.CH"(H)VF#*<&Y=R+B^9P&93#X63QG@(X*L<5*EETN3+2^M
M%B2?)5&*UIUAKL:ZP)*)C(TLKE1U CI31J_T/0^@P3A;O5''--[A3U,)37]'
MTV/M<!.W57-EOYJ:Z7/V9ZWMK5N#9<D@R=)IF3*= R @(*>M3YOFJ?,L3F-H
MK5=\';3M=5RS:66.2<UCW19DE82@=+"1& (!0K^UJ2_$/$\KXIY-Q;JL8Z]%
MR_&2BSV\70Q[UIX:@OCZ9L?!71JS-W$,$L;,&*R"3T*:MY^"$S_[AT\0GB,6
M#/'S.O<2^97XKZ8#'P 1\O$[<'/D(![>Y2^_]7J1OM.,W>SH']QTT]_ZV]GI
M_P!W5O\ [-01_,N%;Z7AK-O]9W,IT_+HVQ_7O^ANWM^D[?'71!ZN3KE/JE/2
M/7-BR#1Z7B./8%<NE]MME*LFJ/*'5+73J(TJV55.2CH*3MLW:KP]:1)7DG8I
M9"/B8],#*OW7R 8Z!2>1FFN<+H>1KFD=4XOTUGT=-QV9=22F<:I5FEACOMLU
M#3;.T,J5HM5GFY%7+5.Q5^]UI[]65!59 "N$S)J*)G(<U O,G&Y<%YE@OA=J
M62LUK"'X=76D<J[_ +W<4N1\!(OSUVQ^U3GU?F/VI7,,S[Y? 4+]*921OV^U
M+-6<#W"&&18@3[O#)M[:KGNMOLD)L?3]7BI15G W;7+NVM,<1)L=.70@=*EI
MN(364504<(@RE$"+%%(Z8F$/8WN7^'J)>5Y&[5Y+G:%>0K4M9&<2KL-G$=EW
M0$D;CI8 ^A'X[C5F?&N!Q.1X!PW,W85DR>.P5-JTA+ Q--CXH92 "%/7&Q4]
M0;8'<;'UUGNG?[MYC_RLY]_BO0?7KYU_<8+_ +!7_P 6QK&^'/\ .<R_\TO?
MZ:CK :Y::].9#RI!Q,LU?R]+RZ_0UI8(&,*\)*2>_:S9F#)Z!BE*59U 3;1T
M4 $P?$N4?Z?< \G(K].UQSC]6O(KV*M"PDJCW1FR%N55;\3&Z,/P8:R?!<+E
M<;SOFV2O0/%1R&:I2UG.W3-''A,97=T]?99H98SOM^9#K=="G)6L8?Q/98%X
M>.G*\TUF<AI!,B2BC&5B=JDW\<\33<)JH*';/&Y#@4Y#$$2^P@(>X>LGF;5B
MAQ;B]ZHQ2U"MMT8;'I=+K,IV.X]" ?4$?/6O<5QM',^1_(F(R<8EQMN3&0RH
M20'BEQ,:2(2I# ,K$$@@C?T(.O1F<F^FL%[0F91P9W)RT;D,G(NSE3(=R^?[
M-%.G;@Q$B)I$,LX5,80*4I0$?X  >OQ@YY;7$N369SU3R1TV8_-FNH2?3T]2
M=_37TYA3K8_R;X]H4T$=.";*1QJ-R%1,3*JJ"22=E 'J2?F=7EXLZ<F^!>:+
M]?[1R7T5=E=<G:Y(YSH\#!UEKBEB<OGS+/<[JMRT)6R.I7,D)2_SBR 2<I#
MS.1ZD*'SG.B1:WGVT<:FP_!Y<S94K-D[)==_0F&(=$9/Z7[K#YJ5(]#KE_\
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I=^FFIZ::GIIJ>FFIZ::GIIJ>FF@3??\ K!C_ /S+_L)/331V]--?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g63026g08x65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g08x65.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 5P'I P$1  (1 0,1 ?_$ .(  0 " P$! 0$
M       '" 4&"0H$ P(! 0 !!0$! 0$            ' P0%!@@) @$*$
M!0,!  P(" D)!@<    " P0%!@ !!P@1$A,4U!55%I;6&!DADI56%Y=8"9'2
MD]-4U5=W,2(CE"6U-C<X03,DM':VMWBXLD,T=#5U0F*$)D9F)Q$   4! P0,
M"0@&!P@# 0    $" P0%$08'(1+2&#&1$U/35)34E587"$%1T2*3%!55&5*2
MHJ.S=18W87$R-39VLB-TM+4X";%"<C-S)#2VH4,E8O_:  P# 0 "$0,1 #\
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M,F[G)4MU:2)24J4('3?P1/7^:F,?X22ZM$:_))_^:F/[A($J/?YFHW\B2?\
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M\J#(K<A%LVVV>#QF,[2ITR1,DPYFYFIDFE$:",BL=2:LT[3.W-LLMR6[-A;
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MS,UF=IF>4S,]DS/QC+(0AM!-MD26TD1$1%81$60B(BR$1%L$/TKY'T)1P?\
MOIQ!]Z, _O8TUM%Q_P"-:/\ >D3[=L:/B=^6UX?N.?\ W5T<\Y-^TD@_[VZ_
MU]17/E3_ 'E(_P"NY_2,=?T7]SQ/[,U_02,)5D,D% "@!0 H 4 * % "@"4&
MG^&_6']U^,?]2>&*VB)^7%\/NN%_C%.&CU#\Y,._ORI?^NU@<U*YK'9P4 *
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MB\ZVTCM+8%W*FT<RA0 H 4 * % "@!0 H 4 * % "@!0 H 4 * % "@!0 H
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MJQG;Y X)&W=M^*43$OD3>0L-  1:4Y<G 9<(CB[" ,M0 H 4 * % "@!0 H
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M6%Y/69$9\AA;3+9/D,X0E-!4F;SEK),\Y3S,<K8) G#*#&IR,6MF0%$> ,1
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DGZ/^/^;_ #Q_F+<<\SN,?TU_PNQOK>7^[_G/!0!OE "@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g63026g14u56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g14u56.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@! 0'; P$1  (1 0,1 ?_$ ,X  0 !!0$! 0$!
M       )!08'" H$ P$""P$! 0$! 0$! 0$           D("@<&!0($$
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MC>XR=\?I9M!)BV.N(.P2=F,4YCSTKE)PJ<F#O$W@;Q@
M                                           ->.+OU3^)_P#R\;J_
MPVLH\\WN\*,S^'L1U.L]>Y?>/>2/%^#?>-LX3Q"QU)   FW[#+UA-N>1I3[[
MU0;9Y&^(6+[&CK-!,[S0>$>7_$<-2NG4 *>H@
M                                                 ->.+OU3^)__
M "\;J_PVLH\\WN\*,S^'L1U.L]>Y?>/>2/%^#?>-LX3Q"QU)   FW[#+UA-N
M>1I3[[U0;9Y&^(6+[&CK-!,[S0>$>7_$<-2NG4 *>H@
M                                                       ->.+O
MU3^)_P#R\;J_PVLH\\WN\*,S^'L1U.L]>Y?>/>2/%^#?>-LX3Q"QU)   FW[
M#+UA-N>1I3[[U0;9Y&^(6+[&CK-!,[S0>$>7_$<-2NG4 *>H@
M
M ->.+OU3^)__ "\;J_PVLH\\WN\*,S^'L1U.L]>Y?>/>2/%^#?>-LX3Q"QU)
M   FW[#+UA-N>1I3[[U0;9Y&^(6+[&CK-!,[S0>$>7_$<-2NG4 *>H@
M
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M.M?,*6L5_P!-$PU;7,Z7R\6?&F@E*
M                !%;VQ_J5S?E$H/RYV,L<XO!:OM&U]*9NORZ?>4M=CW_=
MRN1H20= H  .H'L,O5[VYY95/N15!3WD;X>XOMF.K4$0?-!XN9?\.0UVZ3;#
M;*9H     UXXN_5/XG_\O&ZO\-K*//-[O"C,_A[$=3K/7N7WCWDCQ?@WWC;.
M$\0L=20  )M^PR]83;GD:4^^]4&V>1OB%B^QHZS03.\T'A'E_P 1PU*Z=0 I
MZB
M "*WMC_4KF_*)0?ESL98YQ>"U?:-KZ4S=?ET^\I:['O^[E<C0D@Z!0  =0/8
M9>KWMSRRJ?<BJ"GO(WP]Q?;,=6H(@^:#Q<R_X<AKMTFV&V4S0    !KQQ=^J
M?Q/_ .7C=7^&UE'GF]WA1F?P]B.IUGKW+[Q[R1XOP;[QMG">(6.I(  $V_89
M>L)MSR-*??>J#;/(WQ"Q?8T=9H)G>:#PCR_XCAJ5TZ@!3U$
M                                              $5O;'^I7-^42@_
M+G8RQSB\%J^T;7TIFZ_+I]Y2UV/?]W*Y&A)!T"@  Z@>PR]7O;GEE4^Y%4%/
M>1OA[B^V8ZM01!\T'BYE_P .0UVZ3;#;*9H     UXXN_5/XG_\ +QNK_#:R
MCSS>[PHS/X>Q'4ZSU[E]X]Y(\7X-]XVSA/$+'4D  ";?L,O6$VYY&E/OO5!M
MGD;XA8OL:.LT$SO-!X1Y?\1PU*Z=0 IZB
M                                "*WMC_4KF_*)0?ESL98YQ>"U?:-K
MZ4S=?ET^\I:['O\ NY7(T)(.@4  '4#V&7J][<\LJGW(J@I[R-\/<7VS'5J"
M(/F@\7,O^'(:[=)MAME,T     :\<7?JG\3_ /EXW5_AM91YYO=X49G\/8CJ
M=9Z]R^\>\D>+\&^\;9PGB%CJ2  !-OV&7K";<\C2GWWJ@VSR-\0L7V-'6:"9
MWF@\(\O^(X:E=.H 4]1
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M3Z"2*OD\NS;,W:2JBK?"A")JD-G."FQG(5L
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MX]9PZ=.%H<ZSAPX6/DYSGSDQS9SG.<YR+RY2FC-E7#)IHQC-'#[>,8Q^/_\
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M7U'W+U7T'4_?3_Q+N;F]#UA_:.;TWYX#)
M             .3OMJ?7"C/(U2OV[<A*'G2XP4MC6W>W"]WEK^[O7\1WG<6:
M(P9'4"  !WYZA_A-J_R=TK[M1@OKE'V3PO9UMW,CD^W@^WN.;8O-8J,B#Z%\
M@     (K>V/]2N;\HE!^7.QECG%X+5]HVOI3-U^73[REKL>_[N5R-"2#H%
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MU0;9Y&^(6+[&CK-!,[S0>$>7_$<-2NG4 *>H@
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M5!MGD;XA8OL:.LT$SO-!X1Y?\1PU*Z=0 IZB
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MB%B^QHZS03.\T'A'E_Q'#4KIU "GJ(
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M'U.I;6K2FKF*SWAIJ[-M2;QIS+(MPRYF]KU:UNT95IE_A!X\8JJH$;D552#
M57GN*6?J_# KK_B!N&T;=Q?\,,?Q ;&A)>7J4''Q2=2V)PIVW8:NAY2$@$/!
M:PL>K]MV:J195EW3-O(/81PH\1=-U73H,G<*7$[8+7L/6M6V]=K;(K-:?#TB
MA.H1%:6IVQ;'>&]\GX_9.Q+A"-HV)FR3L-IN:B:6XPS3CI-O$O)TYS8L4"5(
M)4;#%/YJ*7CXVRS=1=JG1,G.UY"N.95L5)4BATT$;77[/"&(Y(7*9^D9J&P0
MV>9DAN0V QUX-+I[0NX/H707H. /!I=/:%W!]"Z"]!P!X-+I[0NX/H707H.
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MG=959TW4=)$D57MPK>M-MRS!9JQR=1%-.#<E75*5,QT2FRJ4-=N_7CZ]FGA
M]^'<_P#+V ._7CZ]FGA ]^'<_P#+V ._7CZ]FGA ]^'<_P#+V ._7CZ]FGA
M]^'<_P#+V ._7CZ]FGA ]^'<_P#+V ._7CZ]FGA ]^'<_P#+V ._7CZ]FGA
M]^'<_P#+V ._7CZ]FGA ]^'<_P#+V ._7CZ]FGA ]^'<_P#+V ._7CZ]FGA
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M0M9Y+KLNO-/_ %%:KUI>RJ5)>KU:D(=,81TPCT:-$6Z'?KQ]>S3P@>_#N?\
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MBZ]N.@:Q':\WKO)/15:KSJU6.@,W%MJ^N&$I3K%.3[)M-G7?7@C-!<R9F:"
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MN(/B?UQ$8IJK\R):SJ+B.VKJ>#2DT'S%EE-XU8TDJ)%B\[+U!(CE7":RJB1
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M9Q<7%LVT=&QL<V191\='LD2-F;%BS;$2;M&;1ND5-)),I2)D+@I<8QC& 'L
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MBS0J*$98VS4SYS7Y!91Z5-E-MV1,K':*9*N1+&3Y+@N.4!>
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M3^;BZ3K[>M*J,9:\W_:M]JN)^(DMZ.YC,C78:MM%'C-/_AY<]$= )$0
M
=                                   '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g63026g22a35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g22a35.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ]0$K P$1  (1 0,1 ?_$ -   0 " @,  P$
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M]Q\V9KSB(L^?4Q>LGHS@E$3RY$;F=@0G72VQ+ \5_+Y6".0/7$26]6_]4/\
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MM&U:SI-%8[1N%_3ZQKM2P9%E=WMA%JZR$R"$A4B9,=:8;*UD)2.?):B$I!)
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MRN*^1ZMN<>J%$>I:<XX4/X#\0,S)X3\O[OX@Y8NZT=]W'\@K7FXP/2VK7HZ
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M]J=7H[C9+^<S64=!63KFWL9)*6(-;6QG9DV4Z0"KP8CLJ4> 2>/0$YT-TW/
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MJ;C^NY7EE\9&)JQJ]4QJ->G[NK4_=IT-CE[6'0N0 !.#X:\ >,?!.S':^!8
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M0?OO44]>F/W*MAN: $@)2 E*0 E(    X  'H !FG))8EF)+$]3)%U544(@
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M_@[Y<_\ 2W(_]FYO]C'_ !&>WO\ V[]-?[S](_TYC_$;Q[_K[9O]-QO[6/\
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M+PGRP78\=MDE/S'%LM.MQ\@>,,7QUMO/<#9,;*OWDUUX."N-CC)R,FQNSV
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MHIA1'/W4RXKB^3Z\<>40#X?$XB5IQ$8B50]\.IJW#VL]O0&FE.2*F@C;8PI
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M7A,]U(^U6:Q<D^&'E?:69]B?;]UQQ^R*[O8M/_O)D"NM3_DO8?G-W.&?Q)/
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%(Q$__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g63026g28x28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g28x28.jpg
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M 0$! 0$! 0$!_\  $0@ (  = P$1  (1 0,1 ?_$ !D   ,  P
M      <)"@4&"/_$ "40  (" P$  0,% 0        0% P8! @<("0 3%!$2
M%187,O_$ !<! 0$! 0                (!  /_Q  F$0$  0,# P0# 0
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M=*XZK]C,:SQ:%Z3$)QU^^VL97VRLDNJ;-TFPWOGV[UG5A,;FY._^;]RMC\Y
MNNF?(_U/T#0]KDYX4=2+#58[K7ZY6:WSQW:U1ZA5.DLUDG8Q77H#!&>"YB$0
M&(8-*<UAB*@FC#FFW-CB'(^^/QTK:<R89XSZF)WQ3E_HTZFW^7'T+Y%ZWU=3
MY<ZQ<>K\TM/%# [&!U^@59'?:PAL]Q2!&FH;/6=G]?L\\*Q5K76&QM8/E.A8
MSR@R":RA2;?732,2 S9,=O/FN>I%B4C"0][>&*5+W.!=2.%%@HNV\3]!5GLU
MML.SOH_.N?K*W<D,U*45^W4)?T?1M1:Y>:M:+M8,VK6(!LR/UL@8KIA_(LRU
M1.@BWPD1;H,7A,3$1 WQ4P9&9O\ %[L3,[,YBU<YTWW)[ Y]MKBG>CNM(Q=2
M]3\JA[>RF0[G9*V.)-EKQDA".8QF;O*6\*F7[SOR9R)W<A\I$^TE].G@Z4?5
MJY>M6H_''VB_>A/%W$NM]1:P/;[9P+@-8G(ZX!5JTGJ_1+=40SI5ZN 5<,62
MM1!2G8"%%&D-V(FA&'TDUATY:@%#RU==*H+Y>EF=)^!=?U;H-VZ9;_65H.M%
M^M+VW/B?\I6?;W:/V1#,O2#3:][9A$AE(S &/KG[8PL<(\6-8X]=<(UP!&/?
MM1=$JSGV[T;/-/PH<+XEKU8+HMT9]U2=3H>*"0D<UJ&IB(A)' +R5XOW ?N)
M?[**P4J9T+J+(9B"48F0.7?)TN-(ZUB+1>J: F;S:I\.E<H^.WAG1+Y2+/TO
MU?V!Q3;E9JW/7J=0.?<G#5%5]R8LF1/+=='-L8,# 9Q=@3FRF@@C,)(9RQ E
MT<D$6KG4E@)W\Z_7-!-([O-OK9IPWQR?*%YNIW,W7%I:$QXCS;E65VO-H+#T
M7_1;'8_[H]NUCMI#=K/7*B,-N(WW'*A%!!E@BU<R#Z[ZQ"PYD&H1E97M732C
'($!^YK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g63026g30r52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g30r52.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"NP,T P$1  (1 0,1 ?_$ /@  0 !! ,! 0$
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M)H&9F52H520&8G0:C4BN-[R7CF-O(\=D<A909"61(TBDGB21Y) 2B(C,&9W
M)10"S '0'2LG<DX%<^M 7:: &.AJU2N;=,Z$_:#X25>KTDYS*J%6R1JPDNRS
MH!,X>$-Y6T;<WMOS:4I/ES9N)<!S/+8+V]MU>'&V6-O;LSM&YB<V4#3O L@&
MWJNHT U\-02-*TGN!W7XYP"ZQF-NWBN<UDLSC;!;9)HA<1C)72VL=R\1;J="
M-VU8A?.T*J=:Q*W7+"\W$/-0,RZU8"_@(%UN+.6W-G>L@;X.(6EC:9(OXAQ+
M?IL[6OSJTGP\=ZUFIKC<BZPND$Q2X?;$0C$2-KIMC.GGMJ0-%U.IT\M;\^8Q
M$;W$<EU;+):1[YP94!A30MOE!;6-=H+;GT&@)UT%5<A3+A$O08\K5++&$69I
MA^ML2$%*!/6%@IY(XST&T2*VN6:(?6E#:F-.:6O>M:\=[\,K7&&S%H\$=U:7
M,4ET 80\3J90QT4Q J#("3H"NNI\!XU;VG)..W\=U-8W]E-%9,RW#1SQ.+=E
M!9A,58B(JH+,'VD $GPKF-HEWC9HZMR%-M0%BC!'3Y*!-KTN+-1X([>G7S3H
MM\-!P@C+6_,MQQM*$I^G>_#.4V"S=M>OC;BSNH\C$A9XFBD61% U+,A4,J@>
M))  'B:X6W*>,WF-BS-GD;"7$3R!(YTN(FAD=CHJ)*KE'8GP"JQ)/@!44S%5
MG:8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*[HZ![P.)USG_MO&FNG
MC*@N:<2E>?\ 5.2Q_$6I'HMN,D56_1</4NTEP\5+TT&2"FF!UK GA&4>+BMH
M7YW-*[GX#N_PK'<?XW%>Y1?0<;A'M+ZP3&A[R=G](W1V^1:..2W5UD5"8KJ-
M1YQ(.YM?-SEGU>>Y>8Y;S*?&X1QE,UR:*_Q>5DS1CQ]HD8M-DUWATFEBO'C>
M%Y L]C*Y\Q0R[4*X:<]QW*%<G<=:Z%,-CJ]GRO;JW[:=PMO<CV^C[>V,CH^Y
M+ZO/5Q*9G_[JOBOB=2FY7^;^$_[V::W<;BAXH77(3"/Z'_>@8;IW!07FNGIF
M_P#\H8^I_#M^_K]?S>E[M2,G9SGHYZ(WQ%NTP[ACD!Y'UK02''Z;CCNGXWXE
M,/\ [KZ73]&%KY_I'[6MB:)[P_:]2RN?QF[]<K%"5;NO&.CB3MR$ZQ;[@Q6*
MYS6ZU2R*LI5HGY^ %M,87+,C+$K,9'QNPEMI:>-0CRBR)@N\';#"RX^V]/O+
MBQM<[CKQ9;A;^XN!##9W,$W6:>66)9T:14,=E!%#TRH5YP-(H@Y3]7COAR2#
M+7OWJQUGD[[BV8QS06;XJTM&N;C(V=U;BV6V@@G:UD2)Y1+DKFXN.LKL\=LS
M:SZG\.]SL+]B)X3JG:>H4OHNN]<W[-)WV*"G[E8.G56EQ$E#[YP=(#66%-9(
MB")!1L8V:2W%Z]1U*EM*2UO(HX/W-LOO)<1<IS64LN1??ZSR+W2++<2WL%M&
M\?H;.)HV!C+=2$2.(/%@2I"U/7<_LEDOI-:7'!.-8/)</^BF1P\=C*\%G!C;
MJ\ECF^^"1M;3(5F6,0W+0QM<^:A"NI>J.$]P', NX_Q#+L1-&(KON!YM[EJY
MR\O4-*+=FI;I'5(&TU)@P1(NR89!\, XXM926D,*UY'-I5O6LHV//^,0<X[A
M9N29QCN08W,PV3=-]9)+R^BG@#+MUC#1J22X4*1HVA\*N,GVFYO<]L.T/&8;
M:,YCB69XY<9-.M$!#%CL7/;73(V[;,4F=558BQ<'<@*@FLL7/WC<SG9SW!:D
M[#8+Q1;!3_9D-SBC3 D^[ GRG'9?C1_38H.)DV_EM:]<:OV!K;ZT#H,T2[Y%
M+^)WY]LS/>'C-]?<@])N+B^P5Q9\=6SMI%E,3/CY,<][&L;C9#J(KI=Q""3>
M^A/4\[0N.?5VYKB\9Q(V5G:8OE%ID>8-D+V%H!.D67BR\>-E>6,]2YVM<6#;
M 9#%TX]RKT1MGQWO.X?7YP>PD=+OW<ARO>_7/<@BNVNGS(2*;0CZ/U"%(C87
MYW82X\NTT"2LT>K0S/P(+KPHVQ776M.;'ST_>;A&/OER$F3O\Y&W-X<P(9[>
M11;VKVU[&4CZDS(T]J\T7F+THF9(^D[H&Z>J6WU;^YV6Q;XB'"XGB\J=LKCC
MQN+6[A<WE\E[C)EDFZ-NDB6M_';3CJ/UYU2683QI(4$U1SGN,7T&7[8./VJN
M0;5:]F'6X0'I=;JO6X%5;9M79^1221RY&WVVY=-L+Z=O$O$L!-;0#HDC0FC?
M.K>ZG'.<6O(+O-QQYJV@2VX9?QK>0P7\71$^1L'T9[B>XO93XNSK&ND6^3I=
M;4FJ/,>V%]Q+'\9FEXU>74E[W(Q4SXZXNL5.+@VN'RT99([2TL\;;KYL:QO,
MP,QCB-P;;:H$<']Y7*PI.]UD"UAF3A',?;930O<%:JYU)0]_FN* 2[%K+G6*
M=8*YU0$*P%S CL:^]I;KRH)A4@QI2VE#8Z/O)Q6"ZO\ &6]VCWS8S#VZY6>&
M^TNI<:L@G:46\L-\JRM)&T+-J6]%0W":E#%F)?JY<[N;+%9J[L)(\6F;Y%>/
M@;6XQFZPAS+Q-:I UY!<8MW@2&5;E$T5!>RBTE*K()Z6G>]BB1UY]MTK)WZ9
MCZ[ ^X_W.='[?&P%8L-8KDO5^GR59=K)9='CI&?!/&DQ42FOE>BI38#9#C*W
M%:<VI=+#]Z\%;YSC=W<W\T>.@Y'FKS))%!-!#)!>O"86:V1Y58.O7^1#S](.
MR%B&):XY%]6GE-WQ?F=A98FVFS%UPWC>.PLD]S;W-Q%<XV.Y%RB7LD<#HT;&
MV_A)BMA.T:2*BE %C-.]SO'P.5Q@CO4+S5R1/9-U_P!MI'$0:M-$5$OH]AA;
MN_'WLF6"FVX'4==IB>8<>>V$^<S)_2^E VM$-8S#]SN'P<6BB?*7UK*G"<AA
MSC5@D-NUY+'<E+HR+*(MES)*I9NFTJS?'"Q@2+FN1=DNX=USN>XCP>+OH).Y
MF)Y$N9>ZA6[3'V\UDLEBL3PF?J64,#JB=9(7MOWIFF)A>:2'O9YE+6CB\X/-
MP-;HL3TCVI6*Q<\8H713[)11N*2%558GP)0JZ&\^"A8L>,/^7.045N2D12ML
M$#LN+=>7FI^]?&;O*86^CGM[;!19+!S36@M;QIK88UX.L5=KEK18T"2]$VL'
M6F1]DD:,6=M;M/JT<VQ^#Y)BY;:[O>4W&&Y1;V]^U]CTM[ULS'="W62);-+]
MYI6D@](6^NA;6\L?5AFD14C6)TSWE\_$9@I"^VVY6:QQ?N7]S%GA;$2+,S]F
MH- Z]QR-I-*N=8-FBF$,OUJZ;5*?+FB&R&EB[>;;2_ME>8G#=Y./PI!<9Z[O
M+G(Q<ES,T<Q626:UM;_'I;6US"TA&AAN=9^BKAU*;U42;#6?Y)]7+EEQ)=6G
M%<?CK+#S\*XY;36ZM#!;7U_B<O)>WEG<I"K$K<V>EMZ0T;1L)>FSF(2+5IY!
M[FZAS2#O5(-[6NXVJ1EN6V2 [3=:WV<^#0#27KF^=S@1%?N,#TQN'C3[&/*Q
M2WAF(]Z3V6V0(WKT#=VO$.YF'XU8W^$GS1O,K)+8S19&YAR+1;;8W):S7I7$
M5Z(T:9)X"R+$TW562)1TYJO^X79/D/-,IB^36W&ACL%#;Y.WGP]G<8>.<O>B
MS5,@QN+2?&F:1+>2UN@DCSI;"W:&X<]6V'71T.PHMU_O-L:4.MNSW"S6%M0<
M,BNB*1-31LDA0M?;DIEN"'VDGZ@:3"TBI\&]/.Z3YU==.0Y!<OG[[*IM*W5Y
M-*-L?17221G\V(/((AYWA&)'V#S=[:;CW"XAB&X_Q/%X%PX>QQUM;D/,;A]8
M84C.ZX,<)G;S?.F,41E.KF--VT0[,/6Q4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2O5'^AY[3_ ,PO</\ >SFW^$N>IWYD':CVAR'Y^S_B%>%/
MZSOOW[(XAZKD?YUI^AY[3_S"]P_WLYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XA
MZKD?YUI^AY[3_P PO</][.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?
MH>>T_P#,+W#_ 'LYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_S
M"]P_WLYM_A+C\R#M1[0Y#\_9_P 0I^L[[]^R.(>JY'^=:?H>>T_\PO</][.;
M?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T_\ ,+W#_>SFW^$N/S(.
MU'M#D/S]G_$*?K.^_?LCB'JN1_G6GZ'GM/\ S"]P_P![.;?X2X_,@[4>T.0_
M/V?\0I^L[[]^R.(>JY'^=:?H>>T_\PO</][.;?X2X_,@[4>T.0_/V?\ $*?K
M.^_?LCB'JN1_G6GZ'GM/_,+W#_>SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB'J
MN1_G6GZ'GM/_ #"]P_WLYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^A
MY[3_ ,PO</\ >SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB'JN1_G6GZ'GM/_,+
MW#_>SFW^$N/S(.U'M#D/S]G_ !"GZSOOW[(XAZKD?YUI^AY[3_S"]P_WLYM_
MA+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_P PO</][.;?X2X_,@[4
M>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T_P#,+W#_ 'LYM_A+C\R#M1[0Y#\_
M9_Q"GZSOOW[(XAZKD?YUI^AY[3_S"]P_WLYM_A+C\R#M1[0Y#\_9_P 0I^L[
M[]^R.(>JY'^=:?H>>T_\PO</][.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY
M'^=:?H>>T_\ ,+W#_>SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB'JN1_G6GZ'G
MM/\ S"]P_P![.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T_\PO<
M/][.;?X2X_,@[4>T.0_/V?\ $*?K.^_?LCB'JN1_G6GZ'GM/_,+W#_>SFW^$
MN/S(.U'M#D/S]G_$*?K.^_?LCB'JN1_G6GZ'GM/_ #"]P_WLYM_A+C\R#M1[
M0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_ ,PO</\ >SFW^$N/S(.U'M#D/S]G
M_$*?K.^_?LCB'JN1_G6GZ'GM/_,+W#_>SFW^$N/S(.U'M#D/S]G_ !"GZSOO
MW[(XAZKD?YUI^AY[3_S"]P_WLYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?
MYUI^AY[3_P PO</][.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T
M_P#,+W#_ 'LYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_S"]P_
MWLYM_A+C\R#M1[0Y#\_9_P 0I^L[[]^R.(>JY'^=:?H>>T_\PO</][.;?X2X
M_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T_\ ,+W#_>SFW^$N/S(.U'M#
MD/S]G_$*?K.^_?LCB'JN1_G6GZ'GM/\ S"]P_P![.;?X2X_,@[4>T.0_/V?\
M0I^L[[]^R.(>JY'^=:?H>>T_\PO</][.;?X2X_,@[4>T.0_/V?\ $*?K.^_?
MLCB'JN1_G6GZ'GM/_,+W#_>SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB'JN1_G
M6GZ'GM/_ #"]P_WLYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_
M ,PO</\ >SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB'JN1_G6GZ'GM/_,+W#_>
MSFW^$N/S(.U'M#D/S]G_ !"GZSOOW[(XAZKD?YUI^AY[3_S"]P_WLYM_A+C\
MR#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_P PO</][.;?X2X_,@[4>T.0
M_/V?\0I^L[[]^R.(>JY'^=:?H>>T_P#,+W#_ 'LYM_A+C\R#M1[0Y#\_9_Q"
MGZSOOW[(XAZKD?YUI^AY[3_S"]P_WLYM_A+C\R#M1[0Y#\_9_P 0I^L[[]^R
M.(>JY'^=:?H>>T_\PO</][.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:
M?H>>T_\ ,+W#_>SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB'JN1_G6GZ'GM/\
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M #"]P_WLYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_ ,PO</\
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M:?H>>T_\PO</][.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T_\
M,+W#_>SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB'JN1_G6GZ'GM/\ S"]P_P![
M.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T_\PO</][.;?X2X_,@
M[4>T.0_/V?\ $*?K.^_?LCB'JN1_G6GZ'GM/_,+W#_>SFW^$N/S(.U'M#D/S
M]G_$*?K.^_?LCB'JN1_G6GZ'GM/_ #"]P_WLYM_A+C\R#M1[0Y#\_9_Q"GZS
MOOW[(XAZKD?YUI^AY[3_ ,PO</\ >SFW^$N/S(.U'M#D/S]G_$*?K.^_?LCB
M'JN1_G6GZ'GM/_,+W#_>SFW^$N/S(.U'M#D/S]G_ !"GZSOOW[(XAZKD?YUI
M^AY[3_S"]P_WLYM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_P P
MO</][.;?X2X_,@[4>T.0_/V?\0I^L[[]^R.(>JY'^=:?H>>T_P#,+W#_ 'LY
MM_A+C\R#M1[0Y#\_9_Q"GZSOOW[(XAZKD?YUI^AY[3_S"]P_WLYM_A+C\R#M
M1[0Y#\_9_P 0I^L[[]^R.(>JY'^=:?H>>T_\PO</][.;?X2X_,@[4>T.0_/V
M?\0I^L[[]^R.(>JY'^=:?H>>T_\ ,+W#_>SFW^$N/S(.U'M#D/S]G_$*?K.^
M_?LCB'JN1_G6NY3.Y%><M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE?#CC;+;CSSB&FFD+<==<6EMMMMM.U
M+<<6K>DH0A.M[WO>]:UK6<6944NY 0#4D^  'E)/O5R1'D<1Q@M(Q   U))\
M  !XDD^05KSRWW7<$[5T:\<MY?T&*N-KY]'"RD]J(TZ_$/"/'NQI3L'-:1J/
ML#,0;Z#9;PBW1VU%LZTXK:E:3'O%NZW N:<CON+<7R$5YE<?&KR]/4QE2Q1C
M%)\241MM#M&60&1 &))TEWG/8;NMVUX=C.<\XQ$^.P.7F:*#JZ+*'5!(HGAU
MZD!E3>T22A9&$4A**%!;8G)$J(*CUNWM-4LZD[VE2:]-;2K6]ZWK>HTG>MZW
MKZ=;UO,?EB1BKDCR^CR?_<&LOQ\ YZR!\0;N'_\ .+7@DA>I=-K9/QE=Z+>X
M OS(7\5"VZP19/G;TXEM7K@R##OF;2\O2=^/CK2M^'[=YX+67*.38V3K8[(W
M]O-J/.CN)4/AKIXJX/AJ=/V3[]?JPR7!N$YF'T?,8?%7=OH1MFM()5T.FHVO
M&P\=!KX>.@]X5N?R3^*+[S.3D"(5U(CI4*.IK;T#U45-Q28AO>O%+UD?<&NR
M%*1XZWM$FG6_'Q5I6]:WJ9^)?6A[R\3D13E&R5DI&L5\OI&[3WYB5N1X>],/
M?()TKK?W ^H[]7'GL4C#!IA<DX.D^+8VFPGWK=0UF=#H=#;'R: @$UW<^UG^
M+SP_M9<?4.M!HX=?3%MBB%RTF@[G4V4O?D0@6U.LAKKQ+^];5Z,FTR.CQ2A!
M;SF])WW:[6_6[X1S66/$<M08//.0JM(^ZTD8^0+.0IB8^7;,JH/!1*['2O,O
MOI_R^.YW;2";D/ )#R?BL8+.L493(0J/$EK4%Q<*ODWVS/(="S6\: FNW)"T
M.(2XVI*VUI2M"T*TI"T*UI25)4G>]*2K6_'6]?1O6=MU8, RD%2-01[M>?K*
MR,4<$.#H0? @CR@BOK/M?*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I5'(2 ,2 =*RA@L=&1@9,A(R!K[8P8((;*R2S"R7E(9'%%'
M;4MQ:]Z2A"=[WO6M91N+B"T@>ZNG6.VB1G=V(55502S,3X!5 ))/@ -35Q:6
MEU?W<5C8QO->S2+''&BEG=W(5$11J69F(55 ))( \:\J/\1/^)7/^X*5E^1\
M5EY*O\*!6_'2\H-MZ.ENL/(<TETJ0\=-& TO6V_ 6/5Y%EHWMXM/BIL<?RK^
ML1]92_[@W4W$N%S26_!4)21QJDE\0?%G\C+;^'F1'0N//F&I6./W?^I_]2[$
M]I+"W[@=RK>&[[I2A9(HFTDBQ8(U"Q^5'O/'Y6<:B(_)VYT#RS:>^S&X]#X[
MV>I]SJJ@XJL4640U>9JQ'JAJJ;59-'PEAK)1RDN;.E)6+>5\$,PT42@S3+Z6
M5>GK>H@[,YCD/#N9VG.<44BQEC+I<R3-TX&@?S986;QW.Z$]-%5W$@1PAVUV
M(^L?QSB'<7MO?]K\Z))\WE(";*&WC$UTEU&=]O<JFHV112@=:1WBC,)DB,@W
MFO8'3IFW]DJM<O<1<XJL4:XPL98J\FFCL34X?!S K9P3Y5BGA%  DN"O(\S3
M,=M;*][3M?F3O6>OV'O,OS'%6V=M+V*UP=Y"DT7HX$DKQ2*&4M-*NU25(U58
M=5.H+:BOSR<BQW'NW.>O.+9#&SWW*,=<R6]P;QFA@CGA8HZK;P.'=0P.C/<:
M.-"%T(-7&R<J@MUN?>-DKO83FX63<87*WBV/Z6^T$^XTG48#*!Q3B5O)3O;7
MP_IJWKP\OT[\;C(\5L#CKAYY+ZXG$+D%[F<^(4D>8KJA\=/-V:'WJM,-SS*C
M,6D=M#C+.U-S&&$5E:KHI=0?E'B>4:#7SNIN ]VO%O-W[KE?;;_$3G5=?%*V
MA#.KSQ>N0ZGUZTO>_0E!JW 2RGW$-[\RT$^IO2-_3^W/%^]S_+<>H^D..MFB
M?R>DXZ&/4_8<0Q2:G3Q(?7P\OEK])6,XIP#+.?HAF+Q9XP2?0LQ<3!1X?&B:
MXGB"@GP!CVZGR>2K*U*<8N7BQ-0$ER>8>W_-3E4(/M-,T\K6M[W)56:))L@
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M#Q(C,@U"QJ!Y._\ ,;^KS;X:]B[\<4@"65Y,L&61!HJW#>$%[H!X=?3HSMX
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MNQ<Y2Q(TY(Y3.TO"D?#$J]-U&]+;7X*3O6]:WC$XJRSO;VUPF14MC[S#Q0R
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MGVEHUH+95.K6GW&]ZTE)1&T^*E*\5>,_,^11=U>]=[R)B?O+->EP3KHMC:*
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M9"I-M([8Z5:5II7J6D/%;RUMWAM+N-'N(7CF)@)7:TMQ*.@G6 A"&YD5 _6
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M3I$CY_-+HH.]Z?TM.QMF?0ASTO%RU/%$?'SX^28F.>ZM9B=NF@MEM%*>#_\
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M;+8G+;#=)9R'0!B0.I;NQ\B3A5 ;4!)%1SYH96[7_5&^L;=?5[[A^DY,R2\
MRNR'(Q+J2BJ3TKR-1KNEMB[$J 3)"\L8 =D9?'IK=TY5=G4.-2U.O5*FB1"A
M"QUA2L+,QSS@AH)P9*/%*D+2ME]EU.T.(VI"TJ2K>M^/H.:XKFRK"6SSEE,5
M96!5XY$)5E92/V596&A&H(()K]$!'&^=\95T:WR/%\E;*ZLC!XIH9 &1T=3Y
M"-'1U(*D!E(8 C*A5>K?8U*F^?ZC*IT9W?KS/,G"&X^,GS=)\Y$IS4TA;8Z7
MBW=;<5".K2\TK:M"J=1I*-;5+C\;S$F^X_TK3D9\9+(D(DK>Z]FQT&K'Q-LQ
M#*21$7  &B09?,]N@,9RSKW_  Y?"')!3)) GD6+(HH+:*/-%XH*, #.L;$L
M=W_;S_%9]S7MPVQ0>IQ;O7:M!^F!J#OKY\'T* 89VG20A+>X&7(.M-MJWI+<
MJ)(+0G2$-+:;3I.3?V\^M5W,[<%<!RF(Y?%0:+TKHM%=Q ?M5N"K.0!Y!/'*
M0-%5D4 5UC[O?4.[*=XPW*^"SKQ_.W6K]>Q5)["=CY7>T#I&"3Y6M98 3N9U
MD<DUVAU+^-O[6I@9C5IIW7Z=(J]!)3?R*NV&):4[I7JJ&D8ZSM2!+(VT_6VL
M%E:M;UM*-[\=)[/XGZ[/:Z\B7[Z6>7L[CPW#I0RQC7RZ.DP<@>[K$I/AH#X@
M='L__P LWOGCIW^\61X]D;,;MIZ]Q;RD#R;HY+8QJ6]P"=P"#JP\">*W_P ;
MGVP0XI&JE2>O7*23M](K;L-7*W#O;:VI+2WY(VRER0S1._#:=ICW5I1X[4E*
MM:3OAE_KM]L+.)OO38Y>\N1KM!CAAC.GDU=IF=0?<TB8Z>4 ^%5./?\ ++[W
MY"=#R#)\>QUD=NXB:XN)EU\H6-+9(V*^(.LZ@G3:Q'B.KGW#?Q3_ '/>YG;_
M #[FD8YR>J3JW0?LYSU^2F;Y8!2DZ95&RMP0.(>Z.XG>TJ;C XW3J%J0]ZJ-
M^&=7NX7UI>YW<PMQ_C41Q.*G)7HVA>2ZE5O#8]P KD'R$0QP[@2K[U.E=X^T
M7U%NR/90+RWFDXS^>M0'](OUCAL8&7QZD5H6= P/B&N9;@J0&CZ;#6M* X:M
M\45J6N*8JV=0'\5PM!9>'E("H&IUO3$M?C1EO R$F&[]=J&86OP6G6REHUO3
M6X5AL\;PH^EYCI7?)U_>[4$/%;M[DETRDJ[J?%;=2?$?*L/BGLM<Y',]RE]
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MV0S%.Q@#+KAB+?ZOF1X>GIO2-Z5OQ5O#83D%]DWLC=P1117U@]RFV0N55#;
M*VJ*"6%QNU'DTV^/EK8^3\2Q>$CR8L+J>XFQ>5BLI"\2QJ[2"])=-)'("&TV
MZ'XVXMJ!HM0.(ZK-';!/8:4R7?V^>-0HKPDQ9(RKDSW,YV]R#ZHJ(2/)2@[3
M,&ZWY&UB^LZI&U.-:\5:P5IRF]GZ<Z#27("T$:E9)D@:6SENG.R/1W $1&@*
M;F(U91J:VG(<$QMKU;61@T&)-^9F#Q6\ERL&2@L8UZLI:.)B9E;<PEV*&VHY
MT!FL)?;039(B+LT(S5 Y#3X0NBHFPEM6$UEL[?QL99$LCQ5?TZZ!XCQ4JPQ(
MECN^JGR*;VTO-66>RDF2AM<G +6*355W1RL)6 ;SDFT"1:E?,@G59I%;<-"N
MTZWD^*X.'#7%]A;EK^XAVNVV6W0VZ$IYDEOJTL^@?Y2YM7>WBD78=P;>MKN_
M69"H/3A@PT1/108EM#CQ!&IQAQNPU*BSUW>:E;,L-V!VV5JO$ O"#-ND@NH2
MM2GMJ=9&M<WRRXQ#SS1K#/:HDZHJB4$2P6TMR1)-M,6C=)XVC0%XF 8ER72*
M^XSP&TY!':VTSW%K?226KR,YA8&WNKV"R!BM@XGU7TB.9)9&6.92RA8P(Y)J
M]=YMXUK:YZ6/6]660^5R@DT.S*+@H^!E@K@7Z1$<\6P;+3,>737Q?*@H1!;3
MR2]:8\CHJ:[9S+QY4<?E6V^^<FQUD ?I)%(MPVA0L&DD1K=DT#H)%83>9M:(
M6J\8X]-@6Y=;O>?>6'JQ/"QC$\D\3VB:K($9(H9$O$EU:*4Q,C6Y,NY)S25V
MXVD:C\T\0PIJSW.>D*^0[(3!;8(#[$7<I\@Y1ORYXR1'":K6VT-[:86\C>OI
M;W]&4L?F,I'@\9JB39.\G>(EI&"J0EQ*6W;"SA1#H!M4L-/%35?,<=P<W)\U
MI));83&VL<ZB.%2[JTMI J;.H$C9S<!F;<X0@^#BOS?3[-Y)J8'K2)&&AG[S
M&%1S LV$:P90Q)])4HY93@TUUZ/F[!7U@C#(1ZK;1+!2W=[4Z,S\^D^3VS7D
M=L)+.%KE&0+(K!K59=SF9EZ1226(Q(@&X*\<I<DO$GWZ$87=;8Z:],.1N4LI
M5D9H71DOG@VQ"V1S<"2&WG$\DC':SQRP+& (YY+Q7KS9B)\"!G80= \D;(LQ
MT\T%/5[<B.%  S;J_LS8@TR0"@B3=AJ5LA]M_;.W=;:4I8S-YC\YDY+^.QOH
M5$<CN$E"RQ;PL2R$]&9=Z[6;ID[V#;=P*DM&F.R_&,+#BI<KB[ES+#'&9("\
M%QTV>=X0/2;=^FX=4$P'31DWB,AU"S212*Z++RQ3<JP:!$/VKF/&)J&BI)J6
MG@@)BVO],DI74;!P^AI.P'HC(A.UM,K%4Z.%ZCCC;;2MZQ5KR*[NY1=(\<+W
M6,QTD:.))562<WKOLBCT>5MD8U52A*1[F954D9Z^X?C[" V,L<MQ%89O,0S2
MQF*!WAM5QL<74FEW1P(9)2 SB0+)-L5'=P#8_P 1[9-Q_09TI@1BJQ?$(BX?
M)0)":AI\6>4OIS$JW'SPS04@(@DFJ(0A_:&7V6D-JTTAS;B=V)Y'EKVWR%]*
MJ+BHL)'<=-7DCE67^&APDH"NNYH  Q"LJA3M#;A64^AV QEWB,7 TCYZ?D\M
MIUGCAF@: #&M$9(&+QN56Z8E 71V9QO9-A$^.Z+. M.S^XZ+>KCECMU2#CTJ
M/3/).J6[0.Y,O$^58CX9\G5W6]B('3L<1>B]E+\JATY^?D5] IOS'$<<;FX@
M5/.ZNZ#K R$^*E6>!ATPHV1GJF5M#&-4MN'XRYD7$B:=<RMG:73R'88"EUZ,
MPA"^#JZ1W*MU6D(DE!MQ NJRFP;Z5?4(2.]!Q3A3\50[,4? PUGM;57A+J/=
MO,,178M;5AMSL9*T]H/XP-(FW-2:25B,M"NI=QYY)GU'3>"(RM%:S,T4<TX@
MCN1<^!A326<H]NL?4C$>O6$C0HL3!LJ.&<49C-'=3B!)[ZV5)YK:U-S-9M9^
M<MQ*#;V@DBNVFZ4IEVFV,*W$CSH4DE]Z2Y6:D-9X<F!DM_967O'PC34U-KGH
M& BQ),Q,$F&'TL8 S1[#?S<CS#!*?8\[#VWTI3DL]R1L;B5R=FT$G\%DN=H$
MDAEBB17;I=,:A6WJ.N^J1[DUC<N ,-Q3AB9K/OA,BEU#_#XK+>3#"()YY7C0
MSF9M&=.F[>B1Z23!)=LL8B)-BMO69VHDW28+B(DFHTJP;KA HQ!F[')J7S6(
MOJ)=DAU+48%IDZ2T!L)3;OJM;^*^);4CX5VQRW++_$RWMY+#"V(LKCHE06ZS
MZV<=T) 3HBZ,_2Z9#;E^5ZJE>DV4P' <7R"#&XZWN+A.09*T](5F5/1X],C+
M8F(J-9'U2/KB8,FUQT.BP;KI):Z=<W+W=HR<+B%N#43G\E%"QVY+Y.$?+374
M&BO4'+<V\ZXGY8,P\2C;6S&QT+]$??@TG)8Z?,MG;VVOGA+K86KHJ;^FK/)>
MAM0QU)\Q%9QM,@0-LC^*,+F+;CB<6QE[C([@(^5OXY6DZ?6=(H<:5T91H >I
M(Z1D,(6D9>I+XNV+8BY=4>A>33CQE9*DY'A]QO%@8>W+-Q4R5'(Y*>"C8@J6
M?A9,U$J6S\9_.-1_Q"UH&)3O;6]7M,SRI[+$WKO;-<R8.XN90>H$D9!8,OFK
MIM=M\B]3Q$6\E8I!YE;UD..<$CR6?QD<=ZEE#R>TLH".D985D.51SO;=NC0Q
M1/TO-:?IJK30D"2LC5GH\Q;)8,B*A5;K!$R7!DLD1<TS,1R HTE]RP%RNV=U
M[X=V890,T"E2G' WVS=$>*OA,V+&\CO<K=I):P?^[&F:(@I()$"H296?3I:&
M0!%B!U,;+,)/'I5IV:X=CL#820W]R/OVELDZE983#(7D51;K%KZ1N$),C3D!
M5F1[8PZ#TBL:WB^6RF-^X"3,F2G*PV^?#U>0\H[;G/+0CC5+E(5A+R&$:7 V
MB>D5^DX\I3HTT\VUK;K9J$B:WF\]EL,N?N9IF.+#-'"_@#:3_>^V>,:Z#Y*>
M5SM+$LERRKYRS@1;GQCBN!Y&_$[*WMD&;*)+<Q^<1D+8Y>\BF.A8Z3VT$8WJ
M@"R6:.Y"/;,9\D3_ $:;BIP@.'C8ZU,E/3\!!1,8B5&,>MD#3YFV)!.M!C*:
MQYI%V#?CUBM>+P+^D.+<<\SS0NQW_([VUOFALXX[I&:6**- X8SQ6\D^UIF'
M1\\Q-$47SHFT9F;5UBTW%<.QE]BTN,A--82(L$\\LIB9!:SW<-J72V0^D_)B
M9)UE;1)T+*J)I&\]A+Z)9I:&E(J")AE6$"JVR;E9 Z#M53<#=B!8M0$-NKS2
M]6"!E3TS;;VR7724BC:8)2P0@MI*;"7D63N[.6TL6A.1CM9Y'=HIX"IC5-L?
M0D/5B=NH&WL7")LD"2"50,K;\/PMAD8+_*)<C$2W]K#%&DUK=!Q*TN^;TF$=
M">).BR=-%C,LG5A,L36[LU.7U\NKQ\8<;H2?BF8(A@]D$>85,,3,+RN3Z6:1
M(V!]K[/Z*,$AE#ZC]:V^CXALE3^];4.CA+R^;%P13S;+BT6 A@HDZ@DCL7O&
M+RD=+<RQE.E\8;ED,GB8Q5@[>V^;NYK6VZEI?M=*T9=H>BT,V3CQR+' IZ^U
M'F$GI!(0]-X1$-%E:9.66TIWT& FFXAB0@*%%VD*3@'3VTH<L2KR+H#;1NE.
M^K".U1.D%I6CXOU/4] ;P]/,P<EE <A87HA6X@L$G5XBX\9O25VZ-XZQF :2
M CJ:[NG'\6M=7"X-AB<KC3<-:7>5EMGCG$9U%OZ$W4U3PTF%T=8B#TMNSJS:
M[ZA =_GHZ,D#11"EL!2L$)8K')-VBY!!:3S#G]C0O[.PBUR4()+KG'6WBQT+
M#!<9<,)0XIW:=X2'/W]O;23Q(YC26)9IG$]PJ_P*UF'R,9WQK)U6#2(#'$5:
M:4,7(K9KCB>*O+V&VGDC$LD$[6]O&;:S=]<E?VY'I$P$<S1"%62*1A-,KK;P
ML@C#"YB6JROV.SLS) !\$)V&JUZJ*@I&3C"!XV3HM6GT?,G!5Z8F E.2ZG5,
MK4MI]QQ7C_-I;UJZBRF2DR-TEXT;V*9B"*#I.Z$(]K!+YY7PD760L5)*L2=?
M-"@64^"PL6&L9,:DL64DX[=7%UUXXY%:2.]NH#TPPW1/I$%#@!D55T\\N31L
M=9MR8:K2QL+"^/0*C$VB $BFYF4>KK1UEY_77TRS;:6BK1ML;H3$AZ8C(+B?
MA71$^KM2"MT4Y9EQ9VMW/#!KD+2.>)4$CF$--:0GJ :-/H+M9=(UC(V-$-^J
MRU<2\!X^<C?6%M<W.F)R$MM.\IAB%P4MK^X7I$DK;:M8/!NE>93U4G/3 :"I
MH3;+JU26YI=;T-,_.I",*4/$6"<T%" RLE'#7+[&CM1UJD42H@3!:8<9;A;*
M#$H]=W32W59F3+9I,(+UK;;>=9T;2.67;&KNBW'HX"3N'55<6Z$R*) .HX4L
M=;AP'&I.3'&K>;\=Z-'*NZ6"'?,\4<C6?IC&2UC,3.\1NY%6)S$6Z49=4$9#
MOUF=L=D,W+5!RI-<WYM-0JEHF6O"R6R8N4.I.DI#<DBOF$E%-L-A^EHMQ:66
M$H0^MSQQL.?R39&YF,MH<2,;9R1_O@^6GDN(_P!R7;>Z*HCV]0D(@4.6K-7'
M%,*F&LK<6^0'(&S.1AFT,)_@]K#9R_NQ&O3CE9VEW&)5,DK,T2I7-&=#N<^9
M&5R&!KC4ZIKH6Y.5F!+!'1KCM"FJA&C_  =>=\LN"BSL6I&UZ?)6J+5K>T_'
MI0G3W*VY#FK^:+'6:6POM+O>\BRHA-K);H-L1^47K"<:[G)@.I'7 &_A>\1X
MWB;>;,9&6\;%AK#IQ0O;R2 7T-W(V^X'R3FV:U(&R,"Y&@/HA8].RL=,GKD)
M3;/$)$@:H9=*?'FBDDDIG7Q):KB60I\HEI38+(;3\F@78:VE:?:1\7HA*=H8
M59Q\EO\ ,Q6>3M D&*>]MT923U2LD"S,6(\T*"X3IE3N4=7J $1G(R\*Q7'+
MC(X3(&2ZST>-NY$957H*T5RUNJJI!<N5C:7JAAL9O1S"2&E%<%UFQ%3$=70X
MR!FI"P$5HB(DV56"!@V(BUP'29P9S2Y6-(,GTQ+/.'-_%L(&9D4%)VAL92-Z
M56AY9D9;R/'0Q037%PT)C<=6*(1SQ7DH.KH6EZ8LS\HH19@XT6,C0VUSP'#P
M8Z;+W$]U;6EHERLL;=">9I;6?'0,-(I%2 RG(+\DYD>W:)MSS!@1]2MRNQLU
M3#HH..W$ZZ)<*J[ #GE"RT^;5N<]-6^DF0)TW'#QQMO@$H&'>8U_,-,'*?UY
MM#)^W69S<][9SVJ1^B??&X@,0=EDE:"SO==7.B!&N(@$1E^*$G,GCTQQL..<
M9ML;D;6_DF^^'WGM+H3M&K10)<Y#&A2L:ZR-(EI.3)(CGSVEM1$=.L:D*X2T
MH]2Y DWTI@>^N5F<@QX>Q5EY<;.5:2-W&'P%C6X^Z]$',,&HD6M.-%#1ZW1U
MM,OO-IJPYBZNGLKB1]+Q;\PRQ".:$E)8';8T4Q))C8)()5U5TB9HV5)'44;G
MCUA8QY*TACW8Y\4+F&=IK>Y DANHTZB3VX"A949X3;L5:*2=4F5Y(HW.=LWJ
MHMIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE
M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE
M,4IBE,4IBE,4IBE,4IBE,4IBE=9_ON_AP4/W:!DW>J/1]"[L$"VP':EM/:@;
MDP&UZ84/>A1&W7E;9;3ID>48;68,UY4+02RVTRCK1WU^KC@>[,+9O%&.PYTB
M +/H>E<!1HL=TJ@GP'FK.H,B#0,)$54'=3ZK/UR.5=@KE.,YY9LKVMDE+/:@
MCKV;.=7FLF<@>))=[9V6&1M65H9'>1O*UVG@?7?;Q;7:;UVDS%.F4[6X ^6V
ME^'G!&UZ3J1KLZ(IZ)FP=JWK6W!GE^DOQ0YI#B5(UY8\TX%R[MYECAN764UG
M>#Q0L-8Y5'[>&5=8Y%^RC':?-;1@0/=CMMW6[?=WL O(^WV3M\CCCH)%4[9H
M6(_>[B!PLL+^\LB+N&C(60AC\1_:;3\ -#V\"O=*A@VDCAAWV-5+'QP^M[\6
M8NS"$Q]KCFM)\-);;.TTG6M:TCP^C?&WYIE.@MGEX[?)6:#15NDZC(/>292D
MZ#W@)=H\/#3PKG=]ML'Z4^1X_+=X7(R-N=[&01)(WORVS+):R'WV:'>=3YVO
MC7(NS<4D?'X[E5JA%JWO>UU/IFM#M^&D>"&0[33[(_I*E:WX[64O>M;^CZ=>
M.<CD^%7'[_BKJ GW8+WP'["SV\Q_Z7-<%PG<JT_\KGK"Y4>Y=8WSCY?$O:W=
MNOO> B'B/]%?B;/Q:/VGX#E-FFE-[UM*[;TM2QWO'S*VD@*JU*L$:2G:O+K;
M9:-[2G7[-[W@9/A=O_Y?%74Q'_Z1>:@_LK!! ?L>$@\/LU].$[D78/I>>LK9
M3[EKCM&'V5>ZNKE?L^=$WB?>TKCD>U6U8)$15!H'FT*6UI@R/Y]&[@29!C6_
MH:E;"M\RU2K2D_0IL@Y;2M?M1G&YYIEC UIBE@QMDXT9+1.D7'O22DM/(/?#
M2E3[U<K/MM@%NDR&>>ZS.2C;<DE_)UUC;WXK<*EK$?>:.%6'N-5?PSVZ]C]Q
M]K;J'(*3*6D]*V?FDDA&@Z[7!7E*\#['8"MM1<0-I"%;1IQSUG]IVAAMUS:4
M;K\&[=\Q[CY48CB%E+=3@C>X&V&%3^VFE;1(U\"1J=S::(K-HIM.Z'>#MUV;
MP)Y#W"R<%C:D'I1D[[BX8?M+>!=996U(!*KL34-*R)JP]6'L8_AV\\]HD8U:
M9AX*]]QDP'!IB[J8=U&5T8Q"-%P%%#*2AT(#:4^F\>ZA)QJ=J\VF&5_#)]5.
MQOU>./=HK492\*7_ #B6,B2YT.R$,/.BM5;0JON-*P$L@UUV(W3'A!]:'ZW_
M "[ZP=\V"QRR8OMA#*&ALMPZMPR$[)[UU)#O^V2!6,$)VZ=61>LW8UG8RNG5
M,4J-II]51._:=->B-6#U%/ZEM C_ !J2EAN1KAR'?)XMR+T:ZH59"?!]8W@R
MI>V]:3K&C#XH7WWS%O#]\-=>IM&[<5*%@=/!RA*%_C%/,)*^%9D\BSK8O[R-
M=W!Q.FWI;VV%0XD"$:^,8D D6,^8LGR@4.2U4$+SVEUYH@:'KX08A<<J((!\
MQ!$>Y%K2EM4=\O*>?"2%MI&D>FEO2/)]7P\OT90LN/8;'HT=G;HD+Q],KXE"
MGDV;&)7;IX::::>'D\*NLER[DF7D2;(W<DEQ'-U5?S5D$H.O4ZBA7+ZG7<6U
MW>=KKXU60-*J56=>?KM<AX9]]AL-;X + [R0&7%NC1C+J$>H/$AN.*VP(WM(
MS'FWZ:$^.\K6&%Q.+8OCK:&%V4+JB@'8#JJ ^41J2=L8T1=3M4:U;Y7DF?SB
M+%E[RXN8E<N%D=F'4( :0@G1I7  >5M9'T&]CI7R?2:M)1T/$DP["8^OH99A
MAPW"8[4>(P+H#Y>.Y'OBNZBR(_7P[XFU;&)'WMIU"V][3OY/A<7<V\-I+"OH
M]N (PI*;%"[=@*%3L*>8R:['3S75E.E<K7DN<LKRXOX+AS=W9)F9PLG49FW]
M1A(K#JK)\HDNG4CDT>-E< U^?8:G:B_DB:S"HBM"Q838+8##;# T&*D*$0*E
MM"=BJAQ4)0*MO:%CZ3KT]IWK6\^?>/#BU]"%M"+38BA0H  B7;&%T^+TU "$
M:%-!M(TI]*.1>G??,WMR;_J2N7+L69IV+S%M3YPF8DRAM1)J=X()H-2*F%(
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MJZ%F:&%MQ4D/%&X(9%(IYJ@4VPB 1\O7H\J.C(TR%$C4H<%CM04@.,,=7R
MW!Q#J\6T"/Z@#Z' UK&87MOSLM*12O<!ALC#';WEO&]O%&T:IXJG2<*K1%5(
M5HF"IK$P,9*(=NJ*16QO+.1XBXEO,?=S1WDTR3/)J&DZ\;,R3K(X9TN$+R;9
MT*R@22J'VR.&N[]>@B5%*(B(]_9LDS,&>L*RYHJ4'CQHI@]_2T[TZ4U&A-,:
M6KQWIIM*?V:R\?'V,A8R11L7D$C:J#N<(J!C[[!%5=?W( \E8^/+Y2$((;B5
M1%"84T8C;$TC2LBZ'P4R.[D#]LQ/E-4D#4*O5MD;KE?B8/93 @I&XP%@/U1
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MSA_&<CRW-%UP^+L+B\G*+O<0VT3S2E5'BS!$;:H\IT'NUD[FWMSZ'U(+H$K
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M"GE'Y[]#^[=;_I<?F+<3]NY'YF'X:?K2.>_BMA_6+CX*?H4\H_/?H?W;K?\
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M/*/SWZ']VZW_ $N/S%N)^W<C\S#\-/UI'/?Q6P_K%Q\%/T*>4?GOT/[MUO\
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M@ ZB'*69@25O#39'-CEB))&U[J-?.Z@V]57\=F;DQ^<>W^NLE.(B):ZW.8D
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M:F2QO>M*WZ;^YM'CKP_:G6]^&M>.M9Y(.G)C[U?!XLC$-?L3!H"/V#U!_P!
M_9K=N&'K19?&MXQSX>X;3_6MBETK?LKT3I]@G34^!R;FS5I-,4IBE:K>Y_\
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M8_*1WO0N))9WCCE$AAW+<3-*K20OJFL)V@K(GG7HY%5K_3Q>=\__ )H&&E[
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M;FXBQIL([A8U-O=R%GO+FR,9FB>.$C=;&?<%\U6Z6UF D;GCK79IVXT@SSA
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M,M^=UM6UM,$[]9M"O%+;VM.)UI>M*U=76*QM[,EQ>012SIIM9E#$ '4#Q'B
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M3T_2!$D[1^/F/-%$L$K#X\):,^!J0YD*Q%,4IBE,4IBE,4IBE:[^WK_XX_\
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MTKX#4<Q7@8\=$DB8:<A]OPA[$HV(Y'(/&E(AX*3&)3%/+"\S;R=_ K4-_P"
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MT43)YL@&@<>76OAZKULDB0+)@HHDB6'D Y1PD$=_<B)+!0T=*"G)=;6@H>0
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M/#^IV_W.GXN]7_,_H?WULG[RQ]+N6>U,CZS-]O3\GW O8>']3M_N=/Q=ZO\
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MUKQWG%W2-#)(0L:@DDG0 #Q))/D ]TUSCCDFD6*)2TK$!5 ))).@  \22?
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ML\OP')9EOE,BX0("VP.\]K>]]SO<GEV#YOF\-8SKDKB.SO'QMG9M930QO:V
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MQ>?_ +Q)61,V&M0IBE,4IBE,4IBE,4IBE,4IBE,4IBE:K<,_KU]ZW]LO,O\
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ML+4A7EWKS)WO6_HWAXHI&5W569=="0"1J-#I[VH\#IY1X4CGGB1HXG=4?3<
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MZSA=V5GD(#;7\,4]L3XI(JNIT\FJL"/#]BJF/R61Q-R+W%7$]M>*"!)$[1N
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MLU\0I%D[YW]S%BDZ[QRP)@YHBNSMJF:-SJ'FP3MQLC$&],O=;H.Y>-D$;TL
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M/E+6<CA98_?(@E9)%\NU))!X "O7VYC'$>X$-[#YN#Y$3#,OD5,A%&7@E'N
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M!6BZ6LF ML'PKC7$,3R#EUID,CD,V;F2*.WNXK1(+2WF]%ZF][2[,ES+<1W
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MSBY5Q>..*.VMI(3'/;1; IZT<_RR(VAA2+1H2J;E(9F1="^N1'<VF1Q&8O\
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MO:6Q3#VSO(SVT220,;>,"YC2.X6=[6VN>R;.R-=,JH)6+CYN,D866$9D(J7
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M,W>W(ISGZP.5]#(>&7*16:Z'53Z.L5HQ'E\TM$S$CP.I8>!K](/U9</+VO\
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M$6S^#1B"-XO!U_)GC=1,Y2QR.":>J5>B!:_]E2896G#ZQ-5"8C;-4K*&Z?\
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M3.!Q]S8Y[L<^:Q:TV1>C]%@TN_63K;RD,*;-O2V#:7W;]205 A/NK+V3EM;
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MG2E,>Z%7>55<(59D5'U"DZLK(NLBLHJ6?">0WZPBSCA>ZGZ)6'KP";;</''
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M5NR[OKK\/*YKR^"4^'TV\7&,;%:^AJ9>EZ);6WQAKT[4NT7[7XVLC;CY#X:
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MK:G)3J"J8I3%*P3VSVR\(]Q48B,[%S6NW%3#.QP)E]EZ.M$2UM?J^G$VJ(>
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MB,Z\K0H( ;3(H@[2?H2AM"4IU^S6=H;2SM+"V2RL(HX+.)0J1QJJ(BCR*JJ
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M*A%5Z$K+H[2T;A8FIPMKKM< "UZFTH'AX2\RXS.MZWX-'NZWX^.MZ4K%EO\
M;?5[+9')L)4/#CR('P4HE=8&D;'$/KN-LOIUBYI;MR <CSNW3=HN99!T@VV:
MM2FAECH%?82]M2LL6#G%)M4L+.3\ +(R0K(8KCJWC&&)4*-,?D8J.L8 I+ %
MIC(:4*=+!%DFBQPC'%OL(;>4I>U*3,%1(FFV.$G XD"DS?VE^THAR_0BC?M[
M*R!=F^.6MQ/A]H9:P$*=^MKS.$[\/#QUK%*J2:K3@S'[.9&1@I8M@=O94P2O
M3&AK Q2E4)^Q/D.NI99>9HR=@+<5X(2+K?C]/UL4J+-<0Y<Q(#R3%60PL:3A
M)UH!F7GFH'[05PYF0@[([66Y1-=(LT<^,TEN2<%4=\.PTQMW;+3;:5*JW:-R
MU]4%2WX&NONUBE:AJ] /(2Z]#4I,E65,HCQW%J='$%F*9%.,/I_G6"H]E;:T
MN(TK%*I$<CYE(A-[&C'GG&UQ:&[)'VNSMVK159D[02(1J\@SK=LW)CGVZ9:)
M(^.^();D2V"%N-/.MJ4KY'Y'S2%=A&(F*'K;@\Q&20;,6>Z"1+$U^8N%Q"!(
M<6\LPT0>?N<M(NLH7K;RR7=.[6PIQM2E7(:G<WM\A#=*"CHR:=E!8>PQ<R&6
M2["SG@*&36K03&#E:@9Z7C@&V?E<F2.^8"QORC.M(4K6U*B]+]OO-JA2XBG.
M0K5@1&U2N51Z6F7"R3W!ZVW$/#%Q'K%O:J3KL_"L2_DB=AH;F$)-3X%)T]BE
M3N*Y[38?82PX1EP@&,GX=LZ2).FI,D"UE0QME;E929*/D9M^=*KP2RWC'7WW
M]C(\R]^&_%2H+6>/\;*J>]UN+^;5RY0M&)9F_M9:ILZ5@JF6NS<Y?C;6?/&S
MS 5;+/\ BHE8Y;>A/.G;.T:TGP4J42W)>=S:=ID*P)M2CY8]QX(F0BBB%6#0
M*;%'E%Q1@11<!9$1@R9*,=6N.D4#M)(8=2VC6E*X[#7>6P$%)ILL;68JO35C
MJTO(CGH8&C9*RU]-8!J*DAJVEE\T%%.BF11VD;TK03:=(5K6];4J@@>(<SK#
MC!,+7W69(1J/9"FI&;GK'-A-P\':ZW"-CRUGDYHWX>$@KQ+"B,K6I@=@UQ"$
M:3X:TI5[IU>I0T=5GJTIF510H*9YE!S3ASLK(!1\/(Q4!9H0F2==<=)-1-T,
M9HY3NU.[+ ^MOS:5XJ5#[?P2AV6)G@@XT6),FY 26VHAE^>KK1S%OA;S*#[I
MDD;NOLPMTL$"RJQ#!-@N32%N;>>T^I+Z%*MD9[<N?;@T15GCF9A;A5D?)&K[
MDW1:JS'W(:%&M=-B:G7Y](PO-K'NO"/GU\M\^/D#&]E&)((6IW:E2J6XARZ:
MTK1U60C3J#!S4QTM/0J9:/D:[6JE)PDZF'E $S]<E:[38D4N,-T_'E(CA]NL
MK6TA6E*N)/)N>%)DT/5H?TY82"$,:9,DQF=.5C0":]+!,C&M-1EEATQ .AY8
M;3,FWJ/#UI_P$&])2KO!4*H5I<2]"00@)$(#88Z.+2I]\Y ]NE8N=M3A1Q3S
MQ<B=9)N%&,.*)6Z264WZKKBG%+4I2HOSF!H],,LT3 3$2?8>@V.R=DFEBJC6
M#9MFU2;8@$W\)&^08B/C(0..B&C$(\2VP6W7E.$..N+4I+<0Y=/2\M-S561*
MF3:Y9X\<^7GB8;XF?J9=%GC0:Z[**K\3(3M2.>!-($%8?+:<5MU:U;\V*57'
MTSF_2&_M(Z"#-.R#40T):8B1.CY<;=4*L[<01!62$-!EX0Z(?M,NR@D(A@C3
M9Q+6U[;<6G:E2VNUN"J44W!UN+$AHADN4.:CP6_2%:+FI4V;E7FV_'>D*-E9
M%]]>M?1YW-^&M:^C%*UQX9_7K[UO[9>9?Z8>(9%G!OZ=<U_WS9?R+C*G7NA_
MA;VU_LYDO[RYJMECX:+E"H0Z0"9*+KDF[,P;[NM[7&RC\-+5YXT;>MZTEYR%
MGC!M[WXZ],A6OV^&]2G4%5$K/%<XM$HQ3[4-7YB6/K]D;:KI^VGBB*U8Q'H6
MS;=C]*\RHR8$<<'=4XGR/?73K>]Z5X*53U[DG/ZN4U(Q<$Z[+MS;-D7/3DW8
M+18S)X>M2=-&EI.QV:5EYV6.%J<P1&M.$D/;:"6EE/@VVVE*E1V;X'SN3K8M
M8"B$1$>+(4IU'INEGJ3!4N_UV_"5)CYB61L2N.$5QH%D9K:60 ?(R,AMIEIM
M*E7=KGG)P"QZN] P14G-5F[,K!G'79V8LU:ER:6)?R9LF<(/DK2B0)&@FI$H
MYPEYSRC(6O>O+K%*X!1*%!@SM$J]F"A;)89.2J_Q,E+.6^R*NBZ&/8&$'?:X
MZ7/L,G#T=(IJ!3''FTQC32/+H?24XI5"/R;D$!6^8<N;BA(R.I-79I?.(T66
MD8689JE=AHD VN"R$.;&R9\ 3$PX>I,!;BPCTCM;):<TA'@I5;KA7*/7E'EU
M =]N6$M@#T>5)S9<*"!?&EMW<*OP!4F]"5<2WJ<4[)MQHXB#B-^L]I;WU\4J
M1R%*J%ME86W&I+F%B-0YL6EFSV!54,^5G*G:]*DU8.833YTN+DWDF@&$AD/#
MD-LO,N)6TRI"E?1O.*3(V5FW&0 K\ZR^(8I_;QB 3)*-2.B(FI2%;)1"2]@@
MFA4(CY H=XZ/;UM SK25*UM2N("N<_GJ0/3HV/AY*CPZ4U0*+#7MT&)>H$K\
ME8!!?:<^(CY6G3U=TAAYIQ!0!P25MK0\TE25*LA'.N4Q30D+(1,>DBVO P ;
MTO*21M@GI2!=F.@ *9GI*0(L!EFCB8HJ82=HG<@EX))'K><=I3:E6RL\#YQ
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M.^DF9':F-';:T,C:4![TI5)W!/0[45TR.J54ZF,5-0O:J'.P3R^K6"L3]9_
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MCP3H%?FK#O26XZ/.<'//?=::'9<=>:0M2I=J[4]2G-)LT(MMFKLW9\I$D*L
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MS,/1@&'T*BBR6E+)=9?;<=;4Q*=057*1Q_;G"+3Q5FQ)'59*7?*BBSIADKT
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M_?;C](/^IOX2I^B/_F/^!J?[A'^37^^W'Z0?]3?PE3]$?_,?\#4_W"/\FO\
M?;C](/\ J;^$J?HC_P"8_P"!J?[A'^37^^W'Z0?]3?PE3]$?_,?\#4_W"/\
M)K_?;C](/^IOX2I^B/\ YC_@:G^X1_DU_OMQ^D'_ %-_"5/T1_\ ,?\  U/]
MPC_)K_?;C](/^IOX2I^B/_F/^!J?[A'^37^^W'Z0?]3?PE3]$?\ S'_ U/\
M<(_R:_WVX_2#_J;^$J?HC_YC_@:G^X1_DU_OMQ^D'_4W\)4_1'_S'_ U/]PC
M_)K_ 'VX_2#_ *F_A*GZ(_\ F/\ @:G^X1_DU_OMQ^D'_4W\)4_1'_S'_ U/
M]PC_ ":_WVX_2#_J;^$J?HC_ .8_X&I_N$?Y-?[[<?I!_P!3?PE3]$?_ #'_
M  -3_<(_R:_WVX_2#_J;^$J?HC_YC_@:G^X1_DU_OMQ^D'_4W\)4_1'_ ,Q_
MP-3_ '"/\FO]]N/T@_ZF_A*GZ(_^8_X&I_N$?Y-?[[<?I!_U-_"5/T1_\Q_P
M-3_<(_R:_P!]N/T@_P"IOX2I^B/_ )C_ (&I_N$?Y-?[[<?I!_U-_"5/T1_\
MQ_P-3_<(_P FO]]N/T@_ZF_A*GZ(_P#F/^!J?[A'^37^^W'Z0?\ 4W\)4_1'
M_P Q_P #4_W"/\FO]]N/T@_ZF_A*GZ(_^8_X&I_N$?Y-?[[<?I!_U-_"5/T1
M_P#,?\#4_P!PC_)K_?;C](/^IOX2I^B/_F/^!J?[A'^37^^W'Z0?]3?PE3]$
M?_,?\#5KM[6/_G>_"!/V-_\ E5^1?BE[@O#[3_BY\V^<_P#S =/^T_C\J_Z/
MY9]I_C/@/_LOP'H^K_.^?(\[6_EO^B'_ +F^BOH/WTRW[]Z?U.I]];WK_$\W
M9UNITOVW2V;_ #]U3!WT_-C_ "A'Z1_3S[Z?>+ _^6^]72Z/WAQOHW[[Y_4]
M&Z/7_:]?J=/Y/;6Q/^X1_DU_OMR0_P!(/^IOX2J'_P!$?_,?\#4_W"/\FO\
M?;C](/\ J;^$J?HC_P"8_P"!J?[A'^37^^W'Z0?]3?PE3]$?_,?\#4_W"/\
M)K_?;C](/^IOX2I^B/\ YC_@:G^X1_DU_OMQ^D'_ %-_"5/T1_\ ,?\  U/]
MPC_)K_?;C](/^IOX2I^B/_F/^!J?[A'^37^^W'Z0?]3?PE3]$?\ S'_ U/\
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M1<>)],KPZE*2X17I>L6Q36O'6D+]"0(J&UI\-^*O!7BGP^C2LZEXOZ\W#)I
MN8PF3MXR?$PR0SZ>]X.;?7[/O>YK7?[-_P#*Z[D6T3-QWDN%NY0/!;B*YM=?
M?&L:W>A][PT/NE:WOXW_ !%/:%V\D.*J_7(F!LANT-LU>_L$TB6<(=5Y6@A"
M9Q#$#+'.[_Y6@32E[W]'AXY.W#?K$]HN;R):XO+Q6^2?0""Z!MI"3Y%4RZ12
M,?<6*1R:ZL]QOJ??6$[8PR7V<X_<7>&BU)N;!EO8@H\2[K"6GB0>Z\\,2CWZ
MW<R;:ZRTQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2H3.]%IU=,^62$RT],[3M2(*)'+G9U?AK7AKY/##G
M2"-+VK6M*6VE/T_M\,PM]R+#XZ;T:XF!O/\ NHPTLOS<89Q^R0!]FMFQ?#^1
MYBW]-M+9EQVOC/*R00#_ /#3,D9T]T!B?L5KO[G+H]8/;5[AHI%+N\0!+<-Z
MU&OV:?B@(F$@V#J'81'9B9'?EMV1$5&-N;?(V/'DD:90KTVG%^5&X[[FYE\A
MVUY#:"RO88)<'?H9I46..(-:RJ9) 9.L$0'<^R)WV@[49M%,O]DN-QXGO1Q"
M_;)8RXNK?E&*D6V@E>6:9DOK=Q#"RQ>CF60C9'U)XX]Y&^1%U8>.E'(&C/!N
M%ZMR":)5M24")M,G7G%KUI/E;0_=:]5P5+=VK6DZT]]._P#Z-^'CPO$$F\VR
MRN'FE_<]=XB?L W,,"ZGW/.K]$[=PI+;S\E@>0VT(\K>C17  ]\K9W%RX TU
M/F> J)6OG%YI"6';169*,#*WK0<KZ;9L&?O?F^B/GHYPN&/WX)WO^9?7]'T_
MLWF)RO',YA KY2VEBA?XLF@:)O\ 8E0M&_\ U6-9_ \QXQR8M'@[V&>Y3X\6
MI2=/_OD$@2:/_KHM;6>U;^(%[@?:J>$#7;"]<>:H>;^8\NMQ9!M>4-I>]O?9
MLM?KGTX]2%KVEP+>AUN;TH@<C24IR5>U??\ [@=JYT@QUPUYQH,-]E.Q:+;K
MX]%CJUNWB=#'YA.ADCDT J!^^WU2^TO?>UENLQ:+CN9E3T\G:(J7&[3P](0;
M4NTU U6;Y0*"L4T.XFO5E[5?=UR7W<T95LYS(.B3,5H9BYT68VTU9J?(D(7M
MMLQIM6VI")-VTM09X^U#DH3M._3?;>8:]5>U?=SB?=O!_?;CDA2]BVBXM9-!
M-;N?(& \'C;0F.5=5< @[75T3P>[[?5]Y_\ 5^Y0,!S&%9,;/N:SO8=3;7<:
MD:E"?&.5-0)H)-)(R01OB>.63:/)1J#:8I3%*IVS!'B"1&2AW2@O1^,&;?:<
M($^)1MP?XEE*MN,>NWK:D>;6O,G7CKQUE-9HGD:)&4RIIN ()74:C4>4:CQ&
MOE'DJL]O<1Q)<2(ZP2:[&*D*VTZ-M)&C;3X'370^!JHRI5&J<8P0Q+BPRART
MLO.#/*&?:?2T0SO6G1W-M*5I#S6]_61OP4G_ (ZRG'-%,"865P&(.A!T(\H.
MGD(]T>456FM[BV(6X1XV90P#*5U4^1AJ!J#[A'@?<K]8*%*V_H8E@C8SZQ2=
M,/-O;'*:TE3@S_IJ5Z3[:5IVI"O!6M;UXZ^G"2Q2[NDRMM8J="#HP\H.GD(U
M&H/C7R6">#:9D= Z!EW C<IUT9=?*IT.A'@=#7/E2J5,4JBCY&/E@V9"*/"D
MP"/4] Z/*8-#?])U;#OHDC+<9<]-YM2%>56_!2=ZW].MY1M[FWNX1<6DB2V[
M:Z,C!E.A(.C D'0@@Z'R@BKF[L[S'W#6E_%)!=IIN2161UU 8:JP!&H((U'B
M"#Y#5;E:K:J)^1CQC 8\D\(<^3^)^6@OE,-&2'P36GS/@1G%I>+^$95I;OII
M5Z:=^*O#647N;>*9+>21%N)=VQ2P#/M&K;5)U;:/%M =!XFKF*SO)K>6[ABD
M>T@V]1U5BD>\[4WL!HF\^"[B-Q\!J:^MG@I.1&*-$U).B.GMQ^R&='. L/,C
MO&H$VOXA8C)!#:%.:3Y$K6E.]^*M:W],\ G%L73TDH6":C<5! +!?+M!(!.F
M@) \I%<1:W1M3>B.3T)9 ADVG8'8%E0OIM#%59@NNI"D@: U5Y5JA3%*8I3%
M*8I5(">#)BM'1I@D@$_Y_1+!(9+%>]-Q;+GI$,+<:<]-UM25>&]^"D[UOZ=9
M2@G@N8A/;.DD+:Z,I#*=#H="-0=""#]D:57N;6ZLIVMKR.2&Y735'4JPU (U
M5@"-001J/$$'R55Y5JA3%*8I3%*8I6JWLQ_J*1_;+[H/]3W8<BSLU_07_C.;
M_EK(5.OUC_\ %(_V<XU_=K$UM3DIU!5,4IBE62=LE?K GQ]BFHR%$WO:4/21
MC B75Z\/%MA+JTK(>^MKP0C2E;\?HUEE?9+'XR'KY&:*&+WW8+K]@:^4_8&I
MK)XO"Y;.7'HN'MIKFX]T1HS:#WVT&BC[+:#[-0M'4@CM:77ZAT&RCJWKTS(^
MKNQ@+^O^*V"[637&'V]?_63O:=^'T;W]&84<H@G\['V>0N8_<9("BG]AIVA!
M'V1X>]6RMP6YM3MR^1Q%E,/*DER)'7[#):K<,I^P0"/= KR??Q *4#;?>)VZ
M<)O]$ILC)SL&XY4;B980;'%*:IM<8TQ*O15;FJNRZ\VSIY'I23R-MK3K:M+W
MM&O*/O\ X6#+=X<W?29"PL[B6>(FWN&E6:/2WA&CF.&2 $@;AMF8;2/'=YH]
MZ_JF<DN>/_5VXSBX<3E,C9P6LX%W:);O;R@WEPVZ(2W$-R0"=AW6R'<K>!71
MCI?)<5Z"%'/34;%A6^"'3YR)FB3,3<P1F_!6U+.37BSC(U*-)WYOB6F?)_WO
M#(7N>%\@@MVO;:)+RQ4:F2UDCN%4>^W29F33W=ZKI[M=D;+N3Q*YO%QMY/+C
M\HYT6&^AELW8^\GI"(DFON=-WU]S6OSDG;^M\'LJ+7R2^6&BS:5-Z*7$%[T!
M*-,+VM D["E((AYX)*][WZ!@[[6E?3Y?'Z<<2YORW@>2&5XE?W%C>C3=TV\U
MP/(LL;:QRK_JR*RZ^.FM.?\ ;'@'=3"G ]P,59Y3&$':)4\^(L-"\$RE9H'(
M\-\,B-IX:Z5Z9_8M_%1ION(+B>7=E'B>==C*VP#"2 [RV*5T0US>FVAHE1;C
MKM=LI*]Z2F/?>=:*<\/AGMN+2,CTP[&?6GPW<.6+B_,EBQW,7T6-P2+:[8^
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M6KR^CK6CC\1RV)I\#&MGR-06:S!)BG \2;0L2RN/$FW8L2/WICILK=5R_(.
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M +7B.)>\N_!YW]K>:Q';Y3DHZU^9;+"-\6!3LGE7WYW4[HU(_P"R0AM/CO\
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M2J54J?$2IQDG*157K<-7XV2DI#6M'R!X,2&(*8<=K7\\ZXE3CO\ WM[S/XO
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ML=C[7%6:6%DNVWC'A[I)/B68^4LQ)9B?$DDU@,SF+_/9*7*Y)]]W*=3H-%4
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MC62G&VWFW&7FT.M.H6VZTXA+C;C;B=I6VXA6MI6A:=[UO6];UO6\V1E5U*.
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MW)*W$+F?6VEU/4M9AJX@D;W2 "T,A\9$5@WG(Q;WS^J;]9_"_65XE<<0YG%
MG<*SM=+V#0"&^MVTC-U"G[4$L%N(AX12.K)HDBJFF710@;I7@NQ0(3 +TA()
M@^E0H+7IB0]U6RLEB="8;0E(L+=1FED(1_R,'-D-)WM/IZR&N10P9K')S&P1
M8WDDZ5Y&HT6.YTW"50/BQW*@N!Y%E$B Z;:[(</N;KC>7E[=Y61I8X8>MCIG
M.KS68(5H'8G5IK-BL9/E>%HI"-=]=E_\&GW,%<\[0?[?[#(+U3.QH>*KK1#V
MDB0_2(8!PD9QG3BM-L:M4(&X$YI/UWRV D:_9G97ZFW<N7CW-). 9"0_>;,@
MM""?-CO(U)4C7P'7C4QG3Q:18172O_F-]E8.7]MHN[.(A'TDXX0MP5'G2XZ9
MPK Z>+>BS.LRZ^"1/<L:]3&>I->&%0>V<RYM?BHDZ]<]H]T-@75/P9ELJ<#8
MRH5]6E:4]$D3 !CL<ZK2M^*F=HWOQWF#RW&>-Y^6*?.X^QO9H#K$T\$4S1GW
MXS(C%#]E=*V? <VYGQ2"XM>+Y?)XVVNUVSI:W4]NLRCR"589$$@^PX(KGE^>
M4"P%FGSU&ITV?)1&J_(FR]9A9(L^!TYZVH0TDT)YXJ(T]]?X9:E,^;Z?+XY4
MO./8#(2O/?V-G//)#TG:2&-V:+77IL64EH]?'8=5U\=*I8_E_+,3;QVF*RF1
MM;6&XZ\:17,T:)/IIUD5' 673PZB@/IX:Z55SU*IMJ)CS+/4JS8S(EL]F**G
MH&*F"8QF590/*-1[\@*0Z&W)#MI;?2WM.GD)TE?CK6M95O\ "X;*R1S9.TMK
MF:(,$:6))"@<:.$+J2H< !@--P&AU%6^*Y+R/!0S6V$R%[9V]P4,JP3RQ+(8
MB6B,BQLH<QL2R%@2A)*Z$T:I5-9E$3C-2K+4TW#-UQN7:@8IN417FD[2U HD
M$BZ+3#-IWX)%TOT-:_8G"X7#)="^2TMA>B$0B01('$0\D6_;NZ8]Q-=OV*/R
M7D<MB<9)D+UL:;DW!B,\IB-P?+.8RVPS'W9=-Y_=5B*_^VGG%VA:]#1##G,D
M5>S'6Z(=YW T$8+YY*0\A!21<I4K;3+?S^P.&1TFZGU)"(*>9<WIQE;;FO-F
MHY_MKQS-65O9VBG&+:W+7$9M(K4+U7C>)V>">WN+64LCL-9;=V4^<A5O&I!X
MGWHYEQK)7F1R#+FVOK)+249">^9^C%+'/&D5W:WEI?P!)(U.V"[C1UU2170[
M:D_+.'<UX]6J_6:=7 4-UMJRMQ\S(!QY5@TJY3CUEMBM2300WP;%@G7MD/BB
M(&"3M#:&V6VFFD(RG%N#\:X?C+?&8>V0+;"8)(ZHTO\ ")3-/YX5=HEE.]DC
M"1C155%5%483G7<_FG</-7>;Y%>2E[UK<R0QO(L'\#@%M:_)EVWM! .FDLK2
M3'5V>1WD=FF<31J3 PLA7(.GU:%KTMLY4K Q-?B8Z%DU2;>V9+<A%AB,@F[D
M&5;0_P"HVKU4[\%^.LS-I@\)864F-L;.UAQTV[?%'%&D;[QH^]%4*V\>#:@[
MAX'6M<O^4<ERN2AS.4R-]<Y>WV=*>6>62:/I'6/IRNY=.F?%-K#8?%=#7#KG
MM!2&7')H]03'GUR/IYP.JU"Z#-J40T^Q%58L707H$UR,8)<0."M*AF4.*TA"
M=*WXTQQ[ "%[86-GZ/););LO1CVM;Q@B.!EVZ&% S!(B"B@D!1J:J'EW*S<Q
MWAR>1-W%>27:/Z3-O2[E*M+=(V_<MQ(RJ9)@1(Y52S$@5R%T.CR L^"?3*H:
M%:] :M(9==B"1;+J*$% B]3X[P:V9C4:""PR/\1IST6F4(1X)0G6N<V!P=Q%
M<03V5H\%WLZZM#&5FV*JIU05(DV*JJF_7:JJ!H *X6_*N3VD]I=6N2OXKFPZ
MGHKI<2JUMU69Y>@P<&'J.[O)TRN]G9FU+$FE,YMSJ0$D #Z#2C@)=,&B5",J
MT$2))HK#2&:VB0&> 6R:FO,M)0#IQ*M")3K37DUK64IN-\=N(I+>XL+)X)NE
MU%:")E?H@"'>"I#=( "+77I@ )I5>WYGS"TN(;NTRV2BNK<S&)TNIU>,W))N
M#&P<%#<$DS;2.J23)N)KF>Y]0B1P1"*14'Q(R;(LT:*]6H9T>/LA1#Q95@!9
M6$IL2;)*)<=<+;TE];CBE;7O:M[WS?C^!DC2&2RM&BBG,R*88R$F8EFE4%=%
ME+$L9!HQ)))U)JE'RWE4,TMQ#D\@D\]JMM(PN)@TENJA%@<A]7A5555B8E J
M@!= !7/]AZ7\$/&?9"K_ "T.P:M@D?\ 9^)^"%M.I%R7U91Q/A/08L&I9Y97
MQB4Z)^(7MSS^?>U9S^\>%Z"VWH=KZ,EQUU3I1[5GWF3K!=N@EZA+]0#?O);7
M<=:I_2?DOI+WOWPOO3)+3T5Y.O+O:UZ8B]&9M^YH.D!%T23'TP$V[0!7+)T^
MI34Q$6&9JU<EI^OKVY 3DG"1A\Q".;\_BY$290KIL:O?J*^EE:-_6W_VYSN<
M/B;V\AR%Y:VTN0MSK%*\2-)$??C=E+(?$_%(\M4[+D7(,;CKC$8Z^O+?$W8T
MG@CFD2&8>'A+&K!)!X#P=6\@I$T^I0$G,3<%5JY"S-A=0_/R\3"1D=)SC[?C
MY'I@\,5DN3=1X[\%/K7O7CBTP^(L+J:]L;6VAO+@ZRR1Q(CRD>0R.JAG(]]B
M:7_(N096RM\9E+Z\N<;9J5@BEFDDC@4^40QNQ6,'W0@45(\R-8>F*4Q2F*4Q
M2F*4Q2F*4Q2HE?+ [5J=8IT9'JG 1C_RQGPTKUY8GRAQ ^]*UM.]/R9#2-^.
MMZ^MF)SV0?%X>XOHAK/'$=@]^1O-C'^ERH_TUL'%<3'G.16>+G.VUEG7J']S
M$OGRMX?N8U8_Z*YJ97&JE5X2O-+]54<"V@LG>]J6;)/;43*'N*WK6U.GR+SK
MRM^&OK+WG/#8Y,3BX,>IU,:#<?W3GQ=C]EG+,?LFJ7(\Q)G\Y<Y=QM6:4E%]
MQ(QYL48'N!(PJ#[ J3YDZPE4Y9@@ [A9Q0X0K7D]4DM]H8=OU%I;1ZCSRD-H
M\[B])UX[UXJWK7[=Y3EFB@C,L[*D0\I8@ :G0:D^'E\/V:K6]O<74HM[5'DG
M;7144LQT&IT !)T )/V!K6I71N[7_P#%T7E''M<6*6+SACH<Y9.EW2:CH]2)
M"SG5L&$AV*O%2FUF,[C''WUO.)UY'$:2GZ-[W$O(^=<@^ER\3X?]Y79<:+N6
M:\N)$31YFA6.,0(^K#868L1X%=!Y34_<.[6<3_)])SWN)])41\RV/@M\=9PR
M2:QVR7#S2M<RQ:(>HJ($4^<K$GR 2G@W=">@PEV9Z&_S^OVV@=(L?/9355M+
MA];F-PP4-)CS4*[.#QLF@0@>;2UM+B%>+K"U:5X*TE.5X'SF7D-E>IR%L?;Y
M?'Y*:T?H3EH9.FL;B2,RA'VD2A="#XJ2#H=!@^ZG:Z#B.3QDG$%RUWQ_+8:W
MR$7I5L$N(>L\T;0S"%I(RZM"6U4CS74$:C<VR>MZ5K2D[TI*M:VE6MZWK>MZ
M\=;UO7T;UO620""-1Y*A@@@Z'P(J"=0YQ5NO\\N/,;J B1J]W@#X"7'4E&W&
MV36MI9.#6M*OAY*+*2V2*\GZ[!+*'$[TI.MZP7*..8OE_'KSC.:C$F+OK=HI
M![H##P9?>=&T=&'BKJK#Q K:>#\RSO;WE^.YMQJ4PYS&7<<\3#70E#XHX'QH
MY5W1RH?!XW9&!#$5XGX:GR7'/<+<>&W=:4M/3]HXG;W/*IH9]H\YV$C9]A"M
MN:T,-,-!2HR][5KR-HWK?T^;/%2SP]SP[N%><'S9\PW$V-N#Y%(=C&DH\O@)
M!'.A\?  Z^[7Z6LCR&S[B]H\=W/XR"9%M+;,V@U!92B":2!CX><T)FM9!X>+
M,"/#2M?]_.:A8M^F\_%6&KS6_3?'7M!,=,PIWU'F'->&T/AFC>9*M?L4G6\C
M\^F8C(^:6BR%K/X$'0I)&WE!]PJRZ@^^*EH?>[D&'\]5GQ%];>*L-5DAF3Q#
M#W5=&T(]XU[S^+7]'5N/\NZ:A"&MW_G]0M[S#>O! I5@@09,P/2?%7EV&62M
MK>O'?AM'[=_MSWCX7GUY7Q#%\F4 >GX^WN"!^U:6)79?^JQ*_P"BORK]RN)M
MP/N'G.%,2PQ.6N[0,?*RP3O&C_\ 750WN>7R5DW-FK2:U<!N'>^@6KIR>=2?
M(8"F4>_$4&(5<J==;#/3),+6*N;8I1\N&OE:CF&&+5+' ,M(87OTPM+4OS+V
MA$709CGO(,KDQQV7$6^&L;\VL?I%O<S2R&.&!IG+1W4* ">26)5"GPC#%M6(
M6<KKCW:GB6"PAYA!R&[Y)D\2M]+Z'=V=O!"LUS<I;Q*DUC<R,S6L4$[L7'G3
M%0NU0S9Z@7K%$U5HKH<G7"IT 4\N>E*Q%2<+7M,,/E$-.A1DK,6&2'0-%I;2
M[YRGMN.H6M.D)4EM.^V#Y&TQ0EY#+;/?1J[2O#&\<6@+$%4>29P%30-K(VK
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MIHJ4?82PVK:%^5;FM^7?[,Q^6O)\?B[G(6T+W-S!;R2)"IT:5D0LL:G0Z,Y
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M*>WK7_+O/1+ZDG*),IV^R'&)VW28J_W(/W,-VI=5T_\ OT=PVONEC[U>/O\
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M-IU^&-.(\-:7(Q>YE[P^G_J)PLF8)WO?@G2E;(.5X[\->._I\-?LS6>'#_\
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M/&<MP>>WR"8RS>-6D9X4NH+F-.N5(25H)NO%'(L;H0FQ[9^GJ721.8\VDO\
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M XP["$M,L,,M)2VRRRVG24I3K24IUK6M>&;?'''#&L,*JD2* J@   #0  >
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MG51U>L1S6G;,)#FUP3XD:*<%2=/LSX>A&5.:<?<>\B=;6E:4\3RS!E6:.5Y
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MX^4BSVFG'FFI"*DA71B$H6M"7FE:2I6M:WM87L.1M%NX P5M05;0,C*Q1T8
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MUM7AX:VK6O\ CK..]-_3U'4(UTU\=!X$Z>]XCQ^S7/IR&,RA3T@0"VATU()
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M>TH;;;0G>U*WO6M:UX[SF[I&ADD(6-0223H !XDDGR >Z:IQQR32+%$I:5B
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M6B951RJN7)S$KSUN1#].-=CO@A'3=-[4R8WM]17ENKB#D!M<@T4]\F=]'O@
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MU0>/L;WZ/8Q5!!UN<A>S)X _M;F]D3R:DC30Z:G7:-,"6VI]]Z3(-VWN=PG
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M1O(P-;#?_7$^LSD8^E<<PR:KHP^2$$!T8:'SH88VU\/-.NJGQ4@DULE1>/\
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M*0I#S.G_ $7M>7SI5M*=Z4JBK]1H]/EFFH(02+FCJC#5YD94H6^<=5*%(RI
M&TB''$.EIB)2_D**.\BB'GY%'Q+KBE->"E?-EYQ5;7*#S<DU.A3(\>J)W+5:
MXW&CR1<7MYPAF.E#J7/0!,P$"2^ZZ(T6IY ;K[RV--J>=VM2L4V#@_*B+5&L
M%'KCQ;4+U@.3H1UNL[P=M'Z-'&KO2:K#EVQ U66ZY+D&GKA1&5K4_P"=6V]Z
M2O2E3RO\9HM>E&9YMB>E[$S8AK7]H+);;//R;L^'3YN@BFK5)2SXJ6F*C8C
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M#A%*>%)(0,EYF.VXV.I4]@ISNC$W6N>:DK%8?M>U ]%CNCSE5E*\Q!56CA:
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M&"?#>"(?1*-3<FTL(/8NWM%'MK%:\Q"%M:4K(T9*1LU'ART.>)*1<B.V6!(
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M@[U ],H$TI4VDN46)-P?N41(PKY/X[!=6&CI+9PK&HIWV\B<%D0'RAAS'-R
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M[(6,A2L7JX;=)D>@#6&:J@J>5B4&NUQ< +*H:L<15^J\<Z'-SLN 3Z;%<.E
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M#EA_A['RAB+/KCZHG3!/G<:(4 /O;.F2#-J"4JOL'?V#F:Y! Q5@B["3=H6
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M8I3%*8I3%*8I3%*U6]F/]12/[9?=!_J>[#D6=FOZ"_\ &<W_ "UD*G7ZQ_\
MBD?[.<:_NUB:SX[1:F]5K!2789E=7M7VQ^T$1M\O3,E]OY&8EKAZKVB-%-?.
MY&?,=7Z;B/3V_O3?DUI.M2G4%5#$\(YHH28#DHZQV5N;K\Y53'[IT/HMZD!J
M]9AFP['%0DI<;7.2=;&GQ6&T&?+GA5$I9;]3:O31Y5*R-(UZ&EI.OS)X*'Y2
MK&FGP1NG'V7P")&).A#M:4PZUHD4N.D'$K8>TXPIS3;OD]5EE:%*CA_,J3(P
M[,&[$OBA"V:=N<>1$34[!343:;-(S\I8)V$L<))Q]AA)"7(M4FV^L0IGU!#R
M!M_],ZMK:E8OE/;X*3<0K'%3[,8*P]3W7#78R9,Z4&'3"TE!UF"Z@Q;HZ2'I
MDNZ\<](@28<PLPN7D'E/:V^E+2E2F*X!RB&) +#KA[KD0U'#0C<I;KI."5^/
MA[76;M$0]<!FK#(!5Z!B;-38L@6/";8"'2$VRVTECQ;VI7ZWP+E3;DRY]GI!
M[YW$VJ!>:+M]U.%BH>Z34?8K%'5,,RQ/BT<8J<B!"F4PR /@G1&=C>CZ3?E4
MJ^E<GHA@1 ;\7(:<)G8^SKF1[/:@[4U9(RH1]!'GP[B)-L6P"9=I<:W&$$L&
MMO&!K?;?4YHDCU5*^V^4<\9B;!!M5@)N*M5/:H5B$0\<G4O56GK23N.->T5I
M]Q\@N[2SSY?GT82^<ZZZZMS>E:4KY"Y31A%6E3T;)3F[I#KKUDU;K1:[LDZO
MN[DMO0+*+A-SB(R$(^;D>J()I@=WSZ\Z-^1'E4JD@N-\^KTP'80XN6.L #\4
M0-/62X7.X3>GH2$N%<BEO2UML$W(%?!PU^F&4Z=<7K>CEJ5K:](4E2J([A/*
MY$Q\\BL+0^8^41*("L%GC0YQPFWV*_)38XZ.F18^R,Q]TMTG)@MGM$-QQ9SR
MQ4L[7O%*D]@YW4[-+BSLH%(-RPXK0#QD-8K)6ER\6.Z8\+#69NN2T4S;8(-Z
M1*6P#*)+$966^I#:=ON[6I7P%S:F1\FW+"13[90]MD;T$TN8G'XR,MDS$V&&
MFIF'A2))V'AGIH.V22S4",,LEEG/%/(62O;V*5:E\;YLL=QA%;2(I0D*$R;'
M2T[&2\>U79.TR\*[#3<=)BS$&> ==I;:2@WV"5-GNM*<VTKR:4JE'XCS<:>&
MLB(F8<E1IB+L:5%76\'1[]EAH=JO@6@^%-L9$+)VA,*PV,[)$CNG$-MIT\ZO
MRIWI2J>R\6JM@BN35X9R3KU=Y%.#RM?CZ_,V"$/0"#S6Y\TCHD.R0LU%V**0
M)%V_:]OM$J==0QMESS)=7O%*OB>3<[;KT[51ZP&# V.$CJ]*@1I$A&>>*B(_
M<9$M@DQY8QD.7%"[UL8H-Q@IAY*7D.)>2E>E*LS'"^:"M$:&BIU@\R3-ES+$
MU?+\BXF&R496H:3T7=TV?5O*"DHNFQ+!(KARA7T1P_J-J])'@I4B%YI2@IU=
MD&B'6Y15E1<&M?-YM<6#9M566I3TS%0+DDN!ARSJW.%,%[%&928M[;[^G'])
M=TI5D:XGS@>+'AA8F7#CX]Z,?@6P;G=@7ZAN'CY2(C&:&<)8F3J $)"39D>D
M>%< 8W'%.B;1L=:FMJ5\G<3Y_).-.',VXC8T;(1H*%]-Z;IF+U*UF3J$A*PP
MZ+>EB%M!-?FC&=S B69;3A3SVB=/N+=VI66,4IBE,4IBE,4IBE,4IBE,4IBE
M,4K5;AG]>OO6_MEYE_IAXAD6<&_IUS7_ 'S9?R+C*G7NA_A;VU_LYDO[RYJM
MJ<E.H*J)2%%J<I.ZLQ\,R3.Z^S'A(*>+2YK[&F6.0K/\VV0AC_V49;I%:/J?
M7V4K2_-I*-)4J+IXISEN.7%,1$J( AT%Z(9!N%T!53UQH9L:%KG9 =A8)YHT
MU%R1 FT5]<8A8;RV%:VRK:-J5=U<OHSD=8XLB$48);JBU1+/L^5FI R=JS+M
MI?3'24D;(OR)+KA%UE7'"E._%NN&+4MU2M)VE2J+7(:&J2+ES8^8FI$J1B91
M!-EN-SM"HPF$L\-<XYJO-V*P2C58C46>NQYC@<<D40AP%C3K2T,MI2I5BN7#
MJ?9*=!U.,CXJ(14H"&JU3W)1CMFAH^L0]DH=E559> .D1F[!6II[G$6*>RZ^
MV2\(TI#9#2U[<Q2D%Q>'9IA51M<B?.MF6ABW(<@I2W4X6M2H3L<['L\_<$M\
ME:Z3%#N1B75#CS+B7'RC->.AR5C:4J\1G&.:1$'9:X#64)B;E7Y"KVE@F5G)
M B=A)69NMADQ9&1D),J2?>/F^BS9+Q&WOB7'9!S:G-^"/(I54'R:@Q]D9M8<
M(^Q+BV"5M8+:9RP[A(RRSP$Y'6"<B:NN556(F3L+%E/7(.C!M+/)*<(?VX_O
MU,4JI&YE2!+0FX#PSB)EN0.F1F]RTTY @3TH$7'2EEC*FY(KJL5:I./D2F"9
M08)J0?9,)0X\I)#^G%*M@'&>;QU<=J8]>6Y /4D_FZP#YRQ2F]422]?1%6:,
MDY8LYB);:(4T.VAU/PC&DM,;;;0A"5*^Y/CW/9<BQ/'PQKK%L%FA;##M66TB
M5J3^T<.7 SQCM4$FF*TU+R\4<\T0<V(@QW;BE[=VYOS8I4EMM-KMXCAHNRAD
M%B RL?. J#E9>$-!EXIW;\;) RD&=&R898;V_,VMMY.]*^G%*Q],^WKDD_&I
MAY&MR'RQR%F:]+!1]QN\,Q;(>PG24K.!WU,-8P-]#^:2TW(&/.3NY%U9DD8_
MM7JF$K=4J_$\AH9T^[9I./F)B866*:.].7&YS@D4\';*W>6$5^*E[ ;$UL35
MJIT66H>/8&8<V RA:%-(TC%*KC>7T"3BF8.3JT9)0S$[<K)J*D$O'1[LQT$:
MX!W0@L,IUU@YFPB7^8;('>2X/M!RTI;3K2/*I5A.XA0)2(?@I3[<2<4:DUJ3
M%D>L]7.^=AR(S81<78'RKJZ3881T1&V] &K(#0AUW26M>L[YU*DT3SZLPUE.
MMXS<V783VI8?XZ=MMMLR(T.=D@Y:7CJZ!8YR5CJM%2!\:*MP2,9$&VD0='D\
MC#*4*5%A.#<I!;TR/5E;'8BBH.+%(GK,8'6H8F5KLXU%TT,R9?&I(,1-5&,+
MC&HA 2(@D%IP+0ZT:WBE79WDE +CJW%RD*18!ZE;HF^P#]IG[':Y4.XP32V(
M:PO3EDEY2:D9&,97Y6%$D/:;2E.M:UY$^"E<1O'N>R#EE^+AC7 K<%/@S\"F
MRVEFIE)M0\B+9C1Z<Q--U6+FK"W+EJ-D! V#BGBGG7'E.NK6I2J>8XW1I0B:
MDFHUT*7EA["IEW4G-$PD1.6:%DH&6MD53GI3[)Q]K.CI<MHB2'$9D"6BR6W'
M]I)?TM2N&H<3H-0BX8%B,(DSH=JHZ;FYB8GY>46[2!#!JTTP7,R\F6!"0SLH
M:\'%M.ZCA'3B%M,I6^ZI:E78KDW.SFTM%5@1U+:K@XPK9,@EX0F^72+Z+9Y
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3,4IBE,4IBE,4IBE,4IBE,4K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g63026g31z78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g31z78.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@'R P$1  (1 0,1 ?_$ ,T  0 " @,! 0$!
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M/8NP32(/Z0"@I*^1>4M*1\8'A,6K)3JBT[FTKBC@!-++,P$>,""'/;C &4<
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M)0ZSA#>&JB*:OR%*V/DP26742:4/+:A"2%"WNL@)>@.SBA1A3EX**..&67@
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M,8QG.>?N'B!<.-$;!@UND/BO<B-:DY+JJJJV(B(D2U55>A$3I53Q1\$L9Y6
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M/[N>2'9K34)*!,'8+60*=J7"<VL@-KU7@EM<A^:R)P0%8?\ N(UPLKCNTTO
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M\K]'*6[YL1*XX X X X X X X X X X X X X X X X X X X X X X X X
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MT]Z^X%<^"A&UGFQ$KFLRTOZEE:_I#E7^IX>8[._?O)=VHWRI"J*3_1G5^_\
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MZI!'Z!"O_(A5S'?Q ?P=]9%4?@C_ )J?4);_ )L1*XX X X X X X X X X
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M[JO+4 >#JW2JBW-88Z@7*@+=[^3U-%K2UL8;;N.UM?=3I!&K\=;-L^J9')(
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MWE,;E2GR:E%@SL"9D01X"!5:-]1K3>4Q"Q+ 0VVK:X16%<*KDD4KF586_7S
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M@%E5780S'RE*YL>0I+#KNVF*)SB(R)JD4P4IBTJUH;3?(ED&9*%@S!I@%UN
M. 4>WJ_A?7G]7E!?OQQYCN-'S11N\M/]^\JCU3OM/>ON!7/@H1M9YL1*YK,M
M+^I96OZ0Y5_J>'F.SOW[R7=J-\J0JBD_T9U?O_*_1REN^;$2N. . . . . :
MZ9OI+*W:E;W@<4L2.M\WL/<Z"[IP-\>XNO51IEF%57[2NPL(ADP;4+RG<WAA
M7R*E4C:Z*TAZ=1Y!88,@&#"P8R!A,*T,M9?/B[4NZVX"_2YYWRD>Y<L;*T@<
MDB4=)8'SIANW3J;:HCQS_-I,\>T8\E6IGLR0G&!PY>6'C#>B$?@! $<4WTRG
M.L:>653*HIK/<2F-:[#UKC$OL J^'@ZQX$J>JV4/:67QN06')VBG"96T5:U'
M.!45$M!B1(4#DE\N0W$MPP+-$:>39_T.?M1K#NAXD$T?&.;)&^U'4R2V ?$S
MW6Q7NP*P8#E<]DCA-K+C%/(5#3'2U+Z[">I&T,P35ZH*M4<:$",/@?NBS9I(
M;IORRZK#;<DLW1=X&V51"90BKYFJ[1NYIO=49C1 I;*'"0O$SG$LM63&J'4W
M)!#>G5(4H$Y_D!*50%Q[SI(^X9#KB]DOR9E+HC8%KNU4E4MHW#,C(;*NM:O0
ML*8P*M,%L4Y56.6L"I$$X(<(\@\/M'@8 *<-V@CE&MCK!MC".LK)A$SOY!LJ
MSI)JZ7 EF<!FC<SQ4T3$RQEOGF:@E"D$WBOM5E?EC>WG,658"C$C@)&6>:!K
M7U@TAV3E%<+J,EL(=8,LD^H3M"WBU+2@5AH3M8[=8+$J^RX?2T*#(-J+-@EQ
M5E+)Z0[+'\RNXY"8^:ECJ/RRI&G]C-2,#9,P:/WG)[)?+DNRVJL5322[':S7
MJ?'JPKZ5,\5CS)KU#9!$@P5$X2B;O;R_KW\3WE4)X-+0@"/O PA"' > 0>#I
M56S)VC8]OM#8E!*WR\=(MJ],CI\M26;*I<]J-BG9H7HKIE9<VLEXCT?5L:%N
M"DS$8XC;V=*!.#"53A.(E*B GVU-);CO11*+%G-F5M$[F?:KU3:FD,/B$F?*
MV8;=U"VUD&VE>2!6WOLD;)%(J]?I-EG;G=KRH1K#49*O!:H&3B_" [$6TCM1
M\LEFOJY;(KTZW%&U=>[ 2EIK6(R!OK]'#*LUQL"@8?6T=,D<A72%<\#/GRM\
M7ORW(<'F'92%HB222A\ Q"Q^GI8#]'VUGA$]@\=EQ&SNQ^P,?O8@BPXK<=("
MOJXR;&\"JW.%REN224@J-*5K/(8\_#S&I6+"(Q>0),E&B4 76B$>MJT:ZO.*
M[!(6F,(9]-+CA<$9HF),4_,E$+/-0B%KY"[(GZ3M2V:2AJ3*)!XJ<PH*1.ZI
MDIR8E4F/+P!KV<.F_>]GUR\06\+IJ-6IANDEA:,4>[UQ6$F92Q1"SW>FW.;6
MA:C<^S9U+621Z+U\BA29B:QDM[6(IP&!6H"N 4D W+\ < < < < HOO7MZV:
MN5OX+(<D76W-2%:*"LYG=."U$A#X*Z9NY&>T.&UF$9C"<L?_ /:LR$L.!%@4
M#*Q[&+$^7P[H.A**U]YIMKFR[%Z=!/8='>G_  ,M]RB_GOL:B*U'JVIO57]7
MB>QTOIZ6IMB0L/J8]CYZ,EJ>E5>EDG"=_P#)&L58CF_J8.D]51[H+7_*0[.K
MD^NCB]O*Y4Z.[NN5.;HY+CAJ5J]P7'C4K%BM0;D1ARA2H,$,8A9SD0LYSGG6
M[,S,Q.3$2;FWNB345ZO>]RVN<YRVN<JKTJJJJJJ_E.^^0D)*E2,&F4V%#@4^
M7A-APH;&HUD.&QJ-8QC4Z&M:U$1$3H1$//YX3W!P!P!P!P#>!TP=V/91[7K/
M:SP'#8K-\M44E<U'=]GK3AY%BOEZL[/=RB7&BSEG$,6,E'YRC#D03$I95=>K
MUBU\6?#N!>2+_P#7<MDE%>OYKE_[9SE_PN7]1;[#OT26HZ&UO5_Z\?JR_'X4
M?&RX4LOQZ&W2JTM";^L8U/\ KV,3ITV(EDVC45',1)E4:YD=\3??RSSJ>(_M
MB%&V55EEUR0X%M)T_K^90HEU-3B6%-ALJCCDQ%N!B0!R<:HM$-?@S)># 9'@
M/=P+';VX U4.W27"XR*QG4JYQ%1R:Z9O%)-M?FPY,9%V':64:^H-5Y/ML PM
MQ(<SWA90$8:8T2U>('):03@(2H8E8<$@2Q96A+W)VZZ0)CZPGQUJGZU'MK3/
M?YE0<V$.6OL!6Q5OFL*LFJ9.UV'!;$1R(:5V:7=G.2K$0"#4H32Q*/-$@9%2
M6K6T5"6.4\LU^5W:$9L>+:Z%;$2VUZ\DRFW)785(5;%ZCFLUB2N-3AJC"8RZ
MXY#T:HPI<487''<2E4 #F6H\L4!5YQZ6MTS/7X.KT]O&L,UA3FCVQVE.L+W%
MZWDR:<>S;NIY!1,5LF\#W2:*FMW=Z[K-J E5-K(!&0_N:D]Q&>D["$90%J-C
MM)YA;EG6S<D(LB.QF:2.)=/[%;MTFBSB]QMIGFAVS^P&R3>;-@-SXV+GF'6>
M*YB6-24CRE7-120U80::?DD!8$3I=&]GDKFZ74IN2D'C8XS?TC>)E2XK:;,=
M,)DBK0)LZ?BVH7)("=/4U6!9JX-7.2:0%*"1KG0E.88WIRC#2  =:KM%-JZ%
M6P^?UI>]#R"XU9>XK;;;U/*9G::NG7&U&XTVV\:I= 82P6YF1,*NN'Z=+VTY
MD6/ZHE\2FE=YR1C2@,- N31-*6/4-Q[3/SA(H2^51>UL([JBB-&V/J*PHW*E
M]7UA7$F8)"J/7*(VYQ\L5:!6(#TQ1"G.%V2C0?V.##0*K-^C>P7\A[!U4<;F
MJ--2Z%UD4MHB2H*PEJVT6N9$;$M.P]2'VKA78B2)2&-U\O;!,[VC0$)E,O3F
M!585,XPF$'@>Q'-(KAE-PL&Q]Y656@[;)ORG[,>&&JX=)6^ )*[I&DKVJV*0
M1I52F1KI"Y29QDE_/3XM>U02B_ $0WEH\!385&@>BATIM&"SRI;%KRPH"X/$
M'VRVPNJ1-DTC<A);5]9[:RJ1OLE8&50QO(U1,Z@Z)T3EH3SPY;UYH#,F@(#D
M., 9;$=)W&+P/6>&9GS<I'0&X-N;1K%Q4</3ER='9[WLV\ B*=-[6'EK6M>=
M@R@F+1B/ >)L,%X0?'QX8%98+TR[B55K *,NR]:VD-84QJQ?VN58O-;U3(XK
M/EZO8>#-=>.,OF8I%8TJ8L!K6'IUJ)(D1 P"0*5@%RC+?E.%(,#M.^@.T]BL
M]G/]IW70X[(>Z2U/JVMVV"5A/6F",KIJ1L [7\PO4V7OMA/4BD">RWY44E<
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MMYS'Z=BT*07C&U<^K[6_2:LXC*%]?+P1M;;6D6T#EM5#YG)(ZFE>%1D%FTS
MWM[DT$*L*26\"CN*3!# $(%TM5Z)N"K97LA9MXSVO9G.]C+)A]@JVRL(<_Q&
M(05%$J>K^J$,2;QR>4REZDPB$\&PH,=#Q(A+#3Q#PC2AR$@L"XO ' */;U?P
MOKS^KR@OWXX\QW&CYHHW>6G^_>51ZIWVGO7W KGP4(VL\V(E<UF6E_4LK7](
M<J_U/#S'9W[]Y+NU&^5(512?Z,ZOW_E?HY2W?-B)7' ' ' ' ' ' ' ' ' '
M ' ' ' ' ' ' ' ' ' ' ' ' ' ' (<OJ\(7KS64@LV;J>Q TE8);&DDTH#E
M)7Y2$>&N/- #.WQ%J\T&>\+LR$@@!AQG866/..*WSO?2;CW?CW@J[OT,)+&,
M14TXL1?S(3+?9<Y?;]AK4<]?<M531\*,+[RXOWWE+D789;-S#M*+%<BK#EH#
M53TLQ%5/89#1>A+45[U9#9:][47Y"KLN29WU9$BLV=+?,O+ZISY=&4(?L]B9
MR!#"UQ]H*'G.2&UK3B[@,9[1F"[QIF1&F#&+K$O;>JJWSKT>\%8?I349W0U/
MS8;$_,AL3VF,3H3VU6USE5RJJ_T.898<7;PHN7)W(NM#T*;*,]T];/21XSK/
M2S$54_.B17=*^TU-%C$:QC6I%'.-G/C)8?#)98,D:X=!HX\RV5/9AY31'H^W
MJ71W<3$R4]<I"D0I"S3SO+HDIIQF<8[ %%B%GL"'.>>]3:94*Q.PZ;2H,68J
M$551D.&U7/=8BN6QJ6JMC455_(B*J]"'QZ_>"AW6I$:OWDFY>1HDNB+%CQWM
MAPH:.<UC=)[E1J:3W-:VU>ESD:G2J(9-'J:MF6S9[K:,5Q-)!8,;$\ ?X6T1
MUS7R9G,CZO#>]EN#,F3F+TIC6O%@@X(@8$ X6 9QWLXQGW9.[-X:C5(M$D)*
M:C5B!I^D@LAN=%9Z-=%^DQ$TD5KO<NM3H7H]D^/5<0+CT.[LO>ZLU>GRMUIM
M(2P)N+'ALEXJ1VZ<%617.1CDB,M>Q46Q6HKO815/):JWL!\;AN[/"Y,YMA<M
M:(&-<B95ZA,":OV%&66*C-+($$+\Y^5,P2ES_:CR'LP'MSC&?7EZ)6)J#\8E
MI6/$@),,@:36.5/3Q+="%:B?K'6+HM]E;/8/>G;VW7ILVDC/U"3@SBR,6=1C
MXK&N64@Z/I9E$5?U,/2;IQ/S41;56RTS.P=<K]JAI"_6335EPAA&<4F]NR2&
MOK8R!5'BR A*:[J$06XE4H%C/AE#,"8/L_9QGGTZQ<N]UWY?XW6Z9/2LHJHG
MI(D&(UEJ^PBO5NBBK[2*MJ^T<?NMBSAA?>>6F71O!1ZC4T:KO0R\W!B1M%O2
MYR0FO6(K6_XG(U6I[:H0OSC)H1^RS#"C &E#&6:6,)A9A8L@,+,!G @# ,.<
M" , L=N,X^W&>?ZURM5'-54<BVHJ>T?E[&1&+#B(CF.145%2U%1?914]M%]M
M#Z<>G1NF"_HB"K[#<B_YPPEL!W5JDP 3)_&$F"R"GTKO9P(U_; Y 6Y QVY-
M[0J@YS@PT!/8+@5BPE]*8EWJY$3_ /4RD/\ .5>F9A)T)$3\L1G0D5/;Z(B?
MG.1O2#ZX_JTNPEO"M^;GP5RZJ<=;6-1520F7VN6 OY($3I=+.Z$;[J OYD-T
M39WR@R'AP"#]G++?:6ULV$N*+)&A?)JFHZV++CB%_(6*F):^P2!/\I:$CTE;
ME[4X*6A2X-18%)9"I,<,D0L -+%G \ :XYMLYNU#UNL]-A'!9I=MUTA;^Q4O
ME=6Z\NLEB$>00=QI%E8ZRB$ EFS4&>'5C;9!<8,/4C4OPEPV]*F+*;4I[GA2
MW =*4[YW]'[#US;7"/-#*Z2"<::59M%18ZF=7$BB+%VH9XWE\A+OLJ7;P(L]
MSR&KY>E<4")@CCPE]F)O#7'!]IHUJ4#B6;P[,0]AO*%V*"O85LXBO+7FK*]K
M^8TY,6FL*ZA>SNU+QKY55Z&V6VVXXMNQU9/L>$D5D)&PZ)O@90WGMCF6SB=D
MA#8!QCVMW15VHS:G,,UUR5V<EV]DNN4JV*64Y.ET.6PU%H^AV]*>&2GFR[D6
M&&W(VN>B6%:WJ90X-@R $.0@$^<]GIP(LN3J97Q M/\ %SLKA!7>\*IIC:JV
M[1K*-4+,I1&)RWZDVC,ZL?IDX35==,;:J$JZ?/$!/*)1G#E,E+4NI8T.%Q+.
MO+6 =\5OW]1NS749LJ"3"F%53-74UT9KV;TV_P (D;K;<Z/V*U4Z9%$.2^-3
MM!8S0U1%2U(I@B5QA$*-NHGUY;UB$\XDLTLU.!AL(W9FNFU32@2N+1F2PVU]
MB^LXQT,D\@_AD\MW>CG5%V?/I^@UK@F=?9BI!?;0_J0-!*=(2M3*(XO&8>,L
MXL) %Q=[P7+^(>E,C8)K4\/NQ9O&<T+IM(XE(7ZK6^2NG3?WX:Y@M9H3B<1J
M0N05I:I:7'6Y0^EC&X&HRU)QH?$P8!!"/?7;.4G533<3CL9>;?6+]]V^<67
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M9&;V@X!9W6W7/%.69NFF3P&)1"E[CMJ RZNX?'$<?1Q!<TD:U4[6L[5"A3.
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MUK8]7D5+SJA[=HJ80B*B7($"5PV9LJPIP\K6T$]32HQ)'!+B2_)MZQ.F)<
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MQ<28_P#!2T31J<Q#=T3$9B_]&QR?\F ]+8ZI;Z2,U(?0R$[TNZ/E7G6H. .
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MAAQJON9$8+(A9SD#R@Z(U "Y06V&2VP%G+M@R_@48&<Y!1'\^3D"I$?;ID-
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MDN[4;Y4A5%)_HSJ_?^5^CE+;FFE$%&'GF%DDDEC-..-&$LHHHL.1F&&&#S@
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MWG0P,NQ2[R*2V>GM9H-LN7**\>2'^VYS["@2DEH/0Q$5IW<G(L*V2V1],<?
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M ' ' ' ' ' ' ' ' */;U?POKS^KR@OWXX\QW&CYHHW>6G^_>51ZIWVGO7W
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MG *K0S%OD5@2*8W*HALJLZR&EJM2US)JE*D!S&6U$.!C,6K797JS\&)@+M\
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M1C(BHY5<J6)9I)_[6K[1LF#>"-Y<)8UY[S7MJ-WOV=%N95Y5B0*G+1XCHT:
MU8;4AM=I+I:#DZ/;L2SI-[W*=.O,< < < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
<< < < < < < < < < < < < < < < < < __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g63026g41k86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g41k86.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!2 P$1  (1 0,1 ?_$ +8   ,! 0$! 0
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M4G8,,U!S8:C=$*ZZ6BGLBJV9R!F\9+-)9BL4YD 1:ND%$5$T4# HF"E=$_\
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M1A#^(XW$^@I6/=/5GBE.XRGF;%>$8)I9<LWRN4*$?R!(I@^L+XC0K^1425<
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/P7%*O^XI1Q2CBE'%*__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g63026g48v36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g48v36.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!- P$1  (1 0,1 ?_$ )$   (" P$!
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MK\8<Z;=,4VJ9B$.L"1%%_C*)OT*4I=)9WDN7Y!^/!?W$\F.L8NS:122&06\
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M(3-\$BJ2C[O6I]P!Y:*2_P 8+9G"A=A[HQ;2B5KH)IN$ANU6\*;>Z85%L?N
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M(-%51U^NI9B269V)=V)9F+$DQSY5ROD7..0W?*^67DU_R&^E,DT\I!9V/3X
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?<4HXI6H7_P#\79O^H=_\.*5M_%*.*4<4HXI1Q2O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g63026g54b79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g54b79.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!M0,T P$1  (1 0,1 ?_$ .0  0 " @,! 0$
M       '" 4& P0) @H! 0$  @(" P$              0@'"0(&! 4* Q
M 00" @ % 00( @0)"P('!@,$!0<! @ ($1(3% D5(187&"(C5-25U5:6,1E!
M)-98,K,T);4F=G<X47-TM#;&-Z?G:(A),R=#87%"@PH1 0 ! @,#! P%#@D+
M @<    ! @,1! 82!0<AI @8,1/35)34595F9PD905$B%+1A<3)SD[/$%76E
M5G8W.(%",W3DY18V%Y&Q(U,D1&2&ATA)4D-B@K)C-"4U_]H # ,!  (1 Q$
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M\XVNESZ'\Y-OV>7K&YD?GO\ D8_9.MO\!*OYYQM=+GT/YR;?L\O6-S(_/?\
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M_GG&UTN?0_G)M^SR]8W,C\]_R,?LG6W^ E7\\XVNESZ'\Y-OV>7K&YD?GO\
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M_B3A8_M#_9_Y[AL3VGMW:>V8;&UM;&U_%V\</XS!/^$FE>M?_@MM9O\ L?\
MVM_%NUVRGYQ\W^<=JQ[9VO9[9L_QNUX8\NS\#S@^2O\ \=- ?]QLY_TX;\Z+
MJW]ZS2_ZOYK\+9.T)^X+KK];MW_Y]WH<Y9Y1(X#@. X#@. X#@. X#@. X#@
M. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X&ECO_C)Z:_\
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MO=\*/4D44WJN-<:85>II::.U<:8QC&F%7&NVV,>&/#&?#G!^3ZX#@. X#@.
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M%T.!7[K/%W[5NGZ;EGZD^644V. X#@. X#@. X#@>=GRI_\ @GM;_P W&_\
M'[\P+TG/V(;\^UV/I-E;+H.?O2:3_G=[Z+?>3(S_ .RXM_V7'/\ H5CS*^E?
M[I[I_)63^C6E<=>_W_U!^7]Y?3K[-<]\ZH<!P' <!P' <!P' <!P' <!P' <
M!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' C6Y/_A38/_9.9_\
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MV:M^^\=;/AQWCJ#P*GNQ[OGC1Y4TAYRJ\6/S&"W]'V=_9JW[[QUL^''>.H/
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MGJFNINH@@HF%CACM;=]PE5<5M0DAUL,YQ[13Z]3BTW+BP'-5D#':PY"NQ@0
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M\]ZAZ"?GK^J3_(6_^ZS_ .1G_P!8>.HMZ4_FW^GGO4/03\]?U2?Y"W_W6?\
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M.-^Z\YZ*&N[7>?B]E-LM-]]=M]<^/AC./'' USJ(XLP1[+UB(2EEW,="5M]
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MOUR)G-RP!W!K.QV+#_I]\R"QQH5ZOG;<K9LD&,UMETJN[V0T5W#9K;Z%W9,
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M\_D5LKO'<J:V:3%YE,+*J9^S+I^MY-?#77PUQC' D#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M_4#32KY$Z=&"HRA4 6YRD2K0RIX-LVWQ84''E6@:E\C5;%%93\C*R)G%$A%
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M/'8RPA)9-DOLS?NMM,^(=SL1WVE86N;_ !(9 ;:H.\PNF9:UZ]?V5&4Q.M"
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M?B FQ""JM9IP>#$/F.,9DNBY:&CAQ^[25EHF.CY%LT5V9.7.R>VN D2R.U,
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MV=Z.&SC"C>OY@Z+W^1>23::M)*)7(%]G\<LNWRZT];SZA3T>^,? NUGR,;M
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M,Y=5X*6%6DW"BU/N(X1>)I,9>>CIM-[*J;:*,FS9'+A4-O,OD;,J_L%C6)*
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M5:-@L"<P[ZKIH J9O<\ $V"32M@$S.U826%U]F;N<C(X4]&23TU2:;IN--M
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M*@61^1&(=SO5;K2773/D%>*BM_\ 5X@MTB&#:= 84);R!/#QQ>1D!'"2C%M
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M' <!P' <!P' <!P' <!P*.=]ZE/+6K6K%*\ -+0F:P['TO<$F!I2@E#RI,+
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MG[>!GT446R*3=NDD@@@GHDB@BGJDBBDGKC5--)/3&NB:>FN,8QC&,8QC@<G
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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MVZ><YUVVQD,AP' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M%H8XK\G@C,.(FF'\$3C4FTF(.79[;[)X<Q\DQ56:ND?/IG7S:;9QXXSC_''
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M4I]75CM(%Q[J08*I^@DZW<Z>3S;IZZYUSD)!X$?FUI E=2@#"F,[]'D[/+T
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M#N,1<L)31!9?13*J@>EW9OK5/R_404I.E!Z'E_PNGJ,FX^L73UG 0%C#%0G
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MW),A,22)$Q[,;,(5T!&+3T\OE8)[]22<Q[?.S-SC&NR01P>]!['D ;O2-#0
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MYJXW1S(S;]",BFF-6R*ZN5'K]SHEK^CX>;;[<XQ]O R<21CT^M+-X*>A9IQ
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M,8]'.V^NN-M<9UVQG(33C.-L8VUSC.NV,9QG&?'&<9QXXSC/^G&<<#^\!P'
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M/^/M,G%1Z<V/648X[(6"C?[L?VB8MY*('T#4DK(O5=V.GU6-VV]VCY'*:6W
MW;0DG!E2^K8ZI6K<Y'U5Z\;T!=[20G+(M<U'2"<',E3#M*$14U8,S-3)R$I4
MA-I3[N+PJZ8(&L?KC7"+I)35,-#L$WO0H&^MUAVG8!$$4?V8VOBYIAW8=D=A
M*Y$ZZFC&6@9*C*K)C6DYV&GZ]W#:Q5WTAV*KII"OICWBRF';Q)OLF'3N26OW
M1.D0RUNSC>/$7'309>5[V"FI?L[4 F5]A5B(Q93A>Q5K' X_)[2C(!L//60^
M5IKZ.TM\>U8;[NGNNX6>$"J7%>[=5Q1/8Q5V*+SN.%Q^8C!4[OL"EZ!=CM2L
MD"$J)J-V50J4JHVP9N,WD-Y:1:QKYG,R;=/361VSLND':[S8[3L[LG:8H@NM
MJ&V[@@0LC7)O#D).H/T59U.?>,@*Y=DNW=H1@*+ED9 BL=(-4UF^LLK,O=LZ
M*9W743")G5KW19%,-KZL*=OZO:4M7MD U];L''OK%'9ZL^N-:UV1!!231ZXV
MB@4  A9UQCC"7E9N-Q'/,Q\EE)9?5JJKG 8T99'YZ6UX !%C=B7_ $_*.Z93
M UY.Q]F6\RFBVD4:91?%$ ^L9Q-ZV#*5&A:VKM* ?JR&-5F*6F&;O9#;.=PV
MZJF-H@G>BS]B%6QX'K),]H=HQ@[$'Y4PDY.Y]*XAFH&I<LWXKS972$O"(KMV
MFV'6(Q0C3WQ.Y7]2*QP(GI>!O2[0J@X"WK#[4)L_\O\ L$Q(=6-L7.$2DE<C
M"R#Y$8(BB:@YZ(GI0V@V#9MLT1>.=\*IZH^NBOHDAA,(K/+;M(Y4K2%M:S+E
M!-AOKQUYD3>WVIGW9!5:=4E9EB1GIK/MNJ]<DH"^=G PAM%2#RQ)X(7895V=
M(KK-=$5-@];.\90\@Z[ZZ*-B8YC.N,W;84POVP0 E.FT^TJ)R-RJD.^G+ #9
M/0\@@2<GL,?K4ZW>I+^GE/#AUJW<./4"B@,PL6QSJF*_ACWL<ZZF$_:#L5'!
M$DRLZZX*6,Z.C0\75AXR>L3!"UL&8K5(TW>Y&Y!S):KN6&OE0=;M=]M=PN3T
MM?\ :?%-BL2E+0Q$/!-J6>&D4E?3RQ9:UWH$,'#UD-X@YQ))PY(7NHSIKHB]
ME?<K.-\:YVV4Q_B'GTK85@C0+V2$:NL:V+F/H*3Z^S+GM$ 6IV!DT9Y.7[/#
MT5.5^:564/E!&G;<BQO#C679"N^[1V-[:8<-V353VW YY!B74^,_)VUI:5MA
MG=NG8-L03L \L&_BF=CNOA,90CN8L82#\E$NZTWD(/=UIDC@F6\WK':N,-W&
MNS?3*(>B7QU_4\0=R.HZ[!RX:W=%L \K^%$R>Y;"B:]]048Y(H&.LN\W\H4$
MFDS-:[OMVN9%VE#N%MVOBCY?2U#R'>D%EW3,&\2$QUNP I;G5KO#!V;4#&[N
MW5H&L+8@<*:RM;"EKS-A2+<:%[(=S>OZJ('<-'#Z,=>Q7P\BE_(J'N9\>V]?
MYZA4JE71(1$T6S#8./G'!0<GY[*Q)G'0\<Q+!S>1LB<GI^%1@9ANHWUB4U$6
M4=Y,I-T$M,>7@72X#@. X#@. X#@.!U'_P#R%[_Z(X_XG?G&O[&?K.=O[.GZ
M\/PCXM6QZ<NTT,ZN,Y\')FAF5I:2H^_59J+MMYY[LHR?H8SLTDXY;;7&5&SE
M-5!3PQYM,^&.:,[&J=1:.UCF=]Z8SE_);SMYN[A7;JPQCMLSLUTSC3<HG#Y5
MNY3515')53,/J3O:#T=Q'X:9#3&N=W97>>X[V[<MC:O48[,]HIB*[=<87+-V
MF)G9NVJJ+E'9IKB7N[U/^9X6(M(P,[316@C/;[HLT+2&F:JPE(;J*:I:*DX^
MCA60&E<8VQE1RT]TTVSG.VR3737[;S\*^F-NO>,6MS<4+49/.\E,9ZS35-BN
M<.2;]FG:KM53/9KMQ7;QG&:+-$8M6O'KV<>_=RS?U)P,OU;RW9$S5.[,Q733
MF[<8XS&6S%6Q;S%-,?8V[O:[T4TQ$5YBY5A/N</D,"60L:1B\U%D0_,-4WT3
M-PC]K*14DS6QXIN6+]DJLU<H;_Z-M-LXY=S(9_([TR=O>&[+UK,9"[3M47+5
M=-RW73/PTUTS--4?5B9AK#WKNG>FXMXWMT;[RU_)[UR]<T7;-^W7:NVZX[--
M=NN*:Z*H^*J(EF.>6]><!P/.GY*7J<-6W7LG>H2&\&']SNMI23/(Z*E)G:''
M8@L=*2DR[9P[-\^PPCT]\;*J:I;8TUSXY\,<"C'9\AL\[+NSG:3JK%G\."Z4
M)65-E%@,PVT@Z6/'6MKQ!$5&@$T9PT*?$2-:5LW?Q_UB):N/1Q);^R44SJKL
MD -F;=K.I2OL'6U^/+MJZD;K [%0K.I#*_K%B=JG?P<C"74!(D-IO)TBMF0E
M$5V;^'C%74DB/2:"FZ>J*JV_F#:&+WL5%O@%S9%U6\ M;1ZS=D[=.C+60L$D
M&JSE38HCG-=9U%$]\Z1+D& LL$$HYLDW<QKG=ZLURW5WW4U"")&TCM_35-0$
M2\D V@XKL58H9>-Q/;[[;&E*V5]/K1N^K\^B;Y3FD;S%*F*#K"*3EMK)Z#R$
MOE5NN\=H[*JY#/S:Y.SC:9%.Q?8"TC:E9#K#V%?5(=U,2=D!5E8U[/#C+2N0
MQT1CZD>?V01P=:/'J$ UEEG&9I)HFYT2>*_K% L60?BR"_"U$H@J]DA]L0=&
MC+*.5%LD W9D/*_>-DU>>UQ!:,)^*G-6RBGJX1U2WTSG;]'&/LX$?7DTORDV
M?R% E%3UV.Q2$'^JQ6/O)\QN*RIZ CC14T0OZ=KLB>RQ(>(2:L7'-G+AK!*[
M[,=\>=JW1^S& U,9+[<I^LYGL'6EWS-\UA5MZ5Y-L*OILFOZTQV,K\T&)\(M
M>(E9ZUWTX2V@V9JR<;.,HS9X^3'9-DHMIJW77VVR$T=+WG;1_>8325ZD]N+Z
MT!"'5U&1C*2,]D?LG\=Q\:5 JL)I9P]RV+$ZS(2XJPR0VW<I1Z ZPQY4\^GJ
MF&-[G_FO8WL=TA3)]<H^V[$#H5;5='D++$[X?J16@M9B8MX(8OFV72(OFX(G
M=D@U98W0;.%T=L:I*;*;^(1D3W,=V!383;-K0EEC<3VTOF:7"6I]<W8JG@7K
MD'B-5K1T(,G4+2+Z,*'4J5V#'3+2,C5?8MY267CE-]\JI-ME BRMK4[>#-,=
M?162.;FW-^[ H5];QJ9,).R74K4ENUSV..HD?/\ 1J5;)&8>P1ZZ*/W$J[<Z
M)34@K"QZSS*KK"BFH7AZ[%#*"[S'($S+3N^MB! QD$K ;VI>K]>D849CH*%8
MU7>-/E[I:JXE-=U&[JP)&Q]K)2[MSLILQVRLXD%@B7M\92.EV]IH6S#>]PHZ
MA*KJ][T,@ZQ*KA&XTJ+'^Y7H4R 2.U[)M16U+$2+4(E&58S+:3WCXS*>,()L
MG+O*@3ITFJ&<@^V7;JPSU"PV1])#O6U0@PYLJU7]>2!K-UI+.++TAQ62,'U?
M3#&(+$U4H[;1HOI#H;>DQV;I*[:[A5VU[&[:U?<=@"<'+7I-!?4FUYKM]-2.
MSXPGDKEZZF"P7$I==TY#;WBI=+-'$R8R$6PUU>)1R,4R3PDEE)NFL&7F):?C
M=.L3?N?9]XC5(V71]W7/-3;$ZN,$RW[#GA] EM5U*8$P%*Q\VPWKZGR9['00
M\X?(1SB5A]=]&RSW5/S!G^LT%?5FV-2S?L&47\NR%NG1@>-8)^:60'14V5QO
M8678TN3V3$P\E"ZSUEK4<I#K2;.5]159VLOL^;;KZ[8T"J]6R78P Z>]@XF=
MEKK#S5#JY=DWU$95Q(G L*I1+:T35T>9>1$+AC(Y[+11&JV=H.'BBRF1I=%6
M!T2U3F=M@L'>,5=2[KNA;L6<=C4C>F;7Z]N:$CH6Q;4:!\0Q=B0(Y-6D57,=
M+)A9C#$CE1=*51?Q\BCC7=?73".RSC*@8P&/ES7O8YE+!LVSJ]&HCM^;C$+.
M+6CWD'P^T58*-4#JPZZ[04(%0/25-DB:HMY9%LU-Y=Y/^.6CZ(]P[>)9"7OE
M .YE,LAZZ'(PW'R_:D;%.@"PF=O]F0B-D3.%EAUG& U85YU]D6;:QKE5][E^
M@I)^=9C'MEM$D5D'#GR!6^S\]A2BH.VEU.3KLHE:U0=:NFMF4DU@#RT("!CK
M5E*AV);$>1];CDE'A94\("5IJE,Q[J.>MLZJ*H>BGA937</KM?HZ,3WL[!6"
M1WF]OF([<=?<T76$!,7'D&<=6(C-.3NI4A7</YZNFQ!8NW*MIR=?M5]FTHP;
M)Y<MUT6&N0]$^^<]]),^K3*R"DU".K,S8Q@UODF"B4["$TG2%9E;RL(PZ.*W
MDX@I%0.0.F[7"RV'31FY?ZM&SI7*"VZ2@49NPU']B2Z8DDM'M%"LHCK=6,E\
M=BD&:]CX>>/R5\O8R<]-P2+)\RE+IMU$F;#[=5 L1EW^(/9HOA/=G(/7#D/Z
MN+VP\MEY)'@M*8-7???XXB Y6BH=VI"_>",I(83L:2BW#-%9BH.Q!7ATELX1
M4W:HXQC&=\8\.!I0%9%@G79)M*!;"PQ47.(CNJ&6]6,I:G9FWIR)D!,;/_N&
ME<;*SW+^J:_)YN4'4),<BX-%LY9Q;G1FR5<1VNV=@UWK<0V4'U'5<)U"G+P)
M;8$/B\*L7Z"&CVVIX?!NP0G6-8QU&C;<)L_7,$"G38I1D&<)%0C1HG(#>BKG
M=%RW]JZR'9L0T(&=27;+=(K=[,E\ R^/BRY>X)Z9L&]"PG&^SB<]6.:N<PTH
M:2CZ?";^?1ZQ?F;B8?=ILV;MM-7#5#9)CKP)=^01%:J]<4C6>;F8F<;0I[:%
M<VB2=CNX"T^7V8G,))Y@*J$:L(%F%@7+I*9TF'/U'/M(IIOKHW8^Q<O/2"OM
MT"K^.7^0PW8'/902[-S'4GKM=53) U_=F067*2M*J3!<TG(8+!["A!8PCAPL
M1U1S%J,'<9"K+Y;H-F^KG*:H6D[,PMONI_Y ;4A3?L2T*Z//.N\IURC!FQK2
MC R#V6$ .0,TX&NX:7;A9E&$KG*S:6;/V$DV]+=QKIHANX=;+!J@X?/#7O>^
M>V!9-GUZ+CW<^?$XDI_$OO0."%B?=N$4"ZTZS[P(N%0O2/2+D+$]G,IHX-W\
ME.[>+&1ALNGKY'8+4=H!0*9_(WTFL(SG+"'6[^I;["!J2B;2N /#9"UTC_KW
M.5<#/HD/+8@.>+FN<3&7L0^;[,BQM')HRB+]"-9IM@K9U1+R@BL;IR\@CZ\I
MOM)+%=G+?(D!FA5;DD'A\!^'%E+3#4HKXI?*@-:MAVZ$AE@!:P[*.]S&*XRV
MPNR5=J9#WIX#@. X#@. X#@. X$.VKV&HBC%H!O<MQ5K5K@IW=:CS<\,X 77
METF&[9.2>LT9=\U44BXK=ZAAV[\,-6F5T\+*:>IIY@V*2MFJX9L9/9BS*^BF
M==0$>5V"[DC,<8M@06EF3N3BB0R7=2220Q 2<;'KN&[Q[E!NL@@HIIOG73;.
M QNMX4UO8VE0)6K7KBU=E7"&U<-B^!=&[==J.Q1>L@]&6[Y688+X$YUE)ZZ+
MHI[;Q[I)QKC*2FN^0AV_^W8=U]LRCZVGQHCGU;@G4XZ7(8/+',-5<))%H76H
MP5'.[E9-1O&%MJ61!P+#1/\ 6KKNEU=,;)LW&= _JG; .'+=[& ]G2 E6H)0
M0[2DVXL@J*V<1&2CFX4"3#6-=XE$V3)@[1D81%HR3T<+K/W#K5-/3U,Z:;!O
M"/:CK.N!1%HIW_3OX=S\I*04&9*6,)HP$P00;:0>30W&2"TJFB^)8AM$NMW,
M<EG9ZAALKYTM?3V\ Y0[M!UPL(E&PT$O:IC L,!C4T%1L;/1J8FB$5V:M'V)
MR(CF$BNZ?,<,'Z"^VR>NV=4%M%,XQIMC;(90.["T181>5@ +<-:EYL#:O=R\
M6'#*!EYP>3C'ZD5*JR<>R?+.&Z41+([M'FV<>5H[URBKG17&=>!7: []T49W
MNI6H-950E];PM&&UQG-N0=H#;^!!LA99!0#N.)%VSA6'AXK>+F,R&7[IX@E[
M?3537&R.^%.!96J;TIJ\XZ6EJ<M &LQA R.(F>6"R6+G]H.4W;I/$H^:08.5
MG$4[79+IKIIN-$]E4%-5-,9TVUVR%?\ KAW>J:\GCX+F#*MPZYD[.OH&C*@P
M?1#XUE8>E[8-:\2(6\"YV83.ZLW#BFDJHWU;[9;H+YVQE1'7"NP3A =BZ#*3
MDLK(;N6LYRP01K)/3$.C#2 >$ XTA5DFTZYE8Y%]LX;(C[M?1&1VSCP8+;ZI
MN/3WVQKD,,%=K>LMC1QS+@=_T\6Q591>)ZPI."L,6D& 8/;-WCI(E(WB$GLW
MBAEPWCG&Z4DKMJQ5U;JYT5V]/?RA"]<]]*4L0_OYI'']6;TM1@/61B^N]C8T
M&]$EL'>I#K),)M_KNG$#ZP^[A-$-M%76R^ZRV--D]-_#78)AUN[K9= '*L(*
M]ZQ(10Y5S5JDL'6L-I.]R$X'WN[$5BIB(F]7T6<R4'NJY8M4MDY+&J>5DM/T
M/-@.HG:_5OKC6S ?5M*J*ZKNK7L74#9D\-Q]NV&9^)A4W4?7ZR.\BH[3*6P^
MCAUF.VUR^PTUV7V3]/&V^ S[[LYURC8())WM[U$A 66S3D:YE<V&*J-#Z.4?
MQL7F0#-TI3?)0P1D)AJDLLRPNDALXT]3;7&V.!%E3]^^I-RBELFPC>%<ZC-)
MEI$*V'*21T$:-X1&"*I$0C2Y52.))+1,(.Y.,WW&Y%7*6DT@HGLWUVVWQIP)
M*6[4=:6U?PUJNK]J!I7!'O)HCYF[L(6:P,X[A5-T9F-B'R\FGI)2\2X2V2<L
MT?.Z06URGNGKOCR\#,C/86B30^?56(W#6Q-9,;%JS3\%@S*!E"II%M\,,NWB
M\(S?*O\ 1)CB5:9<?H>9OATCE3&GJI^8*Y#MY]-C#N9:<4QL 61[*T?6C<'+
MDY _'FB&@"ANX/9[2-@=2A3=UH$/I93$Z[58H[Q:WBBOOKC7' LA5/8&C;TT
MFE*9MVNK2U'%FZ$]]PR^#)]HC=ZGE9CM()Q+UTHU0D$-<J-U=L83<)_I)[;:
M_;P-&M.P^L%FQ]B]=CZWZZ55E@\J:V8#M+,AH@AC@B.9Z??=(ITCYA"3'(7$
M.XV2DO=9;Z[,E5==_P!7G?P#L!_9[JHZKA$M$[\I?-9#4@T \$FMCBC4<B)A
MC#Y>L1=S)O95!NUE\P#/+I%LIMJLJST]?379+]/@=H8[;=7327 Q\1["TV23
MUHZ2F]=0L-8@M(2QI]$4?I2R8['MY/=W).(]6*=ZJI)Z94URT7QY?U*GE#+N
M>S'7=E93BFWEXU2UM9HFXW=UZX/!I$M:9:1>TZZ;NH521U>MGK:"TR^40WUU
M7T98ROG3"7Z? B^IN^75&Y*S,[<%[IK]D#UY/R Z<2<\:AC/(J\:S*L''N)W
M#(BDD8MD4/$]<Q&RV^F\DFJGE'7;.^->!.L%<U1DU<[6_ 6<!2M5)Q[R5<6.
MT+(/<):1T=MOI(O'Q-E[K$,&\=NGMJXV65T]#;7.%/+G&<<#MN;7JUDK.H/+
M* &BXN'-K$)D7)B.H*CM?O$WBK0ZG4U9'3>(#G24>XV3DW&$V6^J"F=5<XTV
M\ TR0[.=<XH_@ZJDKTJ9C9!*WB74 $N3X82))=$@9YDA_P!A%[26'+A0@CM<
MN&">,>H];XRHCC?3&=N!"?8[O)4U. -A3 &85K:UE5U.A,1/U=#6%#*SL7K/
MW6$4T3;3B$-M-2$*]#Y0PS[INNWU53=(ZH*X3SOYL!PE?53J9V)/[0*',I,3
M)1-+#HAV&$*VOVPAT>*7PS#LV\&*W:  !U&0CZ08P.B#?=M)-$G#J.UT0<85
M;?J\A=B.CF,1'L(F+:(,(V+9M8Z.8M4]46S)BR0T;-&C=+3&-4D&[=+7337'
MV:ZXQC@=S@. X#@. X#@. X#@>.GRY=C[LZ\CE./::/9 &=$<V2MIM5A'PC_
M "_09,&*K5-36:BY+33"*BNV<>3&N<^/V^/*A=++B)K3A_N_<M[1V?N9&[F;
MV8INS31;JVXHIMS3$]LHKPPFJ>QAV>5L.]G_ ,'>&O%S?6I,KQ&W59WI8R65
MRE5B*[EZCM=5RY>BN8[3<MS.U%-,?*Q[')@\/O\ ,R[S_P"\&1?VZ"?[*\I5
MUDN-WE_,?<<MW!LVZEO1@_1+)^$9WQH_S,N\_P#O!D7]N@G^RO'62XW>7\Q]
MQRW<#J6]&#]$LGX1G?&C_,R[S_[P9%_;H)_LKQUDN-WE_,?<<MW ZEO1@_1+
M)^$9WQH_S,N\_P#O!D7]N@G^RO'62XW>7\Q]QRW<#J6]&#]$LGX1G?&C_,R[
MS_[P9%_;H)_LKQUDN-WE_,?<<MW ZEO1@_1+)^$9WQI_-ODP[R[Z[:;]@2';
M3?7;3?7(X"9QMKMC.NV,_P#57_3C/(GI)<;IC"=_YC#[5ENX$="[HPQ.,:2R
M>,?\1G?&E('[YW*/WLF_7V<OI%VY?/7.^-<;N';M;=PY7VQIKKIC9593;;.,
M8QCQS]F.84OWKN9O5YB].U>N5355/QU53C,\G)RS/P+-97*V,EE;>2RM,496
MS;IHHIC'Y--$133'+C/)$1'+,RZ?/R>0M#UP[B7UU9F=7U6F3I& 6=8=3 %-
M[+2H/.;9QY%=GD&HMIHS>JIXQCW;/=L[QC7&/5\N/+S)W#GB]KKA?G>WZ8S=
M49"JK&YE;N-S+7>6,=JW,QLU3AAVRU-%W#DBO#&)P=QDZ._"OCINWYKKC=],
M[VHHFFSGK&%K.V.2<-F]$3VRB)F9BS?INV<?E=KVL)C]=74#L@0]G*L8V 14
MZ:5*Z6U0UTT(TT]A\E353\VLR%/U\LY:4A%LZY\%5F2.F,Y\NBBV/T\[8^$?
M$3>'$O2U&H-X;HSFZ;DS$1%W#M5[DQ[9EZIV;E=J?_57;IIQY*:KF%4Q\_\
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M?L)A=64B%(]TELX149+:*:[X]1/9/ 2?+WD%"AJ>C)V0 P+"@@G712]*B>S
M2+QE&Q2$K&(Q.7''DTWGQ1@K,C>C5@_D4D6<R\<;MV>ZJS5?34(6//D,Z<
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M3Q<S .DL(([[XV]/"B:F==M<\#5$^I'8FM+-;7,)@(^=8$_D$NSL#&US$F<
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M[OB[9LS ;:,*K[*D-)'^T2$=BPT"'*WE <,"1Z3$+0'I)F]EY-,5(A#$Q&R
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MFWAX>;/B'8X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M"UI#4B,.(&RCUO)OI*U!H-1E-WL''+-HY%K*(MWBV7"R.-LAU7OQXAKT"["
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M+00K2 J 4D\"*TNLU,2@8'I.90*K3E]9?*3^=561UW;HIHMVK9+&=,A<?@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MTU")0EEQ)G)8E\H?3-G"DY!N4LML*^OKKIC?.N-=L9R$F\!P' <!P' <!P'
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MO>M6AO76C9RWK*.DD*@G*1EJB4G'Q40.V2FR,A[S"SU-ZT9)I!L"=G# POW
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M-3V,\O*+L2$D!!=.PE; ^LLYN2UWTA!Y(6;!J*N^ZKS.^VCW&=]$\8TSN%@
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MGY&T09BEMHAKII#_ '*73]5;7&$VJN/1\/LX$ZQ?5Z\8*S(/7[LH.A<U^/\
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M40,7==1K0A>S#F BDY?19=@^6B,9>8#TRZ]W[$]@!PNE&P<7UX2UW89/55A
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MQ\,Q?)YU:J>DX4VV1U6#2;Z[R/)FO>V,'1@9:<?,4/7CZ1E[S=1P+' 0T03
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M'CF ;TX64235V0Z-45WH:6@9>8FSS=W'K;[8:RC1XI'2K7&J[;=1//J9"WG
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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0 X#@. X#@. X#@. X'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g63026g55e90.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g55e90.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 5 )0 P$1  (1 0,1 ?_$ +@  0 " @,! 0$
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MD*V0$WF)80Y1T255Q[=%["7/S!EQ5K;S.=K30E</L3B-F8E_*^\QC&6U!)0
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MPI&Y48IHN<%#=3D4A3;[<(%5CXU7TS5R!7S"' @ZYE(.R6"M3)QQ\W.(%:V
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4WAON]_N_F[O>_P!>S\>S@U1?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g63026g59s99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g59s99.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X<9F:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C8M8S$T." W.2XQ
M-C0P-3 L(#(P,3DO,3 O,#$M,3@Z,#,Z,38@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX
M;7!'26UG/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(@H@
M(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B"B @(" @
M(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.FEL
M;'5S=')A=&]R/2)H='1P.B\O;G,N861O8F4N8V]M+VEL;'5S=')A=&]R+S$N
M,"\B"B @(" @(" @(" @('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I;3TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO;G,C
M(@H@(" @(" @(" @("!X;6QN<SIX;7!'/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O9R\B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P
M;&EC871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z
M=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \
M<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/F<X-W(P.#PO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @
M(" @(" @(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&
M:6QE($YA;64Z(" @(" @(" @(" @(" @9S4Y<SDY+F%I)B-X03M5<V5R;F%M
M93H@(" @(" @(" @(" @($AO=V52,$--)B-X03M,;V-A;"!4:6UE.B @(" @
M(" @(" @(" P,2U!<'(M,C R," Q-#HU-3HU,28C>$$[15-4(%1I;64Z(" @
M(" @(" @(" @(" P,2U!<'(M,C R," Q-#HU-3HU,28C>$$[4V-R:7!T(%9E
M<G-I;VXZ(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @
M(" R-"XP+C(F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @07)T=V]R:R8C
M>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L971E+B!0
M;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L971E9"!P97(@
M<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@87)E
M('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($)L86-K
M)B-X03LF(WA!.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+28C>$$[/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.D%L=#X*(" @(" @(" @/"]D8SID97-C<FEP=&EO;CX*(" @(" @(" @/'AM
M<#I-971A9&%T841A=&4^,C R,"TP-"TP,50Q-#HU-3HU."TP-#HP,#PO>&UP
M.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C M
M,#0M,#%4,30Z-34Z-3@M,#0Z,# \+WAM<#I-;V1I9GE$871E/@H@(" @(" @
M(" \>&UP.D-R96%T941A=&4^,C R,"TP-"TP,50Q-#HU-3HU."TP-#HP,#PO
M>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O
M8F4@26QL=7-T<F%T;W(@,C0N," H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O
M;#X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F
M.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U
M-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z
M:&5I9VAT/C(R-#PO>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @(" @(" @
M(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*(" @(" @
M(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*4F=!0D%G
M14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!04%!
M04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K1FMB,DIL04=4
M04%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G1T)G9TQ$06]+
M0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X=V)'>'-C
M2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X9B8C>$$[
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF+SA!04519T$T045!07=%4B8C>$$[04%)4D%135)!
M9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!44%(0T%K2T-W
M14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"9V-)0U%O3$5!
M04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%614=%,D5I8UE%
M54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY63-0
M0TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+0G)Y
M-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V63-2,61N
M9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C>$$[
M<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%514)1645#
M04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(=T9-2%(T
M4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G2D-H
M9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2;&19
M5U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S3T5H
M66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A86YQ
M2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$%M4#5Q9FUR<D5U<C-/:6%*
M8TY:,B8C>$$[3FTU:'5,:44X6EI:1C)E:FID5E4W8F1C2TAL:S X,#AH:VUK
M85=1.5AC;&EF<$]+<DU69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5B8C>$$[
M9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<2M'
M96%#45-1>4Y&24]J;U-P2#!J1EAQ;C56+VUR<D57<R8C>$$[5S)I835C=&57
M5C1W:'0W:5DX<%EP5S)11GIU>7-D=FDV67$X<6UL96%6-5I$5C5'3$]F17-A
M;D984E)3>7EP1D5J4U-Y349J:E5&;28C>$$[6FU.04%"=5-4:7%99C19.'DO
M.$%6<'9F*VME6"]M;D989C19.'DO.5=M.2\V4C5F*V%C5F0O:&IZ3"\Q86(S
M+T%+4C5F*V%C5F0O:"8C>$$[:GI,+T%.5VTY+S92-68X06UN1EAF-%DX>2\X
M059P=F8K:V58+VUN1EAF-%DX>2\Y5VTY+S92-68K86-69"]H:GI,+S%A8C,O
M04M2-28C>$$[9BMA8U9D+VAJ>DPO04Y7;3DO-E(U9CA!;6Y&6&8T63AY+SA!
M5G!V9BMK95@O;6Y&6&8T63AY+SE7;3DO-E(U9BMA8U9D+VAJ>DPO,28C>$$[
M86(S+T%+4C5F*V%C5F0O:&IZ3"]!3E=M.2\V4C5F.$%M;D989C19.'DO.$%6
M<'9F*VME6"]M;D989C19.'DO.5=M.2\V4C5F*V%C5B8C>$$[9"]H:GI,+S%A
M8C,O04M2-68K86-69"]H:GI,+T%.5VTY+S92-68X06UN1EAF-%DX>2\X059P
M=F8K:V58+VUN1EAF-%DX>2\Y5VTY+R8C>$$[-E(U9BMA8U9D+VAJ>DPO,6%B
M,R]!2U(U9BMA8U9D+VAJ>DPO04Y7;3DO-E(U9CA!;6Y&6&8T63AY+SA!5G!V
M9BMK95@O;6Y&6&8T628C>$$[.'DO.5=M.2\V4C5F*V%C5F0O:&IZ3"\Q86(S
M+T%+4C5F*V%C5F0O:&IZ3"]!3E=M.2\V4C5F.$%M;D989C19.'DO.$%6<'9F
M*VME6"8C>$$[+VUN1EAF-%DX>2\Y5VTY+S92-68K86-69"]H:GI,+S%A8C,O
M04M2-68K86-69"]H:GI,+T%.5VTY+S92-68X06UN1E5V;&EL:6QE2R8C>$$[
M5D=J;&I9<DI'=TMS<DMA145(8T5(1E<T2G!)2F\U;WI34TIG-DAW2VUO>%9:
M:7%C*U-F*U5Z,$@O=&\R;B]*.4U69E=U0DQS5F1I<B8C>$$[<U9D:7)S5F1I
M<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I
M<G-69&ER<U9F2EAN8B]!2E106'8X028C>$$[=&\S9B]*.3A+16UX5C)+<'HU
M2B\U5%!19BLR:F%F.$%*.4U69E=U0DQS5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<U91;7%A=G!E;"8C>$$[5W)897!8561P8G(Q:VQ92T-F058V;C)'2W-!
M,5 X*R]*.71),&1N1&18-4(R:U)&:FI0>4UH1"]!4$,T8591<V8K8V=F2SAS
M9U,W<R8C>$$[8G4R56XK.%5*2V\Y>E)L8C=G8V%6;G5G*UHY0C$V,SEF4V(R
M3S919F)65%(P<B]/:E5:9G!'0E4P>%8R2W5X5C)+=7A6,DMU>%8R2R8C>$$[
M=7A6,DMU>%8R2W9K<GIT+WEM979F.71'-R\U4'9H46LR2W5X5D]F2E O2UHV
M1"\R,&)4+T%*4'!I<C8Q=TID:7)S5F1I<G-69&ER<R8C>$$[5F1I<G-69&ER
M<U99<BM92&XO5'9+5VTX,W!0<6,T4#%+>G(Y;SE/8C V25!X-D0R5F9.,VU(
M>DQR6&U#+V$Y,5<U8655,31*,&IJ528C>$$[;C=-861&1T9#5UEQ-T955'!M
M<6%J<&0W2&4V9F-083-54G%K<UIO9FMF14AU1'-C5F922#5:9FUD8BMA6419
M,W=71%<T1G%Y1%I*,28C>$$[2%8T>#))+V%8-E)T,%5S.7=+-T9867$W1EA9
M<3=&6%EQ-T9867$W1EA9<2M3=D\S+TM:-CDO,C!B=CA!-5!V:%%K,DMU>%9/
M9DI0+R8C>$$[04-M96<O.$%B4G10*U0V67$K=&-#6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867%H3E@Q4S P<E1,<E5R>'5&=&%2=$Q+4C%O;S9$,U!1928C>$$[
M*TMV;$1Z3C5I=CA!>D1R5GIQ=#8Q6DHR*T-0.6U/3699:E@R568Q=V]3=D98
M67$W1EA9<6ED3C%'.# R+V=V-TM1=S-6<S1K:6M(628C>$$[:CE94%%J1E@Q
M6C50.'DR,VU4>3EA871"4E=M6&I015 Y,7I,<S9F465N=%1!;$]C5F1I<G-6
M9&ER<U9D:7)S5F1I<G-69&ER-4LX-R8C>$$[9CAP;G(S+V)2=2\K5#<T54I.
M:7)S5E1N>50O>6UE9R\Y=$<P+W=#5#99<2MT8T-867$W1EA9<7<W>CDK6FUK
M955O,6A:9G)M<7ER>28C>$$[:7-K8FIX6',X:F(X4C1B5E T-'$X978O04TW
M9GI!=5HR:V=V27)+36XT65E926U51#5Y<DDS-#152F@U9B]0:GI4851Q3EE3
M3%5R528C>$$[;CDT46EW>D%E2VQ!<6915BMK67$Y>#!$6#E,,3=3-'14,'E8
M,6)A5V\S1D=6:#EP2%AS=W=*5$A&6%EQ.',O-7E!,71R8GDO6F%41R8C>$$[
M,4<Q1UEY4V=D-#=E:&]F;3=Q9F]W:%AG;4M(67$W1EA9<3=&6%EQ.6<O-7@W
M,7@P=F13,$XR<DA,1TQY0E0P1&]1:VQ0.5E-=C-9;"8C>$$[3#(W07)S5E$K
M;S9J6F%B67I8,3E-='9A5S8X-7!N-DM".'1Z-T%D8U9E265A9GHV,6EE-65(
M>3=%;&YA2V%*8WI)2DIN.2M*<6EJ,B8C>$$[;V-.25-#,B]/;CAX25I1.&UO
M2F-+3W-5='9!1E!Z.4Y),B](1EAQ,S5E+VTU<#-M859D3W9O:%DV=U%3:4$Q
M:6UO2VXP>61W,RM39B8C>$$[=D]+6&]'0EA9<3=&6%EQ*U-V3S,O2UHV.2\R
M,&)V.$$U4'9H46LR2W5X5D]F2E O04-M96<O.$%B4G10*U0V67$K=&-#6%EQ
M-T95<"8C>$$[.#$V+T0U9CAV6#)R>6=..59J<DA'9&<P:D5,1W8P=5%-5F9+
M1W!A:F5A;&9Z,SDW25IR<35C>5-Y2'54*V]$;T)H46AS5F1I<C!F."8C>$$[
M:B].16UM*V%"<$UR+W=#:&%Q0VY%.49N445X="]S<49F<$AH:7(V2'=*9&ER
M=V8O04IY1FQC*UED3&E**T),47-O.3)L64@O04EI328C>$$[25$X<'A6,DMU
M>%8R2W5X5C)+<S$O2G4U34@U:6%92S!7651X3C$W=T]13G8X;T1&6#!Z9U,W
M1EAG9C4V96-*<C-74C5D=&Y)<W10-"8C>$$[=&-G2%HW:&A89C)25%0U,7=O
M95<T<3=&5CEV8U17.#AD>$$U:FUH65!&27!O>7-P<4-$-&<T<2MS=DIU=G(U
M9SAS-F9Q,G=K=4EH-B8C>$$[-FIO2E5*4U%$,C5Q85E%<'II<G-69&ER-4LX
M-V8X<&YR,R]B4G4O*U0W-%5*3FER<U94;GE4+WEM96<O.71',"]W0U0V67$K
M=&-#6"8C>$$[67$W1EAM,S4K>G9(-4IG4F5K,2]%:B])4GEV*W1":$-V;G)&
M1'-69&EQ3C!/-V5Z,7)4-W5-:U!B,TU5<6ME2T]'+VAI<C="=TID:28C>$$[
M<G=N+T%*>4=T,UA89$MU5#EI4S%E3F9N2$E39BM49W=H1'EF1EA9<3=&6%EQ
M-T9867%Z8CAM8E5Z+VU(<')5-4Q!<SAR*W=%3'%$+R8C>$$[04U%=WA6.4U9
M175X5CAH*UIR<#=R>DAQ='I)4UAM=34S3F8X<5)J5$-H3&-69&ER<U9F45 O
M3U Y,#AV;$,W9V)C5SDV-%$K0W9':B8C>$$[52\T2W!X2UAP=4)867$W1EAY
M5C4R+S544%AV*S)J9"\X;C-W;U-B1EA9<6Y0:VXO04I44%%F.$%T;S)N+THY
M359F5W5"3'-69&ER028C>$$[9GIV,#$W>GE(4$MG-4=X;FEU4T\Y2VU);C9"
M3%A#1F9.*TM(67$W1E4X.&MA3RMS96)D2W-&6&MS;'=J5$0O:7%-.#5$+W=#
M;D98,28C>$$[;&=3-T98;5 U*S9-,3,U5W1T5%)36# R9CDT9D-+8T)'4#A!
M=UE40T9F4"M+2%EQ-T9867$W1EA9<3EJ+W=#8V5T1%DS1W V-4EV=R8C>$$[
M27$R8T15-G-X16MV,T%*.2M*4SER=TLW1EAY9#4X,'@Y33@U87A:<W9%3&13
M4$=+52]D>6XQ22\K16-954I&:7)S5F1I<C9.+TDS4R8C>$$[6'-F23981&EJ
M-FA02F-#=EAG2U),+WEB<CE/2E,Y0G=+-T9867$K4W9/,R]!0VUE=F8X06)2
M=2\K5#<T54I.:7)S5E1N>50O04UP;B8C>$$[;U X03(P8E0O:RMM2W9R6$%L
M,DMU>%9$-FA9,C)O5T9X63-+.#=E-FIE1UIF1EA5<68Q-'$K5%!-=6=8;6=A
M,V0V5&1J.35B3U96-B8C>$$[541O9#!C97I,=FA1;&U+=7A6-U8K44AL8W)&
M965:2C$S:W)A5U92*WE#1$LT*UIO;RM2>$M8<VU"6%EQ9SE:,'4R,6)3<G94
M8F]69R8C>$$[=31M:69X2$E5-40S53=J1EAY4G)';%AM:S9P8S9B94QW=6)3
M47AY1'159$-066IC655)5$9867$W1EA9<7%7,7109%A%5G1B;UI:-28C>$$[
M;E=/2TY25FUD:E)14&UC5F972&MZ>3-$-6,X=#)7:W!1>5%P>75*0BLS32]X
M4TXX=5(R.7-#539X5C)+=D<O>C8X;GE33$(U;G1)*R8C>$$[46I55RMO:%(P
M5W8W<54O9G=0.$%S8TE6-')I:#)+<&@U9C!A-3%V5W)04W)B*SEU-59J1&9Y
M<C%::C=+;TIX5CEB,D9J8C)&:F(R3B8C>$$[<W9',W19,&AH6'=21D-J.$)G
M4W(T<3=&6%EQ*U-V3S,O2UHV.2\R,&)V.$$U4'9H46LR2W5X5D]F2E O04-M
M96<O.$%B4G10*U0V628C>$$[<2MT8T-867$W1EA9<3AX+U!(>3EO3C5O<39P
M8UA53FYQ.6]P1G0V:$%A-&HV;45+4&E99VUQ*T@P-%%R-2]X47(R1F\Q-697
M.6]R<B8C>$$[1S%X2VM1:VM)5D9,<T9Q>$Y!04LW-'$K=71&,&TP,&938E14
M3%%5=#=33EEK.%14<7@Y,D\U=TI2=4MU>%8R2W9*4'IY.&I.9#)W."8C>$$[
M>C)%9&)I,55*<4M+3C)H2#):9FUN42\U4'EW:%AH;4M(67$W1EA9<3EI+TDS
M>4DW>F8T<#%#2VM59%4P=$=(,FTV4$Y1.6PK>79V6"8C>$$[=WA3.7-W2S=&
M6%EQ<%A6<F(S9'1,83--87DR.'EM3U=*:%975FA19S1Q*U5F3W5J-EAO+VU7
M.7-.3'9&=F)/2B]W0C-)<')W<C%J6B8C>$$[=6I-;E%K9C)954I*:7(R4"]N
M2#-Y+V)V3&8V.4MY3DY&+V]T<DA51FQQ03!J;&5O<4M+1#@X4VPW6&=6,DMU
M>%8R2W9K<GIT+W=!<"8C>$$[;G(S+T%',&)V+VLK*T9#5%EQ-T95-3AK+W=$
M2UHV1"]!3G1',"\U4'!I<C8Q=TI5-VDU=#=A1G W:59)655&6&QK64EQ:GA,
M1V='2R8C>$$[<TPQ;C@U=DEU;6QK:G4R,4-:9CDQ,FE&>%@O:DDS0TTO47AX
M<%AN=FU,."]D9'4Q84A28E-05&]Z54,T:TEM;7 T9T5"1BLU<TY)928C>$$[
M6C,K;S,K;S-4,V0O8U-85GI*.75A5FDW2#94,GA61#1Q-T978BM6+WIF.$%.
M*V=W>#)P;%153$M/9U-#-D):;%5D:VM"1&HR<E5$=R8C>$$[>%8V0G!8+T]1
M96A48U8Q4%1B:3!9.5AH6EHP0CA46#!M<#AG8V%3>C-14$]N;&98.71+,4=+
M-&QP57=%;$I10C%0<'5&96<X855W2R8C>$$[;E=+=$]I3VI)-FAK64975FA5
M14A99V<T<2M5+WI",$LR,$QZ:G%7;5=P2#%A2U%00V].94M3;W-G5"]9.#99
M54UE>%8R2W-Y+TLO>28C>$$[2U!.971L8FQW;6U76$=3.$%A:G5#9FAJ561F
M:7!U97<Y-EEQ*VU924EB94-/0T)"2$1%;U-/3E)25E9244%$=T%W2E@T<6Q'
M=F5B=B8C>$$[3&5G2GDQ82]I=&U)<7-*4$M6:#1R1W9*>5!E;4MV4#E8+S5Y
M1#!+0W$V5G P.31W,D5K>DQ!;&9%53E2:CEW=S!R>C-Z4#A!;3<U=R8C>$$[
M,39.-V-Z<EE75&=Q,79A07!Y53EN:TI,;79C5D%0:&EH:%=+=7A66'-R*RMS
M3&AB;7EU2DQA-%0W33!,1D=(,'%18U9E:2M8+W=!*R8C>$$[9DY&:7%X87!$
M1G%S4S=E;V8S33%0.61!5E P<%@S>%8V0F]V-30K4W112W@S8E1A6DTR>#ED
M3U5D9EHT*U<S=7='3DI:,5DV:%E8.28C>$$[=71Z63--5C%B=#EM5T8Q:U4O
M4W!)=TMI359F2EAN8B]!2E106'8X071O,V8O2CDX2T5M>%8R2W!Z-4HO-510
M468K,FIA9CA!2CE-5B8C>$$[9E(O;G)Z-7!8;$Q44E!C+W9R,F%O=$Q*5%)N
M239K.65+1'5C0UAZ;#5O.#5A+S5L=D=U3E1U5V1+,6ET54I71TUE0TI7;C!N
M9D-H2B8C>$$[359D:7)S5F1I<G-65&)1+TM8;5A85T$P<E1P<G!A,$UQ<GAI
M0CDU1S1O4'!/2W91=$4O-7@Y,6UF:DIR1V]1,F%(8W=W07I353A#5"8C>$$[
M=U%(-6-S8E8V0F](-5!E4W1';&IU1G0U3'DW:4E:2C=M46YI=S-Q151G;C-J
M0F%5>3%Z.'AV2FUI:&AE86Y%,'DQ+S!E02MT2E5D:28C>$$[<V9,:B]S<5EQ
M.#(X>2\X04]13GA+:G=E6')(,$LQ079,<6I/4&19;'%O4'I9+TQ$4W9)-W4W
M=6)Y-6QU<G%6<')I6FDX<W)M<DUZ1R8C>$$[<$I/2T9,1EA9<7$R;#5D,F1W
M;'IA5%!B,T5:<DA.17A2,5!S>3!/2W964$MF-3EA:F%+;'0U:71Z9E%Q04)E
M44%,3T(O;$MA22\X028C>$$[=W8P-'$Y83!$>G(U6#$Y1D]L-FA&3DME='5X
M-%1$-7AV4G9P07!G4VQV;68X<F9+2&U'5U,U=7):<F4K;#-E.'1M.4YY9D9G
M95-.."8C>$$[>71C5F5:83<K44=V,C-+5%(W>4LO:DA32U@Y>$PX:%5S:"ML
M:&AT1$%T63AO96%.1W%D4S!Y-'1K6')-54Q29CAJ1G%N-#1Q;$=+=28C>$$[
M>%8R2W5X5C)+;S=2.60Q:E)R<UAE;#-C;'!/3W)2=%%-4$)L*WEW.6E-5F4Y
M9FQP*V).=C5J6DY+,595='1:02]D<W4P9'A15E!%2"8C>$$[-TPP,TLO9#1"
M4SA1.#=F.'!N<C,O8E)U+W=$:RLK2T5M>%8R2V]V4CE29E1.6'-D4U)"23EL
M8U)82WAK,$1'2G<T56XS-#1Q<6$W<B8C>$$[=7 V-7%C,G!A;$U:<FU9-VYO
M<7%/:4E/>6IS35911TMU>%8R2W5X5FQ8;%0X=%!.6&U5<$IA5S,Q97AB<F98
M1E5I<"]K8F-N+W=":28C>$$[359E>656=GE6.'%A4'=M=FQ/<EAQ,$IE-$%%
M24DO;&A&4B]W6F)','!Z<FXU:&53=DQI96AC,S!1;&E(1F)+,4%K9&%F<SA5
M,E0O6B8C>$$[57=+.#,Q-R]!2GE$=EI#,&5H86-K0U8R=4QS.#-).6\P2594
M+W-M=S!R>GI7+T\O;7I7*U$Q3%4U-6]M-G=+,W!X9CAI,#1P*T=+128C>$$[
M:GA6,DMU>%8R2W5X5C)+=7A6=TI"0D)O4G5#359:3F\S-6QE9#E)-')A-G)-
M.%,W0T<T26Y3;F="2GDT+W=#>'!I<D]D2"\U>49V,"8C>$$[-'!R1VQX>D1O
M6G)6:D<S>C10>D)0*WE'3DI:+V](-7-E4TYA2WAP9D-Z=4@R*W(S9SE%,5!B
M:U-9>CE$64923W4O;'8U3#%X5V4V,"8C>$$[,DI*;D929%<S-VU3<"]A<6Q!
M,RMY0GA6-4PU>2])+U=D2FIK=DY&:T]P,E-F13!&2UA+3"]Q:F%3;BM442\U
M3T9$>DEG9VM%54DR228C>$$[3TMU>%8R2W5X5F9B,T4Q=E!(8U%/635O5T1X
M4TMA37)+86=G*TE/2W%U<%@X*V]A:F18.7A4,3=Y85-E6&E+1&Y+>&1Q1'=Q
M8U91*R8C>$$[2W5X5D=A3G!Z86YR1FIP<75);79B:4LR16A&47!L8TIY<'17
M;DQ&6'%N+U%U=#DO,64T=BM21&8X,30R;#,O475T.2\Q931V*U)$9B8C>$$[
M.#$T,G)V.$%O6%<K+W=#<C-&+WE)8B]M=D<Q5EEV.$%N2%-19T=86'=P<G5&
M=&%I;GI-=R]6:F%S>#AR+VLO-5(P2FQN:VE/<%AQ-R8C>$$[:6$V05I64&EK
M44A%9E15*RM#,51N>F0U,3!,>7!9979Q16Q:;49,87IJ;UI:0U U4C)8>%DW
M67$X13@S9FUZ-7$X=W4X4U1(5'1/628C>$$[+T1A5S=%17(O=T%74T-J4"M!
M.7-+1T8T<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&5U8K5"]Z
M3#AZ95=*16IG;4XQ<"8C>$$[=U!X,D4U3$I4+TE05TTO3&)X0GA6.4-E5'9/
M,FDK83E0*W1A935784]G=7)2+S=Y2FHT*TMN<W<V+U!B06QJ;FYF.$%*=E(O
M36PO*R8C>$$[:V)7-2]29#0O=T1V4WE20U-/52]Z1D]59$<X5%AF1&%S5FLO
M-7@P=6<S-W9855IF1G)9<69U16I9,G$S+V]85RLO-G9C6"]):'8X028C>$$[
M;79',60O,$QR9F8Y6'5,+T%*14XO=T$Q-#)R=BMH9&(W+W$Y>&8X04EH=BMA
M.&)6-5AR3VY.<&US6#)M<S1L87EU2F)9>4%51$=*>28C>$$[;DMM.4LX8U5)
M4$9867%N4&MN+VQ-.4(O-V%.<"]W06XP>%8Y831%=7A6,DMU>%9*=DXO;65Y
M.',V1&-A<F1F1C99-%<X3F%'4UIV<R8C>$$[25!N,5!G2VY&6'EZ<G5U-FYR
M;7!Z86QQ57AM=5IJ=68R5E5D15%D;%AS34M%0FER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69"8C>$$[:7)S5F1I<G-65$QY-S5H,5!Y+W%S3W V9$M9
M-31J.%,O<WE)9G1)-#=Q,RME*TMV<6IY>C5H<V9-3VE7,G)76G!&8TPX55I.
M5VIC8B8C>$$[3VIE-FXK=4)+85EQ-T9867$W1EAY5C4R+W=#57HQ-R]!3&%.
M,R]Y9F9#:$IS5F1I<6,K4V8K57HP2"]T;S)N+T%#9E1&6#%R9U,W1B8C>$$[
M6%EQ-T989U@U*V596DQR>D9";W-B9C90<#!995901V%98W0O;$AX<#AZ:%$X
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=28C>$$[>%8R2W5X5C)+
M=7A6,DMV5R]W1&Y(-WI#.$]P,W5G>78K-75K*W,R-FYO2EDV0G=0.5I$6"]9
M-&Q,,U!!<G-69&ER<U9F2EAN8B]L328C>$$[.64O-V%.,R]!36XS=V]38D98
M67%N4&MN+VQ-.4(O-V%.<"]Y9E1&6#%R9U,W1EA9<3=&6'EJ*UE6,#%Z-30Q
M>5)Q:W)E>E)B*T541R8C>$$[369G=49$2#A69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<DM0>7AU,W1F4'5I>4M30SEW2514
M=VU5>"8C>$$[;B]I5TMV<6)!;#)+=7A6,DMV:W)Z="]Y;65V9CET1S<O=T-4
M-S152DYI<G-65&YY5"]Y;65G+SET1S O-5!P:7(V,7=*9&ER<U9D:28C>$$[
M<6DQ;%IS>%IO27EX3E-3:6MK;C9-5F$K;U=0+T%#>GAF.$%V.4U69#E1<V8K
M5V5,+V=&+W!I<G9Q1FHO04US.%@O04PO5$989E5,2"8C>$$[+VQN:2]W0T%8
M*VU+=2MO5U O3%!&+W=#+W="359D.5%S9CA!;&YI+S1"9C99<3<V:%DO.',X
M6"]!04,O,'A6,S%#>"\U6C1V*T%8*R8C>$$[;4MU*V]74"]!0WIX9CA!=CE-
M5F0Y47-F*U=E3"]G1B]P:7)V<49J+T%-<SA8+T%,+U1&6&953$@O;&YI+W=#
M05@K;4MU*V]74"],4"8C>$$[1B]W0R]W0DU69#E1<V8X06QN:2\T0F8V67$W
M-FA9+SAS.%@O04%#+S!X5C,Q0W@O-5HT=BM!6"MM2W4K;U=0+T%#>GAF.$%V
M.4U69"8C>$$[.5%S9BM794PO9T8O<&ER83)D;7)";&=J5FAU0T5514@W<U96
M<U9D:7)S5F1I<C5+.#=F.'!N<C,O8E)U+W=$:RLK1D-467$W1E52<"8C>$$[
M,3EC869Q1G1F,GA!=4Q35DHT4W=Q3V-B0C%Q3RLT>%9N2"]+.'90,RLO<F8O
M:U%U2W4O-5AL-2LO=T(O5R\X07E)6$989CA!2SAV4"8C>$$[,RLO<F8O:U%U
M2W4O-5AL-2LO,SEB+SA!26AC5F0O>79,>CDO=C8S+T%/4D,T<3<O04I8;#4K
M+S,Y8B\X:49X5C,O2SAV4#,K+W)F+R8C>$$[04I%3&ER=BM6-65F=CDO5R]W
M1'E)6$989CAR>3@O9C<K="\K4D,T<3<O;&58;C<O04@Y8B]W1$EH8U9D+W=!
M<GDX+V8W*W0O*U)#-"8C>$$[<3<O;&58;C<O9C%V+W=!:49X5C,O2SAV4#,K
M+W)F.$$U14QI<G8X06QE6&XW+V8Q=B]Y25A&6&8X<GDX+V8W*W0O.$%K475+
M=2\U6"8C>$$[;#4K+S,Y8B]!4$EH8U9D+WEV3'HY+W8V,R\U14QI<G8K5C5E
M9G8X068Q=B]!36E&>%8S+T%#=DQZ.2]V-C,O-45,:7)V*U8U969V.28C>$$[
M+U<O+T%#25A&6&8X<GDX+V8W*W0O=T1K475+=2]W0U8U969V.2]7+R]):&-6
M9"]Y=DQZ.2]V-C,O=T-20S1Q-R]L95AN-R]F,78X028C>$$[.&E&>%8S+TLX
M=E S*R]R9B]K475+=2\U6&PU*R]W0B]7+SA!>4E81EAF.$%+.'90,RLO<F8O
M:U%U2W4O-5AL-2LO,SEB+SA!26AC5B8C>$$[65!Q3CEC86AQ1GIF,TI"=4QU
M5C4U:6]O3V-J1C)O3S(U>%9$-'%M2&U$4UHY2#%U*S!Y9%-S;'!-.&1$,U5(
M-%=(<WDP27A63#A69"8C>$$[:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&EQ
M6658.28C>$$[2FXQ:E<W2%1)1DQ36&-Y4C!(6E-F:5DK>7)5;D98,&0U-2],
M1%%V3FA7-6Q:<E!5:UAG=#5%0653:F]*14Y/64AB8T@S=TIE8U0O."8C>$$[
M-#@V*TI#24Y5=$I)*WI/<VE.+W=)1"]R=S)H5"]W0VAE+TTO+U9X<W9V;"\U
M;WAT6&8X05%V9FUF+W$T,E@S>2]W1$Y'3G$W+V]8=B8C>$$[>E X03E81WDK
M*U@O04IO>'189CE#.2M:+W=$<30R6#-Y+SA!3D=.<3<O;UAV>E O04Y81WDK
M*U@O;6I',60O,$PS-6XO=T-R:EIF9B8C>$$[3"]Z4FIA=2\V1C<X>B\X059X
M<W9V;"\U;WAT6&8Y0SDK6B\K<FI:9F9,+WI2:F%U+W=#:&4O32\O5GAS=G9L
M+S5O>'18;65O5V(R5B8C>$$[+V,R56I"<$QA5C186F5H36)&4U)8='1I<6AI
M<G-69&ER<U9D:7)S5F1I<G-64G5I-EA.<3)R,F5M475S8S$U2VM-8G98:4,U
M;T-A028C>$$[;6U+=E)V.$%O6'9Z4"\Q8V),-S5F*V%-8E8S+T%%3#,U;B\V
M=4YL.3AV.$%Z4FIA=2\V1C<X>B]!4%9X<W9V;"]W0V%-8E8S+U%V9B8C>$$[
M;68X039U3FPY.'8O0412:F%U+S9&-SAZ+W=$5GAS=G9L+S5O>'189CE#.2M:
M+SA!<30R6#-Y+S@P63)R=BMH92]-+R]!1F-B3#<U9B8C>$$[*V%-8E8S+U%V
M9FUF+W$T,E@S>2\X,%DR<G8X06]8=GI0+S%C8DPW-68K84UB5E5G+W=#8V5D
M9DUG12MQ5VMC9F1K5U(R+S1%:% Q-"8C>$$[,G(P9GE.*U=/:&55>6)I2FUV
M3E1D9418:V]!-'%E;VI15D-!.3EY9F9!;&U'2W5X5C)+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMV:U!Z4"8C>$$[+W=!<$QQ,R]!1$<S2"]*,7-+171X5C)+=7A6
M,DMU>%8R2W5X5C)+<V<O3#<O;$].0R\U:EEF.$%I67A6.5A9175X5C)+=7A6
M,DMU>"8C>$$[5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6
M,DMU>%8X:"M:+SA!;$ID5R]W0UDR-"\U3W1H46QU2W5X5C)+=7A6,B8C>$$[
M2W5X5C)+=7A6:T@U9F8X04MC848O=T%X<U X07A-67$K<G-#6%EQ-T9867$W
M1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$T:R8C>$$[2T-384%B:VYO
M0FER>E179GHU.'$R3C(Y=EI7."MO:4UL5VYJ-'!%869Y1FIY8C4P<&AP578O
M-D=(,&8O04MT1G@O>4U4*VU.2S<O;R8C>$$[6692+RMR4F-F.&I%+W!J4W4O
M-D=(,&8O04MT1G@O>4U4*VU.2S<O;UEF4B\K<E)C9CAJ12]P:E-V1G17=D9V
M=%9V3#%62TQD5'EZ2R8C>$$[:#-)16IL9T0Y*TM%3&ER<U9D:7)S5F1I<G-6
M9&ER<U942'DS<7-E:V$O<"MP>5)M5DQ+94]:;S%)0EE),6%!;D98<U@O47<K
M:B\X028C>$$[5F]U4"M2:68P>'!,=BMH:#E(+S9T1G@O>4U4*VU.2S<O;UEF
M4B\X07$P6$@O27A0-EDP<6I,+WIK5F%!+W5D1&MC5C9V8TMM,S!2=B8C>$$[
M:E-S<3AL+VTQ-60X>EA!<W5,5T=P3B]D,C!X0D5N9CDR-&]#9EEG2$%R3CA6
M9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5EDY*UEC;"8C>$$[>$@U2#%T-V-K
M4VDP:S-(54M24B\K1G)I<C53=V]D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<U9D:7)S5F1I<G-69&ER<U98428C>$$[=$US>4Y#5U=:5T)J6DMH9W=/
M,T=M.6$Y359F6'9L.#9K9$,P.#9P+W@P5&)29EA02#%E034Q.38Y8T-59FER
M<U9D:7)S5F1I<G-69"8C>$$[:7)S5F1I<G-65U1W>%1W>5%424I)6E9+4U)S
M2VAL655)23A#359E3C8W+WIJ-#<S8GDV2G%34C(W:VQB9396<6]$,D5I8W51
M*V$T8B8C>$$[5DLO*VAE+TTO=T0Q8V),-S5F.$%M:D<P3R\V1C<X>B]!4%9X
M<W9V;"]W0V%-8E8S+U%V9FUF.$$V=4YL.3AV+T%$4FIA=2\V1C<X>B8C>$$[
M+W=$5GAS=G9L+S5O>'189CE#.2M:+SA!<30R6#-Y+S@P63)R=BMH92]-+R]!
M1F-B3#<U9BMA36)6,R]1=F9M9B]Q-#)8,WDO.#!9,B8C>$$[<G8X06]8=GI0
M+S%C8DPW-68K84UB5C,O045,,S5N+S9U3FPY.'8X07I2:F%U+S9&-SAZ+T%0
M5GAS=G9L+W=#84UB5C,O479F;68X028C>$$[-G5.;#DX=B]!1%)J874O-D8W
M.'HO=T16>'-V=FPO-6]X=%AF.4,Y*UHO.$%Q-#)8,WDO.#!9,G)V*VAE+TTO
M+T%&8V),-S5F*V%-8B8C>$$[5C,O479F;68O<30R6#-Y+S@P63)R=CA!;UAV
M>E O,6-B3#<U9BMA36)6,R]!14PS-6XO-G5.;#DX=CA!>E)J871.+WIJ,S5O
M-&YJ<28C>$$[3FE7<'-#6F=++U P>FIA<W8O3'8X;31.075H<65T>5)8=7!2
M3E<Q:FDU3D)&5&\O>'%H6B]$86<K9315=E1C0W5X5C)+=7A6,DMU>"8C>$$[
M5B\O6CPO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N
M86EL<SX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HT931F
M.3(Y8RUF8S%F+35E-#0M.6(Y9BUB.#%A8S1E,30Y-C$\+WAM<$U-.DEN<W1A
M;F-E240^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z-&4T
M9CDR.6,M9F,Q9BTU930T+3EB.68M8C@Q86,T93$T.38Q/"]X;7!-33I$;V-U
M;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U
M:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+WAM<$U-.D]R
M:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L
M87-S/F1E9F%U;'0\+WAM<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \
M>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C)C9F,S.61F
M+3(U8C,M,F8T82UA,C$V+3,T8S(Q8C<S.3!D-CPO<W12968Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HR8V9C
M,SED9BTR-6(S+3)F-&$M83(Q-BTS-&,R,6(W,SDP9#8\+W-T4F5F.F1O8W5M
M96YT240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^
M=75I9#HU1#(P.#DR-#DS0D9$0C$Q.3$T03@U.3!$,S$U,#A#.#PO<W12968Z
M;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z<F5N9&ET
M:6]N0VQA<W,^9&5F875L=#PO<W12968Z<F5N9&ET:6]N0VQA<W,^"B @(" @
M(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(" @(#QX;7!-33I(:7-T
M;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I%.$0Q.41&
M-#5!1C5%-S$Q041&1CDW-3%#0S0V.# Q1CPO<W1%=G0Z:6YS=&%N8V5)1#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C Q."TP,2TP.50Q,SHR
M-#HQ,"TP-3HP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T
M:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-&4T9CDR.6,M9F,Q9BTU930T+3EB
M.68M8C@Q86,T93$T.38Q/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 T+3 Q5#$T.C4U.C4X+3 T.C P
M/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A
M<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B R-"XP("A7:6YD;W=S*3PO<W1%
M=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H
M86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(
M:7-T;W)Y/@H@(" @(" @(" \:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^
M4')I;G0\+VEL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE/@H@(" @(" @(" \
M:6QL=7-T<F%T;W(Z0W)E871O<E-U8E1O;VP^061O8F4@26QL=7-T<F%T;W(\
M+VEL;'5S=')A=&]R.D-R96%T;W)3=6)4;V]L/@H@(" @(" @(" \>&UP5%!G
M.DAA<U9I<VEB;&5/=F5R<')I;G0^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE
M3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A
M<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/@H@
M(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S/@H@(" @
M(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^-3(R+C P,# P,#PO<W1$:6TZ
M=SX*(" @(" @(" @(" @/'-T1&EM.F@^.#$P+C P,# P,#PO<W1$:6TZ:#X*
M(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S=$1I;3IU;FET/@H@
M(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @(" @(" @/'AM<%10
M9SI0;&%T94YA;65S/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @
M(" @(" @/')D9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI397$^"B @(" @(" @(#PO>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @
M(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" @(" @(" \<F1F.E-E<3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P3F%M93Y$969A=6QT
M(%-W871C:"!'<F]U<#PO>&UP1SIG<F]U<$YA;64^"B @(" @(" @(" @(" @
M(" @(#QX;7!'.F=R;W5P5'EP93XP/"]X;7!'.F=R;W5P5'EP93X*(" @(" @
M(" @(" @(" @(" @/'AM<$<Z0V]L;W)A;G1S/@H@(" @(" @(" @(" @(" @
M(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^5VAI=&4\+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P
M,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y";&%C:SPO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXQ,# N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0TU92R!2960\
M+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0TU92R!996QL;W<\+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D--64L@1W)E96X\+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0TU92R!#>6%N/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXQ,# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+($)L=64\
M+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C$P,"XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0TU92R!-86=E;G1A/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P
M,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#/3$U($T],3 P(%D].3 @2STQ,#PO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^,34N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^.3 N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 N,# P,# P
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STP($T].3 @63TX-2!+/3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^.3 N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXX-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D,],"!-/3@P(%D].34@2STP/"]X;7!'.G-W871C:$YA;64^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO
M>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT
M>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C@P+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^.34N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3 @33TU,"!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-3 N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/3 @33TS-2!9/3@U($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XS-2XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C@U+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STU
M($T],"!9/3DP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.3 N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3(P($T],"!9
M/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT
M>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C(P
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34P($T],"!9/3$P
M,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C4P+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X
M;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3<U($T],"!9/3$P,"!+
M/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C<U+C P,# P
M,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'
M.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA
M8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@U($T],3 @63TQ,# @2STQ
M,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^.#4N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'
M.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA
M8VL^,3 N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STY,"!-/3,P(%D].34@2STS
M,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^.3 N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,S N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXY-2XP,# P,# \+WAM<$<Z
M>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C
M:SXS,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3<U($T],"!9/3<U($L],#PO
M>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-S4N,# P,# P/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C<U+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STX,"!-/3$P(%D]-#4@2STP/"]X;7!'
M.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXX,"XP,# P,# \+WAM<$<Z
M8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT
M83XQ,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C0U+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STW,"!-/3$U(%D],"!+/3 \+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C<P+C P,# P,#PO>&UP1SIC>6%N
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$U
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,].#4@33TU,"!9/3 @2STP/"]X;7!'.G-W871C:$YA
M;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU9
M2SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8WEA;CXX-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XU,"XP,# P
M,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3$P,"!-/3DU(%D]-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XY-2XP,# P,# \
M+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z>65L;&]W/C4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3$P,"!-/3$P,"!9/3(U($L],C4\+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXR-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXR-2XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3<U($T],3 P(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C<U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \
M+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/34P($T],3 P(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C4P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM
M<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/3,U($T],3 P(%D],S4@2STQ,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,S4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,S4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STQ,"!-/3$P,"!9/34P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,3 N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^-3 N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/3 @33TY-2!9/3(P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XY-2XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C(P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STR
M-2!-/3(U(%D]-# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXR-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XR-2XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C0P
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STT,"!-
M/30U(%D]-3 @2STU/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXT,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XT-2XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C4P+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C4N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STU,"!-/34P
M(%D]-C @2STR-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M-3 N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUA9V5N=&$^-3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXV,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXR-2XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34U($T]-C @
M63TV-2!+/30P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXU
M-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XV,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C8U+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C0P+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],C4@33TT,"!9
M/38U($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y
M<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,C4N
M,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUA9V5N=&$^-# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXV-2XP,# P,# \
M+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],S @33TU,"!9/3<U
M($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C,P+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C4P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^-S4N,# P,# P/"]X
M;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8FQA8VL^,3 N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STS-2!-/38P(%D].# @
M2STR-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,S4N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^-C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXX,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXR-2XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/30P($T]-C4@63TY,"!+
M/3,U/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXT,"XP,# P
M,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6%G96YT83XV-2XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDP+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C,U+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-# @33TW,"!9/3$P,"!+
M/34P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXT,"XP,# P
M,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6%G96YT83XW,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXU,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34P($T]-S @63TX,"!+
M/3<P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXU,"XP,# P
M,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6%G96YT83XW,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C@P+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C<P+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(#PO<F1F.E-E
M<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'.D-O;&]R86YT<SX*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP
M1SIG<F]U<$YA;64^1W)A>7,\+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @
M(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,3PO>&UP1SIG<F]U<%1Y<&4^"B @
M(" @(" @(" @(" @(" @(#QX;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @
M(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L]
M,3 P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P
M,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C$P,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/3DP/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C@Y+CDY
M.30P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L].# \+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-SDN.3DX.# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STP($T],"!9/3 @2STW,#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXV.2XY.3DW,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3 @33TP(%D],"!+/38P/"]X;7!'.G-W871C:$YA;64^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM
M;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!2
M3T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C4Y+CDY.3$P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M,"!-/3 @63TP($L]-3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^-3 N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9
M/3 @2STT,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y
M<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP
M,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXS.2XY.3DT,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/3,P
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO
M>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C(Y
M+CDY.#@P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L],C \+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3DN.3DY-S P
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STQ,#PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXY+CDY.3$P,#PO>&UP1SIB
M;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T
M8VA.86UE/D,],"!-/3 @63TP($L]-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXT+CDY.#@P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'.D-O
M;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^0G)I9VAT<SPO>&UP1SIG<F]U
M<$YA;64^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P5'EP93XQ/"]X
M;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z0V]L;W)A
M;G1S/@H@(" @(" @(" @(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STP($T],3 P(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/3 @33TW-2!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO
M9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/
M0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-S4N,# P,# P/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @
M(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#
M/3 @33TQ,"!9/3DU($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,"XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDU
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STX-2!-
M/3$P(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^.#4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,3 N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3$P,"!-
M/3DP(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP
M1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N
M/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XY,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/38P($T].3 @
M63TP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y
M<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-C N
M,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUA9V5N=&$^.3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,S$P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C N,# S,3 P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" @(" @(" @(" \+WAM<$<Z0V]L;W)A;G1S/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@
M(" @(" @(" \+WAM<%109SI3=V%T8VA'<F]U<',^"B @(" @(" @(#QP9&8Z
M4')O9'5C97(^061O8F4@4$1&(&QI8G)A<GD@,3 N,#$\+W!D9CI0<F]D=6-E
M<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X
M.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N
M9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! ?_  !$( "  )0,!$0 "$0$#$0'_Q  7  $! 0$
M       )" <*_\0 )1   04! 0$  @(" P      ! (#!08' 0@)$Q0 $A$5
M4Y+1_\0 %P$! 0$!                 @$# /_$ "<1  $# 0<% 0$!
M      $  A$A$C%!46%QL8&AP='PD2*2_]H # ,!  (1 Q$ /P!N?G+\X?(O
MI_R+1=XW:DSUMTFX36DE6RUD:1?(E4DN)T&SQC)IK,=8PPDO) !9Z67UI+A#
MB7"BG''G'7%-SB"0# $8#)!K00":DXR<]U2]A^8OR>KF6VK:2:LB2S*F0<Y8
M)RV5W:=!L<4V#7F7G9-H,F&N1C1\@VXPH-J.$6Z8_(*:!::44ZAOO6G3$UV'
MI=9;$Q3<^T87DX7Y#>HMT&Q!SRWI>8FVDDT3-+#8=MO,J':C!&'S&HF;$C[(
MQRJ3<D(.ZJ+$;.L,>68C_6\EFS2 &C$;8$S.=!Z^OV(L$Q$95/OZ[=;N_(CY
MBILZ:2JC(Y<EQG9I%2[M]\Y9UPW'.L]EDP/;I_M51G'D]:Z?P3HO'.=1UW^W
M.\_@M.S[#TG9;=%<I/M ?]0<KK?AKTW'9IY=D+GEE.L604VW3<;$WNW$N24\
M_9[_ !G3"SI"8*-=2T''CM#CJ?Z.-WKZV&T+)?4XV_T*P:X@:(._DTD4S.J2
M'SGJF,U7XHMYQI.XU/'[%IM(]#0E1Y*21#E@E"BM#O S20:Q!M2%LEH8PO\
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G^(2%R2L[J0^.?L+Z1^NE"B.I9_,I?&&>()<XXGCA*RT8#K7E?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g63026g74j57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g74j57.jpg
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M_\0 '  !  (# 0$!              <(!@D* P4$_\0 *A   00# 0 !! ,
M 04     ! ,%!@<! @@ "1$2$Q05%B$B"A<E,4'_Q  7 0$! 0$
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M6)BD3W$AWQ45)H>W-@ D;4@_X8S'%!F=U26-Q6'=P#@AQ&FHG-2MO$33X0>
MCZTK8K2D8.]V5;LZB]<0..H87>)5+W@-E:!,J;?8,+J08JG^TY'KYT$:VH/4
MAS=CE4 &T0HU=%!0"ME(] W?T;*PY3$J+=:=YC12*6!GU]"NL8N>W]5$MM&L
M^OZ-T3'>*WA"ZGVN"<LN1P9IDZAX2'#J$4(]"2H"M)9R]%EN\^G?(MH'%8X
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( \ \ \!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g63026g77n77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g77n77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1CJ4&AO=&]S:&]P(#,N,  X0DE-! 0
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M:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M    "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O
M9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN
M=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M    4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L
M<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M     $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M     $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
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M8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M.$))30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M       _@   .$))30/R       *  #_______\  #A"24T$#0      !
M '@X0DE-!!D       0    >.$))30/S       )           ! #A"24TG
M$       "@ !          $X0DE- _0      !( -0    $ +0    8
M  $X0DE- _<      !P  /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$'@      !      X0DE-
M!!H      S4    &              $/   "A          !
M              $              H0   $/                      $
M                        $     $       !N=6QL     @    9B;W5N
M9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,
M969T;&]N9P          0G1O;6QO;F<   $/     %)G:'1L;VYG   "A
M  9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L
M:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU
M;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU
M;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG   !#P    !29VAT;&]N9P   H0    #=7)L5$585     $
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M8\AK6M&KGO>[VM:U9>-];.@9-]5->26G(=LQ[+:K:JK73M#,7*OJKQLE[_\
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M_9_\U:@9'7_K5]5\O_LB%74>B. _RKCUFJQA)#8R
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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>&S)HFJZ<.':_Q(Z[.';APZ7V4<+JJ;S+P\/#S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g63026g85y76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g85y76.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ D@,T P$1  (1 0,1 ?_$ +4  0 " @,! 0$
M       '" 4& P0)"@(! 0$  @,! 0$!            !08#! <( @$)$
M!@(! 00'!@,$!P8& P ! @,$!08 !P@1$A,4%B'2E!55-I8BM'6U%PDQ084C
M-#4846$R8F,D.%(S0]57=T+"1"5VMB>7>!$  @,!  $$ @$# @0& @,   ,!
M @0%!A$2$P<A%"(Q(Q5!%F%"8B11<3,T%PB1=C*SM/_:  P# 0 "$0,1 #\
M^TGS99OCLG[6KZV /-EF^.R?M:OK8 \V6;X[)^UJ^M@#S99OCLG[6KZV /-E
MF^.R?M:OK8 \V6;X[)^UJ^M@#S99OCLG[6KZV /-EF^.R?M:OK8 \V6;X[)^
MUJ^M@#S99OCLG[6KZV /-EF^.R?M:OK8 \V6;X[)^UJ^M@#S99OCLG[6KZV
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M3/V3%Z"':3.(#_J' *^>;+-\=D_:U?6P!YLLWQV3]K5]; 'FRS?'9/VM7UL
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M$RK=0R9S)&9OSF3$Q1 1*)TRCT_T@& 0EYLLWQV3]K5]; 'FRS?'9/VM7UL
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M)$I2!D6LDT!8@%%1LJHU44\.[1[0 HBIV54Q]!B@/HP#9\ 8 P!@# & , 8
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MK,9 /:I6G3A%1(DS.2CUH>3<QQS%[+AK"L(]1!<P?9[YT4I1$R:@% ]OL 8
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M^XR. 5]P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MUJ*I:]55NVT1,+K9EZ+K:\Q$WO6D3[K1$]HBA%"@=,Y%"")@ Q# <HB4PE,
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M-5Y1K(.4C,2,S%!5L1,IBE<#>T>=>:L\?P_8UG8I\;V=;/GG!&>_RTRZNA7
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M#RCR#?NJ+.R,C*RU;+,1RK:08,[R[@6T"Z%!9%99I)JHE. J=! C38&H=7Z
MY#\-9[0M!J6K9B_[/M^H+U6=:U^*I4+=]5ET-M6[J+VF$K32.CID:!:*)#N8
M]RX2.HR%8Z29BE7,40-(TSR2Y)S43P\VGL.=U?*4WE#LB;U1)Z]K-&F8>0J)
MD->;;N=<N4?<WMND5).5=N]3J%D6:L>FS(A(E10_M&PNW(&K:$Y?[GW%L?5R
MS:\4V:KL^.[IW=^M*MJV1=NM%UK6\I),:8V=;"\U+M)-S<56R3)-R=(Y)A=0
M7L:F#-)4@@2+2.0?(A6G<4N0EKG==2FNN4UNUI#NM0PM*DV<MKJL;OAGDQKA
M]"["-:W3BQV>K^(CT[%XN,(R>D,Y4:),>Y*"@&G:TW)M-Q5^-]"U#'ZBU<KN
MSD/SCJ%B?MZ$]=PM>B=1[<W.Y)8H&JQ]AB$'MQL2%3%1VHY= V6DWRCQ0AR%
M%HJ!PRG,;:<)5-?UB]WW6VO)A[RFW[QUO^^CT]RZ@VL/IN&O,U7;3%:W>69P
M6"F+LG!Q[9ZNZ?/X>)<&7$0$'#4A +<<8=G;.M?&QIMK=)6Z]D=&V)/(HQM-
MD* 5[2*W9+#'4R91K4S+3,G'!=ZG"-IQ%-RJ"R"4H1$X"9(3GT>GN7S.;HZ3
M8FRLZ&-F(_K,+K-YB/\ C,1^"3XO+;V^SDXJ+15^S4I%;3_2+-O5<3/_  B;
M>L_\"-6$GM.SWCA9>KQ8*A(1E[L-GMB->@*T_B5JH\G>.NRI1A$LIEQ/283\
M6A%NS)KJKH(KF=)]X0024!%'SIFV>9]CR/Z^\C\CU86Y.EJT:80G/=<YK.X>
M]E%T;9S/F7"[36]KTI>65]]9BE_C7[$V\[ZX\=\/^V_#?#L/41T.+AR8K:=.
MM;J[%Y_*.4ECF(KF5^LZSJ19=%L8N$V^.\2Q<N;CH3;5LK= UA*(%@M2ZM>&
MVHM9+I7-9O;54J]8XK9TE&PD;:(F-DVYZ;5)MJ9TZ?2IA!)5Z(]MRR >TIJ\
M_P W[?)\8X^U<9N'X:R>C+]:.??3F0]?08M2]"ELK.7,VOR,=IGTK9LS[G9X
M_-Y#L?6/C/?\W\BYKIV>3_8ZHX]<N#5UEX]NK*[DJ;H;D<U5HW;,]_A3GQQ$
MWHB(]N?7,>U<_P -:-F[ V)L%*J62JUREZON]>I2\1)55U/2=P64JM2NEH?K
M2Z-CC A6YHNW(M8L44%0*NB==<%B'*B3IV#L>7^3^5=2G%UXLGC_ !NBC)93
M,UG,U3.;-KT7EL/7\5?CTU7G]E+>EZ68SY*VA=>(=7QSZ]\(\$X;?)>?TM_E
MOD?'T[ZO5LIF3AK&S;@QKJBV5W[%H=BN[9#&4]5LHE,JO6S;1U*[?VJ%)M>\
MHR3J:5'JFQ;%64-<KUIZYE9FI4_9+G6L](NK46<;KL;?(NXMT^8))LS-$4S)
M-U4US&,L6J;?.O-(\>V_8V-V*/',75?GKAG/>S&YLN^V!U[:?FK--5[+8Y-:
MJE5*S15Z,M,LB^<WZM^M9\NYGTYT,_3MYCTN#EUVZE=:Z)1MW<JO5S*IC_7M
M5F)5')SZ;V?#V6AKU,36M56R#3>5W7EV6L#H0H;4)R%D-=R?2+=$8!K"-8'V
M;YX2C?>2AF_C]5KLV95#N#)%FG7V2F  2S:1]C>1,W+\.M7/_O2/*;X6?V[1
M3_'KI/0_;A?R3-??SI4J+3>:QK9^(F(]AHZOISP]/+;]BTOK_P#C:?!E=1/]
MZDL_R[61R?\ 'RWXHBWQ]BKWS6JHO.!/YM69EAJ>OM][9NTS2K(P@Y^2K%QO
M3R'D*HGI^W1L+5Z$M(S,7%6=':KIP:*E)F+!JT=20F3\$N51=!N1,Q"*FA/%
M_LOS?R'H<_K9LVEW&W]*ZKYHYFE:L^.6-6O1'1M:5L:OVJ8_UK\5XLQ:JTFM
M;S9O./I7ZR\0Y/7X&W9BS^1<KC+>K9/<Q-?LZ-5(<[);C4K#DH=[WIR1%_V%
MS5+GW96]UUR;3;&ZS:CO>\%'=6?Q51N-T01HT=67@NG= UCM>2K5QD59DTT9
MQYH<U*O2:C<B: MRJIMQ[!A%4#[B/-OL*?!^E]BWOB;BP[]41C7GM[K8N?TF
M9]5Y;+?=^Q;,C1:D5I*XM57\9GW^Z.U?6?U'7[/XWT\M723TNIRL%K=!NNGL
MITNOQE:\*H1&>*_ITVZLE&VLR&S2SX]\1"YK..M]B26Q+IM!6,5BG6MJD^K-
M5JTJR3447G[)[B3L=RD2OQ7%!Q$LB3\>Q0!-( !RV<B)S]0 O1?$_*M?E7D'
M9ODE-_$L+,^;.RD3,N?\,/U,B_N]+*I#T)I[:Q_<6V?=;\>G'O/_  3G^">)
M>.+Z%=*_/^FG7LV)9,17-E_8G+A5*_;[JN9.;3H9-KS/Q.SQ[*^DS::,Z <E
M& , 8 P!@# & :S3ZA!42OM*O6FRC.&8N)1TV;JN5W:A%IF6?3;\PN'*BJQP
M5D9%4X )A H& H=   R(X7"YOC?+7Q^325X%V9:M9M:TQ+67;?\ E:9F?6][
M3_7\>OI'XB"P^5>4]GS/N-\B\@95O5=1-+VK2M(FJ$KSKCVTB*QZ*52LS$?F
M8]9]9F9(YC^/VN8R:9RC9O831T9:'%WAZ:YM=@=42&N#IXYDEK#&5-=^I%-W
M9)1XH[01$AFC-X;Q#=%);[>53+]8>*9.A3:JNJ<J=EM:LMM+[8U:K7LR7KS3
M>5UM\E[-I7TE2FS\JET9_(OF[[O\]Z'(;S7WPQNT<ZO/?NICS4Z+\-%T57*W
M;5<.M24KHEE_=#WHCX'M:K^!VX[1],9R;^7?O;A9GKJN3]18*6ZXS]C\NUJT
MJ,U;%%5\9)XLHQ"7-&-06<',J\,1JD0%@(7LCFR_77 1L;NTLW[-%\CLU)TZ
MG/\ @SZ9I+UH^2\S3Y?C7[KS-FS"Z5]_MCT-;=]P^6:N<CEXD\KG9%;\VUD8
ML.;+^UKQPR,KM/Q+K#/@AKIHJL41%G,O\4WM[H[K/3E,C)NE6&)"<B)*BU)A
M1(LT;/RC9"1J$49!6,@K"V!P9&::,7+<%4Q5 5>V8X&,8ASE-L(\"X&3H\_J
M8?V4:^;AIC7\;V5K?*N:RM+Z^[T;6EJQ:)M_+UFWK,UM:)U-7VMY9T./U^'T
MYQZL'9Z;.BZ&YDWLK:Z+5;HS7]L6SW92TTM%)]GMBDQ6+4K:,3-<>M36*CU_
M74Y61DJG6+0>XPT<XDY/O&TXM)R\HZ6.]3=IO%VSU2?>(KH'.*2K9P=$Q1(/
M3-+H?5WA/5\=R^*]''\W$Q[)U*I9C/6KI8UEIF\6BTUO+FTO29FMELM28]L^
MA)\G[S^S>%YAN\\X_0_7\GZ/.C"]M5)]+9ZJ0FE87-)I6ZXS(NME:Q>CE4;6
M8O'J9VVZHKMLL#:VC(VFLVA"()7EIZG621KSZ1KZ3U>20A94K50S.09-7[I5
M9N*B0K-CK*]RHGWJ@'D>YX3RNWU*=SY=N/LU1")=E>Q%V(B\LA3/;/MO2M[6
MM2;5FZYO?X[5]]_=#>,?9?>\9X;/&(1S>AXY?5.JN;=E5J6K3*ZJMH3-XBZF
M772E&16\+;5:_EI?XU^W;E*S$.*L>FOTW<M KP!JR]1F9*2EGTG$*QPQ3E.5
MF'[IQ+R;MZS,8%W*ZYW*QS&.<XG$3#.VX^%O&G@:8N_FVR_KWAK&,NQ4T^.T
M,;>UFLM>GK[V7O++S,VM:;3,E7IY#U$>21Y7BLK+VJ;HUKLA2DK4^&_-64H7
M2J%46STE:EKJI=8BE*12(J1@;0-*&%J$464O2+R@E?H4ZTH7>?1ML%'R;)I&
MO89"<3=%6=0CB/CVR9VCDJR!S-TE3%%<A50IT_67CT\_!BAW2KHYD7C+HC6Z
M-*:,I5=U0Z+>MDVI1=96R+TF:4O,2RL7.B5^[?+HZW4Z5L_&MD[<KMNQVY^:
MV+0U3+M6^V>:>VFBK6MM5RI6RL-8NMH3>RYU&W<<(24/IJ'K@KPU5U_L"UWF
MR.$[5:65SDI*P4J[1Q)]G:6JR\Y)VE:YV-N^=+O'I.^2(H!S*%Z('@^Y]3\[
M;?@8>3[L_%YG4T['VC1HIJ8Q^372'5T5F7,T3K?1S+M;'OK%_=-X_MVM'B_W
MYV.;3RSJ=[V:_).WP\?.RUG'C9@4K-OY[9S7QWK7.G'7!E;G2M"+?'>RYI5=
MO5U)FH>OJ[KF*?15>)(J#+S+ZQSLK-2KZ<G9^P214$WLQ,RTDLN[>/%&[1%$
MO4031;H)I)E(FF0H7_QKQ?E>*8F8^7#9E^B[W,:R[G.>SVQ=K6LF;7M-:TI'
MYBM:4I2D5I6M8Y/YIYQWO/.DGI=V45C+D7ESI0E>?/FS*FTK0A*JUHND6NQD
M_B;78QC66LR]K3B9#4-%DWT[(O(QRH[LE]HNRY8Y9)^F5>WZX1JZ%3?D(1<I
M$$&*=-8 = @ BOW0]X4W;/UT=7@OC>S3IUO3>7Z^GCWMGY+QZZL$9XS7B(MZ
M1%(RI]:1Z5O[9]T3[K>LGA^T?,N=CQ8,NA=<W/XO1Y*8E2Y]N+J6V6VKF9KZ
MVLR=VGVLMZW7[X]EJ^ROH>:AHK^#N%=<QCD\5>K<E>+(@$D_(=Y8T'D$^3=I
M+E7!5HD#FMM![I(2IB"8ATZ&-U/\&\;T\[?RG)O.+I;HUOCY+Q-GQ9-XM$^[
MUK'N0N?;68K^)CT_,^K)]H^98NQRN]GT+CI\;ESS\MOB7,4RVIH7-+5FOMO/
MLU.CWWB;_P HGU]:U],>ZTQ5U+)*66-E[Q6E;!+-YZS1%5NL_7X&Q3;=LR9!
M*R$?'/$A;/G+*-;I.3LSM1=D1+W_ '@]H1UG> <:_6=U\C^CCOJ?5VA6;6Y"
M7MK6E/DO2EH]M[472K)5*_DBL?)[OS,[N;[9\C7X_F\?Z&7C]!>'+;-D?LP9
MM.G+GM=C/A4UM+>Y=&-;=57U=";7M\/LCTB-VL]0@K@G")3S91T2NV:#M\4"
M;E=MW$[777C8IR<6ZB8K)H./29(_5,X>@P"&6'L<+F]VF>G2I-ZY=B=2_2UJ
M^CD6]R[3[9CUB+?UK/K6?]8DJ/COE/9\69L9Q657??SM&%WK2M_=GU4^-U(]
MT3[9M7\1>OI:O]:S$FJ6G4E<L]C&W)R=MJUF7B64!)S%,L\G7'$Y!1KI\^CH
MN92:*BS>IQSJ3<G;KBF5VW\0H5)4A3F*,+V?!^3V.K_G*NW8NO9-$L;ET,19
MR5VO>BVQ6?;>*68R:7]L,I[[Q2]8M:)LOCGV=WO'>#_M>^?F=+Q^FEFE*-^1
M.JN?0VBUM<BUX]ZY;1*JM7[Y2WXUV8JUJ5F.G*Z5J<Y)13R8E;U*1L4YJ[\*
MM)WRT256D92EJL'5:E9B*D))R,F^CY"*:NU.\4%-X\0*NY(LJ)CFU]OU]Q.E
MK3HWNZ3LB;Y[_KLV:&9KLRS2V=C5W9;Y+TNM;)]UO:UM(:ZK+^MIV^9]N>3<
M;GZ<G*S<;-OTKV+_ '%<[&K8I.^&4UI0Y2J?$MBG.37VUBR$,LG/92HK6N(E
M>.NLYF;DIA\WLAD)6V1E^=5Q"WV-K41O,4[8/4+86MMY%*,][++QB)E0,0S<
MZI16[H%S&5'1V_57B/0Z#=^FFN5NW+VV1&I]<W[B[4O&F$5O"_DF5TFWK$TF
MT?)[/EF;S)\W[W^P>3R,_*QLP0[-S'<VFJV++?;_ (YU&+MBG5=4M^&M6LBD
MQ:&UI,*^24UJN,[-:6H4[$W*(=LI%!*\W:(V/,/&$S),I-O=X!O56\'889^@
MX*O$/(OR5''2*B)4NV@(F(8%% -)=#Z_\:Z.+?A<MM:='HJWMO1K*,KK37-"
M7JO%O<JR_P!1$UBGI7UI/K68M:)AN3]M>:<;I\GJ9G(NSC<=_+0MB%,3;GZ;
M;+:,KUVK-7T=^_JK>6>M_:R(K:LTI->NZTI5I&:A9B8F;W.)03ZKS#2!FKS8
MI*MK6*FH,4J]8WD,X>F;KRS)Q&H.S?P;K2"8.U$CN1%4<3_KWC:^AGW[]'2T
MTS,SMJENQ[$2_+%(0^RK7FLLI9=&S_2EG1\]Z6;ZW,^;[=\DP<C7RN5DXN-F
MU.M%]*.?E5KKEW69.K+1]5Q:J65:Q,?U;3-;]5;*YXA<2_EZ.6C ,U6_F* _
M&HO[\A@%G+)\NS_X+*?<5\ J3@# & , 8 P"']X4O6FQ*6TI>TG3MC#S5RHY
MZX_BYV7K$_&[#A+1&6/7TI6+! N6DK$V2*M<.U<LU4U"E[U("J =,QR&C^AU
M>?RJIMT6T55^A:%^[_G:V?:M<?\ 5>?Q!+<GA=?O6T4X^=FB^7(W4Z*^G]O.
MBOO<VWK,?Q77\V_U]/\ 0X-7Z+I^K)BSVIA)W.X7BXLH*)L=[V+;)2X6E[ U
M=277K=;;.WYR,H:NPKJP/UTF;%NV1,Z>KKJ@HLJ=09 B23H.PPEE;O7<%)-I
M-M'3,W7GJS8QC$;3=<E'4+.1J@F*40<QDJR505#^ '(/01_CD?SNKS^NIC^:
MVCE*T-1>:_TJU#+*<N?^I;*6I;_C$DMV.%U_'WJS=G.S/H?DSZEUOZ>M\^I-
M-&=L>DS_ !:EE&4_U]MH]8@S.2!$E0K#QETCN*R;2M#2T;&:-MBR?E;>-8HV
MSK=6:?L&8J4"RH3N/M\-'/4>Z>)56,;1#X8Y1CXUBW32<"J!<C^?U>?U:NMS
MFT;5&AB&>W_D:J?:Q<_]5)_$DMUN%U^#;/3L9V9[ZLBM28MZ?W,[Z^]+:^DS
M_%E?S7_7T_T)RO&I:5L"NU.J3<>JW@:3=M9WZN,(9?W4BPG-26V#NE*2(1N3
ML>ZF,S76H*-@ "*($%/T .2!$DEX P##1UAA)>2L$1&R39Y)U5^SB[$S1,85
MHF0?P\=/LVCL!* %5<0TLV<% !$.[6*/\?1D?DZO/W:]6'(VC->)M5OI']57
MNJCJ5M_QLIJ[Q_7^-H);?PNOR\&'J=#.Q7/Z2+NRLMZ>UREO;F9>GY_,5>EJ
MI]?3^5+?Z?DQCJ]TQ@^F8Z0M$)&O*\K7$)I.2D&\<2.<6Y<S6KMW"[TZ#<'$
M^[)W35,#B=940(4!,8 '4=Y+P,VG1DU;,ZGY;(JV&7K2*6U3[<];6O,5]SK?
MQ76)];6]*Q'K,1,AF\,\LVX\F_#SMFC+NKJMGE2K-EM<58OLM6JXM;VYJ3[W
M6F(JNGK>TQ6)F-LR;*R, 8!'&SM5U+;T-!UV[(OGL%!WBEW[W0V>G:L)F8H,
M^SM5;9V!N4IB2\"WL4:U=JLE/[%PHV3!0#$ Q3 2/@# & , W37GSA$?U#\K
M>X!-&P_D^7_I_P":,L K'@# & , 8 P!@# -%V=KBI[@UY<]6WMBM)TR_P!<
ME*I9XYL^=QJ[V$F6JC.0;(R#!9N]9J*MU1 %$CE.4?2 @. :'=^-6F-BV6X6
MNW4\DG)[$UDOJ#8"24M-1L;=:*9^,G',;'&1D@S9OI>MO%5QB94"DE8LKI<K
M9PF500P#MT?33;7*5@=1]TVCL21DH8\4Q8[;VC:;;!MVR15%&T>#)Z+R/1!R
MN)2.))5D]E3HB)3+*EZIF T7AAQT;\5^.6O=.F+!FGH=J_F+FZK9GZL$ZN5D
MD',S.I0CJ61;S#NNPJSLL9%'>$(Y")8MB*%*).R &V6SC=JZZO;$XG6=B4CK
M;)MY^Q5EC;K'%U.6LS1DUCV]F>5V/D6\:K-I-F#<>\$G8,LV17,05TB*AS7M
M_4WAOD&C4WI+U3EW.JY^>FEZ\S=%:5I719%&57+HK1?\O3TFZZ,FLMI6\=H\
M9^_?L;Q+)@1QFX*[N9GMFRZV8LKMJ<EV7;;)34U5FUSS=C?XQ;W0MK4UO"67
M7/-8^.^N+3.6"9E"VDJ%KF(:RV2MQUPL,74YJTU]K$L8FROX!@^;LUY1LS@6
M1# (>'6.U2642.NF14/OK?5?B?9Z.K?LC9"MKU:'HIJ>O,W0FJJ+T732]:RR
MM4JB?^2TKI>]+,K%XQ\'[V\]\;X^'E<V>;+^9E?DRZFX<KMN?'IN]CLB]+%V
MO5-[Z7VB?_5I5S%+95-[+G+SVD:#99B[R\NTEET]DUKRK>X1*>EFM?L\>2*<
MP;=U(13=TFD269P[LS=%TB*2J90(<![Q),Y-_I_7?C/7W]'=NH^U.MD_6V)A
MS:HT4A=DUM==;1$-JJTTJRGMM6(K:)]]*6K%<7[?\V\?Y7'Y?+;EHS@=#]SG
M:)S)OIR-EU-%J*=:DS*;OI#+I9%Z6F;UF/C8REN>DZ>JM&GG=K9/;9.VE_!-
M:R\L-OMDW9I%:"8.S/6$:0))THS:-V:YS&*""27;.<ZBG;5444/D\>\$XOCG
M3OV\[-VGLMS5SW?JTMT,E-+>^BX^2TUK6LS,Q[*U]9FUK>Z][VMA\N^U/)?,
M>*KQK6GF8O&T;+ZUYL.+/D570RD+8V?BI%[V96(B99>_MK6E*>U:UTK*N70Y
ML, 8 P!@# & , D[5'S$]_!7'WZ.P#=-K_+K+\:;_<9' *^X P!@# -$V7K.
MD;?IDMK_ &'"$GZM,GCUW3('LC%NV[^'DFDU"2\3,PSN/FH.<@YF/0>,7S)P
M@[9ND$U4E"'*4P 1U0^-FO*+<6>PU)"_W^]Q$)(5FMVK:NPK7L64J5=EEFRT
MI%U4MDDG;""4EBL&Z;Y\@B63DDFZ97;E<"X!W(7CCJ> K&F:?&0;U&!T%;C7
MG6+4\W+K*0UC-7;M51=NW*KLSB82]R["E4^Z=&53[2Y3].TF02@4;XZ<+-VZ
M>GM/-#RU2I<-K*RS<S=KMK[>V\9P-X1$HTM8N*N]XU3U7KNDM40TQ/SS:153
MCWDR2-49 2/*@)@5(!;2C</-*:^G:I*P32Y.8C7DM)SVL*#/[!N%AUMK&:EF
M\LS=2=&H\O+NH2'<M6$Z\;1_:35)#MG*B,>5JD82X!N%:XXZGJ3G7CN#@WK9
M?5MOVY>:892;EW(1UDWC*VJ:V,\7*N[4+()2\A=) Z2*_;2: J4J)2 0@ !6
M??O#,]DDM=SNJ:Y4YM&L;?VSN6VTJY;4V5J):T7';<$XB)29AMQZXKEUO=-2
MCEWRZYXEJR/&R/;3*J4GAT3% L'QHU;>]6:U?5?9-H/:)*2M]JGHZ&/;KAL:
M+H%4F79?<6MH:^;% +O=(6N,$>A'DFD@J8ZYTDT$6R:*1/FU:WK-+Q$TF/28
MG\Q,3_6)C_P/JE[KO#%S-65F)B8GTF)C\Q,3'YB8G^DF3K7'+6-6GJ=8HYM9
M7#W72DB77K:6N%EEHFD1LK"R]?>P=;B'TDM'LX<\5-*) D9-0Q2(MR <"-D"
MI\YY/U1X?QNG@ZN6FNVCE2S]&K-6ABLBV*:BZ4*NR:45*VVK[9K,Q%55BWM4
MN*]D[_WU]A^2<7J\'>SGTR=ZJO\ )W3AR)=T&IT(TKT:GK55K'PY%;S>+5B;
M7?::^_0ZU_Z_X[Z_?U]O40=W:/J ,IJ*E:K%7FRQ\#9(BPS,I.347/L4'X%=
MMI)Y-.B+'3%%=1JJ*!E!1 I :OJSQC3RZ<.+]%7"^-JV9E[-%$O4]K'-6ZD7
M_E5EFLBTU]M[+M\4WE<16/S%]Z^;XNXSRB5<=_E$N0Y.QW.R-TY7Y4)SH=F9
M9?K2RJ(3:E;1==6TAU5PV;7G-/\ 2E*>6]:YH*6B%?OEH!S.1=;M]BKU;LKJ
MK)(-J^YL$#$2#2/D58YFT1;B E*5TT02;N 603(F$AI^O?'G]VW?7.S/I99-
MG+1J>A&BV:(JBSTJO6EYI6M*3^(ABZ44V&+K6L1./[<\NR>+U\3=7G:\2:::
M9W:L675JR4V6M?37-I>J[%0V]V-C\S*7,8]$J=>UYQR_'[7+B<>RRJ%A-'R=
MK+>Y.F^:[ %"D;H1^WE@L;VH>/\ ="[L\PT3>J(B3P:SXOB5$3+]5,U6?6'B
MC>BS=>NJ<KMO[C,O[+_TF:XO5OSWR^_XIM+:U=:GI\5G1\MERS^1O)^[_/4<
M=/,7?#&[/S)YR=_Z>;_)*P2NR?U5[?C^>M(1>V>K(M\],\_KT;5/I0VA/5-$
M2V<ON).#(78+FK%IRTWXIYV#0H/$7@A[M%?W8$B<S9)(SP$O%"V3*CWG=!V,
MF*^%>-4\PMYY7-$>47Q?JRWW6]/B]T7_ /3]?C]\^VM9;[?DFE87[O9'M*[?
M[*\S9]=T^JK[)GP=?2_>KG]E/6-'LLO_ -7V_+\41>]X1[_AAM[-]GR3[C#P
M6F*O6)DLE7Y>\1$4G,2-@2I;"ZS[:DHS$L]=2<DY2@4GA2$9O9-\LY.P[SW:
M*RIA\/\ R#1YO@'&X_0C9RW]%&*'W=&2FMU<D-;>S&6A,6](K=E[LE/N^#W6
MF?B_T)3L_;/D?D/)GG]S+Q]72ME5FMO9@S7Z%D)71*J3IFDS-UI6M5=/M_:B
ME*Q\_P#J;'%4B)J-,EJI48MDHT<J7.4;14Z\>+QCV9N<U-VB62E'1TY!V2,D
MI^=7,J!$U>Z04$J9!*4I,E<7CN+A<!_%X:5RB\ZF56ZUK+NW4UVAD,M,7M"V
M.=>;1%;>VEO2M9B(J0/2\OZ?E'EF;R7R?2Z-*ZX$W=GI2KEHP(SY$RFD2JDN
M5FSKBDS:GO96+7O$VM8U70&J6^D]04?6Z9VJ[R B2FG7K(RZC:0LDDLK)V%X
MV6=D(^79J2SM4&QE_P"V!L5,I_27(;ZQ\*5]>^"\[Q*DTMHS(_O7IZS6[V3+
M'WK-HB\UEMK12;_S^.*Q;\P63[N^RG_;OVEV//V0RF3;J],ZV>V+JR*K"<R[
M5I,KK>$TI+87_;ELWM7\23'E\.5# & , 8 P!@# & , QDVXE6D-+NH*-;3,
MXVC'[B&AWDD,,SE95%JJI'1KN8!C)C%-GSLI$E'(-G'<%.)^Z4[/9$#R XL;
M[VG1-&:(LLSK&P[.W/R_V;9*]$N)KD-;)Z&EI5A![$OQ[=-)V:!EXK4U3@8R
MO/6KIC78MR+>(CT3HMW9T6[, +A6KDSM%O.;)K^M]#1FQ)#1-:K4KNTJVV4Z
MJG'6FPTMM?CZYU:=:@3/ZA6N/K$@S=F/*!58\Z$@V_YDJISI)@:C9.;LP]?+
MHZ5TLMM**1XJ:XY?%L$WL.+UY&+:WV&ZV$5G ) ->MKLUZ6CJ+W\>W[OW:[,
MLJ1R^8%0(HY W'5?*Z>OMWU!!6?3[G7]3Y$:ULNSM*6!Q>(ZR620B:NUJ$NX
MB=C5*)A$XJBS<I6[BA(LR,IN>0,DDHDNJW<@"(@9_8_(/8$'O!+0.K-+H['M
MZFJ66W%YZP[&::[I$3!+V>PU96-EY4E5N<ZG,N9"'1*P3:1CPCDS@XKF:)(&
M6,!H]8YCR^V&&JH_1^I4[5L'86LY7:=CK%_OI-=P&L(2OVD*#,P]HM<14-B/
MGUF4OC60C(]!A$N&[PT4Z647;HD(8X$:/.8VYKC<^*R&J]30B4;L^V[[H.TZ
M9>;XRA;!7MAZ/1N4%<Z8$K%5:TM$4:K8Z@NZ;R*/:++H=VGW+<JO>% [5H_<
M;IU=OEHC"1FLW6OJ1NAIHNS2#O?-=C=VGM 6^+U_8+#6M C67;Z=I54N4BJV
M=KJSK*35;LG#ILP70*0QP-HL?-BS03W9DZEHIP[U%I?>\%HG9%^<;%CV4^23
MGY^G02=EI-"2J[\]HA8(;W'+297<G$+)E4.5F#TZ2@% Z\3OO=\OM;FS2K92
MH6.U=I2(1/7[)5M@ SO$6PD-3>;8Y9DW/2#)+R]F*?QI5U''2#7.5$"O 3[P
MP&%O7,J6T9H'66UUZI2YO7QN/U+V=(/=L\DX6H;FMK8*>G/ST)0JVOKR3:;:
MV''0J22RXN7M<3E7[H$V_0YN@ 0_R=V):DGO[A;ZN7"T1S"'XN\+;)3_ '?.
M2\:$ \M%_P"0I925@T47*(PLC-L8]J1VJ@"2JY&Z15!,"90 "V$_S&CH")VH
MV7H$DKL?7G(ZF<<(?6X3B"3^[3NS7U,7UO9V$J>+%&,KM@I=T3G'"BB*I6+9
M@^3$ZIFXF,!=' & , 8 P#-5OYB@/QJ+^_(8!9RR?+L_^"RGW%? *DX P!@#
M & , KOR+_N&GO\ _1&G/_V0,Y9]J_\ MN#_ /M7+_\ [SNOT/\ ^]\J_P#T
M3N?_ .4A]_M6V([/HDK59_:EBHMGW?+ZOEI&>C-2,=3+I-AN<=(UZJ-FA8_;
M"LI59^O=TE)G;K-'9F:X'<J$,4H433YIVU^8<W;Q=/:U>.;/(F\]C'+YE.;,
M5_:7=&:M?9TI9F<CVUT32ZFRID6;>LQ$=4Q?6OC+?KOM<WR3%XW@\RYWAZ.N
ME69O:9VJS;]!JM.R]_EXT)V9M/OODJRCT0],T0NU;6G1ZY(WJBT79>SX'9$H
M#6%Y<[&B4]:EB*D-:E8NQ<EG]7G(:0>+P;RW+V&93GCKLUT'[<$%0;$(@8HK
M>(KG)U>1^-^-]?S#F]9WPY_.=RXP?%F_78M_?OG<J]I3?3+VPZ;JO1U/9:%5
MJN8EGRW#O8?#?,O,O'_KOM<#/^SK^K^6Z>K+]O[:79?%%Z\[U4KH7BKE1.:J
MWK9F;+*2^]W5M"O@V:N7_D)=9YW:ZO!;-=M&6\)VH*PRBF@F6HFVN:CLQW1K
M,TD"R-J0W*WM+6"B74D+OP??>\RE02;J,3%,I,<KR?[1\AZ5^UQLW8NE?D3L
MLJF>-3F5PYNA;'HK?WZ8ZM=%4J8_Y?B]_P"Q$*HJV:8F]>[WA/T;XCQ5^->1
M[/'E:6^'Y]U7Q'DC.W?J;>33H9+J^+';A6QWT.5E^'Y_C_4FSFOILK-5[_J6
MT3E9B]IGA=<7/89GG(O=1'"-/?:\9*194;&F*:K\;_?*,BH1V*@@GX4[DP"F
M;M@0.R)K/X1V>CR,?:MS^3T.K+/*^K%HRWPTE?H^/2;_ +NS'$Q;UF*_'+)_
M$^Z*_CUI/V=XYQ_(>CXW3K]_D\*JO ^#-;;E]-D.FV6?6%_XWG="T33TB;?-
M543%H]DWGW170+/?^0EGMNX%=906S)!YKF]-ZG2H2$4T$RUF^/$P-6FY-KL%
M6]VJ)V4X/:AEU.KABBD1@Q5;J-.\6!43UCL>3_:/8[?>OXAFZ[7\KI5S9$IG
MBTY]Y4G.UE=L[-*M]IT_+;^::UA*;*NCWWB\VNWCWA/T;X[XQXJO["V>/(R]
M[C6V[]&B/)&=9<.T[,ZK\R.=C=RJQC^&OHO1>]M&BCUZOC5*HIR[1OFVHXO+
M2Y0NRY&%CN/TC 2-*J3.N4]>*E"%T]0KK.1%N>R4 ^FI2'DWDPY!$&SEFZ:G
M<J'[]0"-2-OOS+R7S?)'F_>Y_7;GR^+M3?)FHC+*V1_B\>MRM-V)NUBF7:R*
M_&Q3%RR]ODM%4U5C^N?"_K'?/UCXIUO'T:]_G"-*M^UFK=5R9GN='!G?B6K2
MO.EZ5H5-Y:IZ754NGPKF^F^CN[NVK;*[.VF?H$_M261U]>->5RS-F$9J1#3U
M;<3KVCA*U:Q*V(L?LBP24O!V<C@R\09\,>N]0* H=@X#L?8?FG;Y71V]/QC3
MVGKY?1PHT5HOF1RT6=?)\F=\O]F][&IT1>;Y9=*+M7'JOVVB=3Z@^M?&>[QN
M;Q/-\7C>5W<X_3U9+L;VK=S57.OH?#LRUR_+RLRD:,EEPO;&>-*\[K3#O=28
MP$^6Z1-KYR7RJ[3D:4IK^1KUK8P36(J#R&DI>!XYZYF2KV]S8(66E%X*10CP
M9B@S6CC)D%94%3J]T9"+Z=?(,7;^QO)>+V6\^_,:C31-59;*8U/#PM]=5GJ:
MR4WK3XO8JR)K'R7]]K^R53?$MXET_&?ISPOR3QM'77VT:L;-%W[J/4C3Y1U$
M>W#3,]*:Z%6;+_D?35%K0I<KJKY:NX+'<YIG.;PM\<DC%2LL^X)]\U?1S"5(
MR0MNP(N+F&)VDRR=-O$$CYA=(BHI LW5Z*I"FL0ARX^MW^@CH>1=W)6J-KV>
M'^M;THR*1IVK6VDU;2U?=%&WK%IK%Z6]+TFC*UM&;@^)\G5R/#_%M]KZ>;E3
M]B>VZVL3++8N:YR&1=#*7]LM0N]J1>5MIZJ9#%7O2V9N]\VTU8<C]A1VRY&,
M8Z1VG$0-4I;6N4]2"EXI*JZRL,Y'VYX]@7=@D6TF2Y+HMS-'C%=F;^T%1403
M*G(>0^2^;IS>6>49>NU.;QWM*3FR51EE+5QGY[W4TVNFS[U9&J]:2IJ;JG^?
MNO/MBL3X?X7]8Z=O@7@V_P ?1HV>8>-OT[-]]6Z-"'3LZV;.W%1>FF95E3A7
M=D.1H6^/[?L5$WM?@MFP=MVC:&P:G1K=LB/F*MN#7-*@8NF:_@)C6R%#D(;7
MM@V-*W.^6"AV.-BK7'Q4])*%2</D5$5$6:;5JOWKCM8NWY1YQV/,NIQ/'-W6
M5OQ=W!D2O+B2W!&.ZL+]S-6Q^-ZUZ:+<^T5NZEJ6HBJ4L][?=F\9\'^L/'?K
MGA^3>9<O@/Y72\5ZF_2[?T]*.K;HJ?T\W+3@YV;HY6NQM=FRUFZL[*LK?5?1
MH3\:/;?L Z  "(F$  !,/3J/3^8]D +U'_4 !GIN/Q!XFF?6?6(](/[@_!@#
M & , W37GSA$?U#\K>X!-&P_D^7_ *?^:,L K'@# & , 8!%FW-EJZN@(:7;
M5>1N+^?M]=I<7!13YA'O'4M9W)V,9V74F=)@DEXWL%4,JHF0A#"<3="]!IGG
M'EU_#>9GW)QMWZ=6]&1:5WI2UF:+31?\F3%(CW^D6FUJQ$3-IG\>D](^L/KY
M?V-V]?+T=)'*Q8N5JWNT.6QM*)R4AC?6B8LR9^/W36*5M:UHBL5_EZQ%$UR0
MF:HVN,=:-9*A?*C9]5P):G5[8C.L["SW'-&K]+E(.P2D#6>T=>8;.FJZ#EHW
M[I=J< 4,F8JHTKH?;._B)WY.QQ[?[EP[.<G];/IAU'UZC?@R,2]B<_YEM6+O
M1BJ>VZ[>EII-;STOD_07*\FT<K?XYY#7_9?4YW8TSMUXK9V9K\)$:=Z=&9.G
M7Z15%TN6Q3V^];JS*ZLBRXY[MR'DJ1-PE(DX/64;L!Q45+K8HZU;I:T^I1<2
MK,OX6':05KEJ0,C9YB<7BG1DDAB62"(-S>(61 4S'R>0_:>OQ[HY_'=F;D*\
MGOAG6]>GJURYEKEMU*JG2W)\FAKI6R:U_652OLGY64B:S;#XA]%\_P OY&SS
M#G;/(7^#KZD8,K<?!ONVN="%Z'WT8T]#XLB,]7)B]_W=#+_)7X%-F+Q7@@^3
M25TF]91%)K4*L&PJ!%[%[=TO!*>[&+?3+B$D(*FM6U;LS>\6RO.&2IWK8'$>
MV32.W.#DQ7 "7'SOM^GD'1Y&'Q[)GM'4YB]WKKUQEM\=VV3=.6M4:*Z]*+4M
M+5^]*ZUE5H;,-B8S=C_Z],\2Y'D/4\OZ&ND\/MNY?I@Y\[J?,M%="]&Z]]62
MW/Q::LI7.Z5:6VO5]91%D3%L-;>7=>K%DM;0&5-<5>BW!C2K,[?;0B(C8*\@
MHXB6DU(U/62D,Z<V"&K;F5,FX.M(L'*YVB_AD%RE(930[GWER^/UMJ(7@OQN
M;OIDT6OT%*VS>;*JUF;GRJUGJ19DUO-WI9>5L^%;(BLVE?&/_J]W/(N!S=,N
MZR_(^SRF;\E%\AS^9545=="MO6A]*9GZJ)BRJKRZ5+AR?V')M:]:9NS<CIF
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MB9! ]$F+UM),F<BR5[YF_:MWK1;L*)]ZV=(D705[M4B:J?>)* /9,4I@Z]!
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MO9<VF9%AT5J*US<A8K#0X.3F9A\RD)Q\LFX(:PK1K&(CH]O9$4'"3>QQC%K
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M%B6>K%7D+?\ I1LYUK*$L-T5AV]4BIK9[2IK4*/6F7=@9( <T@*+5=RF1R=
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M-CW>)O6Z(_2<C&P>J=NJVNC6<DX2"M4=<*:PUW+6N"MM:=* "4 ]9-).8/\
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MGUG*S\'*2O>%.J!+\#QQL]>L_)-:"KT+7ZE?^)&@-'ZSA4;"M+#$R^LH3?\
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M7F[)5J!191[VQ0)#'9-Q IE%HYF/=I8!["5A@XBJU7HMV!"NXV#B6#H"& Y
M<,V#=NL!#AZ#D!1,>@_S# ,Y@# ,U6_F* _&HO[\A@%G+)\NS_X+*?<5\ J3
M@# ,5.PD59828KDZR2DH2P14A"3,<N)P0?Q4JT682+)84SIJ DZ:+G3-V3 ;
MH;T" X!4-MPOC%]4V'2=LWOO>\:VDJ3&ZXK4%.R6MFRE(J$/(0TA&HQLA!:T
MB75EGVA(-NS)*3XRSLK!/L (+*NG#@#=[CQ3UY=WFVGLK,W1NKN2_:$V+9RQ
M\C!I)L)OCM.4>P4IK @YKKLS6*E'E 9EE".!=++I*K @JV,8ADP&Q.*>O-F3
M&W9N>F;HT=;H@-%5VTIQ$C!H-V#+CY>K1L"F*P!'E=?J-74G,VQRE*&<'=$6
M:D3*@5L<#*' _27&M"*VG8=C4[;VV*)"7F[0.R-BZLK3JC^1;K=:[%P,(E+.
MG<Q1Y:]0#6PQ-98(S;.)F6+65*S3[PA05> [ T'7G"6LZ^M.I)I/;FW;#6]!
MVR\VO3FNIA?7R%3J:FPZK?*E8(V2<PU B[5;FJ$=L-X+%:1DEGC,4$2E6,4S
MH'0%B=/:IKNDM?1&MJJ]FI"#A9"T235W8'#%W+*+VVV3EQDB.%XV.B69TD).
M?630 J!!*@4A3"<X&.8"#Z;PYJ%/JVN:/^H>S)VGZ>V\QVYJV#EUZ,4M2<1I
M;?X.G&DXVC,)F?JB1KJZ#J_<.)/NT&Q0=AV%3+@9G</$R@[FF=AV2;L5W@I[
M86O=1:_5?UU] )$K8:-VM9-SZ\M-?:RU;ED36-A>[(99R5_XV.=-VJ*)FH%[
MX5@-6_R5U.6BMPM[UM+;-]L&]'.H7E^M<NZH46^!;2EA\PTY&KQ-=H,37*]'
M&4*1LZ0*T6!9NGVP,5THLY5 WF0XY>8=MU'9USVSL2Y16N+E/;!UMKF78ZX9
MUJF6NPUBPT]PX:ST!0H?8,Q$QL#:Y%)FQD)AR@07("MW_AVH( 9;9FB!NUX@
MMI4_95VU%LJ#JTI15+/3FE,FVM@I<K*L)U2O66MW^K6V">I1TS'E=,73=)H_
M:*J+%*N*"ZR*@&G[CX@:]W]4=4U;;-IV%:W>J+:TMC6X#(5:'M-SZLGT99*Q
M>/<-0C*V]IMZBY S:8CH^-C4ET4TP2% 2%' ,/N3AM ;@L.U90VV=L:_@]\Z
MZB=8;JJ=&6H)(^]5F 8V>,ABIRUJH=HL56=!%W!^T>#&.VZ3YLH4BA ,4QS@
M;+:>)&K[BCNIM//K@X;;VU#K73-L20EV#,8JOZH&_K5&=JSAK#).XZUHO=B.
MG"RZZCIJ=9JV$K<A2*E6 T62X.U.WH;.7VIM[<^T;+MO42.EK/:)Z3H<&XCZ
M@QESST2K5(*F4"N5: EXJ:65=%6!DL1RNL<71'!>P4@':6X55BSL=W!MC:VV
M-LSW(#3;#1=[L4^O0:ZJQHT2M<G,2G3HBC4.LPE??L'EZ?N.V=!TDLY4[:J9
MP$Q3 ;R_XS1-F7HTO?\ 9&QKW;:1JS=NI2VR3"AP[^P5_>[FF*V=_-1]8HT+
M"!-0+:AQ[:)4:MFR1$04,\3>KG%8 ,1;.+5>7INMHZK2,JYL6B=&[#T_JQ"S
M22*=?F4;GKN$HB2^Q58.(9S#GLHUAF91:)5CCD%18Q""(IE(!5_AMQ\WYI>R
M:QABQ5YU[KBKZ^7@-Q1]^V)K#8L;LRT1%=AX&GOM?-:?"&L<$A'R*#EV9_(/
M(Y06!2-%&"IE"J- /4_ & ;IKSYPB/ZA^5O< FC8?R?+_P!/_-&6 5CP!@#
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M9Q)DG![@VKKZW4Q1L\(X<KP]<X]:AUO)GD&Y2@9@X+9J8]*1,PB)T2D4_@<
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M0\K)7;MS21ET3M4:@]MN[)DCB/<%3 K^1.UO; QD"@!NV=0.O4@]0([@./\
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M3F!0O0/M!U Y?/M&\X?I[YTJ?G[W;[Y\C^8X?SA[G^*^6O&>^O=O_'[CNO\
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M*Y=Z7<63^2J-OJ]JCHMXXCY-_7)^)G&4<_:% SMB_=1CMT@T>-2CU424,4Y
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M,0BNVAT9NW6^6GK/*,X5NZ5(R07=G09E64!$A 4/U E3 & , 8 P!@# & ,
M8 P!@$G:H^8GOX*X^_1V ;IM?Y=9?C3?[C(X!7W & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# -T^B\ ?1> /HO 'T7@#Z+P!]%X ^B\ ?1> /
MHO 'T7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+
MP!]%X!E(3_&8CY1_Q1A_=O[Q_>TO[O\ \?\ ['^]TP"=9O\ P:7_ .X_PM__
M 'G^[_W17^\?\#_M_P"[UP"NWT7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+P!]%
MX ^B\ ?1> /HO 'T7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+P!]%X ^B\ ?1>
M/HO -GIOS)&_+'_UG^'?WS^X.O\ N?\ YO\ =ZX!)UR^6Y+^Y?\ T?\ B/\
M<_[^U_[[_P"7_>Z8!!7T7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+P!]%X ^B\
M?1> /HO 'T7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+P!]%X ^B\ ?1> /HO -[
MU]_C+GY>_P +6_PG^\?WME_M_P# _P!/^]TP#9]@_P"#-O\ "_\ %$?\6_N_
M]T>_['_'_P!'^[UP"'?HO 'T7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+P!]%X
M^B\ ?1> /HO 'T7@#Z+P!]%X ^B\ ?1> /HO 'T7@#Z+P!]%X ^B\ ?1> /H
$O /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g63026g87b92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g87b92.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ , "Q P$1  (1 0,1 ?_$ )T   ,  P$! 0
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ML$TR+)MP'VK00,!4_53.'+?JW@&_^R?:.;S#E!L7C:Y/W9=@\M#\@U85+'4
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&I$.D3__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g63026g90v60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g90v60.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X;96:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/F5N=F5L;W!E,3PO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.GAM<$=)
M;6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+VEM9R\B/@H@(" @
M(" @(" \>&UP.DUE=&%D871A1&%T93XR,#$X+3 S+3(P5#$Q.C(S.C V+3 T
M.C P/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A
M=&4^,C Q."TP,RTR,%0Q,3HR,SHP-BTP-#HP,#PO>&UP.DUO9&EF>41A=&4^
M"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#$X+3 S+3(P5#$Q.C(S.C V
M+3 T.C P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R
M5&]O;#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]X;7 Z0W)E
M871O<E1O;VP^"B @(" @(" @(#QX;7 Z5&AU;6)N86EL<SX*(" @(" @(" @
M(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIW
M:61T:#XR-38\+WAM<$=);6<Z=VED=&@^"B @(" @(" @(" @(" @(" @(#QX
M;7!'26UG.FAE:6=H=#XQ,38\+WAM<$=);6<Z:&5I9VAT/@H@(" @(" @(" @
M(" @(" @(" \>&UP1TEM9SIF;W)M870^2E!%1SPO>&UP1TEM9SIF;W)M870^
M"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.FEM86=E/B\Y:B\T04%14VM:
M2E)G04)!9T5!4T%"24%!1"\W44%S54=H=F1'.7IA1SEW241-=4U!0311:VQ.
M02LP04%!04%!0D%!4T%!04%!14$F(WA!.T%10DE!04%!05%!0B\K-$%$:T9K
M8C)*;$%'5$%!04%!068O8D%)44%"9U%%0D%514)G549"9VM'0E%92D-W9T="
M9V=,1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W441!-%!%03A/1$)-5$9"451%
M>'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"05E':%521E)O9DAX
M.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46=!9$%%04%W15(F(WA!.T%!
M25)!44U2068O14%A24%!04%(05%%0D%114%!04%!04%!04%!449!=TE'05%!
M2$-!:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!.T%104-!=U%&0F=C
M24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU20D%!1DE227A15D5'
M13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II.$-2>6=V16Q1>E)4
M:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#:&=::$I21E)Q4S!6
M=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY5UHR:'!A;71S8E<U
M=EDS4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\K0VLU4U9L<&59
M;5HF(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q=7-R839V;U)!04E#05%)1$)1
M545"45E%0T%-1&)114%!:$5$0D-%4TU514954DYH26=:>&=:17DF(WA!.V]B
M2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,0T(S4%-.94I%9WAD
M56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W F(WA!.S K4'IH2E-K=$U4
M53504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(
M,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ
M3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!1#A!3R]*+S5Z95I.
M1#E/,G9Y9%8P-60F(WA!.V=K>F9V:T@K4DMA:S X1W(Y1T9$,FY14$](;$AZ
M;%EV1&)Y4C-(3F8Y23 R-59F54$O>6\R<4=(=7129U-W=GIF*U$R;EA83S8X
M='HF(WA!.T-Y;C-*<W!I5VA9+S5$-W-N,#%(>7<R<G@W5U!++VU$4C=X<E!5
M8D=70V1E9TLX;%EE2W5T5EEE-$]+140Y4W90.3A39CA!,SE-5F0F(WA!.SE3
M=E Y.%-F.$$S.4U69#E3=E Y.%-F.$$S.4U69#E3=E X069%;B]!041F,'A6
M,S%+."\S>$HO=T1F,'A6,S%+."\S>$HO=T1F,'@F(WA!.U8S,4LX+S-X2B]W
M1&8P>%8S,4LX+W=".%-F.$%!3B]41EAF57)Z+V9%;B]!3B]41EAF57)Z+V9%
M;B]!3B]41EAF57)Z+V9%;B]!3B\F(WA!.U1&6&95<GHO04AX2B]W04$S.4U6
M9#E3=E Y.%-F.$$S.4U69#E3=E Y.%-F.$$S.4U69#E3=E Y.%-F.$$S.4U6
M9#E3=E X069%;B\F(WA!.T%!1&8P>%8S,4LX+S-X2B]W1&8P>%8S,4LX+S-X
M2B]W1&8P>%8S,4LX+S-X2B]W1&8P>%8S,4LX+W=".%-F.$%!3B]41EAF57)Z
M+V8F(WA!.T5N+T%.+U1&6&95<GHO9D5N+T%.+U1&6&95<GHO9D5N+T%.+U1&
M6&95<GHO04AX2B]W04$S.4U64F5L*UA.9#%7-U<P,"MX;75*,B\F(WA!.UI6
M0T%"-'-X;W%J,TIX5C8Y-5$O25<Q:#186&UA8C9X24M-3$-":4EX-U-38DTS
M>5=N>D].<%IV<FYM>GEB-4IS171P5VET=4,Q9S F(WA!.S(Q5F9523A21W1+
M5B]M86<Y.$-V1V9/2#5Z95ID8S4R,6=4<%=N3G0V8TQ(,6Y(*UA+2TAF=U=N
M,#154% X5EAW5'IW5$I.0DDP53 F(WA!.UI$4GE)4W)+4C!)23-">%8V:C5/
M+U!85F)(,#=4>D1'9%%T4E%#-U-I,T-J>%EB3$HK0CEZ:7(R9E%F375H-B]A
M0S8P;3=3-6HO8E8F(WA!.U12,$HW3VAO>6XU:D%L33A64S8K.'DK6$Y0;DYV
M9C9R6C)L=T%#65HW:4M.-DAO94QS1&EQ1R]X=#5-+S9V,FYF.4IC2"].94MU
M+W@F(WA!.W0U32\V=C)N9CE*8T@O3F5+=2]X=#5-+S9V,FYF.4IC2"].94MU
M+WAT-4TO-G8R;F8Y2F-(+TYE2W4O>'0U32\V=C)N9CE*8T@O3F4F(WA!.TMU
M+WAT-4TO-G8R;F8Y2F-(+TYE2W4O>'0U32\V=C)N9CE*8T@O3F5+=2]X=#5-
M+S9V,FYF.4IC2"].94MU+WAT-4TO-G8R;F8Y2F,F(WA!.T@O3F5+=2]X=#5-
M+S9V,FYF.4IC2"].94MU+WAT-4TO-G8R;F8Y2F-(+TYE2W4O>'0U32\V=C)N
M9CE*8T@O3F5+=2]X=#5-+S9V,FXF(WA!.V8Y2F-(+TYE2W4O>'0U32\V=C)N
M9CE*8T@O3F5+=2]X=#5-+S9V,FYF.4IC2"].94MU+WAT-4TO-G8R;F8Y2F-(
M+TYE2W4O>'0U32\F(WA!.S9V,FYF.4IC2"].94MU+WAT-4TO-G8R;F8Y2F-(
M+TYE2W4O>'0U32\V=C)N9CE*8T@O3F5+=2]X=#5-+S9V,FYF.4IC2"].94MO
M:7DF(WA!.SAZ95<W*S1&=%DV=%HS5G=W2E='0S1I:V-G9&%+<D4T<6U72W!:
M<B]!2FTP4%%,5#8Q<3$R;'1'9G-+>'$W:V1K459:=F]'2W9&+T\F(WA!.T@U
M-C9T9CA!3S$X=E)N5')5-V97;F]B;&@W9%9J*VEP.3A+2&PX,# P.')Z5'E.
M3$Q)951Y3U-Z350S2D\U>%9::7)S5F1I<G-64E<F(WA!.VTV<'%/;#-A6&UN
M,TUL<F-X+UIL:5EQ9FMA9%(W2$98<C-K-S@K9V94=%!.14Y/9T=P44QT.#59
M:"MT4"M">'!,,'4X,#=Y<#5W,&PF(WA!.T=M:F<Q4W=E<&EM53%+:SEE1')2
M:V)X;U%C0W9*4$XO-40V;%IH-W)Y-4UB-C-&5TYL2U%S-FIR.$1B3$HK0BME
M1D1!9CA%*V,O.$$F(WA!.W%W-FHO=T)):R\X07I2:7)8*T-F3V8X03%99%(O
M=T-K4V8X035O>%8S*T-F3V8X03%99%(O=T-K4V8X035O>%8S*T-F3V8X03%9
M9%(F(WA!.R]W0VM39CA!-6]X5C,K0V9/9CA!,5ED4B]W0VM39CA!-6]X5C,K
M0V9/9CA!,5ED4B]W0VM39CA!-6]X5C,K0V9/9CA!,5ED4B]W0VLF(WA!.U-F
M.$$U;WA6,RM#9D]F.$$Q6612+W=#:U-F.$$U;WA6,RM#9D]F.$$Q6612+W=#
M:U-F.$$U;WA6,RM#9D]F.$$Q6612+W=#:U-F.$$F(WA!.S5O>%8S*T-F3V8X
M03%99%(O=T-K4V8X035O>%8S*T-F3V8X03%99%(O=T-K4V8X035O>%8S*T-F
M3V8X03%99%(O=T-K4V8X035O>%8F(WA!.S,K0V9/9CA!,5ED4B]W0VM39CA!
M-6]X5C,K0V9/9CA!,5ED4B]W0VM39CA!-6]X5C,K0V9/9CA!,5ED4B]W0VM3
M9CA!-6]X5C,K0V8F(WA!.T]F.$$Q6612+W=#:U-F.$$U;WA6,RM#9D]F.$$Q
M6612+W=#:U-F.$$U;WA6;FYL2#AI3E=V949Z-6AL3VXR>&]287AL5W5'2'5D
M,&HF(WA!.R]%*S)+6')L;'!N;$AY6G!4=D-K1VPR4S Y831C9TTU2%1N23-X
M3V9!5BM70EAM=FY$."MZ.&1P-5AH.78P;&-,*TUC4B]7+R]!-&$F(WA!.U8U
M1'%/<#9J<60R.3-Q1GI*9%A,+V%L;%ES,5!$9F]"-%EO43)+=7A6,DMU>%8R
M2W5X5C)+=7A633E!.'IA-V]&,SEA,&TW93)C:V4F(WA!.V]G3EDS03=/:"M&
M:#@X5F4P*U0O04TY3DDQ1&AA*UE)>' Q,F%!6%,Q3G,U.38Q85 V86HS>'!,
M,"M'94=E2DIO2D9L:&M!84]20T<F(WA!.U9G96A"1WA'0E=R;31J=')D-35!
M-6IJ2$IH1VIY=E0R4TU--V913599:2\U=V9L,4<W22MQ;$A1;%=6<F$V0D)'
M>$)":7A6<B]L8V8F(WA!.S5B+SE89CA!-F0W<B]Q;&ER=CA!;&-F-6(O.$%6
M,R\V9#=R+T%+<%EQ-R]L8V8U8B]W1%8S+S9D-W(O<6QI<G8K5G@O;'8X03E8
M9B\F(WA!.T%+9#=R+W%L:7)V*U9X+VQV+S%D+W=$<#-U=BMQ5TMU+W=#5G@O
M;'8O=T)89B]P,W5V.$%Q;&ER=BM6>"]L=B]!3EAF+W S=78K<5<F(WA!.TMU
M+S582"M7+W=$,60O.$%P,W5V*W%72W4O-5A(*U<O+U8S+T%/;F4V+S9P67$W
M+T%*6$@K5R\O049D+RMN938O=T-Q5TMU+S582"LF(WA!.U<O.$$Q9"\K;F4V
M+S9P67$W+VQC9C5B+T%05C,O=T-N938O-G!9<3)V-7<O;# W0E8Q67-Z1VEQ
M3&$V2DI044%E;&ER3&)7-6EU<F4F(WA!.T\T:41I3U%C;$5I4$4Y1#1P249D
M9G!'2W)P-31)25AM;FM72T=-8VYK8VA6541U4V1H:7)Y-WIH*V5U;%=(3S$X
M=E)J54QO8D<W96\F(WA!.W0Q4"M33FUK+T%E-7<P<GAJ6'9-=75A+V0O5W17
M=3-U<%(Y9TYS:4$Y:U%55E(X:&EH3$U69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7(F(WA!.W-69&ER269+=FXS>DPU66Q",#(U2G1I87E757189V)X*T=V=VXS
M56<T<3EU.&YF;DHU83$S,#=A.5EA6'%454AP5$XK-61V.&E8668F(WA!.U$Q
M1#16>'!+8RMA+WDW.'(K6C!,,W1U27)W:C1B-D-I5&4S23!)8V8V=T]"6&IM
M=2]K6C5Y<W)S<'!A4C9R8715<$UK:V-,065$<$LF(WA!.WDW+S9P3T9#5R\X
M04MN4'I)+S9T2"]4>&$O.$%66$989CAQ8R]-:B]!2W1(+U1X82]W1%981EAF
M.'%C+TUJ+W$P9CA!5'AA+SE68U8F(WA!.V0O>7!Z.'E0*W)2+S X5W8O5EA&
M6&8X04MN4'I)+S9T2"]4>&$O.$%66$989CAQ8R]-:B]!2W1(+U1X82]W1%98
M1EAF.'%C+TUJ+W$F(WA!.S!F.$%4>&$O.59C5F0O>7!Z.'E0*W)2+S X5W8O
M5EA&6&8X04MN4'I)+S9T2"]4>&$O.$%66$989CAQ8R]-:B]!2W1(+U1X82]W
M1%8F(WA!.UA&57DP4#A!27IZ;F4S6515,&HP<3%'-WI/.&-Z165#2D4W5E K
M<U)I<C),>6XK6%!L9GEW<7E75G8V=#9"4C<V96IY*R](<V<O,5$F(WA!.TU#
M56PX-&9N3C5B,%!N8E="1W$V:75X4T9G2550*UA+2V<P.$9R.4=';&5*96%F
M4&9M6'I.3'DQ3S90,6-'<V1N1E9)1CA09W)U9F0F(WA!.W%N1D1(.%9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<DUV2B]W0V%V;69Y
M,W=G178Q+U16;U!Q5G=347$K150F(WA!.S=S;GDV93)+=F-02T@U;6574$UW
M5TLS;BMQ-F=2=EDS0D-Y13DO5%!2+V\S.6AG4WEZ1E5H.'HK8C=8>35&.5EV
M<D<X;'1+5F$V=&\F(WA!.S%K:E@O6"M-379Z27!I<D9V*U8Y*U(O.3DS=B]!
M0TI4+W%P:'!89CAR-SAJ+W=#*S<S+VM3;B]65$=L9"]W07(W.&HO04\K-S,O
M:U,F(WA!.VXO5E1';&0O>79V>5 O=G4Y+S5%<"\Q57AP6&8X<C<X:B\W-W9F
M.$%K4VXO0495>'!89CAR-SAJ+W=#*S<S+VM3;B]65$=L6E8U63@F(WA!.S-7
M,VU+3#9X6E=&-T1A1593-G59,6EJ9B]5*TUS,WI!<&=64&-666HU=CA!>E X
M04LO;&M01%!..6(Q161,1S-)6G=F*TQ'*WEN,#<F(WA!.RLR2W9$+TXO-7!E
M85!-=D]#4U@V;'!Z8F95<F-K2U(O>%DO,FXO5C=954U0>%8R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=7A6,DMU>%8F(WA!.S)+=7A6,DMU>%8R2W5X5GES>7-'
M56M-1%5%8D5%67$Y1SAN+T%*,2M99$<T5W5Q,3%B5#$R<DDQ3&A"+VMY2#=8
M>68W>&ER,GIY,34F(WA!.S X="M:<F-V<&0P<VMG2#<R,68T6FLO,6]Z=E0S
M1E(W-$5S6C@S+VMV-6$Q=FYC-F5"<%=O35-X94IA=W5F.$%+:7%!2RM+,"MN
M1&$F(WA!.W9%+TY0:U!Z3C5::W!Q9'%F<7A.23=Y3#0T1R\R42MY9EIG1&EH
M:BM+=7A6:UAL6'E"-6XX>E-R*VIR57)A,6\Y.4Y6248X9FEO95(F(WA!.SEL
M0D]+=F)02T@U32M7=$4Y3S5V=TY6,4)D*V-Y:C!58B]):3-"<#1T6#9-8E-Y
M3'I0-3,X=&5724$R<#-14U5R5TMZ:6\X>FIT>%$F(WA!.V1"-VUG.3A#=D5V
M3T@U,"M9.6$U,C)M,3!N5#(R26EA<S=J+T%#<%)4:CAL<#AZ:%$X.$I*2DI.
M4V1Y5&ER<U9D:7)S5F1I<G-69&DF(WA!.W)S5F1I<G-69&ER<U9D:7)S5F1I
M<G-69&ER<U9D:7)S5F1I<G-69&EQ<&$S5GIA5'!C5W-Z=U1X;7-C<V)&2%4K
M25E527A6-G(U4"\F(WA!.T%$-#%#,#E/,#AY4D<Y9T=W=F]10D]O+WDP,E8O
M;G-F;FER,E!3=&$P2'I&<#=45T9X1&8R8V<T4W)S,U5F6FM2:%5B9&U'0DQ!
M9DXF(WA!.R]W0U)E:39J>G5T0FM';5A:,RMR=%9R6FHX:%9O+SA!63%(*U1H
M=%8S;$0X:F1$,'HP-W)82$=Q6'$W*VA3;'%P+S%4.%5N*WDR.7,F(WA!.V)6
M;E=R-C<U9CAU865*=%%U27)',&I(1TM0;U-"*WI(1V]Q,WE5649E3V5C4'HS
M,4\Y-3)V;'E),D9S9&IE4V=.8TU0.&QD,50X5#@F(WA!.W-+2&QL>&-81GI/
M.#EX2S P.&@U4U-Y35=::64U2C-/2W%E2W5X5C)+=7A6,DMU>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DLF(WA!.W5X5C)+=7A6,DMU>%8R2W5X5C)+
M=7A61V%4<D]Q-E)E3&5A6F135VQY=7=K:6%L4C1-3VI$,D\R2W999DHO-3E1
M4SA,5'I00TE8-D0F(WA!.U591DI1*SAK67%6*V$Q*U%X<$MZ>F@K9E5A.#=4
M>79$>F)O9%)U1F]0*V5C4C-0>F8O9V-A5C5"<6UR86YQ=#0Q-7%6>DID,TPY
M6EHF(WA!.U=,1VYG4$%$<T)T:6A#67$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$F(WA!.S=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3<F(WA!.T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T8F(WA!.UA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1E8X.$UK
M13!K36\T>5)-560F(WA!.U0R6E11:D96;4MU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W4F(WA!.WA6,DMU>%9F0D1*4$Y(1$5/56MR0D559#)9,$%X5C9B*V,O-68S
M5VYA<DXU:7-):DIP;#8S<5A9444K:$]X*TET5#EM43<Q+VTR.$TF(WA!.U9E
M6#1Q-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3<F(WA!.T98<4@U369L+V1A
M:G%S4&U++VE-96U75&5P84)W4C8X-FXT4W1F,EEZ=E@K8F)X>%8W,6,O5B]Q
M.&XQ;F@Y6#1N,795<'<T52M,;'DF(WA!.S)P5')806PX,R]M2B]W07%W*W1Y
M+W=#1W9R2#%U<#4K:%0V:EAV>#4O2"]W4'<K1T9$0F-69&ER<U9D:7)S5F1I
M<G-69&ER<U9D:7(F(WA!.W-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I
M<G-69&ER<U9D:7)S5F1I<D\O>3<O-59F.6)I+W=!4V974')D4G@Y96XQ3&PR
M-6,F(WA!.U!J-B]Z9D0T-'$K:C=B-G8Y6&HK<F-0<2]%96HV9$](0VYW.&5/
M,4MD2UE%=B\O6CPO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z
M5&AU;6)N86EL<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @
M(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<W1%
M=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C
M945V96YT(R(^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z
M.3%",T8S.38U,C)#13@Q,3DY0T%#-S,W,S U.#0V034\+WAM<$U-.DEN<W1A
M;F-E240^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z.3%"
M,T8S.38U,C)#13@Q,3DY0T%#-S,W,S U.#0V034\+WAM<$U-.D1O8W5M96YT
M240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#HU
M1#(P.#DR-#DS0D9$0C$Q.3$T03@U.3!$,S$U,#A#.#PO>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ4F5N9&ET:6]N0VQA<W,^
M9&5F875L=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#QX;7!-
M33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(#QS=%)E9CII;G-T86YC94E$/G5U:60Z,#%E,60W-3$M93)D,"TT
M,38X+6(Q-#4M8S(U,3,R,34S-C8P/"]S=%)E9CII;G-T86YC94E$/@H@(" @
M(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.C)%13-%,D4Q1C8Q
M-T4X,3$Y.#)$.#,X138T140V,$4R/"]S=%)E9CID;V-U;65N=$E$/@H@(" @
M(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z-40R,#@Y
M,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+W-T4F5F.F]R:6=I;F%L1&]C
M=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L87-S/F1E
M9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \+WAM<$U-
M.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.4$W13 U-$-%1C$P13@Q,3DW
M,34X145%.4%!,C0Q-30\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IW:&5N/C(P,3@M,#(M,3-4,30Z-3(Z-#(M,#4Z,# \
M+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R
M94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T179T
M.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N
M9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N
M8V5)1#YX;7 N:6ED.C4U1#DX.4(S,#4Q,44X,3$Y-S$U.$5%13E!03(T,34T
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#$X+3 R+3$S5#$V.C0W.C U+3 U.C P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!)
M;&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I
M;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@
M87!P;&EC871I;VXO<&]S='-C<FEP="!T;R!A<'!L:6-A=&EO;B]V;F0N861O
M8F4N:6QL=7-T<F%T;W(\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C)%13-%,D4Q1C8Q-T4X,3$Y.#)$
M.#,X138T140V,$4R/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#$X+3 R+3(R5#$T.C$U.C(R+3 U.C P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS
M;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E
M9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E
M240^>&UP+FEI9#HY,4(S1C,Y-C4R,D-%.#$Q.3E#04,W,S<S,#4X-#9!-3PO
M<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H
M96X^,C Q."TP,RTR,%0Q,3HR,SHP-BTP-#HP,#PO<W1%=G0Z=VAE;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL
M=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T<F%T;W(](FAT=' Z+R]N
M<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(^"B @(" @(" @(#QI;&QU
M<W1R871O<CI3=&%R='5P4')O9FEL93Y0<FEN=#PO:6QL=7-T<F%T;W(Z4W1A
M<G1U<%!R;V9I;&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN
M<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*
M(" @(" @(" @(" @>&UL;G,Z<W1$:6T](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*(" @(" @(" @(" @>&UL;G,Z
M>&UP1STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @
M(" @/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/D9A;'-E/"]X;7!44&<Z
M2&%S5FES:6)L94]V97)P<FEN=#X*(" @(" @(" @/'AM<%109SI(87-6:7-I
M8FQE5')A;G-P87)E;F-Y/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS
M<&%R96YC>3X*(" @(" @(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY0
M86=E<SX*(" @(" @(" @/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=$1I;3IW/C8S,"XP,# P
M,# \+W-T1&EM.G<^"B @(" @(" @(" @(#QS=$1I;3IH/C@Q,"XP,# P,# \
M+W-T1&EM.F@^"B @(" @(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$
M:6TZ=6YI=#X*(" @(" @(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @
M(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @(" @/')D9CI397$^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<%109SI0;&%T94YA;65S
M/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA
M;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM<$<Z9W)O=7!.86UE/@H@(" @
M(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y
M<&4^"B @(" @(" @(" @(" @(" @(#QX;7!'.D-O;&]R86YT<SX*(" @(" @
M(" @(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/E=H:71E/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0FQA8VL\+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z
M;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L
M;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8FQA8VL^,3 P+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D--64L@4F5D/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D--64L@665L;&]W
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO
M>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE
M;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^
M,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+($=R965N/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D--64L@0WEA;CPO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0TU92R!";'5E/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ
M,# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D--64L@36%G96YT
M83PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STQ-2!-/3$P,"!9/3DP($L],3 \
M+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C$T+CDY.3DY.#PO
M>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDP+C P,# P-#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C$P+C P,# P,CPO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3DP(%D].#4@2STP/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/CDP+C P,# P-#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^.#0N.3DY.3DV/"]X;7!'.GEE;&QO
M=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP
M,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TX,"!9/3DU($L],#PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XX
M,"XP,# P,#$\+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/CDT+CDY.3DY.3PO>&UP1SIY96QL;W<^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STP($T]-3 @63TQ,# @2STP/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C4P+C P
M,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STP($T],S4@63TX-2!+/3 \+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,S4N,# P,# R
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXX-"XY.3DY.38\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB
M;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T
M8VA.86UE/D,]-2!-/3 @63TY,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C4N,# P,# Q/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z
M;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L
M;&]W/CDP+C P,# P-#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STR,"!-/3 @63TQ,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXQ.2XY.3DY.3D\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E
M;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^
M,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STU
M,"!-/3 @63TQ,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXU,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STW-2!-
M/3 @63TQ,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXW-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STX-2!-/3$P
M(%D],3 P($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP
M1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N
M/C@T+CDY.3DY-CPO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C$P+C P,# P,CPO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C$P+C P,# P,CPO>&UP1SIB;&%C:SX*(" @(" @(" @
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,].3 @33TS
M,"!9/3DU($L],S \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP
M1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N
M/CDP+C P,# P-#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C,P+C P,# P,3PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.30N.3DY
M.3DY/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,S N,# P,# Q/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STW-2!-/3 @
M63TW-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT
M>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C<U
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXW-2XP,# P,# \
M+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,].# @33TQ,"!9/30U
M($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^.# N,# P
M,# Q/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^,3 N,# P,# R/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXT-"XY.3DY.3D\+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-S @33TQ-2!9/3 @2STP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXV.2XY.3DY.3D\
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XQ-"XY.3DY.3@\+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE
M;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^
M,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@U($T]-3 @63TP($L],#PO>&UP
M1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^.#0N.3DY.3DV/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^-3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STQ,# @33TY-2!9/34@2STP/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M.30N.3DY.3DY/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXU+C P,# P,3PO>&UP1SIY96QL;W<^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STQ,# @33TQ,# @63TR-2!+/3(U/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIY96QL;W<^,C4N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,C4N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STW-2!-/3$P,"!9/3 @2STP/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXW-2XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ
M,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STU,"!-/3$P,"!9/3 @2STP/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXU,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N
M,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STS-2!-/3$P,"!9/3,U($L],3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C,U+C P,# P,CPO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C,U+C P,# P,CPO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C$P+C P,# P,CPO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,],3 @33TQ,# @63TU,"!+/3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C$P+C P,# P,CPO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C4P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STP($T].34@63TR,"!+/3 \+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^.30N.3DY.3DY
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXQ.2XY.3DY.3D\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB
M;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T
M8VA.86UE/D,],C4@33TR-2!9/30P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,C4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,C4N,# P,# P/"]X
M;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.GEE;&QO=SXS.2XY.3DY.3@\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C
M:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.
M86UE/D,]-# @33TT-2!9/34P($L]-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,SDN.3DY.3DX/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-#0N.3DY.3DY/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXU,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXU+C P,# P,3PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,]-3 @33TU,"!9/38P($L],C4\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO
M9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/
M0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIC>6%N/C4P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C4P+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^-C N,# P,# R/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8FQA8VL^,C4N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STU-2!-/38P(%D]-C4@2STT,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^-34N,# P,# Q/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-C N,# P,# R/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXV-"XY.3DY.3@\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXS.2XY.3DY.3@\+WAM<$<Z8FQA8VL^"B @
M(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#
M/3(U($T]-# @63TV-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T53
M4SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIC>6%N/C(U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM86=E;G1A/C,Y+CDY.3DY.#PO>&UP1SIM86=E
M;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^
M-C0N.3DY.3DX/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3,P
M($T]-3 @63TW-2!+/3$P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXS,"XP,# P,#$\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XU,"XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C<U
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C$P+C P,# P,CPO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],S4@
M33TV,"!9/3@P($L],C4\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C,U+C P,# P,CPO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C8P+C P,# P,CPO>&UP1SIM86=E;G1A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.# N
M,# P,# Q/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^,C4N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STT,"!-
M/38U(%D].3 @2STS-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^,SDN.3DY.3DX/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^-C0N.3DY.3DX/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXY,"XP
M,# P,#0\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXS-2XP,# P,#(\+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/30P($T]
M-S @63TQ,# @2STU,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^,SDN.3DY.3DX/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^-CDN.3DY.3DY/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^-3 N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STU,"!-
M/3<P(%D].# @2STW,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^-3 N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^-CDN.3DY.3DY/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXX,"XP
M,# P,#$\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXV.2XY.3DY.3D\+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y004Y43TY%
M(#,R,2!#/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4U!/5#PO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT:6YT/C$P,"XP,# P,# \+WAM<$<Z
M=&EN=#X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y,
M04(\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z3#XT."XR,S4R.3@\+WAM<$<Z3#X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z03XM-38\+WAM<$<Z03X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z0CXM,C(\+WAM<$<Z0CX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(#PO<F1F
M.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'.D-O;&]R86YT<SX*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M>&UP1SIG<F]U<$YA;64^1W)A>7,\+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @
M(" @(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,3PO>&UP1SIG<F]U<%1Y<&4^
M"B @(" @(" @(" @(" @(" @(#QX;7!'.D-O;&]R86YT<SX*(" @(" @(" @
M(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP
M($L],3 P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C$P,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/3DP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO
M>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C@Y
M+CDY.30P,CPO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L].# \+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-SDN.3DX-SDW
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STW,#PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXV.2XY.3DW,#$\+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3 @33TP(%D],"!+/38P/"]X;7!'.G-W871C:$YA;64^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP
M1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E
M/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C4Y+CDY.3$P,CPO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,],"!-/3 @63TP($L]-3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T53
M4SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^-3 N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T]
M,"!9/3 @2STT,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \
M+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIB;&%C:SXS.2XY.3DT,#(\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+
M/3,P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P
M,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C(Y+CDY.#@P,SPO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L],C \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3DN.3DY
M-S Q/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STQ,#PO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P
M,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXY+CDY.3$P,CPO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D,],"!-/3 @63TP($L]-3PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXT+CDY.#@P,SPO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'
M.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^0G)I9VAT<SPO>&UP1SIG
M<F]U<$YA;64^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P5'EP93XQ
M/"]X;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z0V]L
M;W)A;G1S/@H@(" @(" @(" @(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @
M(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C
M:$YA;64^0STP($T],3 P(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X
M;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3 @33TW-2!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-S4N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/3 @33TQ,"!9/3DU($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,"XP,# P,#(\+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/CDT+CDY.3DY.3PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STX
M-2!-/3$P(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^.#0N.3DY.3DV/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 N,# P,# R/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ
M,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3$P
M,"!-/3DP(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XY,"XP,# P,#0\+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/38P($T]
M.3 @63TP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M-C N,# P,# R/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUA9V5N=&$^.3 N,# P,# T/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,S Y
M.3PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C N,# S,#DY/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" \+WAM<$<Z0V]L;W)A;G1S/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q
M/@H@(" @(" @(" \+WAM<%109SI3=V%T8VA'<F]U<',^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC
M;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E(%!$
M1B!L:6)R87)Y(#$P+C Q/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  :
M #@# 1$  A$! Q$!_\0 &@   @,! 0                D#!0@$!__$ "D0
M  (" P$  0,$ 04       ,$ @4!!@<(  D1%!(6%R,8(3-6F-3_Q  7 0$!
M 0$                  @$#_\0 *A$  @$# 08%!0            $1 B$Q
M83)!<9/!\")1@9'A0E*AL='_V@ , P$  A$#$0 _ +SE/NVW7J]<YUZIYSKW
MKGCFOE"*HINC.V"G2](1C*/ZU^?=<KBCW"IK\0B*)-9M';776%U@HKJ5<,_D
MC[.GR;3>8WG%51E)^4Q;U@:ESSD'D'U6V-OQ=P7R'M <5F;"\YAW?IOI3FO:
MM0,$8Y- -0ZYMFY5&ZU0_ODF=GU)N=8&11(L!&UC.23C:=7%.WY*5\*C@U?.
MDGG=ER[SU36#M3<<Z^DO56M:T=*QK++V)Z51L$'5B2$PHZDT43*K2Y8R$=<X
MQE$2,H$A&6,XPY@Y9Q?L'S3_ ,*^D5_W/]&_^GXY@Y9VUO+_ #U<V"534<Z^
MDO:VMDT%*NK:WV+Z4>L'W&21$NHDFJ4K+33!91$%< R%*248#A*6<8RY@Y9Z
M!T7D?D/RHY-KV?P7R%K LUD;"EYCPGIOI7I7:]N*8<Y*KAH-BVO3*?2:LN,8
M)C:-N='6ED(J2RYVL_UL[+JG5V7L;C:5,:*XJWJONFT8KMDY_P"5^;Z[Y'X_
ML)#!N*?G3M@[TO=J^4\_H5Z!UVS*7<;2MS'),0U>I=J-; !DR;*=KC[M$I4[
MVY>O&>[D.K*224[K=>$F!_E$EI27EWK-O7;!K=Q::_?5#8GZF[I+!NJMZMY>
M7ZP.5UDB8#B309XQ(3"QA&'+'WA/&?\ 7X Y+S]]6JU@@?2?66F4_0AV2J]<
MIZ&UWG_+[KNNJX ,2Z;UNCONK7FF]) DN "LL72%?>S4PP=BWMGOQXQAT_:X
MTEQ\%*KS2>K4M?W]ZFF,[GT.,/Y5E[W\1?XKY_NCT./F7B4NQ3:_W<Z-C@7\
M7_NB/0,+?9B5=E_\&-;G%UEC(/NEC)W15/%Q[SCN=YL9<TPM%.)C&>]#,GH'
MZM5N5 &E>3]-IN=!K56*YOT)L&@<PIN[;5@XRKMOU2FA:M1:=S4+JQSJQA1(
M/WD%?QSKW-4[^1&6JE_4V])=OD.J'X86L+N-][B<+N[NMEMK&_V.WM+^]MVS
M/VUU=/MVEM9O,2S-AVPL7BG<=;//.9F89,4Q)9S*<Y9S]_ED%7\ G9682983
M; 55M0Y5FEF!R$==@!)", PIXC,11$A(9!SCB4)QE&6,9QG'P"#X ? #X ?
M#X!.LLPZRNFH K3;9Q+*K '(IV&#DB(( BAB4RE*2<1C'".93G*,8XSG.,?
M&G?62UG6]8]O;\OK6OTFO LDJBZL0T=4A4BL+FV07>M+9T:"Z\&K.R=.9RP?
M/$C3C1BL,%(4DYYBC'KT1=:2=E%NK%5?+(#X ? #X ? &J_1MUG6]G]O:"OL
MNOTFP@K4K>ZK@WE4A;"K[FI08>J[9(;Z[$%;.M= %RO?!$;2;01,+E&4<)XB
-O'KT9="3;E3;JC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g63026g93t37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g93t37.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ] $K P$1  (1 0,1 ?_$ -8  0 " @,! 0$!
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MZ6[Y0/;K5QF/  MS.T)<YWYG)\E?.9T.O0$$<<)^7R./B>?1$XO_ /M=L_\
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MG7=KI6FT.@:S5ZIK<3Z2JJF TWY$+D2GUDKDSICH"?G3)CZE..*X \CPD)2
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M/L2D>I/))]2223D.&Z[KN.^;E?O&[W69&YY-K66V.=6=V.K,3^T_0= .@
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M\3K/O7'OR,@J35B8RD>[DW'4?:@.BIW!K;"E2'O<39+U_H=!UMJM9J6N1RU
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M(Q$8B,1&(C$38%^6OUZYN/N2K=B>CJ<J^M]?N=HD.*1Y1S93(YUVFCK5\$R
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M"J^/8I5E8 JRL-&4@]"""00>A$Y\;)R,+)KS,1WJRZG5T=259'4AE96'4,I
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M>XE8"CY18#<LA#^#UDKA*1ZK0[W?7]0%8US9LA"&D(;;0EMMM*4-MH2$(0A
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MWDJ7R> ;PCIJ2*,Y2I ^@&12K!C] #CH-?5NO21KQO\ Q0<-UKPO+/';*[-
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M]S,X[L5UFI.KX&*YZ]3U:HGJ?7\9D/"\X>:MLK]K;>8<HQZM .VO=<^L:*-
M-%O Z#H/P'I.!_\ QP]O/_[#=,?_ $NT?_[#SJ_]HO%'_P L<>_^'8?_ -3.
M[_\ Z"\]_P#SOR__ .,[C_\ F9EE/U=UGKRT.4'76B4:VP@-KI]1U^L6V$-J
M:0$*A5[!2$-+*1Q\$DCX'*[M_"N&[2P?:MIVS&<>AJQ:*R-!H-"B#30$C^0Z
M2U]V\E>1M_0U[[R#>\U&UU%^=E7 ZD,=19:VNI )U]2 ?69WES2R8Q$8B,1&
M(C$3)=;U.ZVF3\BKC$LH4$R9SW+<**#Z_O7O$\KX]0A(4LCU XY.(EI=0T6I
MU)CR83]79N(\9-D\@!U0/!4U'1ZB-'Y'[()4K^L3P.$3-L1&(C$1B(Q$8B,1
M&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(F)[-I5%M3?\ M"-\N8E'BS8QO%J8T!SX
MI4OQ*7VDD_L.!0')XX/KB)779>KMBH5+>B-*NJ]/)$B"THR&TCU_B((+CR.
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91&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(G__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g63026g97h93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g97h93.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00!& P$1  (1 0,1 ?_$ )X   (" @,!
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M$J$62R)K[HHXOR^HTWB$7C!GD!(:CUKR[*JM9CO'FPE5\-N0")+)1/=,BQ2
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;>GITQG/IC#IC#IC#IC#IC#IC#IC#IC#IC/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g63026g97o48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g97o48.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 0 !% P$1  (1 0,1 ?_$ ),   (# 0 #
M      @)  4*!P,$!@$!  (" P$!              @)! <"!08* Q   00"
M 00! P$%"0       P($!08!!P@ $A,)$105%B(A)!<8&3%1(S,E-:?76!$
M @(!! $$ 00!! ,      0(#! 4 $08'$B$Q$P@402)""3)1@205X6(C_]H
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M0G"!H1UX;Z?\JSF<[JRE[-V);=_(XB9YI)&W9I$GK%&/I_%?)%4>*JK;* %
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M_7+%A)/LC"<L$-Y,+>:GY;;BSM$&*;_R_$-KV]?'R/MOK/%'Z'UE7^(<KO\
MV1=W =@WZS8JV@-=UF5ACN'J*Y,C;7NUWU@MJ]D6<,T;@,W:C21H3!LB(KR(
M<AZKSK\$XSC^HI>?\CO,.07[/P8JI"\9+"&0"U/:0JSK&H#(@!C(;P8^2R)J
MWFWVIS7+?8.#J;AN,1N)8FE^5G<A9BF54-B$M1JT7#)&\S,R22L5E4I\B+X-
M#+H^/1SK^2E-\[2V6IJ7,%3]8*JV7?:M(<6&YV.%>L!)+WI25:8BJONY':KX
M[TJSVY[>[??T>P%FUSS*<E*G\"GB_@\OT^6Q-&R#?]?_ )P2[C8[;@G;TWBE
M_9[RVE1ZKP7"PZ_]ID<Y^3X;@G\>G7F1SMMN 9;4&S;C?9@-_P!VW+N86FMT
M<R[3SWY'<%+&]XZ:$J%/L^M-]3@K=::]%<[[[ITC@NQE0E9K@3M&$37:^T=0
M(Y[L4FR'4MHK*@NI!0+.]4AZY%>^67%F<](3GB'3*HOC]R,DM6\3""U[<Z47
M7SG>%@7M;2CR:WG0;'& 3&['86I4:[G5O$N5R8A#(IPW\0LY4TT>'#;5>X>#
M'-;7,7S_ +%GD7?N1VL835'&KF ZLUFMC/7]EK$.N7L_&M;&SHP6NGM@_.[8
M3_8%S/J!VJ[BNGHFC36COIIJ=--3III37MTY-1VJ] (XZTZFM]N<D.7Y'.GM
M':G2)#LYY*7(U9R&PY(.2BRQC*"1X!TU<*4A.);#;*E# -R<'3\@P&'Y3A;/
M'L_ EG#VXC'+&VX#*?7W4AE8$!E=2&1@&4A@"/1<2Y9R'@O)*?+^*6I*7(L?
M.)8)DV)1QN/56#(ZLI*/&ZLDB,R.K(Q!$[1?H(H-.H5.B]K;_P!C6:U(C6SV
M]+K+>%;,265_A#R=:5R7L3":>?9FCTI M2N&GE*-*2K$A:E#Q&GFWU)X5SCE
MDG([=RQ1I.D2"K2AKP(B1(J *Q1QY$+N69#[@ !5"B:G6?\ 8!V5UAP&+AM#
M'5,IDHY9Y6O9*S<M2R23RO*Q91+$0@+;*BR+Z DDNS,75Z$X]:IXTT0&O-1U
MM,!!X=+DI)RX<FD9JP3!A""XF9Z5<J4X?OS" A&,?H"$:4C",8DI1C?/ NO>
M*=:X)>/<1K?CT?,NY)+R2R$ &261O5F( 'Z*H 5%50 (J=K=N\\[IY2W+^P+
MAMY3XQ'&JJ(X8(025A@B7]J("Q)]W=B7D=W)8AC-^GCU^6:SSMCL6FIR98V&
MRRER?4-WM_<8]8"M<V^5)RTXSUXSOC6KMSO9 QC*#]/EHA9U]@4XP/"/:ZUI
MI5-7X\[HV]5>+GJCV[QVOLE5.*/)Z4M6U.0=MI:4:BO'$?7,K.V/6D?3]@JP
MT"\GMPL+#'U]Q'Q>4R#0<6?+E \(<>!IIO6K_5-P?T[L>G;-HFKK$SEM<S*[
M)KNNS6V]MVR@T2RJ;&:HL%9HMJNTS6V4FT0Z.ILI0"#9D-E;= E(#D333%>F
MFA&YR;YVGQCXVWG>NI=3!W3,ZX7$V&STA4HZBG2]=M) *KW/1QF;5X8SRMU_
MRO<I\:TH $A5)7@>4*::]/\ GMXY_P G'\\_YBC^!/X#^<?7_#?[W]3W_;OP
M3[;]5XOSW\J_T3Z#R_[K_A=_;^OIII9_KWKD'R ]D_L8Y)[IG,6;>_'W==EX
MV:6I4LM"$ZGT1!R$O&0-LK<&;/[JJ_,&JD8?"&CY620)WJ5)&RIII^O334Z:
M:$+EOS2U%P_J8):\NBS=PFP.%T[7,*8.+#8R!SD>79R$P0,%7@'_ $G?G3E.
M/A20H.;&!9U%VWW1Q'J#$K;SC&?,3J?QZ<9'RS$>GD2=Q%$#Z-*PV]PBNX\#
M(/Z__6WL#[#9]L?Q=%K<=K.HN9"8'\>N#Z^"@;&>PR^J0(03Z-(T49^09I=Y
M^SWEWOV;7'5VX2FJ:X_>#:0M*U&9_#2A5'-X6C=U:V6<7*;DG>%H&1 W &IE
M_P"6U'W=O5:O.?L[V[SZZ:V.N2XK'2.%CK4"T;G<[*&G7_D2.VX! =48_P",
M2[[:NEZO^D7U\ZHQHN9C'09[,11EYKF5"31#Q&[LM5_^'#&NQ92T;RHO^4[[
M>6J[0G.OE1Q3V1!36P[-M&QT5X^;KM] VE)6)Z":@5$$WDG5>5<#*)"S[=NK
M"FSINL:%'0)#C!0]P\\.O.[>VNL^45ILS/E[N)ED'ST[;3R&6+V<PB<EHY57
MU1T('D%$@9-U/Z=O_67H#NO@UROQRMQ_&\@@A/XV1QZUHA7G]3$MDU0%EKL_
M[9(Y0Q",YA*2[.-;U9W)JJWUV"M=>V'3I""LD1'3L.]18HD>'4;*M!/61\C*
M[042B-S)SE"\86C/SA6,9QG'5OF,R-/+XZ#*X]Q)1LPI+&WMY(ZAE.Q]1N"/
M0^H]CZZ^>;-8?(\>S%K Y>,Q92E8D@F0D'QDB<HXW&X(# [$$@CU!(.K5Q?=
M=&;G$[NE**U*$HW(W%C@EMR-UH4DR#H(\R-85CSG"L*QVY3\_/[.L[76:QTU
M^N\7C\L-M<=CW.(-ZNHKV=<>;#&/'%D6C5$=MN?XM<G[!.:YB)K(OLCG7\SM
MVM1\'(JPZ^F!%L&*LE\9<.NFFM$O)[U3\3^4^T$[MLK38^L-PGC0P\[LG1M\
M>:WLULC&P -6C>TK;,Y&.EC-6C80$N5-TO%MQ""LJQ!"@;37S6B/4KHGC]MF
MF[AJ^ZN7=GGZ0]=OXR#O^_).PU!\=W&/HI:)R#;0D7F5:I _6KPK-@2UXQY$
MK1\IRTTTOIIK@.[N+>@^1;88MPZTK]O>MHXD5'3YD.(ZSQ+(AEN< BK)%'93
M+((W1%%P-)O%E:E94G.%*QGP/-NKN ]BQA.88RO<F6,HDI!2:-22VR31E9%
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4)>6V)O[C]UPTSD'U'ASV=--?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g63026g99m98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63026g99m98.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1@>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    & *^848X0DE-! 0       \< 5H  QLE1QP"   "/(T .$))300E
M   0S*#UTR5DX-L8&F1^OS>H9SA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$"2P
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#O_XU
M  (  CA"24T$)@      #@             _@   .$))300-       $
M>#A"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          CA"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@             "?@
M!$0          0                         !              1$   "
M?@                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "
M?@    !29VAT;&]N9P  !$0    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   GX     4F=H=&QO;F<
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M# P,# P,# P,# P,# P,_\  $0@ 70"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MDDDE*22224__T?55F=8ZY5TY
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M%*26F\DE2=GMMOM!%1V]:/>S[J)-GT+0;*ZTR_8KA9):$.SYRF8T*%#8'@
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-YQ#3#2&T<XE/.??_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
